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ABSTRACT 
 
Type 1 NKT cells are an innate-like population of T cells that rapidly respond to both 
cytokine and TCR stimulation by the production of pro-inflammatory and immunoregulatory 
cytokines. Different from conventional T cells, which express a diverse repertoire of TCR 
sequences that are generated by random rearrangement and are positively selected by thymic 
epithelium expressing MHC Class I and Class II products, type 1 NKT cells express a highly 
restricted TCR (V14-J18 in mice, and the homologous V24-J18 chain in humans, paired 
with a restricted range of  chains) and are positively selected by ligating 2 Microglobulin 
(2M)/CD1d and SLAM family members expressed on CD4+CD8+ (double positive – DP) 
cortical thymocytes. In the periphery of mice, type 1 NKT cells express a ‘memory’ or ‘activated’ 
like surface phenotype (CD62L-CD69+CD44hi) and the great majority is either CD4+CD8- (single 
positive; SP) or CD4-CD8- (double negative; DN).  
Studies on NKT cell development indicated that they are originated from the same 
progenitor as conventional T cells, and branched off from the mainstream lineage at DP stage. 
NKT cells’ development is thymus dependent, they develop in fetal thymic organ culture; 
neonatal thymectomy on the third day of life selectively depletes them. NKT cells are not found 
in the peripheral tissues of mice until 1-2 weeks after birth. Many efforts have been made to 
understand the molecular mechanisms that govern their commitment and homeostasis. However, 
the very low numbers of developing NKT cells, especially DP NKT cells at Stage 0, makes it 
difficult to analyse transcriptional programs controlling NKT cell development.  
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To further dissect the events surrounding NKT cell lineage commitment and to examine 
transcriptional factors controlling early NKT cell ontogeny, a mouse model with increased numbers 
of immature type 1 NKT cells was generated on the SLAM-deficient, NOD background. These 
mice were found to have greatly increased numbers of CD24+NK1.1- DP NKT cells with the 
characteristics of pre-selection and Stage 0 NKT cells. This provides an opportunity to compare the 
transcriptional profiles of these very immature CD24+NK1.1- DP NKT cells with those of 
conventional T cells (CD24+NK1.1- DP T cells), and those of more mature NKT cell subsets, 
including CD24+NK1.1- CD4+ NKT cells and CD24+NK1.1- DN NKT cells.  
Expression levels of a total of 35,556 transcripts of each biological samples of above 
four different cell populations were obtained by microarray analysis. Principal component 
analysis indicated that the four populations clearly separated, in order, across principal 
component 1 from CD24+NK1.1- DP T cells, to CD24+NK1.1- DP NKT cells, to CD24+NK1.1- 
CD4+ NKT cells, and finally to CD24+NK1.1- DN NKT cells.  
Comparison of gene expression between these populations has provided an overall 
transcriptional profile during TCR validation, positive selection and lineage commitment of NKT 
cells. These findings have further confirmed phenotypic changes during NKT cell development 
observed by previous studies and suggest that immature DP NKT cells are pre-selection 
progenitors of NKT cells. Our transcriptional regulatory network approach mapped TCR 
validation to the transition from DP T to DP NKT cells, while positive selection and lineage 
commitment were associated with the transition from DP NKT to CD4 NKT cells. This is the 
first time that the effects of positive and negative selection have been examined on their actual 
population – the immature DP NKT cells. We confirm by in vivo experimentation that both 
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positive and negative selection occur at the latter transition, separating for the first time in any T 
cell population the events associated with TCR validation from those associated with positive 
selection. NOD.V14Tg mice provide a model to study the earliest identifiable stages of NKT 
cell commitment and differentiation, and to help dissect factors controlling the numbers and 
function of this important immunoregulatory population. 
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1.1. NATURAL KILLER T CELLS 
1.1.1. Definition of NKT cells 
Natural killer T (NKT) cells are a newly recognised member of the immune system. 
Research into NKT cells originated when several groups independently reported the existence 
of a population of T cells in mice with lower levels of  T cell receptor (TCR) expression, but 
a higher frequency of V8 expression, compared to conventional T cells. These cells also 
exhibited a CD4-CD8- (double negative – DN) phenotype, that is, they do not express CD4 or 
CD8 markers (Fowlkes et al., 1987; Budd et al., 1987a). Around that time, other groups 
discovered a subset of -TCR+ T cells that expressed  NK1.1, the typical marker of the natural 
killer (NK) cell lineage, and were either CD4+CD8- or DN (Syles et al., 1990). They were also 
described as a source of immunoregulatory cytokines such as interleukin 4 (IL-4), interferon  
(IFN-), and tumour necrosis factor (TNF) (Bendelac and Schwartz, 1991; Bendelac et al., 
1992; Hayakawa et al., 1992; Arase et al., 1993). Initially, this new subset was referred to as 
NK1.1+ T cells (reviewed in Bendelac et al., 2007).  
Recently, NKT cell studies have been facilitated by the discovery of -
galactosylceramide (-GalCer, which was originally isolated from the sea sponge Agelas 
mauritianus), and the generation of -GalCer loaded CD1d-tetramer (also called CD1d-tet) 
(Kawano et al., 1997). The use of CD1d-tet in NKT cell identification has indicated that the 
name “NK1.1+ T cells” was not broad enough, because in most commonly used mouse strains 
(except C57BL/6) and many NKT cells do not express the NK1.1 marker. Therefore, the term 
“NKT cells” is now widely accepted and applied to mice, humans, and other species, as a minor 
subset of T cells that shares some markers typical of natural killer cells, such as NK1.1 in mice, 
and CD161 in humans (Bendelac et al., 2007; Godfrey et al., 2010).  
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Over a decade of work has revealed that NKT cells are a distinct T cell subset: they 
originate from the same progenitors as conventional T cells but differ in terms of structure and 
function. Firstly, NKT cells express TCRs on their cell surface, but exhibit some markers 
commonly associated with natural killer cells (i.e. NK1.1 in mice or CD16, CD57, CD161 in 
humans). Secondly, while TCRs of conventional T cells are diverse due to the random 
combination of variable, joining, and diverse gene segments, TCRs of NKT cells are 
relatively limited. The most frequent NKT cells (called invariant (i) NKT cells or type I NKT 
cells) express an invariant TCR -chain (V14-J18 in mice or V24-J18 in humans), in 
combination with a restricted -chain (such as V8, V7, V2 in mice and V11 in humans). 
Perhaps the most striking difference is that NKT cells were shown to be reactive to both 
exogenous and endogenous lipid antigens presented by the non-polymorphic MHC-like 
molecule CD1d on cortical CD4+CD8+ (double positive - DP) thymocytes. Conversely, the 
bulk of mainstream T cells respond to short peptides in the context of highly allelic major 
histocompatibility complex (MHC) class I or MHC class II on antigen presenting cells 
(APCs), such as macrophages, B cells, and dendritic cells (Bendelac, 1995; Exley et al., 
1997). It was noted that unlike mainstream T cells, NKT cells also differ in terms of 
immune function. While T cells have a central role in cell-mediated immunity, NKT cells 
play a critical role in immune regulation. They are able to rapidly release large amounts of 
cytokines, such as IL-4 and IFN- upon stimulation. These cytokines modulate the behaviour 
of other cells in the immune system, such as macrophages, B cells, and T cells. Moreover, like 
NK cells, type I NKT cells express cytotoxic granules such as perforin and granzyme that 
polarise upon activation of the TCR and are able to kill target cells such as APCs and T 
regulatory cells (Treg) (McCarthy et al., 2007; Nguyen et al., 2008).  
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Taken together, the body of work on type I NKT cells indicates that they are a very 
interesting subset of T cells that may bridge the innate and adaptive immune systems. 
Their TCR has evolved to recognise different glycolipid antigens in a conserved manner 
and to perform innate-like rather than adaptive functions. They can also mount specific 
responses to antigen with cytokine production and cytotoxic activity (Taniguchi et al., 
2003; Bendelac et al., 2007).  
1.1.2. CD1d – antigen presenting molecule of NKT cells 
CD1d  is a  member of the MHC class I–like glycoprotein family of molecules, which 
plays an important role in presenting foreign and self-lipids as cognate antigens to NKT cells. 
CD1 molecules are encoded by the Cd1 locus, located on chromosome 1 in humans and 
chromosome 3 in mice. CD1 is similar to MHC class I at both the nucleotide and amino acid 
level, as they have a similar intron/exon gene structure. In addition, CD1 proteins share  
sequence homology and overall domain structure with MHC class I molecules. They are type 
I integral membrane proteins comprised of a heavy chain with two extracellular domains (1, 
2) that form the antigen–binding region, and another domain (3) that non-covalently 
associates with 2-microglobulin. Due to these features, CD1 molecules are also called non-
classical MHC I or class I–like molecules. 
There are five human Cd1 genes that encode for the five corresponding CD1 proteins: 
CD1a, b, c, e and CD1d. These proteins are divided into two groups based on sequence 
homology in the 1 and 2 domains: group 1 (consisting of CD1a, b, c and e) and group 2 
(CD1d). However, the number of CD1 isoforms expressed in any given mammal varies 
considerably. For example, humans express all five CD1 isoforms, rabbits lack CD1c, while 
mice express only the CD1d protein. The basis for such varied usage of genes within the CD1 
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locus across mammals is largely unknown, but presumably reflects important functional 
differences related to pathogen-driven evolutionary pressures.  
The TCR of NKT cells engages its ligand, CD1d-lipid co-complex, with conserved 
germline-encoded residues in four-to-five of the six complementarity-determining regions of 
the combined TCR α- and β-chains (Rossjohn et al., 2015). Hence, phylogenetic studies of 
genes encoding CD1 molecules and the invariant NKTCR α-chain can reveal the origin and 
evolution of NKT cells (Kumar et al., 2017). A recent phylogenomic analysis revealed that 
the Cd1 gene is an amniote innovation that evolved in the Mesozoic reptiles and was retained 
in the extant anapsid (green anole lizard Anolis carolinensis) and synapsid (Siamese crocodile 
Crocodylus siamensis and Chinese alligator Alligator sinensis) reptilians (Yang et al., 2015). 
Cd1 genes diversified in mammals, wherein evolved the Cd1d gene that encodes the lipid 
agonist presenting molecule that controls the functions of NKT cells in eutherians (of 
placental mammals) (Boudinot et al., 2016, Kumar et al., 2017). Curiously however, the 
reptilian Cd1 gene has no orthology with avian or mammalian Cd1 genes (Yang et al., 2015), 
suggesting that Cd1 genes may have emerged multiple times during amniote evolution. Or 
alternatively, Cd1 genes may have evolved rapidly and diverged substantially from the 
reptilian form within extinct synapsid and mammal-like reptiles prior to stabilization within 
eutherian species. The latter view is supported by the finding that egg-laying monotremes 
such as platypuses and echidnas do not have Cd1 genes while a CD1d-like gene exists in a 
few metatherian (of marsupial mammals) species such as the opossum (Kumar et al., 2017). 
However, CD1 molecules seem to be conserved between species. Therefore, human NKT 
cells can recognise mouse CD1d and vice versa (Burdin and Kronenberg, 1999). 
There are two Cd1d genes mice, designated Cd1d1 and Cd1d2 (Brigl and Brenner, 
2004). These two genes are located on chromosome 3, arranged in opposite transcriptional 
orientation and are approximately 9 kb apart (Bradbury et al., 1988). The two genes are likely 
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the product of gene duplication, they share 95% sequence homology with each other (Zajonc, 
2016; Dascher and Brenner, 2003). Mouse CD1d molecules are primarily expressed by cells 
of the hematopoietic lineage, including B and T cells, macrophages, and dendritic cells 
(Brossay et al., 1997; Park et al., 1998). At the transcriptional level, Cd1d1 is expressed at 
higher levels than Cd1d2 in all tissues tested except the thymus, where the mRNA levels 
appear to be equal for both genes (Bradbury et al., 1988). There are the 17 amino acid 
differences between CD1d1 and CD1d2 proteins, in which 9 occur within the antigen-binding 
cleft, which includes a Cys168→Trp168 mutation. The cysteine 168 residue participates in an 
intradomain disulfide bond that is highly conserved in classical and nonclassical MHC I 
molecules (Adams and Luoma, 2013; Bradbury et al., 1988; Porcelli, 1995), and is thought to 
be critical for the folding of MHC-I (Bjorkman et al., 1987; Warburton et al., 1994). The 
impact of this mutation on CD1d2 structure and function is unknown. Interestingly, the 
bovine Cd1d gene (Wang et al., 2012) and the primordial CD1-encoding gene found in 
chickens (Zajonc et al., 2008) also contain an amino acid change at position 168. This change 
was previously revealed to affect the nature of the antigens presented by these molecules 
(Zajonc, 2016). Intriguingly, rats possess only one Cd1d gene, which, based on sequence 
homology, more resemble mouse CD1d1 than CD1d2, with a cysteine at position 168 
(Ichimiya et al., 1994).  
Whereas CD1d1 has been found to play the major role in NKT cell development and 
function, that of CD1d2 is unclear. Chen et al. (1999) reported that CD1d2 is expressed on the 
cell surface of thymocytes in some mouse strains including CD1d1-deficient mice derived 
from 129 embryonic stem (ES) cells used in most gene targeting (Chen et al., 1999). Studies 
by Sundararaj et al. (2018) showed that CD1d2 molecules are expressed in the thymus of 
some mouse strains, where they select functional type I NKT cells. However, the T cell 
antigen receptor repertoire and phenotype of CD1d2-selected type I NKT cells in CD1d1−/− 
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mice differed from CD1d1-selected type I NKT cells. High-throughput sequencing of CD1d 
gene transcripts from the thymus of BALB/c mice showed that the transcript ratio of 
CD1d1:CD1d2 was close to 1:1, which supports the possibility for a role of CD1d2 in shaping 
the development of iNKT cells. The crystal structure analysis of CD1d2 indicated that CD1d2 
adopts an overall architecture similar to CD1d1. The Cys168Trp mutation does not collapse the 
antigen-binding groove, however, the CD1d2 A′-pocket was markedly restricted in size, thereby 
favoring the loading of lipid antigens with shorter acylchain length. (Sundararaj et al., 2018). 
Collectively, their results indicated that the two CD1d molecules present different sets of self-
antigen(s) in the mouse thymus, thereby impacting the development of invariant NKT cells. 
Regarding to function, CD1a, CD1b and CD1c molecules generally present self and 
foreign lipid antigens to polyclonal T cells expressing  TCRs, or sometimes to several  T 
cells. In contrast, the CD1d molecule uniquely presents self and foreign lipid antigens to 
CD1-dependent NKT cells (De Libero and Mori, 2005; Borg et al., 2007). Among microbial 
lipid antigens, lipids derived from Mycobacterium tuberculosis are restricted to presentation 
by CD1a, CD1b and CD1c, while CD1d tends to present those derived from other sources 
such as -glucuronosyl-ceramide (from Sphingomonas spp.), -galactosyldiacylglycerol 
(from Borrelia burgdorferi), and Lipophosphoglycan (from Leishmania donovani).  
1.1.3. Lipid antigens of type I NKT cells  
It has been more than two decades since type I NKT cells were identified and 
distinguished from conventional T cell populations based on the invariant V14-J18 
rearrangement in their T cell antigen receptor. NKT cells are now known to recognise lipid 
antigens presented by CD1d, a member of a third family of antigen-presenting molecules. 
However, the knowledge surrounding these NKT cell antigens is still limited. The first and 
most well-known lipid antigen that can be recognised by the TCR of type I NKT cells is -
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GalCer. -GalCer is a glycosphingolipid, a derivative of natural agelasphins and a group of 
closely-related glycolipids, which only differ in the lipid portion. These compounds were 
originally extracted from the marine sponge Agelas mauritanius and their activities were first 
discovered in a screen of natural substances for anti-tumour activity carried out by the Kirin 
Pharmaceutical Company (Natori et al., 1994).  
The most striking characteristic of -GalCer is the -linkage between the ceramide 
moiety and carbohydrate head group in its hexose sugar. Conversely, glycospingolipids from 
mammalian cells have -linked glycolipids. The -linkage is critical for its antigen activity, 
as challenge by the -anomeric conformation completely abrogated or was a much less potent 
stimulator of type I NKT cells. Significant variations to the basic GalCer structure, via changes 
to the sugar and/or the stereochemistry of its linkage to either the ceramide (the sphingosine 
base) or the fatty acid, can still be recognised by type I NKT cells. In some cases these variants 
provide equal or even greater antigen potency than GalCer alone (Schmieg et al., 2003). For 
example,  glucosylceramide (where galactose is replaced by glucose), Gal(1-2)GalCer, and 
C--GalCer (a C-glycosidic form of GalCer) can engender highly differential cytokine responses, 
compared to -GalCer (Pei and Kronenberg, 2012). The discovery of α-galactosylceramide and 
numerous related derivatives has helped to explore the range of antigen specificity among 
type I NKT cells, and has provided powerful agents for pharmacologic stimulation of these 
cells, with various functional outcomes. 
Although -GalCer and other similar compounds are useful tools for the study of type 
I NKT cells, they are not a natural antigen for this population, as the mammalian immune 
system does not typically defend against marine sponges (Sandberg and Ljunggren, 2005). 
Consequent studies have identified a series of microbial lipid compounds that could modulate 
a large fraction of type I NKT cells from mice and humans. These microbial lipid compounds 
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are mainly derived from three types of bacteria. Lipid antigens from Sphingomonas spp. and 
Borrelia burgdorferi share the common features of bearing a lipid with two acyl chains and an 
-linked hexose sugar as in -GalCer. However, in the third type of bacteria, Helicobacter 
pylori, the antigen has a very different structure that contains a cholesterol moiety derived 
from the eukaryotic host (Pei and Kronenberg, 2012).  
The first bacterial glycolipid antigens that were obtained from Sphingomonas spp. 
were glycosphingolipid-1 (GSL-1) from Sphingomonas paucimobilis and glycosphingolipid-
1’ (GSL-1’) from Sphingomonas yanoikuyae. They highly resemble -GalCer in structure, 
with a ceramide backbone containing the -anomeric conformation of a glycosidic bond. The 
main difference between Sphingomonas compounds (GSL-1 or GSL-1’) and GalCer is that 
GSL-1 or GSL-1’ use glucuronic acid or galacturonic acid respectively as the saccharide 
group, while GalCer simply uses galactose (Kinjo et al., 2005; Mattner et al., 2005; Sriram et 
al., 2005; Pei and Kronenberg, 2012). GSL-1, GSL-1’, and other similar compounds with 
more complex carbohydrates have the ability to stimulate both mouse and human type I NKT 
cells (both in vivo and in vitro), but with lesser potency than -GalCer (Kinjo et al., 2005; 
Mattner et al., 2005; Sriram et al., 2005).  
The second type of microbial glycolipid antigens that activate most type I NKT cells 
are derived from Borrelia burgdorferi, a spirochete that causes Lyme disease, which is 
currently the most common vector-borne disease in the USA (Bacon et al., 2008). There are 
two abundant glycolipids present in the cell wall of B. burgdorferi, and they are targets of 
an antibody response in infected individuals (Hossain et al., 2001). One of these is 
cholesteroyl 6-O-acyl--D-galactopyranoside, called B. burgdorferi glycolipid 1 (BbGL-I), 
and the other is 1,2-di-O-acyl-3-O--D-galactopyranosyl-sn-glycerol (BbGL-II; Ben-
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Menachem et al., 2003). BbGL-II was found to activate type I NKT cells in a CD1d-
dependent manner (Kinjo et al., 2006). 
Recently, it was indicated that a cholesterol-containing antigen from a third bacterial 
species, Helicobacter pylori, (the causative agent of many stomach ulcers) could also 
stimulate type I NKT cells (Chang et al., 2011). For example, it has been hypothesized that 
the antigen cholesteroyl 6-O-acyl-glucoside could stimulate type I NKT cells in vitro in a 
CD1d-dependent manner, and modulate the function of type I NKT cells in vivo in favour of 
IFN production. Cholesteroyl 6-O-acyl-glucoside protects young mice exposed to this 
compound from asthma (Chang et al., 2011), however, the underlying biochemistry of the 
interactions between the H. pylori antigen, CD1d, and the TCR is not known and requires 
further investigation. 
In a variety of contexts, type I NKT cells exhibit CD1d-dependent stimulation in the 
apparent absence of microbial antigens. Therefore, it is believed that type I NKT cells are 
self-reactive, and there might be a single self-antigen, or a limited set of closely associated 
and relatively high affinity self-antigens that can stimulate the invariant TCR. Although this 
hypothesis remains unproven (Gapin, 2010), a large number of potential self-antigens have 
been proposed over the years, and all are capable of activating NKT cells in vitro and/or in 
vivo. They are either glycospingolipids and non-glycospingolipid antigens (Pei et al., 2011).  
The first self-derived cellular lipid was phosphatidylinositol (PI), which was originally 
found by Gumperz and colleagues (2000) from an extract of tumour cells, and was presented 
by plate-bound mouse CD1d molecules to type I NKT cell hybridomas. Compared to its 
derivatives, PI has the highest antigenic potency. However, PI-binding NKT cell hybridomas 
did not subsequently respond to GalCer, and therefore these cells apparently do not represent 
the typical type I NKT cell population (Gumperz et al., 2000). Another self-derived cellular 
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lipid, disialoganglioside (GD3), was reported to activate a subset of type I NKT cells. GD3 
immunisation was required in order to detect a GD3-reactive type I NKT cell population (Wu 
et al., 2003). A number of efforts were made to identify glycospingolipid self-antigens but no 
particular structures were found (Paget et al., 2007; Salio et al., 2007). However, several 
papers have reported the identification of factors and enzymes important for glycospingolipid 
biosynthesis. For example, CpG ODN, a Toll-like receptor (TLR) 9 ligand, was found to 
activate dendritic cells to synthesise -linked glycospingolipids and also to secrete type I IFN, 
both of which are required to modulate type I NKT cells (Paget et al., 2007). 
An intriguing finding in the identification of NKT cell self-antigens was the 
identification of the glycospingolipid isoglobotrihexosyl ceramide (iGb3) as a putative self-
antigen required not only for NKT cell development, but also for the activation of 
autoreactive NKT cells in the periphery (Zhou et al., 2004; Mattner et al., 2005). There is 
compelling evidence against iGb3 as the main positively-selecting self-antigen because NKT 
cell numbers and function are normal in mice deficient for iGb3 synthase (Porubsky et al., 
2007). While iGb3 is clearly a glycospingolipid self-antigen that activates type I NKT cells, it 
is highly unlikely that iGb3 is required as the major self-antigen. Data from several groups 
indicates that there are other glycospingolipid self-antigens (such as phosphatidylinositol, 
phosphatidylglycerol, and phosphatidylethanolamine) that are presented by CD1d to activate 
NKT cells. However, they do not have strong affinity for CD1d like other potent compounds 
that mimic -GalCer (Gumperz et al., 2000). Thus, synthetic -GalCer is still an excellent 
lipid antigen to use to identify and study NKT cell development. 
It has recently been proposed that β-linked monoglycosylceramides, such as β-
glucosylceramides (β-GluCer), were natural endogenous ligands of NKT cells. Synthetic 
preparations of C12:0 and C24:1 β-GluCer have been shown to be strong activators of type 1 
NKT cells (Ortaldo et al., 2004; Parekh et al., 2004; Zigmond et al., 2007; Brennan et al., 
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2011). However, β-GluCer is one of the most abundant glycosylceramides in all cell types, it 
remains very difficult to conceive the regulation of its presentation by CD1 molecules and 
recognition by NKT cells. In addition, because of the limitations of the analytical methods of 
lipids, there is a possibility that α-anomers could contaminate the synthetic preparations. In 
2014, Kain and colleagues demonstrated that β-GluCer has no stimulatory properties toward 
NKT cells and that contamination of synthetic β-linked glycolipids with α-anomers is an 
important issue for above biological studies. To overcome the limitations of direct chemical 
methods, Kain and colleagues had used the specificity of immunological and enzymatic 
assays to characterize and isolate the endogenous ligands of NKT cells in the thymus and in 
DCs. They found that the endogenous ligands NKT cells are α-linked 
monoglycosylceramides, a class of glycolipids that were thought to be absent from 
mammalian cells given that the only two glycosylceramide synthases (glucosylceramide 
synthase and ceramide galactosyltransferase) were thought to be inverting 
glycosyltransferases. In addition, they demonstrated that α-GalCer is one of the endogenous 
ligands of NKT cells and that catabolic enzymes tightly control the level of α-
galactosylceramide (α-GalCer) in cells and tissues. 
Other potentially relevant self-antigens for type I NKT cells include 
lysophosphatidyl-choline (LPC) and lysosphingomyelin, which can be found at elevated 
levels during inflammatory responses (Fox et al., 2009; Lopez-Sagaseta et al., 2012). These 
two self-antigens weakly stimulate some human type I NKT cells (Fox et al., 2009) but 
apparently fail to trigger a response by mouse type I NKT cells (Brennan et al., 2011; Pei et 
al., 2011; Facciotti el al., 2012). This raises the possibility that mouse and human self-
antigen(s) for type I NKT cells might be distinct, due to differing trafficking requirements and 
sequence differences between mouse and human CD1d (Chen et al., 2007). Further, 
differences in the fine specificity of human and mouse type I NKT cells for the recognition of 
α-GalCer analogues have been reported (Wun et al., 2012). Taken together, it seems likely 
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that there is not simply one self-antigen for type I NKT cells but rather several different self-
antigens with various structures might be capable of providing an agonistic signal when 
recognized by the type I NKT TCR. 
1.1.4. Classification of NKT cells 
Although the definition of NKT cells is still vague and broad, the classification of 
NKT cells has been facilitated to a certain extent by the availablity of markers such as TCR, 
CD1d-tet, and NK1.1. NKT cells are initially divided into two distinct groups: CD1d-
dependent and CD1d-independent NKT cells (Bendelac et al., 2007, Godfrey et al., 2010). 
CD1d-dependent NKT cells are the major group. Their TCRs only recognise antigens 
presented in the context of CD1d, and thus, they need antigens presented by CD1d for their 
maturation (Godfrey and Berzins, 2007). In contrast, CD1d-independent NKT cells are a 
smaller group, and their TCRs recognise antigens presented on other molecules (Godfrey and 
Berzins, 2007). Due to the different requirements for antigen presenting molecules, the CD1d-
independent NKT cells can be identified in CD1d-/- mice but cannot be detected in 2M-/- 
mouse strains (Kronenberg and Gapin, 2002). 
CD1d-dependent NKT cells are further classified into two subclasses: type I and type 
II NKT cells (Kronenberg and Gapin, 2002). In mice, type I CD1d-dependent NKT cells are 
distinguished by the reactivity of their TCRs to -GalCer loaded on CD1d tetramer. These 
TCRs are comprised of an invariant TCR chain (V14-J18 in mice or V24-J18 in 
humans) in combination with a limited set of TCR chains (V8.2, V7 or V2 in mice or 
V11 in humans). Type I NKT cells account for approximately 80% of the total numbers of 
NKT cells and approximately 85% of CD1d-dependent NKT cells (Lantz et al., 1994; 
Matsuda et al., 2000; Park et al., 2001; Bendelac et al., 2007). Due to the use of the invariant 
TCR chain, type I CD1d-dependent NKT cells are also called invariant (i) NKT cells. By 
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combining tetramer staining with analysis of NK1.1 expression, type I NKT cells can be 
classified into two smaller populations: NK1.1- and NK1.1+ NKT cells. NK1.1- NKT cells are 
immature and can develop into mature NK1.1+ NKT cells by acquiring NK1.1 on their 
surface (Pellicci et al., 2002). In mice, the larger population of type I NKT cells are CD4+ and 
the remaining cells are CD4-CD8-. They do not simultaneously express CD4 and CD8 
antigens, nor do they express only CD8 (as in humans; Lantz and Bendelac, 1994).  
In humans, type I NKT cells also express an invariant TCR  chain, which is V24-
J18 in combination with a limited set of TCR  chains that are biased toward the use of 
V11. Similar with its murine counterpart, human type I NKT cells react with -GalCer. 
They express CD161 (a marker, homologous and functionally equivalent to murine NK1.1) at 
mature stages and are CD4+, DN, or CD8+ (Baev et al., 2004; Berzins et al., 2005). 
In contrast, type II NKT cells, also known as non-classical NKT cells, have a diverse 
TCR repertoire. They do not bear a V14-J18 rearrangement but are still CD1d-restricted 
and exhibit many of the same phenotypic and functional properties as invariant NKT cells. 
Type II NKT cells do express activated or memory markers such as NK1.1 in C57BL/6 mice, 
but do not recognise -GalCer. Until now, this cell type has not been well-characterised 
because of the absence of a specific surface marker and agonistic antigens. Sequencing of the 
TCR repertoire of V14- CD1d-restricted T cell hybridomas derived from MHC class II-
deficient mice has revealed that they use V3.2-J9 or V8 TCR chains paired 
preferentially with the V8 TCR chain (Park et al., 2001). Other studies have identified 
additional type II NKT cells that do not use V3.2-J9 or V8 TCR, but still bias the use of 
genes from the V8 family (Behar and Cardell, 2000). This cell type recognises a range of 
hydrophobic antigens including sulfatide, lysophosphatidylcholine, and small aromatic 
molecules. Sulfatide-loaded CD1d tetramer has been produced to identify type II NKT cells, 
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however, this complex cannot detect all kinds of type II NKT cells (Blomqvist et al., 2009). 
Currently, the best way to study this cell subset is through the comparison of CD1d-deficient 
and J18-deficient mice.  
In addition to above classification, recently iNKT (or type I NKT) cells have been 
identified into five major functionally distinct subsets, each producing a different set of 
cytokines. Each subset can be further characterized by the expression of distinct transcription 
factors that generally correlate with their cytokine response upon activation. Particularly, 
iNKT1 cells express T-bet+, PLZFlo, RORγt- and secrete predominantly TH1 cytokines 
(IFNγ); iNKT2 cells express T-bet-, PLZFhi, RORγt- and secrete TH2 cytokines (IL-4 and IL-
13) (Lee et al., 2013); iNKT17 cells are T-bet-, PLZFint, RORγt+ and secrete TH17 cytokines 
(IL-17); iNKTFH (follicular helper) express Bcl-6 and provide help to B cells in an IL-21 
dependent fashion (Chang et al., 2012); iNKT10 cells represent a unique subset of iNKT cells 
that are PLZF negative but express Nfil3 (E4BP4) and secrete IL-10 to create an 
immunoregulatory environment (Lynch et al., 2012; 2014).  Each subpopulation expresses 
particular cytokine receptors: iNKT1 expresses IL-12R, iNKT2 expresses IL-17RB and 
iNKT17 expresses IL-23R (Watarai et al., 2012). When stimulated with the corresponding 
cytokine, each subset produced only the cytokine corresponding to their subset (Watarai et al., 
2012). 
Recent studies on gene expression and epigenetic profiling largely supports the subset 
model of differentiation as each subtype had a distinct gene expression profile (Engel et al., 
2016; Lee et al., 2016; Georgiev et al., 2016), yet it is likely that both pathways are 
interrelated. For example, the iNKT1 subset is equivalent to stage 3 iNKT cells. Furthermore, 
it was showed that stage 1 and stage 2 iNKT cells are composed of two populations, IL-
17RB+ cells that make up iNKT2 and iNKT17 subsets, and IL-17RB- cells that are 
progenitors of the iNKT1 subset (Watarai et al., 2012).  Furthermore, Kronenberg and 
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colleagues found that the iNKT2 subset was composed of two subpopulations, in which one 
expressed a large amount of genes involved in cell cycle progression, indicating that it is 
likely a progenitor of other iNKT cells (Engel et al., 2016). 
It is expected that all iNKT cell subsets are of thymic origin. iNKT1, iNKT2 and 
iNKT17 cells acquire their functional capacity in the thymus during their development 
(Michel et al., 2008; Watarai et al., 2012; Lee et al., 2013), before they migrate in the 
peripheral organs in a tissues specific manner (Lee et al., 2015). To date, iNKTFH and 
iNKT10 cells have not been described in the thymus and their origins and developmental cues 
remain unclear. It is possible that these two subsets develop toward these phenotypes at very 
low frequencies in the thymus before migration, or that they may represent distinct states of 
activation. It is indicated that iNKT10 and iNKTFH subsets arise in the periphery under the 
proper stimulations conditions. For example, iNKTFH cells are induced in the spleen of mice 
following injection of lipid antigens (Chang et al., 2012). Similarly, ‘induced’ iNKT10 cells 
that share common characteristics with the iNKT10 cells found at steady state in the adipose 
tissues have been described following antigen stimulation (Lynch et al., 2014; Sag et al., 2014). 
Recent studies on gene expression and epigenetic profiling largely supports the subset 
model of differentiation as each subtype had a distinct gene expression profile (Engel et al., 
2016; Lee et al., 2016; Georgiev et al., 2016), yet it is likely that both pathways are 
interrelated. For example, the iNKT1 subset is equivalent to stage 3 iNKT cells. Furthermore, 
it was showed that stage 1 and stage 2 iNKT cells are composed of two populations, IL-
17RB+ cells that make up iNKT2 and iNKT17 subsets, and IL-17RB- cells that are 
progenitors of the iNKT1 subset (Watarai et al., 2012).  Furthermore, Kronenberg and 
colleagues found that the iNKT2 subset was composed of two subpopulations, in which one 
expressed a large amount of genes involved in cell cycle progression, indicating that it is 
likely a progenitor of other iNKT cells (Engel et al., 2016). 
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It is worth noting that the subset model is not completely set in stone. First, although 
each subset has a tendency to produce particular cytokines, when stimulated with a strong 
stimulus such as phorbol 12-myristate 13-acetate (PMA)/ionomycin or αGC, a large 
proportion of these cells will co-produce cytokines of other subsets, particularly IL-4 and IL-
13 (Yoshimoto, 1994; Watarai et al., 2012), and each subset expressed some cytokines of 
other subsets (Engel et al., 2016; Georgiev et al., 2016). Therefore, it is interesting to 
speculate that upon cytokine stimulation, each subset will produce specific cytokines, yet 
under antigen stimulation all iNKT cells have the potential to produce all cytokines. 
1.2. THE ROLE OF NKT CELLS IN THE IMMUNE SYSTEM 
NKT cells play a crucial role in immune regulation due to their unique ability to 
rapidly secrete large amounts of cytokines within 90 minutes of in vivo TCR stimulation 
(Matsuda et al., 2000). Once activated, the NKT cells rapidly release both Th1 and Th2 
cytokines, including IL-2, IL-4, IL-10, IL-13, TNF, IFN- and chemokines, such as RANTES, 
Eotaxin, MIP-1, and MIP-1 (Godfrey et al., 2004; Chang et al., 2005). These cytokines 
modulate the behaviour of other cells in both innate and adaptive immune responses 
(Kronenberg and Gapin, 2002). For example, IFN- produced by activated NKT cells 
promotes the activity of NK cells and macrophages as a part of innate immunity, and activates 
the maturation of dendritic cells (DCs) (Lang, 2009). In turn, the mature dendritic cells induce 
a Th1 cell response to activate adaptive immunity. In contrast, NKT cells also produce large 
amounts of IL-4, which controls the differentiation and development of Th2 cells, thus 
indirectly regulating Th1-mediated autoimmunity. 
In addition to rapid cytokine production, activation of type I NKT cells through TCR 
stimulation also augments the bidirectional cross-talk with DCs in a CD40/CD40L and CD1d-
dependent manner. This interaction promotes the maturation, activation, and the up-regulation 
of other co-stimulatory receptors, such as CD80 and CD86 on DCs, as well as the release of 
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IL-12. As a consequence of direct interaction with type I NKT cells, DCs can promote the 
activity of antigen-specific CD4+ and CD8+ T cells (Fujii et al., 2003; Hermans et al., 2003). 
Type I NKT cells can also prime the adaptive immune response through directly activating 
CD1d-expressing B cells (Barral et al., 2008; Leadbetter et al., 2008). Therefore, through 
cytokine production and other mechanisms, NKT cells form an important link between innate 
and adaptive immune responses. They can enhance microbial immunity, tumour rejection, 
maintain self-tolerance, and suppress autoimmune diseases (Matsuda et al., 2008).  
1.2.1. Role of NKT cells in autoimmune diseases 
Recently, studies on various disease-prone mouse strains have demonstrated that 
defects in NKT cell function and numbers are correlated to autoimmune diseases. This 
relationship was first identified in MRL/lpr mice, a mouse model for human systemic lupus 
erythematosus (SLE; Chen et al., 2015). In MRL/lpr mice, NKT cell numbers start reducing at 
around 3-4 weeks of age - before the onset of the disease. When the autoimmune disease 
manifests, NKT cells are completely absent. The introduction of rearranged V14-Ja18 gene 
segments into these mice delayed the decrease in NKT cell numbers and the disease onset 
(Mieza et al., 1996). In humans, the participation of NKT cells in SLE is not well understood. 
An increase in the  DN T cell proportion as well as IL-4 production after stimulation have 
been observed in patients with SLE, compared to healthy controls (Crispín et al., 2008). This 
cell population was not V24 NKT cells, but perhaps represents other pathogenic DN T cells. 
Therefore, the involvement of NKT cells in human SLE requires further examination. 
In addition, experiments in non-obese diabetic (NOD) mice, a well-established model 
of type I diabetes (T1D), have shown a profound defect in NKT cell numbers and function. 
NOD NKT cells exhibit a dramatic reduction in IL-4 production following TCR ligation 
(Gombert et al., 1996; Baxter et al., 1997; Hammond et al., 1998). The onset of type I 
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diabetes was reported to be accelerated in NOD mice lacking CD1d expression for NKT cell 
development. Conversely, in vivo stimulation of NKT cells by -GalCer, or raising NKT cell 
numbers either by transferring thymic type I NKT cells from nondiabetic (BALB/c x NOD) 
F1 mice (Baxter et al., 1997; Hammond et al., 1998), or introducing the V14-J18 transgene 
(Lehuen et al., 1998), could suppress the development of type I diabetes in NOD mice. The 
protection against diabetes development is reported to be associated with the recovery of Th2 
cytokine production, such as IL-4 and IL-10. However, treatment of NOD mice with Th1 
cytokines (IL-12), or anti-Th2 cytokine antibodies (such as anti-IL-4), abolished the 
protective impact conferred by type I NKT cells (Trembleau et al., 1995; Hammond et al., 
1998; Laloux et al., 2001). 
Although it is not well documented, similar abnormalities have been found in patients 
with insulin-dependent diabetes mellitus (IDDM). Type I diabetic patients have been reported 
to have lower frequencies of DN V24 NKT cells in their peripheral blood than their non-
diabetic twins. In addition, NKT cells from normal controls or non-diabetic siblings were 
found to secrete both IFN- and IL-4, although those from diabetic patients only produced 
IFN- (Wilson et al., 1998; Kukreja et al., 2002). These findings suggest that the decrease in 
NKT cell numbers results in the failure of IL-4 production, and subsequently tissue damage 
mediated by Th1 cells. However, a recent study using CD1d-tet has indicated that there is no 
difference between IDDM patients and healthy controls in NKT cell numbers and the ability 
to produce IL-4 (Lee et al., 2002b). A separate study also challenged the hypothesis that NKT 
cell deficiencies were associated with T1D in humans, as it indicated that NKT cell numbers 
were increased in the blood of T1D patients (Oikawa et al., 2002). Due to these discrepancies 
as well as the limitation in collecting samples, the involvement of NKT cells in human T1D 
requires further investigation. 
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NKT cell function has been studied in experimental autoimmune encephalomyelitis 
(EAE) mice, a model for multiple sclerosis (MS). EAE in mice is induced by immunising 
the central nervous system with myelin oligodendrocyte glycoprotein (MOG) or myelin 
basic protein (MBP) in a mycobacterium-containing adjuvant. In this model, NKT cells 
confer a Th2-biased immune response that plays a role in protection from EAE. The 
augmentation of NKT cells in NOD mice via the introduction of the V14-J18 transgene 
has significantly suppressed MOG-induced EAE (Mars et al., 2002). Consistent with this, 
the deletion of the CD1d gene from B6 mice resulted in a more severe form of EAE 
compared to wild type control mice (Teige et al., 2004). In contrast, other groups have 
found no differences in disease course between CD1d-/- (Singh et al., 2001) or J18-/- 
(Furlan et al., 2003) mice compared to wild type littermates. There have been conflicting 
results for -GalCer treatment in EAE studies. For example, the administration of -GalCer 
in B10.PL and C57BL/6 mice (before immunisation with peptide from MBP or 
accompanied with an encephalitogenic MOG peptide, respectively) was found to reduce the 
severity of EAE (Jahng et al., 2001). On the other hand, there were reports of EAE 
exacerbation in B10.PL and SJL/L mice, following co-administration of -GalCer and MBP 
(Singh et al., 2001; Furlan et al., 2003).  
These conflicting reports raise the question as to what extent NKT cells contribute to 
the immune response against MS. While Jahng opposed the role of IL-4 in disease protection 
by -GalCer in C57BL/6 mice (Jahng et al., 2001), others suggested that the protective 
effects of -GalCer depend on the ability of the mouse strain to produce IL-4 upon 
stimulation with -GalCer. In fact, disease suppression was seen in strains producing higher 
levels of IL-4 in response to -GalCer treatment. Moreover, the protective effect of α-GalCer 
in EAE was not seen in IL-4- or IL-10-deficient mice (Singh et al., 2001), whereas disease 
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was suppressed in IFN-γ-deficient mice (Jahng et al., 2001; Pal et al., 2001). Although one 
study demonstrated that IFN-γ but not IL-4 is critical for disease protection by α-GalCer in 
C57BL/6 mice (Jahng et al., 2001), the above findings suggest that EAE protection by α-
GalCer is mediated by Th2 cytokines produced by NKT cells.  
There is a substantial body of evidence to support Th2-mediated protection. For 
example, in vivo injection of α-GalCer-pulsed APCs with CD86 blockade (treated with anti-
B7.2 antibodies) not only polarizes NKT cells toward a Th2-like phenotype but also mediates 
concomitant suppression of EAE. In contrast, α-GalCer presented by anti-CD40-activated 
APCs induces a bias of NKT cells toward a Th1-like phenotype and exacerbated EAE (Pal et 
al., 2001). Moreover, in mice, in vivo administration of the altered glycolipid ligand OCH, a 
sphingosine-truncated analog of α-GalCer, ameliorates EAE and T1D by preferentially 
inducing IL-4 from NKT cells without enhancing pathogenic Th1 responses (Oki et al., 2004; 
Goff et al., 2004; Oki et al., 2005). OCH has been shown to be more effective than α-GalCer 
in protecting C57BL/6 mice from EAE, and it possesses some efficacy even when treatment 
was initiated several days after EAE induction. OCH was also effective when administered 
orally, which is the favored treatment route for humans. The protective effect of OCH was 
abrogated by neutralisation of IL-4 (Miyamoto et al., 2001). Taken together, this evidence 
indicates that NKT cells appear to work as a regulator in EAE, and targeted activation of NKT 
cells could lead to amelioration of EAE.  These studies have provided a strong foundation for 
the rational design of NKT-cell-based immunotherapies for MS that induce tolerance while 
sparing overall immune function. Nevertheless, additional pre-clinical and clinical studies will 
be required to bring this goal to fruition (Van Kaer et al., 2015). 
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1.2.2. Role of NKT cells in tumour surveillance 
The involvement of NKT cells in the immune response against tumours has been 
analyzed in a range of different tumour models. V14-deficient mice have a higher incidence of 
methylcholanthrene-induced fibrosarcomas and earlier tumour progression than control 
C57BL/6 mice (Smyth et al., 2000; Smyth et al., 2001). However, this model could not rule out 
the effects of NK cells that are known to contribute to immunological surveillance. To confirm 
and extend previous observations using methylcholanthrene tumour models, the authors 
demonstrated that adoptive transfer of type I NKT cells into J18-/- mice was able to protect 
the mice from methylcholanthrene-induced sarcomas via direct interaction of the type I NKT 
TCR with CD1d molecules (Crowe et al., 2002).  
NKT cells, perhaps, control tumour development through both direct and indirect 
cytotoxic activity. NKT cells could serve as cytotoxic effector cells to directly kill tumour cells 
and this could be the reason why V14 NKT-deficient mice could not be protected against 
experimental liver metastasis of melanoma (Kawano et al., 1998). On the contrary, it is more 
likely that NKT cells suppress tumour development in an indirect manner through the activation 
of effector cells, such as CD8+ T cells and NK cells (Smyth et al., 2000; Smyth et al., 2002). In 
particular, it has been suggested that NKT cells are activated through TCR interaction to 
produce IL-4, IFN-, and to up-regulate CD40L expression. IFN- and CD40L expression 
subsequently promote the production of IL-12 by DCs. Finally, IL-12 activates a second burst 
of IFN- production by NKT cells to stimulate NK and CD8+ T cells to induce tumour killing 
(Smyth et al., 2000; Taniguchi et al., 2003a). 
The role of NKT cells in tumour killing has been examined recently in several mouse 
tumour models. A study of the 15-12RM tumour model indicated that CD4+ NKT cells play an 
immunosuppressive role leading to tumour progression by inhibiting CD8+ cytotoxic T 
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lymphocytes (CTL). Although the immunosuppressive mechanism remains to be determined, it 
could be an indirect pathway, mediated through IL-13 derived from CD4+ NKT cells and other 
cell types (Taniguchi et al., 2003b). In a subsequent study, Terabe and colleagues demonstrated 
that type I NKT cells are not necessary for immune suppression. Interestingly, in the absence of 
both type I NKT cells and Treg cells, type II NKT cells are sufficient to suppress 
immunosurveillance of tumors (Terabe et al., 2005). A new mechanism of action was 
discovered a by O’Konek and colleagues, in which activation of type I NKT cells with beta-
mannosylceramide (-ManCer) induced tumour elimination in the absence of IFN- through a 
nitric oxide and TNF--dependent mechanism (O’Konek et al., 2011). Other studies of murine 
tumour models have indicated that two subsets of NKT cells, type I and type II, can play 
opposing roles and cross-regulate each other, forming an immunoregulatory axis that may 
influence the balance of other immune responses. Consistent with this, multiple other studies 
also found that type I NKT cells enhance and type II NKT cells suppress tumor immunity 
(Terabe and Berzofky, 2014).  
NKT cells also have an impact on tumour development in humans. For example, human 
NKT cells exhibit cytotoxicity against several tumour cell lines, such as haematological 
malignancies, through effector mechanisms with a distinct from those of conventional T cells 
and NK cells (Nicol et al., 2000). NKT cells also display a cytotoxic activity against the U937 
tumour cell line through the perforin pathway after receiving activation from -GalCer in the 
presence of DCs (Takahashi et al., 2000). Patients with advanced cancer show a decrease in 
NK, T, and NKT cells compared with normal controls (Kobashi et al., 2001). Similar to murine 
type II NKT cells, CD1d-dependent type II NKT cells in humans enhance immune-suppressive 
functions in MLR mice by releasing Th2 cytokines (Baker et al., 2001). 
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1.2.3. Role of NKT cells in microbial infection. 
In addition to their effects on autoimmune diseases and tumour surveillance, NKT cells 
participate in immune responses against microbial infections caused by bacterial, viral and 
protozoan agents. NKT cells respond to a range of infectious organisms through the 
recognition of microbial lipids, such as α-galactosyldiacylglycerol from Borrelia burgdorferi 
(Kinjo et al., 2006), lipophosphoglycan from Leishmania donovani (Amprey et al., 2004), α-
glucosyldiacylglycerol from S. pneumoniae (Kinjo et al., 2011), α-glucuronosylceramide and 
α-galacturonosylceramide from Sphingomonas species (Kinjo et al., 2005; Sriram et al., 2005; 
Mattner et al., 2005), and a cholesteryl α-glucoside from Helicobacter pylori (Chang et al., 
2011) presented by CD1d+ APCs (Slauenwhite and Johnston, 2015). For example, NKT cells 
could form granulomas as an early immune response when the host is infected with 
Mycobacterium tuberculosis. Despite this, NKT cells are not responsible for the resistance to 
Mycobacterium tuberculosis because there is no difference between the protective immune 
responses against this pathogen in 2M-deficient, CD1d-deficient, and wild type mice. Studies 
of granuloma models indicate that NKT cells are the major cell type detected in early 
granulomas, and the development of a sizable, granuloma-like structure depends on the 
recruitment of NKT cells as V14 NKT cell-deficient mice did not develop granulomas 
(Apostolou et al., 1999). Importantly, the recruitment of Va14 NKT cells to granulomas does 
not require specific presentation of mycobacterial antigens by CD1d, as it can occur even when 
NKT cells are adoptively transferred into CD1d-/- mice. However, it has been demonstrated 
that NKT cells participate in pathogen clearance mediated by IFN- (Emoto et al., 1999; 
Mempel et al., 2002). 
NKT cell stimulation by microbial ligands is not restricted to microbial lipid antigens 
that are recognised directly by the Vα14–Jα18 TCR. Other microbial products also activate 
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APCs via pattern recognition receptors (such as TLRs, NOD-like receptors, etc), leading to an 
increased accumulation of weak self-glycolipid antigens and the production of NKT cell-
stimulating cytokines (IL-12, IL-18, and type I IFNs) (Brigl et al., 2003; Mattner et al., 2005; 
Paget et al., 2007; Salio et al., 2007; Nagarajan et al., 2007; Brigl et al., 2011). In that case, 
CD1d-presented antigens may not be required and IL-12, IL-18, or type I IFNs alone or in 
combination may be sufficient to drive NKT cell activation and IFN-γ production (Nagarajan 
et al., 2007; Wesley et al., 2008). In particular, NKT cells could indirectly induce protective 
immune responses toward lipopolysaccharide (LPS). It has been demonstrated that two 
consecutive low-dose injections of LPS are able to induce a lethal shock in mice (Dieli et al., 
2000). In terms of a mechanism for this lethal shock syndome, it has been suggested that LPS 
stimulates macrophages via TLR-4 to generate IL-12, which in turn directly promotes NKT 
cells to produce large amounts of IFN- and TNF. IFN- continuously enhances the production 
of TNF, which induces hepatocyte injury (Ozmen et al., 1994). Although the cell type 
producing TNF in this step remains unclear, it could be generally concluded that the effect of 
the NKT cells lies in their IL-12, IFN-, and TNF production. Consistent with this finding, 
another study suggested that V14-deficient mice were resistant to this low-dose LPS shock. 
They also exhibit a reduction in IFN- and TNF secretion, but not  IL-12, compared to wild type 
mice. The injection of recombinant IFN- but not IL-12 could restore LPS-induced mortality 
and TNF production (Ozmen et al., 1994). In addition, weak signalling produced by 
endogenous lipid ligands through the NKT-cell TCR, although not sufficient for full NKT 
cell activation, triggers NKT cells to release IFN-γ upon exposure to the cytokines IL-12 
and IL-18 (Wang et al., 2012).  
In contrast to the precise knowledge about the role of NKT cells in murine models of 
microbial infection, little is known about the role of NKT cells in human infectious diseases. 
Although there is a decrease in circulating NKT cells in human immunodeficiency virus (HIV-1) 
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patients, they do not appear to affect disease progression (van de Vliet et al., 2002). Another 
report indicated that NKT cells play an important role in controlling herpes simplex virus 
(HSV) (Grubor-Bauk et al., 2003). In fact, V14- and CD1d-deficient mice failed to clear HSV 
compared to wild type mice. Moreover, NKT cells are able to inhibit HBV replication when 
they are activated by -GalCer, even though this activity is attributed to both primary cytokines 
(produced by NKT cells) and secondary cytokines (produced by NK cells; Kakimi et al., 2000). 
In addition to the functions reported above, NKT cells are involved in other immune 
responses such as transplant rejection and allergic disorders, though the exact function of 
NKT cells in these instances is unclear. However, it does appear that their proinflammatory 
actions usually outweigh their immunosuppressive roles.  
1.3. NKT CELL NUMBERS AND NOD MICE  
1.3.1. NKT cell numbers 
NKT cells are a minor cell population in the immune system. Their prevalence is quite 
different between species and between organs. In mice, NKT cell numbers vary between 
strains. Among the commonly used mouse strains, C57BL/6 mice have relatively high NKT 
cell numbers, while NOD mice exhibit a significantly lower number of NKT cells. These 
findings were found by both older studies using surrogate markers (Gombert et al., 1996; 
Baxter et al., 1997), and more recent studies that utilise CD1d-tet for NKT cell identification 
(Hammond et al., 2001; Poulton et al., 2001). 
In terms of tissue distribution, NKT cells are found primarily in the liver, thymus, and 
spleen, although the relative proportions of NKT cells vary. In mice, type I NKT cells account 
for 30-50% of T cells in the liver and 20-30% in the bone marrow. In the thymus, NKT cells 
represent 10-20% of mature (HSA-) T cells and only 0.3-0.5% of total thymocytes (Eberl et 
al., 1999a; Benlagha et al., 2000; Matsuda et al., 2000; Hammond et al., 2001). In other 
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tissues, NKT cells represent a minor proportion of T cells including spleen (3%), lymph node 
(0.3%), blood (4%), lung (7%) and adipose tissue (2.4%) (Eberl et al., 1999a; Matsuda et al., 
2000; Huh et al., 2013).  
NKT cell distribution is not well-studied in humans, as the proportion of V24 NKT 
cells is considerably lower than in mice (Bendelac et al., 2007). They constitute 0.1% - 0.2% 
of blood T cells but this proportion is highly variable among individuals (Gumperz et al., 
2002; Lee et al., 2002a; Montoya et al., 2007). In humans, V24 NKT cells are not highly 
enriched in the liver but accumulate in the ometum, making up approximately 10% of the T 
cell population in that site (Lynch et al., 2009). 
1.3.2. NOD mice 
Due to the role of NKT cells in immune regulation, a large number of studies have 
focused on NOD mice, a mouse strain in which NKT cell numbers are severely reduced. 
Compared with eight other commonly used mouse strains, such as C57BL/6 and BALB.B6-
Cmv1r mice, NOD mice have relatively lower numbers of type I NKT cells in the thymus 
and peripheral lymphoid organs, including the spleen and liver (Gombert et al., 1996; 
Baxter et al., 1997; Godfrey et al., 1997; Poulton et al., 2001; Hammond et al., 2001). In 
addition to these numerical deficiencies, NKT cells derived from NOD mice produce 
relatively less IL-4, which is two to four-fold lower in plasma in response to anti-CD3 
administration than in C57BL/6 mice. Similarly, there are 20-fold fewer IL-4-secreting 
thymic NKT cells in NOD mice than in C57BL/6 mice (Gombert et al., 1996; Hammond et 
al., 2001; Poulton et al., 2001).  
The concomitant deficiencies in NKT cell numbers and function appear to contribute  
to the autoimmune phenotypes observed in NOD mice. These mice spontaneously develop 
T1D, which characterised by the destruction of pancreatic islet beta cells (Baxter et al., 1994). 
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There is a tight relationship between the spontaneous development of T1D and the severe 
decrease in NKT cell numbers and function in NOD mice (Makino et al., 1980; Baxter et al., 
1997; Hammond et al., 1998). The course and the severity of T1D in these mice was able to 
be modulated by increasing NKT cell numbers through adoptive transfer (Hammond et al., 
1998; Laloux et al., 2001), congenesis (Jordan et al., 2007; Chen et al., 2007; Fletcher et al., 
2008), introduction of V14-J18 (Lehuen et al., 1998) or Cd1d transgenes (Falcone et al., 
2004), or activation with -GalCer (Seokmann et al., 2001; Sharif  et al., 2001).  
NOD mice are also susceptible to other autoimmune diseases such as systemic lupus 
erythematosus (Baxter et al., 1994; Esteban et al., 2003), and hemolytic anemia (Baxter and 
Mandel, 1991). Notably, the injection of BCG into these mice is reported to be able to inhibit 
T1D but instead induces an SLE-like disease. It could be postulated that a common factor 
may control these two autoimmune diseases. 
A genetic linkage study of a first backcross between NOD and C57BL/6 mice has 
revealed that the defect in NKT cell numbers in NOD mice is controlled by 2 genetic regions: 
Nkt1 and Nkt2, which map to regions containing lupus and diabetes susceptibility genes, 
respectively (Esteban et al., 2003). The congenic replacement of these 2 regions with 
corresponding regions derived from C57BL/6 mice partly increased NKT cell numbers and 
the congenic replacement of Nkt2 delayed the onset of type I diabetes in the NOD recipient 
mice (Jordan et al., 2007; Fletcher et al., 2008). However, it did not completely rescue NKT 
cell numbers or entirely prevent T1D (Jordan et al., 2007; 2011; Chung et al., 2005; 2008; 
Nichols et al., 2005; Pasquier et al., 2005; Griewank et al., 2007). There might be other 
factors that contribute to the reduced number and function of NKT cells in NOD mice, though 
this requires further investigation. 
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1.4. NKT CELL DEVELOPMENT 
1.4.1. NKT cell origin 
While much is known about the role of NKT cells in immune regulation, details of 
NKT cell origins and their developmental program are still elusive. Previously, two different 
models have been proposed to explain the developmental pathway of NKT cells (MacDonald, 
2002). The first model, called the instructive model or mainstream model, posited that NKT 
cells develop from the same progenitors as conventional T cells (Bendelac et al., 1997), as 
they are a thymus-dependent T cell subset, absent from nude mice, and undetectable in mice 
after thymectomy (Bendelac, 1995; Taniguchi et al., 2000; MacDonald et al., 2002). In 
contrast, the pre-commitment model suggested that NKT cells are derived from distinct 
precursors (Sato et al., 1999). These precursors are generated very early during 
embryogenesis, perhaps even before the development of thymus or the formation of 
conventional T cells (Makino et al., 1996; Baur et al., 2001; Iwabuchi et al., 2001).  
The most convincing argument for the pre-commitment model was reported by 
Iwabuchi (2001). In this research, NK1.1+ TCR- cells were identified in the thymus of 
ZAP-70-/- mice while neither NK1.1+TCR+ nor NK1.1+TCR+ cells were detected in 
either the thymus or the spleen. These cells did not express surface TCR because TCRV 
gene segments were not rearranged. However, sorted NK1.1+ TCR- thymocytes in the 
presence of phorbol ester and ionomycin in fetal thymic organ culture (FTOC) led to the 
formation of some NK1.1+ TCR+ cells and detectable V14-J281 rearrangement. This 
raised the possibility that pre-NKT cells might exist in the thymus of ZAP-70-deficient mice 
(Iwabuchi et al., 2001). In another study, two NK1.1+TCR+ populations were identified in 
the spleen of V8.2 transgenic mice. One population expressed CD3high and V14 mRNA, the 
other expressed precursor phenotypes, including CD3dim, and no V14 mRNA (but did 
Chapter 1: An Introduction to Natural Killer T Cells 
 - 30 - 
exhibit transcripts relevant to the immature developing T cell lineage, such as RAG-1, RAG-2 
and pT). When CD3dim RAG+ V14- cells were purified from the bone marrow of these 
mice and cultured in combination with IL-15, GM-CSF, and in the presence of stroma cells, 
they were able to differentiate in vitro into mature CD3e+ V14+ NKT cells (Sato et al., 
1999). In another study, NK1.1+ thymocytes were detected in TCR/CD3-signalling-deficient 
mice. These cells did not exhibit V14-J18 rearrangement or an TCR, even though they 
had undergone TCR VDJ rearrangement. This observation suggested that they may contain 
pre-NKT cells, which were blocked in the absence of CD3/TCR signaling (Baur et al., 2001). 
However, whether or not pre-NKT cells actually exist should be elucidated, because these 
findings do not rule out the possibility that the absence of ZAP70 and the presence of 
pharmacological stimulators or aberrant NKT cell precursors may result in changes in the 
normal pathway of thymocyte differentiation and/or abnormal TCR expression.  
In sharp contrast, there is overwhelming evidence supporting the mainstream model 
by which mature NKT cells are derived from CD4+CD8+ (double positive - DP) thymocytes 
(the same progenitors as conventional T cells), because rearranged TCR α chains first appear 
on DP thymocytes. However, direct identification of such putative DP Vα14 NKT precursors 
has been controversial, because their frequency is extremely low. It is generally accepted that 
no cells that stain with CD1d-tet can be identified among conventional DP thymocytes 
expressing high levels of both CD4 and CD8. However, several groups detected rare CD1d-
tet-stained cells in a DP “dull” population, which could represent post-selection Vα14 NKT 
progenitors that have partially down-regulated CD4 and CD8 (Benlagha et al., 2005; Cannons 
et al., 2006), while other groups found a detectable frequency of in-frame Vα14-Jα18 
rearrangement in purified DP thymocytes (Gapin et al., 2001; Dao et al., 2004). These 
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rearrangements can even be detected in DP thymocytes from CD1d-/- mice (Gapin et al., 
2001), suggesting the presence of unselected DP Vα14 NKT precursors. 
The most convincing evidence came from the work of Dashtsoodol and colleages, in 
which CD4+CD8+ thymocytes were sorted and injected into J18-/- (a strain that lacks type I 
NKT cells but possesses the CD1d ligand) and CD1d-/- mice. The results revealed that mature 
(CD4+ or DN) NKT cells could be detected in the thymus, spleen and liver of J18-/- mice, 
whereas they did not exist in the thymus, spleen and liver of CD1d-/- mice, even though they 
had received DP cells intrathymically (Dashtsoodol et al., 2008). A similar finding was also 
achieved when DP thymocytes from CD1d-/- mice were sorted and re-injected into thymus of 
wild type mice that had a CD45.1-congenic region. In CD1d-/- mice, NKT cells cannot 
differentiate because of the deficiency of CD1d ligand interactions necessary for positive 
selection of DP thymocytes. The transfer of these cells into CD1d+ recipients resulted in their 
differentiation into mature NKT cells (Gapin et al., 2001). In addition to phenotypic findings, 
Egawa has provided genetic evidence for type I NKT cell development by using fate mapping 
and mutative analysis. The results show that type I NKT cells are selected from a common 
pool of DP thymocytes (Egawa et al., 2005). Collectively, this data strongly supports the 
instructive model in which CD4+CD8+ thymocytes are progenitors of NKT cells.  
1.4.2. Rearrangement of TCR gene segments. 
The TCR gene rearrangement common to both the T and NKT cell lineages occurs at 
the TCR-CD4-CD8- (triple negative - TN) stage and is essentially the same as what has been 
described for conventional T cells. During the TN stage, the development of the common 
progenitors is divided into four small stages (CD44+CD25-TN -> CD44+CD25+TN -> 
CD44-CD25+TN -> CD44-CD25-TN), based on the expression of CD25 and CD44 markers. 
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The rearrangement of TCR and  loci occurs first when the common precursors transit 
from the CD44+CD25+TN to the CD44-CD25+TN stage (reviewed in Godfrey et al., 1993a, 
Godfrey et al., 1993b). This transition is followed by TCR expression, then -selection for 
a functional TCR  chain. After passing through -selection, these common progenitors 
down-regulate CD25 expression to become CD44-CD25-CD4lowCD8low thymocytes, which 
is accompanied by rearrangement of TCR gene segments. The TCR locus randomly 
combines variable (V) with diverse (D) segments, and then with one joining (J) segment. 
This is in contrast to the rearrangement of TCR which occurs between V and J segments 
to create a common TCR repertoire.  
In accordance with the aforementioned insights into TCR and  rearrangement, the 
invariant TCR chain of type I NKT cells is formed when V14 in mice (or V24 in humans) 
randomly combines with a J18 segment. The TCR chains are formed by recombining a 
range of V chains (mostly V8.2, V7, V2 in mice or V11 in humans) with J genes. 
Therefore, the resulting TCR chains of type I NKT cells are moderately diverse, which  
explains why NKT cells can recognise a range of different antigens (Bendelac et al., 2007; 
Godfrey et al., 2010).  
There are two opposing opinions regarding the method of V14-J18 rearrangement: 
one is in favor of a random process and the other supports a predetermined program. 
However, if the pre-NKT cells implement a genetic program leading to a directed 
rearrangement, there would be around 50,000 type I NKT cell precursors doomed to die for 
every cell that achieved the correct V14-J18 rearrangement (Asarnow et al., 1993; 
Bendelac et al., 1997). To date, there is no evidence supporting a directed program 
(Shimamura et al., 1997). A study on the nucleotide sequence of TCR junctional regions 
(CDR3s) has shown that approximately 40% of type I NKT cells display greater nucleotide 
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trimming and an addition of N nucleotides, even though they still conserve the canonical 
amino acid length and sequence. Furthermore, analysis by RT-PCR on immature DP 
thymocytes has shown that V14 could rearrange with a range of J gene segments, not just 
J18 (Gapin et al., 2001). Collectively, these findings suggest that NKT cell precursors have 
been selected rather than programmed. 
1.4.3. Positive selection of NKT cells 
It is suggested that after common DP thymocytes undergo random rearrangement of 
the TCR V and V gene segments and form a rearranged TCR repertoire, they quickly 
undergo positive selection. Unlike conventional T cells, which are selected by peptide 
antigens presented in the context of MHC class I or II molecules on cortical epithelial cells, 
NKT cells are selected by glycolipid antigens presented by CD1d on cortical DP thymocytes 
(Bendelac, 1995; Godfrey and Berzins, 2007). This antigen presenting activity depends on the 
presence of 2-microglobulin (2M), but is independent of MHC class II. Therefore, NKT 
cells are absent in 2M KO mice but intact in MHC II-deficient mice. In contrast, NKT cell 
numbers are seriously affected in Cd1d-/- mice, even though V14-J18 rearrangement is still 
detected in their DP thymocytes (Cole and Raulet, 2000; Chun et al., 2003). Furthermore, 
adoptive transfer of DP thymocytes into lethally-irradiated wild type mice could give rise to 
mature NKT cells, but could not when DP thymocytes from wild type were adoptively 
transferred into Cd1d-/- recipient mice (Bendelac, 1995). Collectively, these findings suggest 
that CD1d is required for NKT cells to be positively selected.  
Due to the requirement of CD1d for positive selection, the generation of NKT cells is 
also affected by factors contributing to CD1d production. During the formation process, 
CD1d must traffic through intracellular pathways in APCs where glycolipid antigens are 
processed and loaded onto CD1d. Mice lacking AP-3 or prosaposin revealed impairments in 
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NKT cell activation and development, as AP-3 and prosaposin play important roles in the 
loading of glycolipids into the CD1d antigen-binding groove (Sugita et al., 2002). In this 
case, AP-3 links to a tyrosine-based motif on the cytoplasmic tail of CD1d and serves as an 
indicator that assists in trafficking CD1d to the endoplasmic reticulum to load lipid 
antigens. Prosaposin is a protein precursor of four saposins (termed A, B, C and D), which 
are small lysosomal glycoproteins required for the processing and hydrolysis of 
sphingolipids (Hiraiwa el al., 1997). Therefore, deficiency in either AP3 or prosaposin, or 
mutation in the CD1d cytoplasmic tail, leads to a blockade in NKT cell development (Chui 
et al., 2002; Lawton et al., 2005). 
While conventional CD4 and CD8 T cells are positively selected by peptide antigens 
in the context of MHC class I or II on cortical epithelial cells, NKT cells are positively 
selected by lipid antigens presented by CD1d on cortical DP thymocytes. The cortical DP 
thymocytes are the major cell population that exhibit CD1d in thymus, while cortical 
epithelial cells do not seem to express CD1d. According to Bendelac and colleagues (1995), 
they are immature cortical DP thymocytes rather than a professional antigen-presenting cell, 
such as a B cell or a mature T cell (Bendelac et al., 1995). NKT cells could not be generated in 
lethally irradiated 2M+/+ mice reconstituted with 2M-/- fetal liver cells, though they were able 
to be generated in reciprocal chimeras (2M-/- mice constituted with 2M+/+ fetal liver cells) 
(Bendelac, 1995; Cole and Raulet, 2000; Gapin et al., 2001). This indicates that the generation 
of NKT cells requires the presence of bone marrow-derived cells. The proximal Lck promoter 
was used to restrict transgenic expression of mouse or human CD1d on DP thymocytes, and 
subsequently demonstrated that CD1d-expressing DP thymocytes are sufficient to promote 
positive selection of V14 NKT cells (Wei et al., 2005; Zimmer et al., 2006). 
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As mentioned above, the random rearrangement of TCR and  produces an 
unselected, varied TCR repertoire, which will later determine the avidity for peptide or lipid 
antigens on APCs. The DP thymocytes expressing TCR with appropriate avidity for self-
peptide antigens are positively selected upon interaction with MHC class I or II molecules 
expressed on thymic epithelial cells (Godfrey and Zlotnik, 1993a). The cells that successfully 
pass through thymic selection subsequently undergo maturation to become conventional 
CD4+CD8- or CD4-CD8+ (single positive) T cells. In contrast, the DP thymocytes whose TCR 
has appropriate avidity for glycolipid antigens presented in the context of CD1d on cortical 
DP thymocytes are positively selected as NKT cells (Bendelac, 1995; Godfrey and Berzins, 
2007). DP thymocytes whose TCR have insufficient or overly strong avidity for endogenous 
antigens (either peptide or glycolipid antigens) are deleted by neglect or negative selection, 
respectively (Pellicci et al., 2003; Chun et al., 2003; Schumann et al., 2005; Godfrey and 
Berzins, 2007).  
However, precisely how iTCR-CD1d interaction could induce the positive selection of 
type I NKT cells remains an enigma. Several findings indicated that NKT cells could be 
selected by the specificity of their invariant TCR repertoire for CD1d. The TCR amino acid 
chains of type I NKT cells are typically invariant, their TCR DNA junction regions are 
variable as a result of trimming, followed by N-region additions. For example, the analysis of 
nucleotide sequence data has revealed that the complementarity-determining region 3 (CDR3) 
of 40% NKT cells are trimmed and contain added N nucleotides, even though they still conserve 
the canonical amino acid length and sequence (Lantz et al., 1994; Ronet et al., 2001).  
TCR chains could also partly contribute to positive selection of NKT cells (Ohteki 
and MacDonald, 1996; Dao et al., 2004). In fact, the most prominent  chain families that 
were found to be associated with type I NKT cells were V8.2, V7, V8.3, V2 and V8.1 
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in mice, and V11 in humans (Bendelac et al., 1997). With this observation arises the 
question of whether this biased usage of V chains is a result of TCR repertoire selection or 
the inability of the invariant TCR chain to pair other V chains. A study on V14-J18 
TCR transgenesis has shown that an invariant TCR chain could pair indiscriminately with 
many V families (Wei et al., 2006), which rules out the V pairing issue. Furthermore, 
differences within the Vβ domains (such as V8.2 and V7) of NKT TCR-CD1d complexes 
resulted in altered TCRβ-CD1d-mediated contacts, while altered recognition was mediated by 
the invariant alpha chain (Pellicci et al., 2009). Mallevaey and colleagues demonstrated that 
specific sequences within the CDR2β and CDR3β loops are responsible for shaping the type I 
NKT cell repertoire in vivo, and do so by constraining type I NKT TCR interaction with 
antigen(s)/CD1d complexes (Mallevaey et al., 2009). Moreover, transgenesis of V8.2 and 
V8.1 TCR chains resulted in decreased NKT cell numbers (Takahama et al., 1991). The 
transgenesis of V14-J18 gene segments into B6 mice increased the affinity for CD1d in T 
cells bearing CD8. As a result, this led to a selective depletion of 50-90% CD8+ T cells 
bearing V8 or V7 chains, which are most commonly expressed by mouse V14 NKT cells 
(Bendelac et al., 1996). Two recent studies also provide further evidence corroborating the 
notion that the restricted TCRβ repertoire is shaped by positive selection (Pellicci et al., 2009; 
Mallevaey et al., 2009). Altogether, these results suggest a role for V regions in contributing 
CD1d specificity for positive selection (Bendelac et al., 1997).  
It is well demonstrated in conventional T cell positive selection that the interactions 
between the newly formed TCRs and endogenous ligands induce a series of intracellular 
signalling cascades, which will direct the DP thymocytes to positive or negative selection 
(Starr et al., 2003). Upon engagement of the TCRs by antigens presented by MHC molecules, 
the Src family kinases Lck and Fyn are activated and phosphorylate immunoreceptor tyrosine-
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based activation motifs (ITAMs) on CD3 (Kane et al
promote the recruitment and subsequent activation of another tyrosine kinase, ZAP-70, which, 
in turn, phosphorylates the tyrosine residues on the adapter molecule Linker for Activation of 
T cells (LAT) (Samelson, 2002). The phosphorylation of LAT results in recruitment of 
several components of the TCR signal transduction pathway, including Growth Factor 
Receptor-Bound Protein-2-Related Adaptor Protein-2 (GADs), SH2 Domain-Containing 
Leukocyte Protein-76 (SLP-76), Phospholipase C gamma 1 (PLC 1) and Growth factor 
receptor-bound protein 2 (GRB2) (Wange, 2000; Koretzky et al., 2006). In the presence of a 
moderate-avidity TCR ligand, partial LAT phosphorylation recruits PLC 1 and GADs/SLP-
76/IL2 Inducible T-cell Kinase (ITK), resulting in the activation of the Ras pathway and 
calcium signalling. The Ras pathway stimulates sustained, low-level Extracellular Signal-
Regulated Kinase (ERK) activation, while the calcium flux activates Nuclear Factor of 
Activated T-cells (NFAT) (Brownlie and Zamoyska, 2013). These signals ultimately lead to 
thymocyte survival, cessation of TCR gene recombination, antigen receptor tuning, cell 
migration into a new thymic environment, and lineage commitment. In contrast, a high-
avidity TCR interaction results in complete phosphorylation of LAT, which, in turn, recruits 
GRB2/Son of Sevenless homolog 1 (SOS1). This results in strong, transient activation of 
ERK, coupled with p38 and c-Jun N-terminal Kinase (JNK) activation, which leads to 
negative selection or programmed cell death (Starr et al., 2003).    
1.4.4. Negative selection of NKT cells 
While positive selection of NKT cells is gradually being clarified, the question of 
whether type I NKT cells are subject to negative selection remains controversial. The most 
compelling evidence indicates that the early introduction of -GalCer, both in vivo and in 
vitro, could specifically ablate NKT cell development. However, it has been shown that the 
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introduction is unable to do so if the challenge is delayed until after NKT cells have 
differentiated (Pellicci et al., 2003). In addition, a study using FTOC has shown that NKT 
cells could not be generated in the thymic lobes if cultivated in the presence of -GalCer, 
while normal development was observed in cultures which employed -GalCer or DMSO 
(Chun et al., 2003; Pellicci et al., 2003). However, treatment of mice with α-GalCer via 
intraperitoneal injection from days 3 to 14 after birth results in depletion of α-GalCer-
loaded CD1d-tet+ cells, with no significant effect on any other T lymphocyte populations 
(Pellicci et al., 2003). Moreover, addition of this antigen to FTOC or in vivo administration 
after the development of type I NKT cells does not affect the absolute number of cells. In 
these studies, the presence of -GalCer, a potent antigen, mediated negative selection of 
type I NKT cells. Unfortunately, -GalCer is not a mammalian self-antigen for the semi-
invariant TCR, thus these studies do not address the question of whether type I NKT cells 
can be negatively selected under physiological conditions.  
More recent studies have examined the effects of ligand-expressing cells by altering 
ligand density. In these experiments, overexpression of CD1d (derived from both mice and 
humans) in transgenic mice impairs NKT cell development and leads to reduced NKT cell 
numbers (Schumann et al., 2005). This is consistent with the possibility that the high levels 
of CD1d result in significant negative selection of NKT cells.  
In addition, by creating mice expressing a transgenic TCR-β chain that pairs with the 
canonical Vα14-Jα18 TCR-α chain and confers high affinity for self-lipid/CD1d complexes, 
Bedel et al. (2014) indicated that effective functional maturation of invariant natural killer T 
cells is constrained by negative selection and T-cell antigen receptor affinity. Analysis with 
PBS57-loaded CD1 tetramers revealed a large reduction in, but not complete loss of, the 
proportion and total number of iNKT cells in the thymus, spleen, and liver of the 2A3-D Tg 
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mice compared with the wildtype mice. While the impairment occurs at the transition from 
stage 1 to stage 2 of NKT cell development the remained iNKT cells that avoid negative 
selection in these mice express natural sequence variants of the canonical TCR-α and 
decreased affinity for self/CD1d. These results directly demonstrates that the TCR signaling 
by agonist self-ligands is the trigger of the iNKT cell differentiation pathway. It also 
emphasizes that only a limited range of TCR affinity for self is actually compatible with 
iNKT cell development versus death by neglect or negative selection (Bedel et al., 2014). 
Collectively, these findings support the hypothesis that the increased affinity or avidity of 
antigen presented intrathymically can induce negative selection of NKT cells.  
The specific types of APCs that could mediate negative selection of NKT cells remain 
a source of controversy. By transferring CD1d-overexpressing DCs into irradiated RAG-/- 
mice reconstituted with wildtype bone-marrow cells, Chun and colleagues demonstrated that 
bone marrow-derived DCs, but not thymic epithelial cells, might be the main cell population 
mediating negative selection of V14NKT cells (Chun et al., 2003). Another study on human 
CD1d transgenic mice has revealed that both thymocytes and APCs (such as DCs, 
macrophages and B cells) may independently induce negative selection. However, 
professional APCs appear to be more efficient in negatively selecting type I NKT cells than 
thymocytes (Schumann et al., 2005). 
1.4.5. NKT cell lineage commitment and maturation 
Following positive selection, nascent NKT cells progress down a pathway of lineage 
commitment and maturation that is marked by the sequential acquisition of specific patterns 
of surface marker expression. Currently, it is believed that this differentiation pathway can be 
subdivided into at least four sequential stages based upon the expression of a variety of 
phenotypic markers, such as the heat stable antigen (HSA or CD24), CD44 and NK1.1. The 
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most immature NKT cells are defined as CD24highCD44lowNK1.1- (Stage 0), followed by 
CD24lowCD44lowNK1.1- (Stage 1), CD24lowCD44highNK1.1- (Stage 2), and finally CD24low 
CD44high NK1.1+ (Stage 3) (Benlagha et al., 2002; Gadue and Stein, 2002; Pellicci et al., 
2002; Benlagha et al., 2005; Bendelac et al., 2007; MacDonald et al., 2007). Stage 0 NKT 
cells exit the DP pool as CD4+
 
cells and are characterised by high expression of heat stable 
antigen, a phenotype consistent with developmental immaturity. This CD4+ CD24high subset 
has a CD44low NK1.1- phenotype indicative of its immature status. Interestingly, CD4+ 
CD24high Vα14 NKT cells are small in size and present in very low numbers (approximately 1 
in every million thymocytes), (Godfrey and Berzins, 2007) consistent with the observation 
that they do not undergo proliferation. Although these cells are non-cycling, they already 
display a marked bias for expression of Vβ8, indicating that Vβ repertoire selection by CD1d 
precedes cell expansion in this lineage. Furthermore, most CD4+ CD24high Vα14 NKT cells 
express the early activation marker CD69, suggesting that they may represent cells that have 
recently undergone positive selection (Bendelac et al., 2007; MacDonald et al., 2007).  
Conversely, intrathymic type I NKT cells in Stage 1 are characterised by the decreased 
expression of CD24 and CD69, although they still remain CD44low and do not express NK1.1. 
They are rapidly cycling, as determined by their large size and ability to incorporate 5-bromo-
2-deoxyuridine (BrdU) in short-term in vivo labelling studies (Berzins et al., 2006). This 
suggests that the post-selection expansion of lineage-committed type I NKT cells occurs at 
this stage. In addition, transition from Stage 0 to Stage 1 marks another unique phase of NKT 
cell maturation, where a proportion of cells lose CD4 expression and give rise to a subset of 
NKT cells that are DN. Using intrathymic cell transfers of purified Vα14 NKT cell subsets, 
several groups have indicated that DN Vα14 NKT cells are in fact derived from immature 
CD4+ (Stage 2 or 3) precursors (Benlagha et al., 2002; Gadue and Stein, 2002; Pellicci et al., 
Chapter 1: An Introduction to Natural Killer T Cells 
 - 41 - 
2002). However, the mechanism responsible for down-regulation of CD4 expression during 
this maturation step remains unclear. 
Stage 2 of Vα14 NKT cell development is defined by up-regulation of CD44, and the 
cells thus acquire a phenotype similar to memory or activated conventional T cells. CD4+ 
CD24low CD44high Vα14 NKT cells do not yet express NK1.1 or other NK-associated 
markers such as the Ly-49 family of inhibitory receptors, but continue to undergo rapid 
proliferation. A majority of the CD24lowCD44highNK1.1- cells emigrate to peripheral tissues, 
where they stop proliferating and rapidly express NK1.1 and other NK lineage markers such 
as NKG2D, Ly49A, C/I, and G2, as well as markers of T cell activation such as CD69 and 
CD122 (Matsuda et al., 2006). Interestingly, a small fraction of CD44high and NK1.1+ cells 
stay in the thymus and accumulate there over the life of the mouse as terminally mature long-
lived resident cells (Berzins et al., 2006). 
The final stage (Stage 3) is distinguished by the acquisition of NK1.1 and Ly-49 
inhibitory receptors. Microarray analysis has indicated concomittant expression of multiple 
NK-related markers at this stage (Matsuda et al., 2006). Stage 3 cells also differ from their 
precursors as they have both CD4+ and CD4-CD8- phenotypes. The CD4-CD8- NKT cells 
account for 30-40% of CD1d-tet-staining cells in adult mouse thymi (MacDonald and Mycko, 
2007). DN Vα14 NKT cells appear to be mature cells since they can express NK cell markers 
such as NK1.1 and Ly-49 family members. Significantly, Stage 3 Vα14 NKT cells cease to 
cycle, consistent with entering a terminal stage of differentiation.  
The classic ‘stage 0-1-2-3’ model has been largely enriched by the discovery of 
alternative NKT1, NKT2 and NKT17 sublineages (Lee et al., 2013; Constantinides and 
Bendelac, 2016; Jameson et al., 2016). However, the new findings also challenge the 
conventional classification of iNKT cells, in which CD44lo NK1.1−  (stage 1) cells upregulate 
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CD44 (stage 2) before finally expressing NK1.1 (stage 3) (Benlagha et al., 2002; Berzins et 
al., 2006; Godfrey and Berzins, 2007). In fact, iIL17RB+ NK1.1− cells do not give rise to 
NK1.1+ cells (Wararai et al., 2012) while NKT2 cells are not precursors of NKT1 cells, and 
that NK1.1− iNKT cells are heterogeneous, containing terminally differentiated IL-4 
producers (hCD2+ NKT2 cells), NKT17 cells, as well as the progenitors for NKT1 cells (Lee 
et al., 2013; Constantinides and Bendelac, 2016; Jameson et al., 2016). 
Recent advances have elucidated, in great detail, the TCR signaling pathway and the 
transcriptional network governing NKT lineage development (Lee et al., 2013; Constantinides 
and Bendelac, 2016; Jameson et al., 2016; Georgiev et al., 2016). It has been suggested that 
IL-17RB, a key component of the receptor for IL-25, was selectively expressed in NKT2 and 
NKT17 precursors but not in NKT1 precursors (Watarai et al., 2012). Strikingly, mice lacking 
IL-17RB lacked both NKT2 and NKT17, but not NKT1 thymocytes, suggesting that 
commitment to these sublineages required signaling through this receptor (Watarai et al., 
2012). As IL-17RB is expressed as early at stage 1 cells, the commitment to NKT1 vs NKT2 
or 17 sublineages may occur very early. Because ~50% of stage 1 and 75% of stage 2 cells are 
IL-17RB+ in the B6 background, the implication of these findings is that there are more 
thymic precursors to the NKT2 and NKT17 lineage than to the NKT1 lineage, which is in 
apparent conflict with the overall predominance of mature NKT1 cells in B6 mice both in 
thymus and in periphery. One possibility is that the NKT2 and NKT17 cells are short-lived 
compared with NKT1 cells, which exhibit IL-15-driven self-renewing properties (Matsuda et 
al., 2002).  
In addition, studies of mice lacking T-bet, GATA3 and RORγt, the signature 
transcription factors of NKT sublineages have shed partial light on the mechanisms regulating 
the NKT sublineage decisions. T-bet-deficient (Townsend et al., 2004) and IL-15-deficient 
mice (Matsuda et al., 2002) exhibited a block in the development of NKT1 thymocytes at a 
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IL-2Rβ− NK1.1− and IL-2Rβlow NK1.1low stage 2, respectively. Interestingly, they also 
exhibited a relative increase in NKT2/NKT17 cells (Watarai et al., 2012; Townsend et al., 
2004). These findings warrant a modification of the early model of NKT cell development 
proposed by Godfrey and colleagues, and raise the question of the branch point at which 
NKT1, NKT2 and NKT17 cells emerge. 
1.5. TRANSCRIPTIONAL REGULATION IN NKT CELL DEVELOPMENT 
The major questions in any developmental system, as well as in NKT cell ontogeny, 
are: 1) what are the factors determining cell fate? 2) how do extrinsic factors influence cell 
fate decisions? and 3), how do cell fate decisions determine cellular function? In the context 
of NKT cell development, there might be special factors at play, as this lineage shows a 
combination of features from multiple cell types (Th1, Th2 and NK cells), and arises from an 
unconventional selection event. In order for type I NKT cells to develop and function 
properly, signals emanating from TCR ligation and the signaling lymphocytic-activation 
molecule (SLAM) receptor interactions must culminate in the coordinated regulation of genes 
that allow for the specification and maturation of this lineage. A number of studies, including 
some quite recent, have provided valuable insights into the transcriptional mechanisms 
regulating type I NKT cell development, such as V14-J18 rearrangement, selection, 
expansion, maturation and acquisition of effector function. 
1.5.1. V14-J18 rearrangement and factors controlling DP thymocyte lifespan 
The rearrangement of V14-J18 gene segments is controlled by a large range of 
factors. Firstly, this process occurs in order from proximal to distal, and as a result, the 
combination of V14 with J18 is secondary (Hu et al., 2010). Therefore, in the process of 
NKT cell development, DP precursors need a relatively long lifespan to achieve V14-J18 
recombination. Mice lacking several transcription or transition factors such as retinoic acid 
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receptor-related orphan receptor (RORt), and anti-apoptotic protein Bcl-xL, possess DP 
precursors with a shortened lifespan, consequently leading to an absence of type I NKT cells 
(Guo et al., 2002). In this case, RORt acts as a transcription factor that induces the 
expression of Bcl-xL, thus prolonging the survival of DP thymocytes (Sun et al., 2000), 
allowing sufficient time for rearrangement of the more distal V-J gene segments required 
for V14-J18 recombination (Bezbradicae et al., 2005; Gadola et al., 2006).  
In addition to these factors, c-Myb - a transcription factor expressed in progenitors of 
all hematopoietic lineages, hematopoietic stem cells, and necessary for definitive 
hematopoiesis – has been shown to influence NKT cell development (Mucenski et al., 1991). 
The expression of c-Myb is highest in DN and DP thymocytes, and then decreases after 
positive selection. c-Myb deficiency strongly impacts early T cell development (especially the 
transition from DN to DP) (Allen et al., 1999), the survival of DP thymocytes, and the 
differentiation of CD4+ single positive thymocytes (Bender et al., 2004). The presence of c-
Myb is also critical for type I NKT cell ontogeny, during which c-Myb primes CD4+CD8+ 
immature thymocytes for selection into the type I NKT lineage. In c-Myb-deficient mice, both 
V14-J18 rearrangement and type I NKT cells are absent. Quantitative RT-PCR analysis of 
the expression of survival factors in sorted DP thymocytes from c-Myb-deficient mice showed 
that Bcl-xL expression is 50% lower in c-Myb-/- mice compared to wild type controls, while 
the expression of other survival factors (such as RORt, Bcl2 and Mcl-1) is almost intact (Hu 
et al., 2010). The effects of c-Myb may be independent of RORt and upstream of Bcl-xL, 
because the retrovirus-mediated addition of Bcl-xL has been shown to restore the V14-J18 
rearrangement, while the introduction of both Bcl-xL and RORt transgene into c-Myb-/- Cd4-
Cre mice is not able to correct the deficiency in NKT cell numbers (Hu et al., 2010). This 
complete block in NKT cell development may be a consequence of a defect in CD1d and 
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SLAM expression because CD1d and SLAM expression is reduced in c-Myb-/- mice. In fact, 
J18-deficient thymocytes can support the differentiation of CD1d-deficient type I NKT cells 
in mixed-bone marrow chimeras, while c-Myb-/- Cd4-Cre thymocytes could not. Therefore, it 
is possible that the deficiency in c-Myb leads to alterations in Bcl-xL, CD1d, and SLAM 
expression, and thus defects in NKT cell development. 
Another signaling molecule that acts very early during NKT cell ontogeny is the Src 
tyrosine kinase Fyn. Results from Gadue’s work indicated that NKT cells are severely 
deficient in Fyn-mutant mice, especially immature NK1.1- NKT cells, while T or NK cell 
development is largely normal (Gadue et al., 1999). Interestingly, the introduction of 
transgenic V14-J18 rearrangement completely rescued NKT cell development, suggesting 
that Fyn is required before -chain rearrangement, rather than for positive selection or NKT 
cell expansion in the periphery. The studies in RORt-/- mice demonstrated that Fyn 
deficiency reduces the period of time for TCR rearrangement, and consequently impairs 
NKT-associated TCR generation (Gadue et al., 1999).  
The E protein family of basic helix-loop-helix transcription factors is comprised of 
HEB, E12, E47 (E2A), and E2-2. Homodimers or heterodimers of HEB members bind to 
DNA at E-box sites and control the expression of genes essential for lineage development. 
The role of E proteins in conventional T cell development has been studied extensively. Both 
E2A and HEB promote TCR gene rearrangement and control thymocyte survival, 
proliferation and positive selection (Bain et al., 1997; Barndt et al., 1999; Barndt et al., 2000; 
Wojciechowski et al., 2007). However, D’Cruz and colleagues (2010) have recently reported 
that specific E proteins also play a role in type I NKT cell development. In this work, deletion 
of HEB in DP thymocytes led to extreme paucity of type I NKT cells at the earliest stage 
(CD24high CD44-NK1.1-), but had minimal impact on the development of conventional CD4+ 
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or CD8+ T cells. In contrast, deletion of E2A has no distinguishable effects on type I NKT 
cell ontogeny. Interestingly, loss of expression of both HEB and E2A impairs T cell 
development, but does not have further effects on type I NKT cell ontogeny, compared to the 
absence of HEB only. The authors concluded that there is a unique requirement for HEB in 
the development of type I NKT cells (D’Cruz et al., 2010). Deficiency of HEB results in 
reduced levels of RORγt and Bcl-XL mRNA, poor survival of DP thymocytes, and 
impairments in generation of distal Jα gene rearrangements, including Vα14-Jα18. Directed 
expression of Bcl-XL or a rearranged Vα14 TCR rescues the type I NKT cell phenotype and 
function, providing further evidence that HEB regulates type I NKT cell development by 
driving the expression of genes stimulating thymocyte survival, thereby allowing for distal 
TCRα rearrangements (D’Cruz et al., 2010; D’Cruz et al., 2014). 
1.5.2. Transcriptional factors that regulate NKT cell ontogeny at the DP stage 
In addition to the strict requirement for signals from invariant TCR-CD1d interaction,  
positive selection of NKT cells requires the homotypic interactions between two members of 
the SLAM family (Griewank et al., 2007). SLAM family molecules are encoded by the Slam 
locus. There are 6 members in the SLAM family, namely SLAMF1, SLAMF3, SLAMF4, 
SLAMF5, SLAMF6, and SLAMF7. They are mostly expressed by cells of hemopoietic origin 
and play a role as TCR-dependent or independent regulators of adhesion and cellular 
activation (Engel et al., 2003). During positive selection of NKT cells, the expression of 
SLAM on thymocytes induces the formation of SLAM-receptor-initiated signaling, which is 
mediated by SLAM–associated protein (SAP), an adaptor that recruits the Src kinase Fyn. 
SAP acts as a stimulator that phosphorylates SLAM receptors by binding to their cytoplasmic 
tails. SAP also binds to the tyrosine kinase Fyn and enhances kinase activity (Simarro et al., 
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2004). These complexes subsequently act as a docking site for a set of signalling molecules in 
NKT cell development.  
There is clear evidence for the relationship between SLAM expression and NKT cell 
development. Mice lacking SLAM or SAP exhibit lower NKT cell numbers, although 
conventional T cells are intact (Chung et al., 2005; Chung et al., 2008). In the absence of SAP 
and Fyn, NKT cell development is arrested at the CD24high CD1d-tethigh CD69+ stage, which 
results in the reduction of mature type I NKT cells by 85% (Griewank et al., 2007). In 
humans, mutations in SAP cause an X-linked immunodeficiency (XLP), which is 
characterised by a deficiency in V24 NKT cells. In the same study by Griewank and 
colleagues (2007), a genetic condition was engineered so that each partner cell in the DP-DP 
interaction was lacking only one SLAM receptor, either SLAMF1 (CD150) or SLAMF6 
(Ly108). The results indicated that NKT precursors lacking one of the two SLAM receptors 
exhibited only modest defects (Griewank et al., 2007). However, in mixed bone marrow 
chimeras designed to abrogate both SLAMF1 and SLAMF6 signalling during CD1d ligand 
recognition in the thymus, a stronger developmental arrest was observed. This scenario 
proved that SLAMF1 and SLAMF6 exerted essential and intrinsic (but partly redundant) 
effects through homophilic self-association across the cell-cell synapse. The Vα14-Jα18 TCR 
recognition of CD1d guided the DP-DP interaction and concurrently permitted other signals 
such as SLAM-SLAM engagement (Griewank et al., 2007).  
Previously, Jordan and colleagues (2007) reported that SLAMF1 expression on DP 
thymocytes from NOD mice is far lower than that of DP thymocytes from C57BL/6 mice. 
The authors have postulated that this low expression is partly responsible for the decreased 
NKT cell numbers observed in the NOD genetic background (Jordan et al., 2007). A genetic 
linkage study in a first backcross from C57BL/6 to NOD.Nkrp1b mice indicated that the 
Slam locus maps to distal chromosome 1, in the same region as the NOD mouse lupus 
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susceptibility gene Babs3/Bana3 (Esteban et al., 2003; Jordan et al., 2007). This genetic 
region together with the chromosome 2 genetic region Nkt2 (containing diabetes 
susceptibility loci), controls NKT cell numbers in NOD mice (Esteban et al., 2003; Jordan 
et al., 2007; Fletcher et al., 2008). Introgression of the C57BL/6-derived Slamf1 allele by 
both congenics and transgenesis corrected the defect of retarded SLAM expression in NOD 
mice and resulted in increased NKT cell numbers in both the thymus and the periphery 
(Jordan et al., 2007; Jordan et al., 2011). 
However, the mechanism by which the SLAM receptor-SAP signals coordinate with 
those emanating from the TCR to support type I NKT cell development remains enigmatic. In 
T cells, stimulation of the SLAM-SAP-Fyn pathway leads to recruitment of the SH2 domain–
containing inositol phosphatase (SHIP), the Dok1/2 adaptor proteins, and the Ras GTPase-
activating protein (RasGAP) (Latour et al., 2001; Wang et al., 2004). It was possible that in 
the absence of SAP, Dok1/2 binds to RasGAP and consequently inhibits Ras-MAPK 
activation (Latour et al., 2001; Wang et al., 2004), which might result in impairment of type I 
NKT cell development because of a failure to negatively regulate Ras signaling. However, 
when the Ras-MAPK pathway was inhibited (using dominant-negative Ras and Mek-1 
transgene), NK1.1+ T cell development seemed unperturbed (Alberola-Ila et al., 1996). As 
these studies were performed prior to the availability of CD1d-tet, it would be worthwhile re-
examining these models using this more specific reagent.  
The SLAM-SAP-Fyn complex also binds to NFκB via protein kinase θ (PKCθ) and 
the Bcl10 adaptor protein (Cannons et al., 2004). In the absence of SAP or Fyn, T cells have 
impaired IκBα degradation, reduced NFκB nuclear translocation in response to TCR 
activation, and fail to recruit PKCθ and Bcl10 to the immunological synapse. This suggests 
that this pathway may interact directly with TCR signaling cascades (Cannons et al., 2004). 
PKCθ or Bcl-10 knockout mice show a severe reduction in type I NKT cell numbers in the 
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thymus and spleen, respectively (Schmitdt-Supprian et al., 2004; Stanic et al., 2004b). Taken 
together, PKCθ, Bcl-10, and NFκB seem to critically modulate type I NKT cell ontogeny, 
however, the developmental stage(s) at which these molecules are required have not yet been 
characterised (Sivakumar et al., 2003; Stanic et al., 2004b).  
The nuclear factor NFκB is likely implicated in Vα14 NKT cell development by 
another important mechanism: Mice deficient in NFκB, or those expressing a dominant 
negative IκBα transgene, showed severely reduced type I NKT cell populations. Importantly, 
the few remaining Vα14 NKT lineage cells in the NFκB-deficient mice did not exhibit mature 
NK markers, such as NK1.1 and Ly-49 inhibitory receptors, and displayed a predominantly 
CD4+ CD44low phenotype (Stanic et al., 2004a). A proportion of these CD4+ NK1.1- CD44low 
Vα14 NKT cells also expressed high levels of CD24, suggesting that they were impaired at 
Stage 1. This block at the immature Vα14 NKT cell stage could be completely rescued by 
overexpression of a Bcl-XL transgene, suggesting that the other function of NFκB in early 
Vα14 NKT cell development is to promote survival (Stanic et al., 2004a). 
The Runt related transcription factor 1 (Runx1) is also a critical regulator of type I 
NKT cell ontogeny at the DP stage. In the absence of Runx1, type I NKT cell development is 
impaired at the earliest detectable type I NKT committed subset, but Vα14-Jα18 
rearrangement is still identified in DP cells lacking Runx1 (Egawa et al., 2005). This indicates 
that Runx1 activity is required for different aspects of type I NKT development, perhaps 
during positive selection or for expansion of post-selection precursors. 
The Myelocytomatosis oncogene (c-Myc) transcription factor is also known to play 
important roles in regulating cell proliferation, survival and apoptosis of the T cell lineage. c-
Myc is expressed at high levels in immature DN thymocytes but reduces as cells enter the DP 
stage (Huang et al., 2008). Targetted deletion of c-Myc during early T cell development 
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results in profound defects in pre-TCR-mediated proliferation, consequently leading to a 
severe impairment of T cell development (Dose et al., 2006). c-Myc deficiency (by the Cd4-
Cre system) in DP thymocytes selectively blocks NKT cell development without effects on 
conventional and natural regulatory T cells. For example, in the absence of c-Myc, type I 
NKT cells appear to be arrested at the CD24lowCD44- stage because of a failure to undergo 
lineage expansion (Mycko et al., 2009), or a later stage of intrathymic proliferation that 
precedes memory acquisition (Dose et al., 2009). Both studies show that the type I NKT cell 
developmental block is not due to impaired survival, as transgenic expression of Bcl-2 does 
not compensate for this defect. Although the reason for the discrepancy between the two 
reports remains unclear, they both demonstrate that c-Myc is indispensible for acquisition of a 
mature CD44+NK1.1+ phenotype (Mycko et al., 2009). 
1.5.3. Transcriptional factors regulating lineage commitment, maturation and homeostasis 
GATA-3 
GATA-3 is a C2C2 type zinc finger transcription factor that is expressed on NK, T, and type I 
NKT cells (Kim et al., 2006). Regarding the T-cell lineage, GATA-3 functions at several 
levels, including differentiation of common lymphoid progenitors into early triple negative 
(TN) cells, progression through β-selection, and during the development of CD4+ T cells (Pai 
et al., 2003; Hernandez-Hoyos et al., 2003). GATA-3 is also important for the differentiation 
of CD4+ T cells into Th2 cytokine-secreting cells (Pai et al., 2003; Hernandez-Hoyos et al., 
2003). GATA-3 operates upstream, downstream, or synergistically (Wang et al., 2008; Ho et 
al., 2009)
 
with Zinc finger transcription factor (ThPOK) in driving the CD4 lineage. Lack of 
GATA-3 at the DP stage results in a cell-intrinsic block in the generation of CD4+ type I NKT 
cells (Kim et al., 2006). This defect is evident in mice from two weeks of age, and involves 
both NK1.1- and NK1.1+ progenitors. Interestingly, in the event of GATA-3 loss extra-thymic 
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NKT cells undergo increased apoptosis, leading to diminished numbers of splenic and more 
notably hepatic type I NKT cells (Kim et al., 2006). Peripheral type I NKT cells also fail to 
express CD69 and do not secrete Th1- or Th2-type cytokines in response to -GalCer (Kim et 
al., 2006). When proximal TCR signals are bypassed using PMA and ionomycin, CD69 
expression and IFN-γ production are restored; however, this challenge fails to compensate for 
the loss of IL-4 and IL-13 secretion. Several important characteristics regarding GATA-3 in 
type I NKT cell development have been emphasized by this work. Firstly, GATA-3 is 
important for the formation of the CD4+ type I NKT cell lineage and secretion of Th2-type 
cytokines. Secondly, GATA-3 is crucial for type I NKT cell survival, especially in the liver. 
However, whether this mechanism is mediated by altered modulation of genes controlling 
hepatic type I NKT cell apoptosis, such as CXC chemokine receptor 6 (CXCR6) (Germanov 
et al., 2008) remains unclear. Thirdly, given the observation that PMA and ionomycin restore 
TCR-induced up-regulation of CD69 and IFN-γ secretion, this suggests that GATA-3 seems 
to function downstream of the TCR to modulate type I NKT cell activation.  
ThPOK 
ThPOK, a member of the BTB-POZ family of zinc finger transcription factors, is required for 
the generation of CD4 NKT cells. Although mice that possess spontaneous mutations in 
Zbtb7b (encoding ThPOK) have normal frequencies and numbers of thymic and peripheral 
NKT cells, their mature NKT cells completely lack CD4 expression and express CD8 on large 
numbers of NKT cells (Dave et al., 1998; He et al., 2005). Additionally, ThPOK-deficient 
mice exhibit defects in the production of IL-4, and, to a lesser extent, IFN- (Dave et al., 
1998; He et al., 2005). It has been suggested that GATA-3 may play a role upstream of 
ThPOK in CD4+ T cell lineage commitment (Germain, 2002). Therefore, it is possible that 
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GATA-3 and ThPOK might function in a similar linear pathway in type I NKT cells to permit 
development of the CD4+ subset and subsequently acquisition of specific effector functions. 
PLZF 
Promyelocytic leukaemia zinc finger (PLZF) transcriptional factor is a key regulator of type I 
NKT cell development and function. Plzf -/- mice or animals bearing a natural mutation in 
Zbtb16 (the gene encoding PLZF), show a severe reduction in type I NKT cell numbers in the 
thymus, but no changes are observed in the development of conventional T cells (Kovalovsky 
et al., 2008; Savage et al., 2008). Thymic NKT cells of PLZF-deficient mice do not acquire 
the typical “activated” phenotypic characteristics, while peripheral NKT cells fail to co-
secrete Th1 and Th2 cytokines upon primary stimulation. However, PLZF-deficient type I 
NKT cells are able to produce IL-4 and IFN- upon secondary activation (Kovalovsky et al., 
2008; Savage et al., 2008). Transgenic expression of PLZF in T cells leads to the acquisition 
of memory-like characteristics in peripheral CD4+ and CD8+ T cells, such as increased CD44 
and reduced CD62L expression. However, these cells show no acquisition of NK or NKT 
cell-associated markers, such as NK1.1, DX5, NKG2D and 2B4 (Savage et al., 2008; 
Raberger et al., 2008; Kovalovsky et al., 2010). PLZF transgenic T cells also express altered 
patterns of cytokine production and enhanced proliferation compared to non-transgenic cells 
(Kovalovsky et al., 2010) that are independent of SAP- and Fyn-mediated signals 
(Kovalovsky et al., 2010). PLZF is expressed in the most immature CD24highCD44- type I 
NKT cells, while the remaining rare CD1d-tet+ cells in the thymi of SAP- or Fyn-deficient 
mice express normal levels of PLZF (Kovalovsky et al., 2008; Savage et al., 2008), indicating 
that PLZF might function early in ontogeny after lineage commitment ((Kovalovsky et al., 
2008), and play a role downstream of the SLAM receptor-SAP-Fyn signaling axis to direct 
the development of type I NKT cells (Das et al., 2010).   
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T-bet 
T-bet is a transcription factor that was originally revealed to be a regulator of Th1 lineage 
specification which also played a critical role in the final maturation stages of type I NKT 
cells (Townsend et al., 2004; Matsuda et al., 2006). Vα14 NKT cells deficient in T-bet are 
selectively blocked at a relatively late stage of development, between Stage 2 (CD44high 
NK1.1-) and Stage 3 (CD44high NK1.1+). Thymic T-bet-/- type I NKT cells do not express 
NK1.1 or other NK-related markers such as members of the Ly-49 inhibitory receptor family. 
They also lack CD122, a component of the IL-15 receptor. Consequently, type I NKT cells 
lacking T-bet fail to proliferate in response to IL-15 (Townsend et al., 2004). In addition, T-
bet-deficient cells do not acquire characteristics of type I NKT cell effector functions, such as 
the ability to produce IFN-γ in response to TCR stimulation, or exhibition of cytolytic activity 
(Townsend et al., 2004; Matsuda et al., 2006; Matsuda et al., 2007). Consistent with these 
developmental and functional defects, T-bet expression increases from Stage 1 to 3 of type I 
NKT cell maturation and directly regulates the stimulation of genes associated with mature 
type I NKT cell functions, such a perforin, FasL, and IFNγ (Matsuda et al., 2006). T-bet 
knockout results in a similar developmental impairment in NK cells (Townsend et al., 2004), 
which indicates that T-bet controls multiple genes involved in migration, survival, and 
effector function of Vα14 NKT cells (Matsuda et al., 2000), and that its role in Vα14 NKT 
cell development may be relatively complex.  
CXCR6 and Inhibitor of DNA-binding proteins (Id)  
CXCR6 has been shown to play a critical role in homeostasis and activation of NKT 
cells by mediating the accumulation of NKT cells in the liver (Germanov et al., 2008). Cells 
lacking CXCR6 show depleted NKT cells in the liver and lungs, but alternatively accumulate 
NKT cells in the bone marrow (Geissmann et al., 2005; Germanov et al., 2008). Similarly, 
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NKT cell survival and homeostasis are also under the regulation of Id2, the inhibitor of DNA-
binding protein. Id2 deficiency results in a drastic and selective reduction of NKT cells in the 
liver, while normal numbers remain in the thymus and spleen. Studies into the mechanisms 
responsible for the reduced number of hepatic cells have revealed no defects in homing to the 
liver. In contrast, Id2-deficient cells showed greater levels of apoptosis. Additionally, Id2-
deficient cells have lower expression of CXCR6, which, as was mentioned above, is 
implicated in the recruitment of hepatic type I NKT cells (Geissmann et al., 2005; Germanov 
et al., 2008; Monticelli et al., 2009). Mice lacking Id2 showed more severely reduced type I 
NKT cell numbers in their livers compared to CXCR6-deficient individuals. Hepatic Id2-
deficient type I NKT cells exhibited reduced expression of Bcl-2 and Bcl-XL, while genetic 
deletion of the pro-apoptotic molecule Bim in Id2-deficient cells rescued type I NKT cell 
numbers. This suggests that Id2 modulates type I NKT cell homeostasis in the liver by 
modulating E protein activity to maintain a favorable balance between pro- and anti-
apoptotic signals.  
Despite the progress made over the last decade, many questions remain regarding the 
molecular mechanisms controlling type I NKT cell development and maturation. For 
example, what is the functional relationship between these crucial transcription factors? Also, 
what governs the activity of these and other transcriptional regulators that function later in 
type I NKT cell development or in the homeostasis of type I NKT cells? Answering these 
questions could lead to a greater understanding of the transcriptional networks regulating type 
I NKT cell development.  
Recently, the identification of an increasing number of αβT cell subsets deriving from 
a common DP precursor has prompted studies investigating genetic factors of these groups. 
Related studies have indicated a number of factors are involved, and these have been 
characterised as “master regulators” of different T cell lineages (Szabo et al., 2000; Hori et 
Chapter 1: An Introduction to Natural Killer T Cells 
 - 55 - 
al., 2003; He et al., 2005; Ivanov et al., 2006). The concept of a master regulator is derived 
from empirical evidence implicating the necessity and sufficiency of a gene in controlling a 
cellular phenotype. However, it should be emphasised that in this context, determination of 
the sufficiency is most often an examination of whether the gene has a dominant impact on 
lineage choice of the immediate progenitor, or changes the fate of the lineage. Generally, the 
dominance of master regulators is typically only evaluated in the transcriptional milieu in 
which they are active. One transcription factor may be necessary for gene expression, but it 
may not be truly sufficient. It can only seem sufficient under precisely limited conditions, 
when all the other needed transcription factors are already present. There might be 
antagonistic or cooperative effects of multiple transcription factors, called a “transcription 
factor network” playing a pivotal role in establishment of lineage diversities from stem cells 
(Sieweke and Graf, 1998; Orkin, 2000; reviewed in Rothenberg, 2007).  
In post-selection T cell ontogeny, ThPOK, Foxp3, T-bet, and RORγt are considered 
master regulators by the criteria mentioned above. They respectively drive CD4 (He et al., 
2005; Sun et al., 2005), regulatory (Hori et al., 2003; Khattri et al., 2003; Fontenot et al., 
2003), Th1 (Szabo et al., 2000), and Th17 (Ivanov et al., 2006)
 
T cell phenotypes. However, a 
closer examination of these systems has revealed additional complexities. For example, 
studies of Foxp3 regulation and activity by Rudensky and colleagues have indicated that 
Foxp3 is not the primary factor in Treg lineage development (Fontenot et al., 2005; Gavin et 
al., 2007). Likewise, there is continued debate regarding the primacy of ThPOK in CD4 
lineage commitment, with evidence that Gata-3 operates upstream, downstream, or 
synergistically with ThPOK in driving the CD4 lineage (Wang et al., 2008; Ho et al., 2009). 
Thus, it is clear that developmental choices are not a linear progression but rather a network 
of interrelated processes, which synergise toward a stable program. Nonetheless, 
accumulating evidence supports the idea that a limited number of unique transcriptional 
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regulators are largely responsible for the differentiation and characteristics of a given lineage, 
perhaps occupying critical “nodes” in the network of interactions or representing the output of 
complex molecular decision circuits (Rothenberg, 2007; Laslo et al., 2008). The behaviour of 
most complex systems can be modelled by the activity of many critical components (nodes) 
that interact with each other through pairwise interactions (termed edges) forming a network. 
Therefore, the compelling question in NKT cell ontogeny is “is the unique NKT cell 
transcriptional milieu organized in the pattern of a distinct lineage?” or “is the NKT cell 
program governed by a signature transcription factor(s)?” 
While transcriptional factors driving conventional T cell development have been well 
studied, those of NKT cell ontogeny are still enigmatic. Since the time NKT cells were first 
described, many efforts have been made to understand the molecular mechanisms that govern 
their homeostasis and function. Transcriptional analyses have previously been made to compare 
gene expression between NKT cells with NK cells, naïve conventional CD4+ T helper, and 
regulatory T cells (Niemeyer et al., 2007), or to shed light on the transcriptional programs 
regulating type I NKT cell development (Cohen et al., 2013). However, due to the lack of DP 
NKT cells (the earliest NKT cell progenitors), these authors can only compare CD44-NK1.1- 
(Stage 1) with CD44+NK1.1- (Stage 2) and CD44+NK1.1+ (Stage 3) NKT cells.  
More recent, many attempts were made to determine the original signals that 
determine which and to what extent a given signaling pathway and/or transcription factor 
expression is required for the commitment to various iNKT cell subsets. The ‘choice’ to 
become iNKT1/ iNKT2/iNKT17 cells  or CD4/DN NKT cells appears to be set in the thymus 
during development, however, it remains unclear whether each ‘fate’ is permanently set or 
can be further modulated. Therefore, understanding the mechanisms of iNKT cell subset 
differentiation is a prerequisite to the manipulation of the iNKT cell response for therapeutic 
purposes. By combining single-cell RNA-Seq, ‘micro-scaled’ RNA-Seq and H3K27ac CHIP-
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Seq assays, Engel and colleagues comprehensively elucidated the differentiation and function 
of thymic iNKT1 (T-bet+PLZFloRORγt−); NKT2 (PLZFhiRORγt−T-bet−) and NKT17 (RORγt+ 
T-bet−PLZFint) cell subsets. Their findings demonstrated that these subsets were substantially 
different in their expression of not only transcriptional factors and cytokine but also molecules 
involved in homing, inhibitory receptors that presumably help to modulate autoreactivity, and 
also effector molecules that provide host defense and the regulation of inflammation (Engel et 
al., 2016). 
To provide new insights into iNKT cell function and development based on the 
iNKT1/2/17 classification, Georgiev and colleagues investigated the transcriptomes of 
iNKT1, 2 and 17 cells from thymus of BALB/c and C57BL/6 mice. The results confirmed 
that a subdivision into iNKT1, 2 and 17 cells is suitable to characterize iNKT cells 
independent of the strain but also revealed candidate genes that may explain strain dependent 
variations in iNKT subset composition reported earlier by Lee et al. (2013). Many candidate 
genes that may affect iNKT cell development, migration or function were identified. They 
showed that Fcer1g is involved in generation of iNKT1 cells and that SerpinB1 modulates 
frequency of iNKT17 cells. The results provided comprehensive support for the iNKT1/2/17-
concept. The in depth characterization of iNKT1, 2 and 17 thymocytes reveals that each 
subset is not composed of a uniform population of cells because IL-4+ iNKT2 cells are clearly 
distinct from IL-4− iNKT2 cells and a substantial proportion of iNKT17 cells express IL-4 
along with IL-17 (Georgiev et al., 2016). However, it remains to be determined whether IL-
4+IL-17+ iNKT cells represent a transitory population differentiating into IL-17+ cells. Their 
current view would be in line with a hypothesis that each iNKT subset contains a population 
of terminally matured cells (CD4− iNKT1, IL-4+ iNKT2, IL-17+ iNKT17) but also a 
population of cells not yet finally differentiated (CD4+ iNKT1 cells, IL-4− iNKT2, IL-4+ IL-
17+ iNKT17) (Georgiev et al., 2016). 
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To address these issues, Lee et al. (2016) also performed RNAseq analysis of iNKT 
subsets, including NKTp, NKT1, NKT2 and NKT17 cells. Importantly, they found only 
NKT1 cells, but not NKT2 and NKT17 cells, shared a transcriptional program with NK 
(Cohen et al., 2013), activated CD8 T and intraepithelial γδ-T cells. They also identified that 
NKTp signature genes were shared amongst differentiating or proliferating hematopoietic 
cells including developing thymocytes, which were associated with an upstream regulator 
Myc protein (Lee et al., 2016). Using previously published data sets, these authors measured 
the transcriptional similarity of iNKT subsets to those of analogous γδ-T cells, ILC and Th 
cells. Signature genes of NKT1 cells were defined, and found to be highly shared with ILC1 
and Th1 cells, indicating profound similarity between the transcriptional programs of all IFN-
γ - producing cells (Lee et al., 2016). NKT2 cells were most similar to thymic CD24low Vδ6+ 
γδ-T cells, both of which expressed high levels of PLZF, followed by ILC2. NKT17 cells 
were similar to thymic CD24low Vγ2+ γδ-T cells and ILC3 cells. Although Th2 and Th17 cells 
shared a small core of effector signature genes with the analogous subsets of ILC, γδ-T and 
iNKT cells, their overall transcriptional profiles were more distinct (Lee et al., 2016). 
There was also a majority of work been done to study transcriptional regulation of NKT 
cells, however, these work mainly queried common factors or reaffirmed the roles of specific 
factors, which were referred from conventional T cell development, or mainly performed on 
relatively mature or mature NKT cells (i.e. at Stage 3). The early development of NKT cells 
especially stage 0 remains unclear. One reason is the very low numbers of developing NKT cells, 
especially DP NKT cells, makes it difficult to analyse transcriptional programs controlling NKT 
cell development. Therefore, to examine transcriptional factors controlling early NKT cell 
ontogeny, especially during the DP stage, transgenic expression of rearranged V14-J18 
segment has been used to increase NKT cell numbers at different stages. This has paved the way 
for transcriptional analysis of NKT cell development at its early stages by microarray. 
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CONCLUSION  
Like many other cell lineages, NKT cells play an important role in bridging innate and 
adaptive immunity.  They have various effects on microbial infection, allergy, cancer, and 
autoimmune diseases. In this work, transgenic expression of rearranged V14-J8 segment 
has increased numbers of CD4+CD8+ (DP) NKT cells in both NOD and C57BL/6 mice. This 
provides an opportunity to compare the transcriptional profiles of the very immature 
CD24+NK1.1- DP NKT cells with those of conventional T cells (CD24+NK1.1- DP T cells), 
and those of more mature NKT cell subsets, which include CD24+NK1.1- CD4+ NKT cells 
and CD24+NK1.1- DN NKT cells. Via microarray analysis, expression levels of a total of 
35,556 transcripts for each biological sample of four different cell populations were obtained. 
Principal component analysis (PCA), which was conducted on all transcripts under 
investigation, indicated that the four populations clearly separated, in order, across principal 
component 1 (PC1) from CD24+NK1.1- DP T cells (P1), to CD24+NK1.1- DP NKT cells 
(P2), to CD24+NK1.1- CD4+ NKT cells (P3), and finally to CD24+NK1.1- DN NKT cells 
(P4). Comparison of gene expression between the populations (in this order) has revealed 
highly differentially expressed genes at transitions. Here, the aim has been to extend this work 
to understand the change in expression of transcriptional factors during NKT cell ontogeny. 
Gene co-expression network analyses were also undertaken to assess the relationship between 
transcripts during mouse NKT cell development. 
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2.1. ANIMALS FOR STUDIES 
Non-obese diabetic (NOD) and C57BL/6J (B6), congenic, transgenic and mutant mice 
were maintained under specific pathogenic-free conditions at the Immunogenetics Research 
Facility of James Cook University (Douglas, QLD, Australia). Mice of both sexes were used 
at 6-12 weeks of age. In a single experiment, experimental mice were age and sex - matched 
with controls. All mouse experiments were reviewed and approved by the Animal Ethics 
Committee at James Cook University (A1753, A2142 and A2162). 
 As this study focuses on NKT cell development, the natural killer (NK) cell gene 
complex had previously been introduced into all NOD mouse strains to permit the use of the 
NK1.1 marker for characterising NKT cell maturation. This complex (called Nkrp1b) was 
originally derived from chromosome 6 of B6 mice; the proximal boundary lay between 
D6mit323 and D6mit105 and the distal boundary lay between D6mit135 and D6mit259. There 
was no evidence that the Nkrp1b congenic segment altered the number or function of NKT 
cells in the NOD.Nkrp1b congenic line (Matsuda et al., 2001; Hammond et al., 2001; Poulton 
et al., 2001; Matsuki et al., 2003; Rogner et al., 2001), therefore, NOD.Nkrp1b mice were 
used as wild type controls for all experiments on a NOD background.   
2.1.1. Inbred mouse strains 
A number of mouse strains used in this research were originally purchased from the 
Jackson laboratory (Jackson lab., Maine, USA) and Animal Resource Centre (Canning Vale, 
WA), or kindly provided from previous studies. They were inbred in the Immunogenetics 
Research Facility at Douglas campus, James Cook University, Australia. 
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Table 2.1. Inbred mouse strains used in this study 
Mouse strains Description Source 
NOD/Lt Wild type NOD strain The Jackson lab. 
NOD.Nkrp1b Congenic for NK1.1 marker from B6 background The Jackson lab. 
NOD.Nkrp1b.Cd1d-/- Congenic for NK1.1 marker from B6 and mutant for Cd1d. Dr. Margaret Jordan 
C57BL/6J Wild type B6 strain The Jackson lab. 
B6.Ccr2-/- B6 with Ccr2 knock out The Jackson lab. 
B6.Ccr7-/- B6 with Ccr7 knock out The Jackson lab. 
B6.Nkg7-/- B6 with Nkg7 knock out 
Australian 
Phenomics Facility 
B6.Cd1d-/- B6 with Cd1d knock out The Jackson lab. 
 
2.1.2. Production of Vα14-Jα18 transgenic (Va14Tg) mouse strains 
 NOD and B6 Vα14-Jα18 transgenic mice were generated by Dr. Margaret Jordan 
using the previously published construct, kindly provided by Prof. Albert Bendelac (Lantz 
and Bendelac, 1994). Briefly, the pre-rearranged Vα14-Jα18 TCR α chain complementary 
DNA (cDNA) was PCR-amplified from the CD1-specific T cell hybridoma DN32.D3 (Lantz 
and Bedelac, 1994). Then, Vα14-Jα18 cDNA was inserted into the SalI site of a plasmid 
containing the minimal CD4 promoter, enhancer and the intronic silencer (Sawada et al., 
1994; Matsuda et al., 2001). The linearized (via NotI) construct was purified by agarose gel 
electrophoresis, agarase treated, re-purified and injected directly into NOD/Lt embryonic 
pronuclei at the Walter and Elisa Hall microinjection unit (Melbourne, Australia). The 
manipulated embryos were placed in the reproductive tracts of pseudo-pregnant NOD/Lt 
recipient female mice. Transgenic mice were screened by polymerase chain reaction (PCR) 
and crossed onto the NOD.Nkrp1b line to permit the use of the NK1.1 developmental marker.  
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Table 2.2. Va14 transgenic mouse strains 
Mouse strains Description Source 
NOD.Nkrp1b.V14Tg (line 1, 2, 3, 4) Transgenic for V14-J18 
segment. 
Generated by Dr. Margaret 
Jordan using a construct gifted 
by Prof. A. Bendelac B6.V14Tg (line 2, 5) 
 
2.1.3. In-house established mouse strains 
Three mouse strains (Table 2.3) were established in-house by crossing inbred mouse 
strains carrying different genes of interest. In short, mice from two different strains were 
crossed to generate heterozygous progeny. Resultant heterozygous mice were then 
intercrossed and the subsequent generations were genotyped to identify founder mice for the 
next generation. If the genes or genetic regions of interest were congenic (such as Nkrp1b), 
homozygous congenic founders were selected to establish the congenic line. If the genes of 
interest were targeted deletion mutations, mutant mice were selected for the next generation. 
Intercrosses were set up until mice with the desired combination of genes were produced. 
Table 2.3. In-house established mouse strains 
Strain Description Source 
NOD.Nkrp1b.Cd1d-/-.V14Tg A strain resulting from intercrossing Cd1d
-/- 
from NOD.Nkrp1b.Cd1d-/- to 
NOD.Nkrp1b.V14Tg 
Generated in this study 
B6.Cd1d-/-V14Tg. A strain resulting from intercrossing Cd1d
-/- 
from B6.Cd1d-/- to B6.V14Tg  
Generated in this study 
B6.Ccr7-/-.V14Tg A strain resulting from intercrossing Ccr7
-/- 
from B6.Ccr7-/- to B6.V14Tg  
Generated in this study 
 
For the remainder of this thesis, the strain designation “NOD” refers to NOD.Nkrp1b 
mice. For example, “NOD.V14Tg” refers to NOD.Nkrp1b.V14Tg mice, NOD.Cd1d-/- refers 
to NOD.Nkrp1b.Cd1d-/- mice, and so on. 
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2.2. GENOTYPING 
Pups from intercrosses were genotyped to set up new combinations of target genes. 
The appearance or absence of a gene was checked by PCR, or by flow cytometry, depending 
on the availability of suitable antibodies. 
2.2.1. Genotyping by PCR 
Genomic DNA was extracted from tail tips or ear punches using a CAS-1810 X-
tractor Gene (Corbett Robotics) liquid handling platform. Tail tips (11 mm from top) or ear 
punches were collected into 1.5 ml Eppendoft tubes, then digested overnight in 420 µL Tissue 
digest buffer (100mM TrisHCl pH 8, 10 mM EDTA, 100 mM NaCl, 0.5% SDS, 50 mM DTT, 
100 mM Proteinase K) at 56oC, 30 rpm in a VORTEMP 56EVC (Labnet, Hialeah, FL, USA) 
or overnight, in a 56oC incubator (MIR-262, Sanyo, Japan). Samples were mixed by vortexing 
and then centrifuged to separate out fur and/or bones. Two hundred and twenty µL from each 
digested sample was loaded in a 96-deep well plate, before adding 440 µL Lysis buffer 
(consisting of 5.25 M Guanidine thiocyanate, 10 mM Tris HCl pH 6.5, 20 mM EDTA, 4% 
Triton-X, 64.8 mM DTT) was added to each sample. Samples were then loaded on a glass 
filter (GF/B) polypropylene microplate (Whatman International, Clifton, USA) and vacuumed 
to capture the DNA on the filter. Samples were washed once by adding 200 µL Lysing buffer 
then vacuumed to remove unbound fractions. Samples were washed twice in Propanol wash 
buffer and once in 100% ethanol. DNA was then eluted in 100 µL Elution buffer (10 mM 
Tris-HCl pH 8.5, 0.5 mM EDTA). DNA concentration was measured using a NanoDrop 
ND1000 spectrophotometer (Bio-Rad Laboratories). 
Genotyping of the crosses between mouse strains carrying congenic regions from B6 
(Nkrp1b) were performed by using primers chosen from the simple sequence length 
polymorphism library, Whitehead Institute (Cambridge, MA; Dietrich 1996), or primers 
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designed in-house on the basis of PCR product length polymorphism between C57BL/6 and 
NOD/Lt strains (Table 2.4). Genotyping of knock-out genes was based on the protocols 
provided.  
With regards to the transgenic mouse strains (V14Tg), genotyping followed in-house 
established primers and PCR protocols. DNA from subsequent generations and controls 
(including homozygous, heterozygous, and negative DNA controls) was measured and 
diluted to the same concentration (usually at 7.5 ng/µL). PCR reactions and electrophoresis 
were performed at the same conditions between samples and controls. The results were 
assessed based on the intensity of the electrophoretic bands compared to controls. The 
samples from homozygous mice possibly have stronger bands than samples from 
heterozygous mice. Mice with the brightest transgenic bands were chosen as founders for 
the next generation. Confirmation of homozygosis was performed by outercrossing to wild 
type mice. Male and female homozygous transgenic mice were used to generate the 
homozygous transgenic mouse strains. 
Table 2.4. Primer details 
Targeted 
gene or 
region 
Primer 
(from 5’-3’) 
Expected results 
Nkrp1b D6mit135 
Primer 1: CCTAACAGTTCAATTTGTCAGCC  
Primer 2: CCAGCCCCCAATTTGATATA  
B6 allele = 140 bp 
NOD allele = 130 bp 
Ccr7-/- WT reverse: GGTGATCAAGGCCTCCACT 
Mutant reverse: AGACTGCCTTGGGAAAAGCG 
Common: TAAGGGCATCTTTGGCATCT 
Mutant =  110 bp 
Het =  110 bp and 280 bp 
WT = 280 bp 
V14Tg Forward primer: TGTAGGCTCAGATTCCCAACC 
Reverse primer: GAGGATGGAGCTTGGGAGTCAGG 
WT = no band 
Het. or Hom. = 1000 bp 
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2.2.2. Confirmation of genotype of target mutant Cd1d mice by FACS 
The presence or absence of a gene’s products can be identified using a fluorescent 
conjugated antibody. For example, in this work, knock-outs of Cd1d genes from mice resulted 
in the absence of the CD1d marker on the surface of their lymphocytes, which can be 
confirmed by flow cytometric analysis, using a fluorescent conjugated anti-mouse CD1d 
antibody. Briefly, 30µL blood samples were collected by retro-orbital bleeding. Red blood 
cells were lysed using Red blood cell lysing buffer (Sigma-Aldrich). Peripheral blood 
mononuclear cells (PBMCs) were collected by centrifugation at 300g, then labeled with PE-
conjugated anti-mouse CD1d antibody (eBioscience). Results were assessed by fluorescent 
intensity of CD1d compared to controls (Cd1d knock out and wild type blood samples; 
Figure 2.1.). 
 
Figure 2.1. Genotyping Cd1d knockout mice by FACS from blood. Density plot (left panel) presents 
PBMCs by forward scatter area and side scatter area. The histogram (right panel) shows the fluorescent 
intensity of CD1d expression on lymphocytes. KO stands for Cd1d knockout; Het stands for Cd1d heterozygous; 
and WT stands for Cd1d wild type. 
2.3. FLOW CYTOMETRIC CELL ANALYSES 
2.3.1. Organ harvesting and single cell suspension preparation 
Experimental mice were sacrificed by CO2 asphyxiation. Thymi and spleens were 
collected into 10 ml tubes containing 3 ml ice-cold MACS buffer (DPBS containing 2 mM 
EDTA (Amresco, Solon, Ohio, USA), 10% (v/v) Bovine Serum (Invitrogen, Melbourne, 
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Australia), and 0.02% (w/v) Sodium Azide; Jordan et al., 2011). Livers were perfused with 5-
10 ml chilled PBS via the portal vein to flush red blood cells out of the liver tissues; they were 
then harvested into marked 50 ml conical tubes containing 5 ml 1x PBS. Single cell 
suspensions were prepared and counted using a cell counter (Beckman Counter); total cell 
numbers per organ were calculated based on the volume of the single cell suspension and the 
number of cells counted per milliliter. 
Single cell suspensions from thymus samples were prepared by gently disrupting the 
thymus between two frosted microscope slides in MACS buffer. Cell suspensions were 
collected and passed through 40µm meshes. The thymic cells were washed by spinning at 300 
g for 8 min at 4oC and re-suspended in 1 ml MACS buffer for flow cytometric cell analyses. 
Single cell suspensions from spleens were prepared by flushing with 3 ml MACS 
buffer using a 3 ml syringe and a 25 gauge needle, and then gently disrupting them between 
two frosted microscope slides. Cell suspensions were collected and passed through 40µm 
meshes. The cells were centrifuged at 300 g for 8 min at 4oC before being treated with 2 ml 
Red Blood Cell Lysing buffer (Sigma Aldrich, Castle Hill, NSW, Australia), at room 
temperature for 5 min. After adding 2 ml MACS buffer to stop the reaction, cells were 
washed and resuspended in 1 ml MACS buffer. 
 Individual livers were cut into small pieces and gently pressed through an 180µm wire 
stainless steel mesh. The cells were collected by spinning at 500 g for 5 min at 4oC and washed 
twice with 25 ml chilled PBS. Parenchymal cells were removed over a 33.75% Percoll gradient 
(GE Healthcare, NSW, Australia). Liver lymphocytes were collected then washed twice with 1x 
PBS following by spinning at 300g for 8 min at 4oC. Cells were treated with 3 ml Red Blood 
Cell Lysing buffer at room temperature for 5 min. After adding 25 ml MACS buffer to stop the 
reaction, cells were washed by spinning at 300 g for 8 min at 4oC and re-suspended in 1 ml 
MACS buffer for flow cytometric cell analyses. 
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2.3.2. Surface staining and flow cytometric cell analyses 
For flow cytometric cell analyses, 3-5 million cells were surface labeled with various 
combinations of the following antibodies:  
Table 2.5. List of antibodies used in staining mouse cells for flow cytometric cell analyses 
Antibody 
Fluorescence 
conjugated 
Host Isotype Reactivity Clone Company 
anti-CD16/32 Unconjugated Rat IgG2a, λ Mouse 93 eBioscience 
anti-TCR 
APC or FITC Hamster IgG2, λ1 Mouse H57-597 BD Bioscience 
PerCP Cy5.5 Hamster IgG Mouse H57-597 eBioscience 
anti-CD4 
FITC, V500, 
BV510 or BV650 
Rat IgG2b, κ Mouse RM4-5 BD Bioscience 
anti-CD8 
APC-Cy7, FITC 
or V450 
Rat IgG2a, κ Mouse 53-6.7 BD Bioscience 
anti-CD44 V450 or FITC Rat IgG2b, κ Mouse IM7 BD Bioscience 
anti-NK1.1 
APC, PE-Cy7 or 
PerCP Cy5.5 
Mouse IgG2a, κ Mouse PK136 BD Bioscience 
PerCP Cy5.5 Mouse IgG2a, κ Mouse PK136 Biolegend 
anti-CD24 FITC or BV605 Rat IgG2b, κ Mouse M1/69 BD Bioscience 
anti TCR V8.1, 8.2 FITC Mouse IgG2a, κ Mouse MR5-2 BD Bioscience 
anti TCR V8.3 FITC Hamster IgG3, λ1 Mouse 1B3.3 BD Bioscience 
anti TCR V7 FITC Rat IgG2b, κ Mouse TR310 BD Bioscience 
anti TCR V2 FITC Rat IgG2a, κ Mouse B20.6 BD Bioscience 
anti-CD1d PE Rat IgG2b, k Mouse 1B1 eBioscience 
anti-CD150 
PE, APC or PE-
Cy7 
Rat IgG2a, λ Mouse 
TC15-
12F12.2 
Biolegend 
anti-CD5 V450 Rat IgG2a, λ Mouse 53-7.3 BD Bioscience 
anti-CD25 APC Rat IgG1, λ Mouse PC61.5 eBioscience 
anti-CD53 Alexa Fluor 647 Rat IgM, k Mouse OX-79 BD Bioscience 
anti-ICOS (CD278) PE Rat IgG2b, κ Mouse 7E.17G9 eBioscience 
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Alpha galactosylceramide (-GalCer) loaded CD1d-tetramers (CD1d-tet) were 
produced by Mr. Marcin Ciula in Prof. Dale Godfrey’s laboratory (University of Melbourne). 
Firstly, mouse CD1d protein (mCD1d) was made in a baculovirus expression system as 
described previously (Matsuda et al., 2000). Purified mCD1d protein was then biotinylated 
with BirA enzyme and loaded with -GalCer. Consequently, -GalCer loaded mCD1d was 
tetramerized by adding neutravidin -PE, APC, or BV421. This protocol was originally 
provided by Prof. Mitchell Kronenberg’s laboratory (La Jolla Institute for Allergy and 
Immunology, San Diego, CA). 
 For surface staining, antibodies were diluted in MACS buffer. Cells were pre-
incubated with unconjugated anti-CD16/32 (clone 93, eBiosciences, San Diego, CA, USA) 
for 15 min at 4oC to prevent Fc receptor binding of labelled antibodies, before the addition of 
surface staining antibody cocktails. Lymphocytes were identified by forward and side scatter 
profiles. A forward scatter-area against forward scatter-height gate was used to exclude 
doublets from analysis. Dead cells were excluded from analysis by propidium iodide staining. 
Where possible, an empty fluorescent channel was used to exclude auto-fluorescent cells. 
Data were acquired on a BD LSRII Fortessa cytometer (BD Bioscience, San Jose, California, 
USA) and analysed using FlowJo software (Tree Star, Inc., Ashland, OR). 
2.3.3. Cell sorting 
Single cell suspensions from thymi of 6 week old female NOD.V14Tg line 1 mice 
were stained on ice for 25 min with specific antibodies, such as anti-TCR (H57-597), CD1d-
tetramer, anti-CD4 (RM4-5), anti-CD8 (53-6.7), anti-CD24 (M1/69) and anti-NK1.1 (PK 
136). Cells were sorted on a BD FACSAria II. Cell doublets were excluded using 3 
comparisons: forward scatter-area to forward scatter-height, forward scatter-height to forward 
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scatter-width, and side scatter-height to side scatter-width. Dead cells were excluded from 
analysis by propidium iodide staining. All samples were analysed after sorting to confirm 
viability and cell purities were over 97%. 
2.4. FUNCTIONAL ASSAYS 
2.4.1. In vivo treatment with -GalCer   
Alpha-GalCer (Enzo Life Science, NY, USA) was reconstituted in PBS containing 
0.5% Tween-20 (Sigma-Aldrich) to the concentration of 200 mg/ml by sonicating for 2 hours 
at 37oC. Six-week old mice were intravenously injected with 4 µg of -GalCer in 200 µl 
PBS1X or control vehicle (200 µl PBS1X containing 0.05% Tween-20). Mice were bled four 
hourly following injection; sera were collected and immediately stored in a - 80oC freezer for 
cytokine bead assays to assess NKT cell function. In different experiments, 6-week old mice 
were injected with -GalCer (4 µg in 200 µl PBS for an intravenous injection or 2 µg in 10 µl 
PBS for an intrathymic injection) or control vehicle. Injected mice were culled 40 hours later 
to harvest lymphoid organs (thymus, spleen and liver) for flow cytometric cell analyses. 
2.4.2. In vitro NKT cell culture 
Single-cell suspensions obtained from whole thymus were labeled with anti-TCR 
(H57-597), CD1d-tetramer, anti-CD4 (RM4-5), anti-CD8 (53-6.7), anti-CD24 (M1/69) and 
anti-NK1.1 (PK 136). Immature CD4 NKT cells and immature DN NKT cells were isolated 
by FACS on an BD Aria II (as described previously in section 2.3.3). Isolated NKT cells were 
resuspended and plated at 1 x 104/200l in RPMI 1640 supplemented with 10% (v/v) FCS 
(Invitrogen Life Technologies, Mulgrave, Victoria, Australia), 2mM L-glutamine, 100U/ml 
penicillin, 100g/ml streptomycin sulfate, and 50 M 2-ME (Invitrogen Life Technologies, 
Mulgrave, Victoria, Australia). Culture wells were coated with 100 l anti CD3e  
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(eBioscience, Campus Vienna Biocenter 2, 1030 Vienna, Austria) overnight at the 
concentration 10g/ml PBS. Cells were cultured in the presence or absence of 100U/ml 
murine rIL-2 and 100U/ml murine rIL-15 (R&D system, Inc., Minneapolis, MN, USA) for 
70h at 37oC, 5% CO2 and humidity in an incubator (MCO-20AIC, Sanyo, Japan). 
2.4.3. Cytokine bead assays 
Quantitative detection of cytokines from mouse sera and cell culture supernatants 
was performed by cytometric bead array using Bender Medsystems mouse Th1/Th2 10plex 
(Bender Medsystems, Vienna, Austria). Samples were analysed following the 
manufacturer's protocol. The detection limits were 10.9 pg/ml for GM-CSF, 6.5 pg/ml for 
IFN-γ, 15.7 pg/ml for IL-1α, 8.8 pg/ml for IL-2, 0.7 pg/ml for IL-4, 4.0 pg/ml for IL-5, 22 
pg/ml for IL-6, 5.5 pg/ml for IL-10, 2.4 pg/ml for IL-17 and 2.1 pg/ml for TNF-α. Data 
were acquired on a BD LSRII Fortessa flow cytometer (BD Bioscience, San Jose, 
California, USA) and analysed with FlowCytomisTM Pro version 3.0 (eBioscience, 
Campus Vienna Biocenter 2, Vienna, Austria). 
2.4.4. Diabetes incidence and insulitis assessment 
NOD wild type control mice and NKT cell transgenic mice (NOD.V14Tg line 1) 
(both males and females) were checked weekly for diabetes from 10 weeks of age by random 
blood glucose measurements. Mice were considered diabetic if measurements of blood 
glucose were > 12.5 mg/L on two consecutive readings. Mice with blood glucose 
measurements < 12.5 mg/L were followed until at least 32 weeks of age. At this point, they 
were considered protected. 
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2.4.5. In vivo BrdU incorporation assays 
NOD.Va14Tg mice received 3 intraperitoneal (i.p.) injections of 1mg (in 100 µl PBS) 
BrdU (Sigma-Aldrich; B5002) at 12 hour intervals for a total of 3 mg per mouse at the 
indicated time point before harvest. The mice were culled and thymocytes were isolated. One 
million cells from each sample were distributed into the wells of a 96 well round bottomed 
microplate (Greiner). Cells were pre-incubated with unconjugated anti-CD16/32 (provided 
with FITC BrdU flow kit; BD Bioscience, Pharmingen) for 15 min on ice to prevent Fc 
receptor binding of labelled antibodies. The cells were then surface stained with antibodies in 
a U bottom well plate. The surface stained cells were fixed, permeabilised and intracellularly 
stained with anti-BrdU FITC following the manufacturer’s protocol. Cells were washed twice 
and resuspended in MACS buffer. Five hundred thousand cells were acquired on a BD LSRII 
Fortessa flow cytometer at the flow rate around 400 events per second. 
2.5. MICROARRAY – GENE EXPRESSION ANALYSES 
2.5.1. RNA preparation 
Sorted immature thymic T and NKT cell subsets (7 biological replicates / subset) were 
individually homogenized in the RLT buffer of an RNeasy kit (Qiagen, Venlo, Limburg, 
Netherlands). Homogenates were passed through Qiashedder columns (Qiagen, Limburg, 
Netherlands) and RNA was extracted using the standard RNeasy protocol (RNeasy; Qiagen, 
Limburg, Netherlands). The RNA yields were quantified spectrophotometrically on a 
Nanodrop ND-1000 using the convention that 1 absorbance unit at 260 nm is equal to 40 
µg/ml RNA. Absorbance of sample at 260 and 280 nm was checked and aliquots 
electrophoresed for determination of sample concentration and purity. This technique was 
carried out by Dr. Margaret Jordan and Ms. Letitia Smith (Comparative Genomic Centre, 
James Cook University, Australia). 
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2.5.2. Microarray analysis 
100ng of RNA from each sample were labelled and hybridized. The expression 
microarray hybridizations were performed using the WT Expression kit (Life Technologies, 
CA, USA), WT Terminal Labelling and Controls Kit (Affymetrix, CA, USA) and 
Affymetrix Mouse Gene_1.0ST arrays, which contained 770,317 probe sets representing an 
estimated 28,853 mouse genes. The probed arrays were washed and stained using the 
GeneChip Hybridization Wash and Stain Kit (Affymetrix, CA, USA), and then scanned 
using the GeneChip Scanner 3000. Images (.dat files) were processed using GeneChip 
Command Console (Affymetrix, CA, USA) and the CEL files were imported into Partek 
Genomics Suite 6.6 (Partek SG, Singapore) using an RMA summarisation algorithm for 
further analysis. A statistical significance threshold was set by a Mann-Whitney U test and a 
U-statistic of 0 (i.e. no overlap in signals between two subsets); subsequently the highly 
differentially expressed gene list was refined. This technique was carried out with assistance 
from Dr. Margaret Jordan and Ms. Letitia Smith (Comparative Genomic Centre, James 
Cook University, Australia). 
2.5.3. Gene Co-expression Network  
A gene co-expression network was generated using the Affymetrix Mouse 
Gene_1.0ST array analyses of thymocyte subsets – a total of 28 microarrays. The Affymetrix 
CEL files were normalised using RMA background subtraction in Bioconductor and batch 
effects were removed using the nonparametric CombatR algorithm (Johnson et al., 2007). 
Variability of transcripts across all arrays was ranked by standard deviation (Hahne et al., 
2008) and the 1,929 most variable were used for network construction. Application of the 
WGCNA algorithm in R (Langfelder and Horvath, 2008) generated a weighted gene co-
expression network of 1,929 nodes (transcripts) and 10,626 edges (representing significant 
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correlations at a p<0.02) assigned to 12 significantly co-expressed modules. This technique 
was carried out with assistance from Prof. Alan Baxter, Dr. Margaret Jordan (Comparative 
Genomic Centre, James Cook University, Australia) and Dr Dragana Stanley (Central 
Queensland University, School of Medical and Applied Sciences, Rockhampton, Queensland, 
Australia). 
2.5.4. Gene Ontology Analysis  
Gene lists were generally split into those upregulated and those downregulated before 
being submitted to The Database for Annotation, Visualization and Integrated Discovery 
(DAVID) Bioinformatics Resources v6.7 (Huang et al., 2007; 2009) for gene ontology 
analysis of functional annotation clustering against Clusters of Orthologous Groups (COG) 
Analysis Ontology, Sp Pir Keywords (SP-PIR), Gene Ontology Biological Process (GO-BP), 
Molecular Function (GO-MF), Cellular Compartment (GO-CC), UniProt Sequence annotation 
(UP_SEQ_FEATURE), Online Mendelian Inheritance in Man (OMIM_DISEASE), Biological 
Biochemical Image Database (BBID), BioCarta Pathways (BIOCARTA), and KEGG. This 
technique was carried out with assistance from Prof. Alan Baxter, Dr. Margaret Jordan 
(Comparative Genomic Centre, James Cook University, Australia). 
2.6. REAL-TIME QUANTITATIVE PCR 
Real-time quantitative PCR (qPCR) was conducted with assistance from Dr. Morgane 
Moreau to verify microarray data on gene expression comparison between immature thymic T 
and NKT cell subsets. Briefly, primers were designed and titrated template standards were 
processed in parallel with unknown controls. qPCR were performed on independent sample 
sets of RNA from FACS sorted immature thymic T and NKT cell subsets. PCR mixes were 
set up using a CAS1200 liquid handling platform (Corbett Robotics, Brisbane) and all qPCR 
were carried out on the Rotorgene 3000 or Rotorgene 6000 (Corbett, Sydney, Australia). Each 
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25 µl (15 µl) reaction contained 12.5 µl (7.5 µl) Platinum Syber Green qPCR Supermix, 0.1 
mM (0.08 mM) each primer, and 5 µl (2.5 µl) cDNA. PCR condition included denaturation 
50oC, 2 min, 95oC, 2 min, then 40 cycles (95oC, 30 sec; 50-56oC (primer dependent 
annealing) 30 sec; 72oC, 30 sec; 78oC, 30 sec). Data were acquired at both 72oC and 78oC.  
2.7. STATISTICAL ANALYSES 
Qualitative data were compared by Fisher’s exact test or contingency table (Chi 
squared) analysis. Quantitative data were analysed using GraphPad Prism software versions 
6.0 for Mac and Windows (La Jolla, CA, USA). In flow cytometry experiments, data were 
analysed using BD FACSDiva software (BD Bioscience, San Jose, California, USA) or 
FlowJo software (Tree Star, Inc., Ashland, OR). Data were then exported into .csv or 
Microsoft Excel files and copied into GraphPad for further analyses. Depending on the 
sample size, appropriate statistical test were performed.  
 The statistical significance threshold of the microarray study comparing FACS sorted 
thymic DPhigh CD24high NK1.1-CD1d-tet+TCR+ cells (immature DP NKT cells) and DPhigh 
CD24high NK1.1- CD1d-tet-TCR+ cells (immature DP conventional T cells) from individual 
NOD.V14Tg mice was set at a Mann-Whitney U statistic of 0 (i.e. p <0.001, n=7; equating 
to no overlap between groups). We have previously published empiric validations of 
microarray expression analyses of similar design by using congenic intervals to differentiate 
“on target” from “off target” differential expression (Jordan et al., 2007, Fletcher et al., 2008). 
A comparison group of CD4+CD8-CD24high NK1.1-CD1d-tet+TCR+ cells (immature CD4+ 
NKT cells) and CD4-CD8-CD24high NK1.1-CD1d-tet+TCRint cells (immature DN NKT cells) 
sorted from the same thymi were also analysed, but required some pooling of samples to 
obtain adequate amounts of RNA. Uncorrected significance values are provided for a 
comparison of transcripts of these cells with those from immature DP NKT cells. 
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3.1. INTRODUCTION 
Type I NKT cells are the most prevalent NKT cell subpopulation in mice and humans. 
In mice, they account for more than 85% of NK1.1+ T cells (Lantz et al., 1994; Matsuda et 
al., 2000). Type I NKT cells are characterised by the expression of an invariant TCR  chain, 
which is V14-J18 in mice or V24-J18 in humans (Lantz et al., 1994), in combination 
with a limited set of TCR  chains (mostly V8, V7, V2 in mice and V11 in humans; 
Fowlkes et al., 1987; Budd et al., 1987b; Takahama et al., 1991; Hayakawa et al., 1992; 
Arase et al., 1992; Porcelli et al., 1993; Park et al., 2001). This cell type has evolved to 
recognise glycolipid antigens presented by the non-classical major histocompatibility 
complex class I – like molecule CD1d (Bendelac, 1995). Upon stimulation, they are able to 
rapidly produce large amounts of cytokines, which modulate the behavior of other cells in the 
immune system, including dendritic cells, T cells, B cells and natural killer cells. Through this 
activity, they form an important link between innate and adaptive immune responses and have 
various biological effects on infection, allergy, asthma, cancer and autoimmunity (Berzins et 
al., 2011).  
The definition and classification of type I NKT cells has been made possible through 
the discovery by Kawano and colleagues (1997) that the NKT-associated invariant TCR  
chain, in both mice and humans, shows a uniform reactivity to the marine sponge derived 
glycolipid alpha-galactosylceramide (-GalCer) presented by CD1d (Kawano et al., 1997), 
and the development of -GalCer-loaded CD1d tetramers 3 years later. Prior to these 
innovations, the co-expression of NK1.1+ and TCR as a surrogate phenotype could not track 
type I NKT cells as a whole, because some mouse strains, such as NOD/Lt and BALB/c, do 
not express the NK1.1 marker (Giorda et al., 1992; Matsuda et al., 2000). Furthermore, large 
numbers of type I NKT cells do not express NK1.1 at certain stages during their development.  
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It is now clear that type I NKT cells can be found among mature CD24lowCD44high 
thymocytes (Lantz et al., 1994). In mice, they express either CD4 at intermediate levels or 
else express neither CD4 nor CD8 (double negative – DN). Type I NKT cells can be further 
subdivided on the basis of expression of NK1.1. While NK1.1+ type I NKT cells seem to be 
mature, thymic NK1.1- populations likely represent a pool of immature type I NKT cells. In 
contrast, peripheral NK1.1- type I NKT cells are composed of immature cells that have 
emigrated from thymus and mature type I NKT cells, which have down-regulated the NK1.1 
marker following antigenic stimulation (Chen et al., 1997; Chen and Paul, 1998). In humans, 
NKT cells are either CD4+ or DN or CD8+, with or without the expression of CD56. 
The frequency of type I NKT cells varies consistently between organs. In mice, they 
account for about 0.5% of total thymocytes, but have a higher frequency in peripheral 
lymphoid tissues (around 1% of spleen cells and 30-40% of liver cells; Benlagha et al., 2000; 
Matsuda et al., 2000; Hammond et al., 2001). In humans, the proportion of type I NKT cells 
is not well studied, due to the limitation of sample access. However, it is now known that they 
constitute 0.008-1.176% of blood T cells in the periphery (Marsh et al., 2009), 0.001-0.01 of 
total thymocytes (Baev et al., 2004; Berzins et al., 2005) and 1% of liver lymphocytes 
(Benlagha et al., 2000; Matsuda et al., 2000). 
Studies in the 1990’s and 2000’s have revealed that type I NKT cell numbers are strain 
dependent. Both proportions and absolute numbers of type I NKT cells vary between mouse 
strains. Compared with eight other commonly used mouse strains, such as C57BL/6 and 
BALB.B6-Cmv1r mice, non-obese diabetic (NOD) mice have relatively lower numbers of type I 
NKT cells in their thymi and peripheral lymphoid organs, including their spleens and livers 
(Gombert et al., 1996; Baxter et al., 1997; Godfrey et al., 1997; Poulton et al., 2001; Hammond 
et al., 2001). In addition to the numerical deficiencies, NKT cells derived from NOD mice 
produce relatively less IL-4; 2 to 4-fold lower IL-4 plasma levels in response to anti-CD3 
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administration and 20-fold fewer IL-4 secreting thymic NKT cells than C57BL/6 mice 
(Gombert et al., 1996; Hammond et al., 2001; Poulton et al., 2001).  
The concomitant deficiencies in NKT cell numbers and function have contributed to the 
autoimmune phenotypes seen in NOD mice. These mice spontaneously develop type I diabetes 
(T1D), characterised by the destruction of pancreatic islet beta cells (Baxter et al., 1994). They are 
also susceptible to other autoimmune diseases, such as systemic lupus erythematosus (SLE; 
Esteban et al., 2003), and hemolytic anemia (Baxter et al., 1991). There is a tight relationship 
between the spontaneous development of type I diabetes and the severe decrease in NKT cell 
numbers and function in NOD mice (Makino et al., 1980; Baxter et al., 1997; Hammond et al., 
1998); the course and the severity of type I diabetes in these mice could be moderated by 
increasing NKT cell numbers through adoptive transfer (Hammond et al., 1998; Laloux et al., 
2001), congenesis (Jordan et al., 2007; Chen et al., 2007; Fletcher et al., 2008), transgene of 
V14-J18 (Lehuen et al., 1998) or CD1d (Falcone et al., 2004), or activating them with -
GalCer (Seokmann et al., 2001; Sharif et al., 2001).  
Many endeavours have sought to identify the original factors leading to the reduction of 
NKT cell numbers and function in NOD mice. A genetic linkage study of a first backcross 
between NOD and C57BL/6 mice has revealed that the defect in NKT cell numbers in NOD 
mice is controlled by at least two loci: Nkt1 and Nkt2, which map to regions containing lupus 
and diabetic susceptibility genes, respectively (Esteban et al., 2003). The congenic replacement 
of these two regions, with corresponding regions derived from C57BL/6 mice, partly increased 
NKT cell numbers and delayed the onset of type I diabetes in NOD recipients (Jordan et al., 
2007; Fletcher et al., 2008). However, it did not completely rescue NKT cell numbers nor 
NOD mice from type I diabetes (Chung et al., 2005; 2008; Nichols et al., 2005; Pasquier et al., 
2005; Griewank et al., 2007; Jordan et al., 2007; 2011).  
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In this chapter, type I NKT cell transgenic mice were generated to increase NKT cell 
numbers on both NOD and B6 backgrounds. We were able to provide sufficient numbers of 
immature NKT cells to dissect transcriptional changes associated with NKT cell selection and 
lineage commitment. 
The following hypothesis was tested: “Expression of V14-J18 on a CD4 minimal 
transgenic construct on the NOD strain background will produce functional NKT cells and 
increase NKT cell numbers in early developmental stages, including NKT cells at stage 0”. 
Specifically, the aims of this chapter were: 
1. To investigate the effect of V14-J18 expression on type I NKT cell numbers; 
2. To assess the phenotype of type I NKT cells generated by V14-J18 transgenic mice; 
3. To assess TCR V usage of type I NKT cells generated by V14-J18 transgenic mice; 
4. To assess the function of type I NKT cells generated by V14-J18 transgenic mice. 
3.2. RESULTS 
3.2.1. Production of V14-J18 transgenic mice 
 Vα14-Jα18 transgenic (Vα14Tg) mice have been previously developed to assist 
functional and developmental studies of type 1 NKT cells in B6 mice (Bendelac et al., 1994; 
Griewank et al., 2007). Here, we used their validated transgenic construct containing a type I 
NKT-associated Vα14-Jα18 TCR α chain complementary DNA (cDNA) under the regulatory 
control of a minimal CD4 promoter, enhancer and intronic silencer (Griewank et al., 2007; 
Figure 3.1) to produce transgenic mice on both B6 and NOD backgrounds. Firstly, the pre-
rearranged Vα14-Jα18 TCR α chain cDNA was PCR-amplified from the CD1 specific T cell 
hybridoma DN32.D3 (Lantz et al., 1994). Vα14-Jα18 cDNA was then ligated into the SalI site 
of a plasmid containing the minimal CD4 promoter, enhancer and the intronic silencer 
(Sawada et al., 1994; Matsuda et al., 2001; Fig. 3.1 A).  
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Figure 3.1. Generation of NOD.V14Tg mice. A. A diagram of the transgenic construct, which consists of a CD4 
minigene (including a minimal CD4 promoter/enhancer and the CD4 intronic silencer), 5’ of Vα14-Jα18 TCR α 
chain cDNA and a poly-A tail (Griewank et al., 2007). B. Genotyping gel picture. Pups were genotyped using 
construct-specific primers. mwm = molecular weight marker; +/+ = homozygote for Vα14Tg; +/- = heterozygote 
for Vα14Tg; -/- = wild type (WT); ntc = no template control.  
The construct was prepared by digestion of 10-15g pDNA with Not1 and undergone gel 
electrophoresis to separate the transgene from the backbone. It was then agarase-treated 
and dialysed before being stored at -20C in injection buffer at a concentration of 2g/ml until 
ready to inject. The purified, linearized constructs were directly injected into B6 and NOD/Lt 
embryonic pronuclei at the Transgenic Production Facility of the Walter and Eliza Hall Institute; 
and the manipulated embryos mice were placed in the reproductive tracts of pseudo-pregnant B6 
and NOD/Lt recipient females. The resultant mice were then genotyped by a PCR spanning the 
CD4 to TCR sequence to identify transgene incorporation and germ-line transmission.  
Seven different transgenic founders were identified on the B6 background and seven 
on the NOD background. We ultimately created four different homozygous NOD transgenic 
lines (lines 1, 2, 3, 4) and two B6 transgenic lines (lines 2 and 5). The other founding lines 
either did not obtain germ-line transmission, were poor breeders, or else had malocclusion 
and were therefore culled. All V14Tg NOD lines have been crossed onto the NOD.Nkrp1b 
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line to permit the use of the NK1.1 developmental marker. However, in the text we will use 
the abbreviation NOD.V14Tg instead of NOD.Nkrp1b.V14Tg. 
3.2.2. NKT cells in V14-J18 transgenic mice 
 To investigate the effect of V14-J18 transgenic expression on type I NKT cell 
development, lymphoid organs were collected from 6 - 8 weeks old V14Tg, and wild type 
control mice, to make single cell suspensions. Total cells were counted and 5 million cells from 
each organ were stained with antibodies, and then analysed on a flow cytometer (FACS 
Fortessa from BD Bioscience). Lymphocytes were gated by side scatter area and forward scatter 
area to exclude red blood cells and debris. Single lymphocytes were then selected by using 
forward scatter height against forward scatter area before an exclusion of dead cells by using PI 
and an empty channel (if possible) to exclude autofluorescent cells. Thymic, hepatic and splenic 
NKT cells were identified using fluorochrome conjugated anti-mouse TCR antibody and -
GalCer loaded CD1d-tetramers. NKT cells from V14Tg NOD and B6 mice were compared 
with NOD and B6 wild type controls, respectively. 
Flow cytometric cell analyses revealed that transgenic expression of V14-J18 had 
increased NKT cell numbers on a NOD background. However, the proportions and absolute 
numbers of NKT cells differed between the different transgenic lines.  
In the thymi, there were significant increases in both proportion and absolute numbers 
of NKT cells in all V14Tg NOD lines (p<0.0001, Mann-Whitney U test; Fig. 3.2). Of total 
thymocytes, NKT cells constituted 6.6% in line 1; 8.0% in line 3, and 0.23% in lines 2 and 4 
compared with 0.09% in NOD WT mice. In terms of absolute numbers, transgenic lines 1 and 3 
had a 60-90 fold increases in thymic NKT cell numbers, while lines 2 and 4 had 3-fold increases. 
There were no differences in thymus size between NOD WT control and V14Tg mice, except 
in line 3, which had a significant reduction in total thymocyte numbers (p=0.0115; Fig 3.2). 
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Figure 3.2. Characterisation of NKT cells in the thymi of NOD.V14Tg lines. A. Representative FACS plots 
showing NKT cell gating strategy and the frequencies of NKT cells (TCRintCD1d-tet+) among total cells from 
thymi of NOD WT and four NOD.Vα14Tg lines (1, 2, 3 and 4). B. Dot plots show the frequencies (left panel) and 
absolute numbers (right panel) of NKT cells among total cells from thymus of NOD WT mice compared to four 
NOD.V14Tg lines. Data are means (±SEM) from 5 males and 5 females for each group. Data illustrated are 
combined from two independent experiments. Mann-Whitney U test, **** p<0.0001. 
To assess the effect of V14 transgene on T cell development, thymic T cells were 
gated (Fig. 3.2). There were no significant differences in the proportions of thymic T cells 
between NOD WT and V14Tg mice, except a considerable increase in T cell proportions in 
line 3 (Fig. 3.3; p<0.001). With regard to the absolute numbers, there were significantly 
greater numbers of T cells in lines 1 and 4, while similar T cell numbers were seen in lines 2 
and 3 compared with NOD WT mice (Fig. 3.3). 
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Figure 3.3. Frequencies and absolute numbers of thymic T cells from NOD WT mice compared to four 
NOD.V14Tg lines. Thymic T cells were identified as TCR+ CD1d-tet
-
 from total thymocytes (Figure 3.2). Data 
are means (±SEM) from 5 males and 5 females for each group. Data illustrated are combined from two 
independent experiments. Mann-Whitney U test, * p<0.05, *** p<0.001. 
 
Figure 3.4. Characterisation of NKT cells in the livers of NOD.V14Tg mice. A. Representative FACS plots showing 
NKT cell gating strategy and the frequencies of NKT cells (TCRintCD1d-tet+) among total cells from livers of NOD 
WT and four NOD.Vα14Tg lines (1 to 4). B. Dot plot graphs show the frequencies (left panel) and absolute 
numbers (right panel) of NKT cells among total cells from livers of NOD WT mice compared to four NOD.V14Tg 
lines. Data are means (±SEM) from 5 males and 5 females for each group. Data illustrated are combined from two 
independent experiments. Mann-Whitney U test, * p<0.05, ** p<0.01, *** p<0.001, **** p< 0.0001. 
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V14Tg expression also increased hepatic NKT cell numbers in V14Tg lines 1, 2 
and 3. The numbers of hepatic NKT cells were raised ~4-fold in lines 1 and 3, and by 50% in 
line 2. In sharp contrast, V14Tg line 4 had considerably fewer NKT cells, in both proportion 
and absolute numbers, than NOD WT mice (Fig. 3.4). There were no differences in total 
lymphocyte numbers in the livers. Thus, the increase in hepatic NKT cells may explain a 
slight reduction in proportions of conventional T cells in the liver of all NOD.V14Tg lines 
(Fig. 3.5). 
 
Figure 3.5. Frequencies and absolute numbers of hepatic T cells from NOD WT mice compared to the four 
NOD.V14Tg lines. Hepatic T cells were identified as TCR+ CD1d-tet
-
 from total hepatic leukocytes (Figure 
3.4). Data are means (±SEM) from 5 males and 5 females for each group. Data illustrated are combined from 
two independent experiments. Mann-Whitney U test, ** p<0.01, *** p<0.001, **** p< 0.0001. 
In the spleens, there were significant increases in the percentage of NKT cells in the 
four V14Tg lines (Fig. 3.6). While in WT controls, only 0.56% of total spleen cells were 
NKT cells, the proportion of NKT cells in spleens of V14Tg line 1 was 3.8%, that of line 2 
was 0.80%, line 3 was 5.1% and line 4 was 0.88%. In terms of absolute numbers, lines 1 and 
3 had ~7-fold increases in splenic NKT cell numbers, whereas lines 2 and 4 had similar 
numbers to the non-transgenic parental strain.  
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Figure 3.6. Characterisation of NKT cells in the spleens of NOD.V14Tg mice. A. Representative FACS plots 
showing NKT cell gating strategy and the frequencies of NKT cells (TCRintCD1d-tet+) among total cells from 
spleens of NOD WT and four NOD.Vα14Tg lines (line 1, 2, 3, 4). B. Dot plot graphs show the frequencies (left 
panel) and absolute numbers (right panel) of NKT cells among total splenocytes of NOD WT compared to four 
NOD.V14Tg lines. Data are means (±SEM) from 5 males and 5 females for each group. Data illustrated are 
combined from two independent experiments. Mann-Whitney U test, ** p<0.01, **** p< 0.0001. 
The introduction of V14Tg also affected T cell production in the spleens of 
NOD.V14Tg mice (Fig. 3.7). There were considerable decreases in proportions of 
conventional T cells in lines 1 and 3 compared to the NOD WT controls; line 2 was 
unchanged, while splenic T cell proportions in line 4 were slightly greater. With regards to the 
absolute numbers of conventional T cells, there were no significant differences between WT 
controls and V14Tg lines, except for line 3, in which they were markedly decreased 
(p=0.0001; Mann-Whitney U test; Fig. 3.7). 
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Figure 3.7. Frequencies and absolute numbers of splenic T cells from NOD WT mice compared to the four 
NOD.V14Tg lines. Splenic T cells were identified as TCR+ CD1d-tet
-
 from total splenocytes (Figure 3.6). Data 
are means (±SEM) from 5 males and 5 females for each group. Data illustrated are combined from two 
independent experiments. Mann-Whitney U test, *** p<0.001, **** p< 0.0001. 
The effects of the V14 transgene on B6 mice was examined in comparison with B6 
WT control mice. There was a three-fold reduction in thymus size of both B6.V14Tg line 2 
and line 5 mice compared to B6 WT mice (Fig. 3.8). No significant differences were seen in 
total cell counts from the livers and spleens between line 2 and B6 WT control mice. In 
contrast, total cell counts from the livers of B6.V14Tg line 5 mice were slightly increased 
(p<0.05), and those of spleens from line 5 were decreased compared to B6 WT control mice 
(p<0.05; Fig. 3.8).  
 
Figure 3.8. Total leukocyte counts of thymi, spleens and livers from B6 WT and B6.V14Tg lines 2 and 5 mice. 
Data are means (±SEM) from 5 males and 5 females for each group. Data illustrated are combined from two 
independent experiments 
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NKT cell analyses revealed that the B6 V14-J18 transgenic mice also exhibited 
an augmented frequency of thymic type I NKT cells identified as TCRint CD1d-tet+ (Fig. 
3.9). This was reflected in 35- and 46-fold increases in both proportions and absolute 
numbers of thymic NKT cells in B6.V14Tg lines 2 and 5, respectively. The frequencies 
and absolute numbers of NKT cells in the livers of B6.V14Tg lines 2 and 5 were increased 
by 75%, whereas those of splenic NKT cells were increased more than 6-fold in line 2, and 
9-fold in line 5. B6.V14Tg line 5 had significantly more NKT cells in their thymi and 
spleens compared to line 2, but they had similar NKT cell proportions and numbers in their 
livers (Fig. 3.9).  
 
Figure 3.9. Characterisation of NKT cells from B6.V14Tg mice. A. Representative FACS plots showing the 
frequencies of NKT cells among total cells from thymi (top row), livers (middle row) and spleens (lower row) of 
B6, B6.Vα14Tg line 2 and 5 mice. B. Dot plot graphs show the frequencies (left panel) and absolute numbers 
(right panel) of NKT cells in thymi (top row), livers (middle row) and spleens (lower row) from the two 
B6.V14Tg mouse lines compared to B6 mice. Data are means (±SEM) from 5 males and 5 females for each 
group. Data are combined from two different experiments. 
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In contrast, there were decreased frequencies and absolute numbers of conventional T 
cells in all thymi, livers and spleens of B6.V14Tg lines 2 and 5, except for a slight increase 
in the frequency of mature thymic T cells in line 5 (Fig. 3.10).  
 
 
Figure 3.10. Frequencies and absolute numbers of thymic, hepatic and splenic T cells of the two B6.V14Tg 
lines compared to B6 WT mice. Data are means (±SEM) from 5 males and 5 females for each group. Data are 
combined from two independent experiments 
Taken together, these data indicated that the introduction of a rearranged V14-J18 
transgene significantly increased NKT cell numbers in NOD and B6 mice. 
3.2.3. Characterisation of NKT cell subsets from V14Tg mice  
3.2.3.1. NKT cell subsets from NOD.V14Tg mice 
To investigate whether the introduction of the V14 transgene could increase NKT 
cell numbers at different developmental stages and to analyse NKT cell phenotypes in greater 
detail, TCRintCD1d-tet+ cells were labelled with stage-specific markers (CD4, CD8, CD24, 
CD44 and NK1.1) and subjected to flow cytometry. Using these markers, NKT cells were 
divided into subsets based on the cell surface expression of CD4 and CD8, CD24 and CD44, 
or CD44 and NK1.1 molecules.  
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Flow cytometric cell analyses revealed that both the CD4+ and CD4-CD8- (double 
negative - DN) populations of NKT cells could be identified in the thymi (Fig. 3.11 and 3.12), 
livers (Fig. 3.13) and spleens (Fig. 3.14) of WT mice and mice from the NOD.V14Tg lines. In 
the thymi of NOD.V14Tg mice, these two major subsets totaled 30-60% of NKT cells with a 
DN:CD4 ratio of 3:2, compared to 95% and a 3:4 ratio in WT mice (Fig. 3.11 A). 
 
Figure 3.11. NKT cell subsets from thymi of NOD.V14Tg mice. A. CD4/CD8 NKT cell subsets. B. CD24/CD44 NKT cell 
subsets. C. CD44/NK1.1 NKT cell subsets. D. CD4/NK1.1 NKT cell subsets. For all figures, the representative FACS plots 
show the mean frequencies (±SEM) of NKT cell subsets in total NKT cells from thymi of NOD WT and NOD.V14Tg 
line 1 mice. Bar graphs show the mean frequencies and absolute numbers of thymic NKT cell subsets between NOD 
WT (clear bars) and four NOD.V14Tg mouse lines (filled bars). n = 10 for each group. Data are combined from two 
independent experiments. The NKT gates applied are those illustrated in Figure 3.2. 
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Within the NKT cell population of NOD WT mice, ~92% of thymic NKT cells 
expressed the relatively mature CD24low CD44high phenotype, and <5% expressed the less 
mature CD24high CD44low phenotype (Fig. 3.11 B). By contrast, within the transgenic lines, 
the larger the number of NKT cells present, the lower the proportion of mature CD24low 
CD44high NKT cells present. For example, line 1, which had the highest numbers of thymic 
NKT cells (1.0 x 107 cells/thymus; Fig. 3.2), also had the lowest proportion of CD24low 
CD44high NKT cells (about 7.2% of total NKT cells; Fig. 3.11 B). A semi-log fit of thymic 
NKT cell numbers against proportion of CD24low CD44high cells in a combined data set, 
incorporating five male and five female mice of each strain (WT and the 4 transgenic lines), 
showed a very strong inverse correlation (r2 = 0.94; df=48; n=50; data not shown).  
Thymic NKT cells were further analysed for the expression of CD44, CD4 and 
NK1.1, which can be used to classify NKT cells into developmental stages such as immature 
CD44lowNK1.1-, semi-mature CD44highNK1.1-, and mature CD44highNK1.1+ (Fig. 3.11 C and 
D). A similar trend was seen with the proportion of NK1.1 expressing NKT cells. The 
proportions of mature NK1.1+ NKT cells were reduced in transgenic lines with more NKT 
cells (r2 = 0.74; data not shown). For example, in line 1, only ~3.4% of thymic NKT cells 
expressed NK1.1, compared to >60% in WT mice (Fig. 3.11 C).  
One of the most striking characteristics of the thymic NKT cell population in 
NOD.V14Tg mice was the presence, in very large numbers, of the CD4+CD8+ (double 
positive - DP) subset (Fig. 3.12 A). This population constituted less than 5% of all thymic 
NKT cells in WT NOD mice (estimated at less than 5/106 thymocytes), but between 37 and 
64% of thymic NKT cells in the various lines of NOD.V14Tg mice. The abnormal 
presence of large numbers of DP NKT cells encouraged further analysis of the CD4+CD8-, 
CD4+CD8+, CD4-CD8- and CD4-CD8+ NKT cell subsets for the expression of CD24, CD44 
and NK1.1 (Fig. 3.12).  
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Figure 3.12. Flow cytometric comparison of thymic CD4/CD8 NKT cell subsets in NOD WT and NOD.V14Tg 
line 1 mice. A. Representative FACS plots show the mean frequencies (±SEM) of CD4/CD8 NKT cell subsets of 
total NKT cells from thymi of NOD WT and NOD.V14Tg/1 mice. B. Representative FACS plots show profiles of 
the expression of CD24, CD44 and NK1.1 in the four different thymic CD4/CD8 NKT cell subsets of NOD WT 
(upper rows) and NOD.V14Tg/1 mice (lower rows). C. Graphs show CD24/CD44 expression of the 4 different 
CD4/CD8 NKT cell subsets. D. Graphs show CD44/NK1.1 expression of the 4 different CD4/CD8 NKT cell subsets. 
Data are presented for ten mice/group combined from two independent experiments. The NKT gates applied 
are illustrated in Figure 3.2. 
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As shown in Figure 3.12 B, more than 97% of DP NKT cells expressed a CD24high 
CD44low NK1.1- phenotype, consistent with being the earliest identifiable NKT cells (Fig. 
3.12 C and D). Interestingly, the CD4lowCD8+ NKT cell subset (lying within the CD4-CD8+ 
quadrant gate in our analysis of NOD.V14Tg mice) also expressed a relatively immature 
phenotype: CD24high CD44low NK1.1-.  Comparison with Figure 2 of Gapin and colleagues’ 
(2001) paper suggested that these cells were the DPdull population, previously identified as 
post-selection NKT cells. Conversely, 23-25% of the CD4+ and DN NKT cells had the more 
mature phenotype CD24lowCD44high (Fig. 3.12). Taken together, the above data indicated that 
the transgenic expression of V14-J8 enhanced the production of NKT cells in the thymi 
of NOD.V14Tg mice. However, this enhancement is biased toward the production of 
immature NKT cells at different development stages, especially the generation of DP NKT 
cells at stage 0 (Fig. 3.12). 
In contrast to the thymi, virtually all (>99%) NKT cells in the livers and spleens of 
NOD.V14Tg mice were either CD4+ or DN, although the proportions of these major subsets 
differed from those of WT NOD mice. In the livers, the DN:CD4 ratio was 1:2 in WT mice, 
but ranged from 1.5:1 to 5:1 in NOD.V4Tg mice (Fig. 3.13 A). Similarly, in the spleens, 
the DN:CD4 ratio was 1:4 in WT mice, but varied from 1:2 to 2:1 in NOD.V14Tg lines (Fig. 
3.14 A).  
 
 
PART A                      Chapter 3: Characterisation of type I NKT Cells from Transgenic Mice 
 - 95 - 
 
Figure 3.13. NKT cell subsets in the livers of NOD.V14Tg mice. A. CD4/CD8 NKT cell subsets. B. CD24/CD44 
NKT cell subsets. C. CD44/NK1.1 NKT cell subsets. D. CD4/NK1.1 NKT cell subsets. For all figures, representative 
FACS plots (left panel) show the mean frequencies (±SEM) of NKT cell subsets in total hepatic NKT cells of NOD 
WT and NOD.V14Tg/1 mice. Bar graphs (right panel) show the mean frequencies and absolute numbers of 
hepatic NKT cell subsets between NOD WT (clear bars) and the four NOD.V14Tg mouse lines (filled bars). n = 
10 for each group. Data are combined from two independent experiments. The NKT gates applied are 
illustrated in Figure 3.4. 
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Figure 3.14. NKT cell subsets from the spleens of NOD.V14Tg mice. A. CD4/CD8 NKT cell subsets. B. 
CD24/CD44 NKT cell subsets. C. CD44/NK1.1 NKT cell subsets. D. CD4/NK1.1 NKT cell subsets. For all figures, 
the representative FACS plots (left panels) show the mean frequencies (±SEM) of NKT cell subsets in total 
splenic NKT cells of NOD WT and NOD.V14Tg/1 mice. Bar graphs (right panels) show the mean frequencies 
and absolute numbers of splenic NKT cell subsets between NOD WT (clear bars) and the four NOD.V14Tg 
mouse lines (filled bars). n = 10 for each group. Data are combined from two dependent experiments. The NKT 
gates applied are illustrated in Figure 3.6. 
Additionally, NKT cells from both livers and spleens of NOD.V14Tg mice expressed 
a relatively mature CD24low CD44high phenotype. These CD24low CD44high NKT cells 
comprised more than 98% of hepatic leukocytes and over 82% of splenocytes. This phenotype 
was relatively similar to that of NOD WT controls (Fig. 3.13 B and 3.14 B). Peripheral NKT 
cells were also examined for the expression of CD44 and NK1.1. The proportions of NKT 
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cells with CD44-NK1.1-, CD44+NK1.1- or CD44+NK1.1+ phenotypes in NOD.V14Tg mice 
were similar to those of NOD WT mice (Fig. 3.13 C and 3.14 C).  
In terms of absolute numbers, NOD.V14Tg mice produced more mature NKT cells 
in their peripheries than NOD WT control mice, except for the slightly lower number of 
hepatic CD24-CD44+ NKT cells in line 4 (Fig 3.13 B). For example, the absolute numbers of 
hepatic CD24-CD44+ NKT cells were twofold higher in line 2, threefold higher in line 1 and 
more than 4-fold higher in line 3 compared to those of NOD WT mice (Fig. 3.13 B). In the 
spleens, the absolute numbers of CD24-CD44+ NKT cells were relatively similar between 
NOD.V14Tg line 2 and line 4 mice and NOD WT mice, but it was doubled in NOD.V14Tg 
lines 1 and 3 (Fig. 3.14 B).   
Taken together, these data suggest that NOD.V14Tg mice produced increased 
numbers of immature NKT cells in their thymi and mature NKT cells in their peripheries. 
3.2.3.2. NKT cell subsets from B6.V14Tg mice 
Similar to what had been observed in NOD.V14Tg mice, both CD4 and DN NKT 
cells were identified in the thymi, spleens and livers of B6.V14Tg mice. In the thymi of 
B6.V14Tg mice, the proportion of these two subsets were 45% of total NKT cells in line 2, 
and 67% in line 5, compared to 97% in B6 WT mice (Fig. 3.15 A). The DN:CD4 ratio was 
2:3 in WT, whereas it was 4:1 in B6.V14Tg line 2 and 1.2:1 in line 5. DP NKT cells were 
also seen in the thymi of B6.V14Tg, but to a lower extent than in those of NOD.V14Tg 
mice. They accounted for 49% of total thymic NKT cells in line 2, and 29% in line 5, relative 
to between 37% and 64% on the NOD background. In terms of absolute numbers, B6.V14Tg 
mice produced significantly lower numbers of DP NKT cells than did NOD.V14Tg lines 1 
and 3. However, in comparison with B6 WT mice, B6.V14Tg mice produced much higher 
numbers of CD4+, DN NKT and DP NKT cells.  
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Figure 3.15. NKT cell subsets in the thymi of B6.V14Tg mice. A. CD4/CD8 NKT cell subsets. B. CD24/CD44 NKT 
cell subsets. C. CD44/NK1.1 NKT cell subsets. D. CD4/NK1.1 NKT cell subsets. For all figures, representative 
FACS plots (left panels) show the mean frequencies (±SEM) of NKT cell subsets in total thymic NKT cells of B6 
and B6.V14Tg/2 mice. Bar graphs (right panels) show the mean frequencies and absolute numbers of thymic 
NKT cell subsets between B6 (clear bars) and B6.V14Tg line 2 and 5 mice (filled bars). n = 10 for each group. 
Data are combined from two independent experiments. The NKT gates applied are illustrated in Figure 3.9. 
Additionally, ~94% of thymic NKT cells from B6 WT mice expressed the mature 
phenotype with CD24low CD44high and less than 4% expressing the immature CD24high CD44low 
phenotype (Fig. 3.15 B). In sharp contrast, 18% of thymic NKT cells in B6.V14Tg line 2 and 
34% in line 5 expressed the mature CD24low CD44high phenotype, whereas the immature 
CD24high CD44low compartment comprised 78% in line 2, and 54% in line 5 (Fig. 3.15 B).  
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The same pattern was observed when the expression of CD44 and NK1.1 by thymic 
NKT cells was examined (Fig. 3.15 C). In B6 WT mice, 80% of thymic NKT cells showed 
the mature CD44highNK1.1+ phenotype, 15% were CD44highNK1.1- and only 4.4% expressed 
the CD44lowNK1.1- phenotype. In comparison, the mature CD44highNK1.1+ NKT cells 
constituted only 8.7% and 13% of total thymic NKT cells in B6.V14Tg lines 2 and 5, 
respectively, and the CD44high NK1.1- subset made up 11% of total thymic NKT cells in line 
2, and 22% in line 5. Most of the thymic NKT cells in B6 transgenic mice were the relatively 
immature CD44lowNK1.1- subset. They accounted for 81% in line 2 and 64% in line 5. With 
regards to absolute numbers, although the transgenic expression of V14-J18 considerably 
increased mature CD44highNK1.1+ and CD44highNK1.1- NKT cells, the increase in total 
thymic NKT cell numbers was largely contributed by the expansion of the immature 
CD44lowNK1.1- NKT cell subset (Fig. 3.15 C). 
In contrast to the thymi, virtually all (>99%) NKT cells in the livers and spleens of 
B6.V14Tg mice were either CD4+ or DN, although the proportions of these major subsets 
differed from those of WT B6 mice (Fig. 3.16 A; 3.17 A). In the livers, the DN:CD4 ratio was 
1:3 in WT mice, but was 3:1 in both B6.V14Tg lines. With regard to the absolute numbers, 
there was a slight increase in the numbers of CD4+ NKT cells, whereas those of the DN NKT 
cells were more than 10-fold higher (Fig. 3.16 A). Similarly, in the spleens, the DN:CD4 ratio 
was 1:5.6 in WT mice but was 5:2 and 3:2 in B6.V14Tg lines 2 and 5, respectively (Fig. 
3.17 A). These data are consistent with a previous observation by Lehuen et al. (1998), in 
which they found that the NK1.1+ T cells were mainly of the DN phenotype. 
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Figure 3.16. NKT cell subsets in the livers of B6.V14Tg mice. A. CD4/CD8 NKT cell subsets. B. CD24/CD44 
NKT cell subsets. C. CD44/NK1.1 NKT cell subsets. D. CD4/NK1.1 NKT cell subsets. For all figures, 
representative FACS plots (left panels) show the mean frequencies (±SEM) of NKT cell subsets in total NKT 
cells from livers of B6 and B6.V14Tg/2 mice. Bar graphs (right panels) show the mean frequencies and 
absolute numbers of hepatic NKT cell subsets between B6 (clear bars) and B6.V14Tg line 2 and 5 mice 
(filled bars). n = 10 for each group. Data are combined from two independent experiments. The NKT gates 
applied are illustrated in Figure 3.9. 
Similar to what was seen in the peripheral organs of NOD.V14Tg mice, more than 
98% of hepatic NKT cells (Fig. 3.16 B) and more than 80% of splenic NKT cells (Fig. 3.17 
B) of B6.V14Tg mice expressed the mature CD24lowCD44high phenotype. Of those, the 
majority expressed the NK1.1 marker (Fig. 3.16 C; 3.17 C). In terms of absolute numbers, 
both B6.V14Tg line 2 and line 5 mice produced considerably more CD24lowCD44high NKT 
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cells compared to B6 WT mice. For example, the numbers of hepatic CD24lowCD44high NKT 
cells in B6.V14Tg lines 2 and 5 were more than three times higher than those of B6 mice. 
Similarly, in the spleens, there were four times more CD24lowCD44high NKT cells in line 2 
and five times more in line 5 compared to B6 WT mice (Fig. 3.16 B; 3.17 B). 
 
Figure 3.17. NKT cell subsets in the spleens of B6.V14Tg mice. A: CD4/CD8 NKT cell subsets. B: CD24/CD44 
NKT cell subsets. C: CD44/NK1.1 NKT cell subsets. D: CD4/NK1.1 NKT cell subsets. For all figures, 
representative FACS plots (left panel) show the mean frequencies (±SEM) of NKT cell subsets in total NKT 
cells from spleens of B6 and B6.V14Tg/2 mice. Bar graphs (right panel) show the mean frequencies and 
absolute numbers of splenic NKT cell subsets between B6 (clear bars) and B6.V14Tg lines 2 and 5 mice 
(filled bars). n = 10 for each group. Data are combined from two dependent experiments. The NKT gates 
applied are illustrated in Figure 3.9. 
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As presented earlier, there were a large number of very immature NKT cells (DPhigh 
CD24high CD44low NK1.1-) in the thymi of both NOD and B6 V14 transgenic mice. 
However, their absence in the periphery and the finding that the vast majority of peripheral 
NKT cells were mature suggested that the transgenic expression of V14-J18 had 
successfully resulted in an increase in production of mature NKT cells. The thymic DPhigh 
CD24high CD44low NK1.1- NKT cells likely represent a very immature - possibly pre-
selection - population of NKT cells. 
3.2.4. V usage of NKT cells in V14Tg mice 
We further examined if NKT cells generated by V14Tg mice exhibited typical 
biological features of NKT cells. TCR V usage of NKT cells from NOD.V14Tg line 1 mice 
was compared with that of NOD WT mice. In NOD WT mice, thymic and splenic NKT cells 
were gated using CD3  and CD1d-tet+. The proportions of these NKT cells using TCR V2, 
V7, V8.1-8.2 and V8.3 were identified via histogram plots (Fig. 3.18) and represented by 
bar graphs (Fig. 3.19). In NOD.V14Tg line 1 mice, TCR V usage was examined in five 
different thymic cell populations, including immature DP T cells, DP CD44lowNK1.1- NKT 
cells, CD4 CD44lowNK1.1- NKT cells, DN CD44lowNK1.1- NKT cells and mature CD44+ 
NKT cells (Fig. 3.18 C). TCR V2, V7, V8.1-8.2 and V8.3 usage was identified using 
histogram plots (Fig. 3.18 C) and represented via bar graphs (Fig. 3.19). The TCR V usage 
of splenic NKT cells in NOD.V14Tg line 1 mice was identified in a similar manner to that 
of spleens of NOD WT mice.  
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Figure 3.18. Gating strategy for TCR V usage of NKT cells from NOD WT and NOD.V14Tg/1 mice. A. 
Representative FACS plots show the gating strategy for TCR V8.1-8.2 analysis of thymic NKT cells from NOD 
WT mice. B. Representative FACS plots show the gating strategy for TCR V8.1-8.2 analysis of splenic NKT cells 
from NOD WT mice. C. Representative FACS plots show the gating strategy for TCR V8.1-8.2 analysis of thymic 
NKT cells from NOD.V14Tg/1 mice (n = 6 for NOD WT mice and n=10 for NOD.V14Tg/1 mice).  
Flow cytometric analyses indicated that TCR V usage was variable between cell 
populations and between NOD WT and NOD.V14Tg/1 mice. In wild type mice, almost all 
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thymic and splenic NKT cells used TCR V8.1-8.2, V8.3, V7 or V2; 58% of thymic NKT 
cells used TCR V8.1-8.2, 9.2% used TCR V8.3, 19% used TCR V7 and 13% used TCR 
V2. The same pattern was seen with NKT cells from the spleens of NOD WT mice, with a 
total of 83% of splenic NKT cells presenting this bias (Fig. 3.19 A).  
 
 
Figure 3.19. TCR V usage in NOD.V14Tg/1 mice. A. Bar graph representatives of the mean frequencies of 
TCR V usage of NKT cells in thymus and spleen of NOD WT mice. B. Bar graphs show the mean frequencies of 
TCR V usage of immature and mature thymic and splenic cells from NOD.V4Tg/1 mice (n = 6 for NOD WT 
mice and n=10 for NOD.V14Tg/1 mice).  
 NKT cells generated by NOD.V14Tg mice were also biased toward the use of 
TCR V8.1-8.2, V.3, V7 and V2, as were the NKT cells from NOD WT mice, but to a 
lesser extent in immature thymic NKT cells. A total of 19% of immature DP NKT cells, 
29% of immature CD4 NKT cells and 27% of DN NKT cells presented the TCR V8.1-8.2, 
V.3, V7 and V2 chains. In contrast, 64% of mature thymic CD44+ NKT cells and 74% 
of splenic NKT cells from NOD.V14Tg mice used TCR V8.1-8.2, V.3, V7 and V2 
(Fig. 3.19 B). Although the results are showing that NKT cells generated by 
NOD.V14Tg/1 mice exhibited the same characteristic of TCR V usage as NKT cells from 
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WT mice, 70-80% of CD44- NKT cells and ~38% of CD44+ NKT cells in the thymus of 
NOD.Vα14Tg mice use TCR Vβ chains other than Vβ8, Vβ7 or Vβ2, exceeding by far the 
frequency detected in the thymus of WT NOD mice (~0%). These findings suggest that the 
choice of TCRβ chain affects the probability that a α-GalCer/mCD1d tetramer-binding 
thymocyte will transition from a CD44- to a CD44+ phenotype. 
3.2.5. Generation of functional NKT cells in V14Tg mice 
 In order to confirm that NOD.V14Tg mice generated increased numbers of 
functionally mature NKT cells, six-week old NOD WT and NOD.V14Tg/1 mice were 
intravenously injected with 4µg -GalCer and bled for cytokine analyses by bead array four 
hours later. The following cytokines were examined: GM-CSF, IFN-γ, IL-1α, IL-2, IL-4, IL-
5, IL-6, IL-10, IL-17 and TNF-α (Fig. 3.20).
 
Figure 3.20. V14 transgenic expression increased cytokine production in NOD.V14Tg mice. Bar graphs show 
the mean concentration (±SEM) of IL-4, IFN-, IL-6, IL-2, GM-CSF, TNF- and IL-1 in serum of NOD WT mice (clear 
bars) and NOD.V14Tg line 1 mice (filled bars), 4 hours after challenge with -GalCer (n = 6 for control and 
injected NOD WT mice, n = 10 for control and injected NOD.V14Tg line 1 mice). 
Without stimulation, both NOD WT and NOD.V14Tg/1 mice produced detectable 
levels of TNF and IL-1 but not of the other cytokines assayed. However, in response to -
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GalCer injection, NOD.V14Tg line 1 mice produced large amounts (broadly in the ng range) 
of IL-4, IFN-, IL-2, GM-CSF, IL-6, TNF- and IL-1 compared with NOD WT mice (Fig. 
3.20). However, IL-5, IL-10, and IL-17 could not be detected in any samples. Among 
detected cytokines, IL-4 and IFN- were produced in the largest amounts. NOD WT mice 
secreted three fold greater IFN- than IL-4; whereas an opposite profile was seen in 
NOD.V14Tg/1 mice with two times higher the amount of IL-4. NOD.V14Tg/1 mice 
released 120-fold more IL-4 and 20-fold greater IFN- in response to -GalCer stimulation 
than NOD WT controls. These results are consistent with the substantial increases in NKT 
cell numbers observed in the NOD transgenic mice and suggested a major expansion of 
functional NKT cells in NOD.V14Tg/1 mice. 
To test whether transgenic expression of V14-J18 also produced functionally 
mature NKT cells on a B6 background, the same experiment was conducted to compare 
cytokine production between B6 WT and B6.V14Tg line 2 and line 5 mice. Consistent with 
the findings in NOD mice, sera from both un-injected WT and transgenic B6 mice contained 
detectable levels of TNF- and IL-1 but not of the other cytokines assayed. In contrast, 
B6.V14Tg mice produced large amounts (also in the ng range) of IL-4, IFN-, IL-2, GM-
CSF, IL-6, TNF IL-5 and IL-1 in response to -GalCer compared to B6 WT control mice 
(Fig. 3.21). IL-10 and IL-17 were not detected in any samples.  
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Figure 3.21. V14 transgenic expression increased cytokine production in B6.V14Tg mice. Bar graphs show 
the mean concentration (±SEM) of IL-4, IFN-, IL-6, IL-2, GM-CSF, TNF-, IL-5 and IL-1 in serum of B6 WT (clear 
bars), B6.V14Tg line 2 (grey filled bars) and line 5 mice (black filled bars) 4 hours after challenge with -GalCer. 
(n = 10 for B6 WT control and injected B6.V14Tg line 2 groups, n = 9 for injected B6.V14Tg line 5 group).  
In agreement with a previous study by Bendelac et al. (1996), our data showed that 
upon -GalCer stimulation, B6.V14Tg mice produced markedly higher amounts of IL-4 and 
IFN- than did B6 WT mice (Fig. 3.21): B6.V14Tg line 2 mice released at least 50 times 
more IL-4 and IFN- than B6 WT controls injected with the same amount of -GalCer, while 
line 5 secreted at least 115 times more of each cytokine than the control mice. In comparison 
between the two transgenic lines, B6.V14Tg line 5 produced 2.5 times more IL-4 and 2.3 
times higher IFN- than did line 2 (Fig. 3.21).  
PART A                      Chapter 3: Characterisation of type I NKT Cells from Transgenic Mice 
 - 108 - 
 
Figure 3.22. The correspondence between NKT cell numbers and cytokine production in WT and 
V14Tg mice injected with -GalCer. A. Absolute numbers of thymic, hepatic and splenic NKT cells from NOD 
and B6, WT and V14Tg mice. B. Mean concentration of IL-4 and IFN- in serum of NOD and B6 mice, WT and 
V14Tg, 4 hours after challenge with -GalCer.  
 
Although cytokine production on the NOD and B6 backgrounds were tested on two 
different days, the sera were collected and immediately kept at -80oC and then were analysed 
in parallel. Comparison of the two backgrounds revealed that B6 transgenic mice produced 
significantly more cytokines than NOD transgenic mice. For example, B6.V14Tg line 2 
produced six times more IL-2, 23 times more IL-6, five times more IFN- and three times 
more IL-4 than did NOD.V14Tg line 1. When the numbers of NKT cells were compared to 
the amount of cytokines released by WT and V14 transgenic mouse lines (NOD.V14Tg 
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lines 1 and 3, B6.V14Tg lines 2 and 5), the increase in IL-4 and IFN- production ran 
parallel to the numerical increase in mature NKT cells in the peripheral organs (Fig. 3.20, 
3.21 and 3.22). These results are consistent with greater numbers of functionally mature NKT 
cells being produced by B6.V14Tg mice than by NOD.V14Tg mice.  
3.2.6. Incidence of spontaneous diabetes in NOD.V14Tg line 1 mice 
It is well demonstrated that NOD mice spontaneously develop diabetes at early ages 
and that their reduction in NKT cell numbers and function contributed to this autoimmune 
phenotype (Baxter et al., 1994). Increases in NKT cell numbers by adoptive transfer 
(Hammond et al., 1998; Laloux et al., 2001), V14 TCR transgene expression (Lehuen et al., 
1998) and stimulation of NKT cells in NOD mice by -GalCer (Singh et al., 2001; Hong et 
al., 2001) delayed the disease onset and the severity of insulitis. As presented in early sections 
of this chapter, NOD.V14Tg mice showed the increased proportion and absolute numbers of 
NKT cells. They also produced large amounts of cytokine, such as IL-4 and IF- after in vivo 
stimulation with -GalCer. Therefore, we further examined the function of NKT cells 
produced by NOD.V14Tg mice in protecting these mice from spontaneous development of 
diabetes. NOD wild type control mice and V14 transgenic mice (NOD.V14Tg line 1; both 
males and females) were checked weekly for diabetes from 10 weeks of age by random blood 
glucose measurements (Fig. 3.23). Mice were considered diabetic if measurements of blood 
glucose were >12.5 mg/L on two consecutive readings. Mice with blood glucose 
measurements <12.5 mg/L were followed until at least 32 weeks of age. At this point, they 
were considered protected. 
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Figure 3.23. Diabetes incidence of the NOD.V14Tg line 1 mice. Life-table analysis of diabetes in cohorts of 
male and female NOD WT and NOD.V14Tg mice, which were checked weekly for glucose blood levels from 
10-32 weeks of age   
Our data (Fig. 3.23) showed that by 32 weeks of age, male NOD.V14Tg mice had 
not developed diabetes, while 12/27 (44%) male NOD WT mice did so (p<0.0001, Fisher’s 
exact test). By the same age, 5/27 (19%) female NOD.V14Tg mice had spontaneously 
developed diabetes, compared to 14/30 (47%) female NOD WT control mice (p<0.05, Fisher’s 
exact test; Fig. 3.23). Although 5 out of 27 female NOD.V14Tg mice developed diabetes, this 
occurred at a later stage (19 weeks old) than either male or female NOD WT mice. These data, 
which are consistent with those of Lehuen 1998, show that raising NKT cell numbers by 
expression of a V14-J18 transgene reduced the incidence of diabetes in NOD.V14Tg mice 
compared to NOD WT controls (Fig. 3.23).  
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3.3. DISCUSSION 
In the present study, the transgenic expression of a V14-J18 TCR  chain resulted 
in overproduction of type I NKT cells on both NOD and B6 genetic backgrounds. This 
augmentation was seen in the thymi, spleens and livers of the transgenic mice. 
Flow cytometric analysis of NKT cell subsets using stage-specific markers indicated 
that there was a major expansion of TCR+ CD1d-tet+ DPhigh CD24high CD44low and NK1.1- 
(immature DP NKT) cells in the thymi of both NOD and B6 V14 transgenic mice. In 
contrast, this cell population was relatively rare in the thymi of WT mice, estimated at less 
than 5/106 thymocytes. They were therefore normally excluded from previous analyses. Gapin 
et al. (2001) applied a magnetic bead enrichment strategy to examine the earliest NKT cell 
progenitors. After the enrichment process, the authors identified a DPdull population, which 
accounted for around 25% of enriched CD1d-tetramer+ thymocytes of 9-day old mice. This 
cell population was reported to decrease with age and was almost undetectable in the thymi of 
adult mice. Benlagha et al. (2005) applied a similar CD1d tetramer-based enrichment process 
and identified DPlow CD24high CD44low NK1.1- NKT cells from MACS-enriched CD1d tet+ 
thymocytes of 8-day to 5-week old mice. In comparison with the findings of Gapin et al. 
(2001) and Benlagha et al. (2005), the immature thymic DPhigh NKT cells from our NOD and 
B6 V14 transgenic mice are likely to precede the DPdull and DPlow stages of development and 
represent a very immature - possibly pre-selection - population of NKT cells. 
In earlier studies, Bendelac et al. (1996) and Lehuen et al. (1998) produced V14Tg 
mice on B6 and NOD backgrounds, respectively, using a TCR  shuttle vector containing the 
V11 endogenous promoter and the Ig enhancer. In their studies, V14Tg mice also produced 
an increase in NKT cell numbers; however, neither study reported the presence of immature 
DP NKT cells in the thymi of their transgenic mice. One possibility is that they used  
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TCR+ and NK1.1+ markers to identify the NKT cells, inadvertently missing the relatively 
immature NKT cells from their analyses. Alternatively, their transgenic system may not have 
increased numbers of immature DP NKT cells. Here, the use of TCR and CD1d-tet, along 
with stage-specific markers, identified large numbers of very immature thymic DP NKT cells 
expressing a CD24high CD44low and NK1.1- phenotype. This therefore represents the first 
mouse model that produced large numbers of immature DP NKT cells. 
Although both NOD and B6 V14 transgenic mice produced immature thymic DP 
NKT cells, numbers were higher in NOD.V14Tg mice. In contrast, the peripheral NKT cells 
in both strains were mature, either CD4+ or DN and expressed the CD24lowCD44high mature 
phenotype. They accounted for more than 80% of total NKT cells in the spleens and 95% of 
the livers of both NOD and B6 V14Tg mice. In terms of absolute numbers, V14 transgenic 
mice produced >two-fold increase in mature CD24low CD44high NKT cells in the periphery 
than did WT mice. Comparing between the two transgenic mouse strains, B6.V14Tg mice 
produced ~2-fold more mature NKT cells in both spleens and livers than did NOD.V14Tg 
mice. For example, B6.V14Tg mice produced 7.7 million CD24lowCD44high NKT cells per 
spleen in line 2 and 9.3 million cells in line 5, whereas NOD.V14Tg mice has only 3.7 
million cells per spleen in line 1, and 4.2 million cells in line 3.  
The presence of larger numbers of immature NKT cells in the thymi of NOD.V14Tg 
mice, but lower numbers of mature NKT cells in the periphery compared to B6.V14Tg mice 
suggested that many immature NKT cells failed to leave the thymus or that there was a 
deficiency in NKT cell development in the thymi of NOD.V14Tg compared B6.V14Tg. 
Mingueneau et al. (2012) identified a selective defect in Erk1/2 activation in response to TCR 
engagement in NOD versus B6 thymocytes and T cells. When transgenes drive premature 
TCR expression in thymocytes, this difference appears to modulate the cellular response to 
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pre-TCR engagement, resulting in an expanded DP population in NOD mice. Because of a 
selective defect in the Erk1/2 signaling module, the same Tg TCRs wired to NOD 
signalosomes are perceived like pre-TCRs, rather than -TCRs, leading to amplification and 
abundant differentiation into DPs. Competition for selecting ligands may be altered when the 
DP population is expanded. As a consequence, thymi from NOD TCR Tg mice show higher 
numbers of DP thymocytes than their B6 counterparts, and relatively inefficient positive 
selection, promoting compensatory rearrangements of endogenous TCR- loci, which rescue 
some measure of positive selection (Mingueneau et al., 2012). The novel perspective 
available in this thesis is that the DP population contains both the cells vying for selection, 
and the cells presenting the ligand for selection, into the NKT cell lineage. 
Supporting these hypotheses, the positive selection of invariant NKT cells, which is 
also Ras-Mapk-Egr dependent (Hu et al., 2011), is impaired in NOD mice that have few 
thymic iNKT cells (Gombert et al., 1996). Because iNKT cells express an invariant TCR, no 
repertoire compensation could counterbalance the Erk1/2 defect, potentially explaining their 
decreased numbers in NOD mice. 
In support of this marked increase in mature NKT cells in the periphery of the V14 
transgenic mouse studies, NKT cells from both NOD and B6 V14 transgenic mice rapidly 
released massive amount of cytokines, such as IL-4 and IFN- shortly after an intravenous 
injection of -GalCer. These data are consistent with previous studies in mice showing that 
NKT cells contain pre-formed mRNA for these cytokines (Matsuda et al., 2003); they are able 
to produce both IFN- and IL-4 immediately after -GalCer injection (Matsuda et al., 2000; 
2003; Stetson et al., 2003). 
In addition to the evidence of massive increases in cytokine production, the fewer 
numbers of NOD.Vα14Tg mice developing diabetes compared to NOD mice supported the 
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hypothesis that the increased NKT cell numbers prevented NOD.Vα14Tg mice from 
spontaneous development of type I diabetes. However, it is raising another possibility that the 
Vα14 transgene limited the TCR repertoire diversity of conventional T cells, which may 
contributed to the delayed onset of the disease in these mice. The data in this chapter 
indicated that splenic T cells of NOD.V14Tg line 1 mice were not affected by the 
introduction of a Vα14-Jα281 rearranged TCR transgene, the numbers of thymic T cells 
even slightly increased but the numbers of hepatic T cells significantly decreased in 
NOD.V14Tg line 1 mice compared to NOD wild type mice.The fixation of one TCR chain 
through the preferential expression of the rearranged Vα14-Jα281 transgene has been 
shown to blunt or even prevent the development of immunopathological disease (Doherty et 
al., 1994; Mars et al., 2002).  
Previous studies indicate that there are strain-dependent differences in NKT cell 
numbers between commonly used mouse strains; however, NOD mice particularly exhibited a 
severe reduction in NKT cell numbers and function compared to other strains (Baxter et al., 
1997; Godfrey et al., 1997; Poulton et al., 2001). This natural reduction in NKT cell numbers 
in NOD mice has been associated with their susceptibility to several autoimmune diseases, 
including type 1 diabetes, lupus and experimental autoimmune encephalomyelitis (EAE), and 
that increasing NKT cell numbers by adoptive transfer (Baxter et al., 1997; Godfrey et al., 
1997), transgenic expression of V14-J18 TCR  chain (Lehuen et al., 1998 and our own 
data) or stimulating them with the superantigen-like ligand, -GalCer, all inhibit the onset of 
type I diabetes, transgenic expression of the V14-J18 TCR  chain in NOD mice 
dramatically reduced the incidence and severity of neurological signs in EAE – a mouse model 
for multiple sclerosis (Mars et al., 2002), and NKT cell numbers are decreased in lupus-prone 
NOD mice (Baxter et al., 1994; Horsfall et al., 1998; Hawke et al., 2003).  
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Several genetic studies of mice congenic between the NOD strain and various 
diabetes-resistant inbred strains have identified insulin dependent diabetes (Idd) susceptibility 
loci. In addition, a genetic linkage analysis of the genetic control of NKT cell numbers was 
undertaken in a first backcross from C56BL/6 to NOD.Nkrp1b mice. Here two major regions 
were identified exhibiting significant linkage to NKT cell numbers (Esteban et al., 2003). The 
first region (Nkt1) mapping to distal chromosome 1, was in the same region as lupus 
susceptibility gene Babs2/Babs3. The second region (Nkt2) was on chromosome 2, mapped in 
the same region as Idd13 (Jordan et al., 2007; Fletcher et al., 2008). NOD mice congenic for 
these two regions derived from B6 showed significant increase NKT cell numbers (Rocha-
Campos et al., 2006; Jordan et al., 2007; Chen et al., 2007; Fletcher et al., 2008; Jordan et al., 
2011). The Nkt1 region harbours SLAM family members, Slamf1 and Slamf6 (Jordan et al., 
2007; which have been confirmed as NKT-control genes through congenic and transgenic 
manipulation (Jordan et al., 2007; Jordan et al., 2011), while Pxmp4 has been implicated as 
the control gene for Nkt2 (Fletcher et al., 2008). In addition, Zekavat et al. (2010) found that 
Cd93, an autoimmune susceptibility gene residing within the Idd13 locus, also plays a role in 
regulating absolute numbers of CD4+ NKT cells. Congenesis for a further region, on 
chromosome 4, harbouring the Idd9 gene has also been shown to increase NKT cell numbers, 
but in this case the increase in NKT cell numbers was only slightly (Matsuki et al., 2003). 
An additional explanation for the higher numbers of DP NKT cells in NOD.V14Tg 
mice is that DP thymocytes on the NOD background expressed lower levels of SLAMF1 
(CD150) expression than did DP thymocytes on B6 mice (Jordan et al., 2007; Jordan et al., 
2011). In our own observations, DP NKT cells from NOD.V14Tg mice expressed lower 
levels of SLAMF1 than did DP NKT from B6.V14Tg mice. The lower expression of 
SLAMF1 on the NOD background may contribute to the higher accumulation of DP NKT 
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cells in the thymi of NOD.V14Tg mice because SLAMF1 expression on both DP NKT cells 
and DP T cells is required for successful NKT cell development (Godfrey et al., 2010).  
Evidence supporting the relationship between SLAM expression and NKT cell 
ontogeny includes: 1) Mice lacking SLAM or SLAM adaptor protein (SAP) - a necessary factor 
for SLAM signaling, are deficient in NKT cells, although conventional T cells are intact (Chung 
et al., 2005; 2008); 2) In the absence of SAP and Fyn, NKT cell development is arrested at the 
CD24hi Tetramerhi CD69+ stage, which resulted in the reduction of 85% of mature type I NKT 
cells (Griewank et al., 2007); 3) Mutations in SAP cause an X-linked lymphoproliferative 
(XLP) immunodeficiency in humans, which is characterized by deficiency in V24 NKT cells; 
and 4) A genetic linkage study of a first backcross between NOD and B6 mice indicated that the 
SLAM locus was mapped to the same region as the SLE susceptibility locus (Nkt1). This 
genetic region, along with the genetic region Nkt2 (containing diabetic susceptibility locus), 
control NKT cell numbers in NOD mice (Jordan et al., 2007).  
In addition to the abnormally increased numbers of DP NKT cells in the manipulated 
Vα14 transgenic mice, it was reported in this chapter that the Vα14 transgene also promotes 
DN NKT development to a greater extent than CD4 NKT development. The DN:CD4 ratio of 
thymic NKT cells in NOD.V14Tg mice was 3:2, compared to a 3:4 ratio in WT mice (Fig. 
3.11 A). In the livers, the DN:CD4 ratio was 1:2 in WT mice, but ranged from 1.5:1 to 5:1 in 
NOD.V4Tg mice (Fig. 3.13 A). In the spleens, the DN:CD4 ratio was 1:4 in WT mice, but 
varied from 1:2 to 2:1 in NOD.V14Tg lines (Fig. 3.14 A). Similar patterns were seen in all 
thymi, spleens and livers of B6.V14Tg lines (Fig. 3.16 A; Fig. 3.17 A). These data are 
consistent with a previous observation by Lehuen et al. (1998), in which they found that the 
NK1.1+ T cells were mainly of the DN phenotype.  
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It is well demonstrated that the T cell development begins with the migration into the 
thymus of bone marrow-derived lymphoid progenitors and by the differentiation of CD4-CD8- 
double negative (DN) thymocytes (Godfrey and Zlotnik, 1993). These common progenitors 
develop through sequential stages, including DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 
(CD25+CD44-), and DN4 (CD25-CD44-). At the DN3 stage, random rearrangement of TCR 
chain (VDJ) gene segments occurs and subsequently the beta selection takes place for a 
functional TCR chain (Godfrey and Zlotnik, 1993). The polypeptide TCRchain then pairs 
with an invariant pre-TCR and signals the thymocyte to undergo further differentiation. At 
this point, the DN progenitor also up-regulates CD4 and CD8 to become double positive (DP) 
and initiates rearrangement at the TCR gene locus. If a productive TCR gene 
rearrangement occurs, the  chain can pair with the already expressed TCR chain and be 
expressed on the surface. All subsequent selection events are based on the antigen-binding 
site formed by this heterodimer. It is currently demonstrated that thymocytes bearing a TCR 
with high affinity for self-MHC-peptide complexes are deleted from the repertoire, whereas 
those with a low affinity are positively selected. If the TCR has negligible affinity for self-
MHC, the thymocyte undergoes death by neglect while the cells that successfully pass 
through thymic selection subsequently undergo maturation to conventional CD4+CD8- or 
CD4-CD8+ single positive T cells (Godfrey and Zlotnik, 1993; Michie and Zuniga-Pflucker, 
2002; Starr et al., 2003). A key feature of these selective events and a hallmark of T cell 
development are the ordered and sequential rearrangement and expression of the TCR and 
TCR chains to ensure the production of a clonally expressed repertoire with a minimum of 
energy expenditure.  
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However, this temporal control is lost in TCR transgenics because TCR transgenic 
model systems both TCR and - chains are expressed early at the CD4CD8 double negative 
(DN) stage (Terrence et al., 2000; Lacorazza et al., 2001; Wolfer et al., 2002). The early 
expression of TCR has been suggested to affect -selection even in the presence of the pre-
TCR because TCR has a higher affinity for TCR than it does for pre-T (Trop et al., 
2000). Although the TCR heterodimer can mediate -selection if expressed at the DN 
stage, it is highly inefficient (Borowski el al., 2004). In addition, early expression may affect 
/ lineage commitment, which results in a large population of mature DN TCR+ cells both 
in the thymus and the periphery (Bruno et al., 1996; Fritsch et al., 1998; Terrence et al., 2000; 
Lacorazza et al., 2001). In the thymus, these cells represent a terminally differentiated 
population without the ability to seed the DP compartment (Lacorazza et al., 2001) while in 
the periphery, they display properties consistent with -lineage cell (Terrence et al., 2000). 
These lineage-misdirected cells are not observed in wild-type mice or mice that express a 
transgenic TCR chain. 
In this work the premature expression of transgenic Vα14TCR promotes DN T cell 
development (Baldwin et al., 2005; McDonald et al,. 2014). The DN:CD4 inversion seen in 
both NOD and B6 Vα14 transgenic mice might be due to TCR engagement in developing 
NKT cells occurring earlier, on average, in Vα14 transgenic mice compared to controls. The 
results could be postulated that, in the normal thymus, NKT cells might bifurcate into DN and 
CD4 subsets due to a difference in the “age” of the DP cell when it is positively selected into 
the NKT lineage. 
In summary, data from this chapter confirm: 
1. V14-J18 transgenic expression increased NKT cell numbers in both NOD and B6 mice. 
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2. NOD and B6 V14 transgenic mice produce far more of the most immature NKT 
subset in the thymus, while the increase in the periphery is due mainly to an increase 
in mature NKT cells. 
3. The NKT cells generated by V14Tg NOD mice also express the strong bias toward 
the use of the VVVand V as seen in WT NKT cells. 
4. Mature NKT cells from V14 transgenic mice produced large amounts of cytokines 
typical of NKT cells. 
5. NOD. V14Tg line 1 mice showed significant protection from diabetes compared to 
NOD WT mice. 
The generation of immature DP NKT cells in V14 transgenic mice provides an 
opportunity to study the earliest identifiable stages of NKT cell development, and will help 
dissect factors controlling the numbers and function of this important immune regulatory 
population.  
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I. INTRODUCTION 
Natural killer T (NKT) cells are recently recognised members of the immune system. 
They express both the T cell receptor (TCR) and several markers typical of natural killer 
(NK) cells on their cell surfaces (Godfrey et al., 2010). NKT cells differ from conventional T 
cells in several ways. While conventional T cells exhibit a diverse TCR repertoire, the TCRs 
of NKT cells are relatively limited. The best-studied and most frequent NKT cells express an 
invariant TCR  chain and a restricted set of TCR  chains. In addition, the TCR of NKT 
cells recognises glycolipid antigens presented by the CD1d molecule rather than peptide 
antigens presented on major histocompatibility (MHC) class I or II (Bendelac, 1995; 
Kronenberg, 2005). 
NKT cells are well known for their role in immune-regulation. Upon stimulation, they 
rapidly secrete large amounts of cytokines (Matsuda et al., 2000) that modulate the behavior 
of other cells of the immune system, including T cells, B cells, macrophages, dendritic and 
natural killer cells. Through this activity, they form an important link between innate and 
adaptive immune responses (Kronenberg and Gapin, 2002) and modulate immune responses 
in the context of autoimmunity, cancer and microbial infection (Matsuda et al., 2008; 
Slauenwhite and Johnston, 2015).  
Recently, there has been overwhelming research supporting the mainstream model 
of NKT cell development, in which NKT cells are thought to derive from the same 
progenitors as conventional T cells. Consistent with this model, NKT cells are not found in 
the peripheral tissues of mice until 1-2 weeks after birth; their development is thymus 
dependent. NKT cells develop in fetal thymic organ culture (Bendelac et al., 1994; Pellicci 
et al., 2002), while neonatal thymectomy on the third day after birth, selectively depletes 
them (Hammond et al., 1998).  
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The NKT cell lineage shares the early developmental progression with conventional T 
cells, which begins with the migration into the thymus of bone marrow-derived lymphoid 
progenitors and is followed by the differentiation of lineage (Lin)-, CD4-CD8- double negative 
(DN) thymocytes (Godfrey and Zlotnik, 1993). These common progenitors develop through 
sequential stages, including DN1 (CD25-CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-), 
and DN4 (CD25-CD44-). At the DN3 stage, random rearrangement of TCR  chain (VDJ) 
gene segments occurs and subsequently the beta selection takes place for a functional TCR  
chain (Godfrey and Zlotnik, 1993). The cells that survive the beta selection process mature to 
the DN4 stage and then become CD4+CD8+ double positive (DP) thymocyes. During the DP 
stage, rearrangement of the TCR  chain (VJ) gene segments occurs forming the unselected 
TCR repertoire (MacDonald et al., 2001). The DP thymocytes expressing TCR with 
appropriate avidity for self-peptide antigens are positively selected upon interaction with 
MHC class I or II molecules expressed on thymic epithelial cells (Godfrey and Zlotnik, 1993). 
The cells that successfully pass through thymic selection subsequently undergo maturation to 
conventional CD4+CD8- or CD4-CD8+ single positive T cells.  
In contrast, the DP thymocytes whose TCR has appropriate affinity for glycolipid 
antigens presented in the context of CD1d on cortical DP thymocytes are positively selected 
as NKT cells. These NKT cells will engage in maturation processes and up-regulate the 
expression of the activation markers, CD44 and NK1.1 (Bendelac, 1995; Godfrey and 
Berzins, 2007). DP thymocytes whose TCR have insufficient affinity or overly strong affinity 
for endogenous antigens (either peptide or glycolipid antigens) are deleted by neglect or 
negative selection, respectively (Pellicci et al., 2003; Chun et al., 2003; Schumann et al., 
2005; Godfrey and Berzins, 2007).  
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In an attempt to identify the earliest CD1d-tet+ thymic NKT cells, Gapin et al. (2001) 
stained mouse thymocytes with CD1d-tet-phycoerythrin (PE), and enriched positive cells with 
anti-PE magnetic beads. Of the NKT cells obtained from thymi of nine-day old mice, 25% 
were “DPdull”, a population whose frequency declined with age, was not seen in the periphery 
at any time and was absent in Cd1d-/- mice (Gapin et al., 2001). This population probably 
represented early post-selection NKT cells because, in conventional T cell development, TCR 
ligation of DPhigh thymocytes triggers CD4 and CD8 down-regulation (Swat et al., 1992; Page 
et al., 1993). In contrast, quantitative polymerase chain reaction (PCR) analysis found 
equivalent proportions of V14-J18 encoded transcripts from sorted DPhigh thymocytes in 
wild type (WT) and Cd1d-/- mice, consistent with the DPhi phenotype containing pre-selection 
NKT cells (Gapin et al., 2001). There were also V14-J18 encoded transcripts in the DN4 
thymocytes from B6 WT and Cd1d-/- mice. These cells were reported to have the potential to 
generate mature NKT cells both in vivo and in vitro (Dashtsoodol et al., 2008). Further 
evidence of the DPhigh to DPdull transition representing positive selection was obtained by 
CDR3 spectratyping. In WT mice, only a single peak could be detected in the DPdull 
population, which corresponded to the canonical V14-J18 rearrangement. This contrasted 
with the multiple rearrangements detected in DPhigh thymocytes (Gapin et al., 2001).  
 Benlagha et al. (2005) applied a similar tetramer-based enrichment strategy and 
identified CD24high NKT cells in the thymi of newborn mice. The average proportion of the 
CD24high NKT cells decreased with age, from 70% of tet-enriched cells at day 3 to 57% at day 
4, 13% at day 5 and almost undetectable at 5 weeks of age. Nearly all (90%) of the CD24high 
NKT cells found in 3-day old mice were CD4+ CD44low NK1.1-, while very few cells were 
DPlow CD44low NK1.1-. However, in contrast with the reduction of tet-enriched CD24high NKT 
cells, their DPlow CD24high NKT cell subset increased with age, from very few cells at day 3 to 
10% at day 8, 68% at day 14 and 73% at 5 weeks of age. As they were CD24high CD44low 
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NK1.1-, and the DPdull cells identified by Gapin et al. (2001) were CD24low, these DPlow 
CD24high NK1.1- NKT cells are likely to precede the DPdull population discovered by Gapin et 
al. (2001). Furthermore, as the CD24high NKT cells already exhibited the same V8 bias 
characteristic of mature NKT cells and are non-dividing, they are likely to be post-selection, 
making them the earliest population of post-selection NKT cells identified to date. 
Conversely, the tet-enriched CD24low NKT cells contained two subsets (CD44low and 
CD44high), both of which were rapidly proliferating. On the basis of the changing proportions 
with aging from 2 to 6 weeks, Benlagha et al. (2005) proposed that the CD44low population 
precedes the CD44high population in maturation. Therefore, the postulated developmental 
pathway of NKT cells in mice is: DP CD24high CD44low NK1.1-  selection  DPlow 
CD24high CD44low NK1.1-  DPlow CD24low CD44low NK1.1-  DN or CD4+ CD24low 
CD44low NK1.1-  DN or CD4+ CD24low CD44high NK1.1-  DN or CD4+ CD24low CD44high 
NK1.1+ (Benlagha et al., 2005; Godfrey et al., 2010).  
As presented in Chapter 3, the presence of large numbers of DPhigh CD24high CD44low 
NK1.1-, CD1d-tet+TCR+ cells in the thymus and their absence in the periphery of V14Tg 
mice, suggested that these cells likely represent a very immature - possibly pre-selection - 
population of NKT cells. To test this hypothesis, thymocytes from NOD.Va14Tg mice were 
subjected to Fluorescence-activated cell sorting (FACS) to isolate four subsets: DPhigh 
CD24high NK1.1- CD1d-tet- TCR+ (immature DP conventional T) cells, DPhigh CD24high 
CD44low NK1.1- CD1d-tet+ TCR+ (immature DP NKT) cells, CD4+CD8-CD24high NK1.1-
CD1d-tet+ TCR+ (immature CD4 NKT) cells and CD4-CD8- CD24high NK1.1-CD1d-tet+ 
TCR+ (immature DN NKT) cells for transcriptional analysis by microarray. This provided us 
with an opportunity to compare the transcriptional profiles of very immature DP NKT cells 
with those of more mature NKT cell subsets in order to identify the transcriptional transitions 
associated with TCR validation, positive selection and lineage commitment.  
PART B: TRANSCRIPTIONAL ANALYSIS OF NKT CELL DEVELOPMENT 
 
 
 
- 125 -  
Generally, the aims of part B were: 
1. To profile gene expression of the four populations: immature DP T cells, immature 
DP NKT cells, immature CD4 NKT cells and immature DN NKT cells by microarray. 
2. To provide data for the transcriptional changes at the early stages of NKT cell 
development and events surrounding thymic selection and lineage commitment of NKT cells. 
3. To functionally validate gene expression changes during NKT cell development. 
II. OVERVIEW OF RESULTS 
 Immature DP conventional T cells (P1), immature DP NKT cells (P2), immature CD4 
NKT cells (P3) and immature DN NKT cells (P4) were sorted from the thymi of 
NOD.Va14Tg mice (Fig. B.1). Cell samples were kept cool during the sorting processes and 
then immediately stored in RLT buffer at -80oC for RNA isolation. RNA preparation, labeling 
and scanning were conducted by Dr. Margaret Jordan and Ms. Letitia Smith (Comparative 
Genomic Centre, James Cook University, Australia), as described in Chapter 2: Materials and 
Methods. The expression microarray hybridizations were performed using a WT Expression 
kit (Life Technologies, CA, USA), WT Terminal Labelling and Controls Kit (Affymetrix, 
CA, USA) and Affymetrix Mouse Gene_1.0ST arrays, which contained 35,556 transcripts 
representing an estimated 28,853 mouse genes. The probed arrays were washed and stained 
using the GeneChip Hybridization Wash and Stain Kit (Affymetrix, CA, USA), and then 
scanned using a GeneChip Scanner 3000. Images (.dat files) were processed using GeneChip 
Command Console (Affymetrix, CA, USA) and the CEL files were imported into Partek 
Genomics Suite 6.6 (Partek SG, Singapore) using an RMA summarisation algorithm for 
further analysis.  
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Figure B.1. Gating strategy for sorting of populations by FACS. Population (P) 1 represents for DPhigh CD24high 
NK1.1- CD1d-tet- TCR+ cells or immature DP T cells, P2 represents DPhigh CD24high CD44low NK1.1- CD1d-tet+ 
TCR+ cells or immature DP NKT cells, P3 represents CD4+CD8-CD24high NK1.1-CD1d-tet+ TCR+ cells or immature 
CD4 NKT cells, and P4 represents CD4-CD8- CD24high NK1.1-CD1d-tet+ TCR+ cells or immature DN NKT cells.  
Microarray data were analysed by Dr. Margaret Jordan using Partek Genomics Suite 
6.6 software. In our experience of microarray expression analyses of mouse thymocytes, the 
use of seven replicates and a significance threshold of a Mann-Whitney U statistic of zero (i.e. 
no overlap between groups) provides robust and reliable identification of differentially 
expressed transcripts (Jordan et al., 2007, Fletcher et al., 2008; Jordan et al., 2011). After data 
processing, expression levels of a total of 35,556 transcripts for each biological sample of four 
different cell populations (seven biological samples from each cell population) were obtained. 
Principal component analysis (PCA) was conducted on all transcripts under 
investigation to determine expression trends within the data set. Figure B.2 illustrates the 
scores of seven biological samples from each of the four different cell populations on the 
first three principal components. The PCA revealed that the seven samples from each cell 
population clustered together, with the PC1 accounting for 29% of total variance, the PC2 
accounting for 19% of variance and the PC3 accounting for 10% of variance. The PCA 
indicated that the four populations clearly separated in order across PC1, from immature DP 
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T cells (P1) to immature DP NKT cells (P2) then to immature CD4 NKT cells (P3) and to 
immature DN NKT cells (P4).  
 
Figure B.2. Principal component analysis of 35,556 transcripts of 7 biological replicates from 4 different cell 
populations during NKT cell development. The green circles correspond to gene expression of immature DP T cell 
samples (P1); the purple circles correspond to gene expression of immature DP NKT cell samples (P2); red circles 
correspond to gene expression of immature CD4 NKT cell samples (P3); and blue circles correspond to gene 
expression of immature DN NKT cell samples (P4). The three largest PC explain >58% of variation; samples from 
each of the four cell types cluster together into groups, and the groups are distributed separately across PC1 (X 
axis), which explains >29% of variation. A graphic illustrating the proposed NKT cell maturation pathway is 
provided for comparison. Data were generated with assistance from Dr. Margaret Jordan and Prof. Alan Baxter. 
This transcriptional progression of NKT cell subsets, therefore, mirrors the 
postulated developmental progression described by Godfrey’s group based on their and 
other’s work (Coquet et al., 2008; Godfrey et al., 2010). Of particular interest is the 
possibility that our analysis of DP NKT cells might identify the transcriptional events 
associated with Control Point 1 of NKT cell development, which Godfrey and Berzins 
(2007) attributed to selection.  
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A transcriptional regulatory network was constructed by Dr. Dragana Stanley (School 
of Medical and Applied Sciences, Central Queensland University) using the Weighted Gene 
Correlation Network Analysis (WGCNA) algorithm in R (Langfelder et al., 2008), 
representing the expression data from 35,556 transcripts from each of the 28 samples (7 
replicates x 4 populations). The resulting network contained 1,929 nodes (transcripts) in 
twelve modules (co-expressed transcript clusters) with 10,626 edges (pair-wise significant 
correlations; Fig. B.3).  
 
Figure B.3. Weighted Gene Co-expression Network Analysis. Undirected, weighted transcriptional regulatory 
network generated from thymic NKT cell subsets P1-P4 (n=7/population), consisting of 1,929 transcripts 
(nodes) and 10,626 pair-wise correlations (edges) across twelve co-regulated clusters (modules), named: Black 
(587 nodes), Cyan (71), GreenYellow (177), Grey (32), LightCyan (42), LightGreen (26), Magenta (127), 
MidnightBlue (68), Pink (525), Purple (188), Salmon (37) and Tan (49). Data were generated with assistance 
from Dr. Dragana Stanley, Dr. Margaret Jordan and Prof. Alan Baxter. 
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The network was then analysed as three progressive transitions: 1) DP T cells → DP 
NKT cells; 2) DP NKT cells → CD4 NKT cells; 3) CD4 NKT cells → DN NKT cells. For 
each transition, uncorrected Student’s t-Test p values of pair-wise comparisons of each 
transcript were mapped onto the nodes within the network and visualised using a heat map in 
Cytoscape 3 (Shannon et al., 2003). Highly differentially expressed (HDE) transcripts were 
defined as significant after Bonferroni p value correction (p<1.5 x 10-6).  
The next three chapters present findings from transcriptional analyses across each 
transition to provide transcriptional evidence of an early developmental program for 
NKT cells. 
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4.1. INTRODUCTION 
Mainstream  T cell development encompasses two consecutive phases of thymic 
selection:  selection and repertoire selection.  selection occurs during the CD4-CD8- double 
negative (DN) stage of thymocyte development, following rearrangement of the T cell 
receptor (TCR)  genes (Levelt and Eichmann, 1995). The expression of successfully 
recombined TCR chains with a surrogate  chain generates signals essential for survival, 
proliferation and maturation to the CD4+CD8+ double positive stage (Saint-Ruf et al., 1994; 
Wiest et al., 1994; Baur et al., 2001). The second phase of selection, termed repertoire 
selection or positive selection, takes place among DP cells following TCR gene 
rearrangement. Development of thymocytes through the positive selection checkpoint requires 
the rearrangement and expression of a suitable TCR chain that can pair with the already-
expressed  chain to make a TCR that is selectable. That is, it must have sufficient avidity for 
self MHC-peptide interaction to induce signals required for differentiation, but not too strong 
so as to induce cell death.  
During thymic selection processes, allelic exclusion takes place to ensure most 
thymocytes express only a single specificity of T cell receptor, which is encoded by one 
TCR allele and one TCR allele. Allelic exclusion of TCR genes is regulated differently 
between  and  chains (Rybakin et al., 2014). For the TCR chain, a successfully completed 
in-frame rearrangement of one locus effectively inhibits the rearrangement of the second 
locus. This inhibition is achieved at the DNA level as a result of signalling originated from a 
successfully formed dimer of the  chain with pre-T. In contrast, both TCR alleles are 
rearranged, often multiple times, until the positive selection stage, when a single  chain in 
conjunction with a fixed  chain allows the thymocyte to differentiate and the protein product 
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of the alternative  locus to be internalised, ubiquitinated and degraded (Borgulya et al., 
1992). A majority of immature thymocytes express more than one  chain on the cell surface, 
while after positive selection only one chain is expressed on the vast majority of conventional 
T cells (Gascoigne and Alam, 1999). 
Allelic exclusion of antigen receptor chains is a fundamental mechanism of 
immunological self-tolerance. Incomplete allelic exclusion results in dual TCR expression, 
which can allow developing autoreactive  T lymphocytes to escape clonal deletion and 
cause autoimmunity in some systems (Sarukhan et al., 1998; Auger et al., 2012). 
NKT cells represent a minor subset of T lymphocytes expressing TCR as well as 
markers typical of the NK cell lineage (MacDonald, 1995; Bendelac et al., 1997). The 
repertoire of TCR of invariant NKT cells is dominated by an invariant TCR  chain 
(V4-J18 in mice or V24-J18 in humans) and a limited choice of TCR  chain (mostly 
V8, V7 and V2). Although NKT cells share the common progenitors with conventional 
T cells; they branch off from the mainstream lineage at the DP stage. The developmental 
pathway of NKT cells is less well understood compared to conventional T cells. NKT cell 
development is impaired in mice bearing a variety of genetic defects, which are partly 
equivalent to the requirements for mainstream  T cells. The requirement for Cd1d (Chen 
et al., 1997; Mendiratta et al., 1997), and TCR V14 and J18 genes (Cui et al., 1997) for 
positive selection of NKT cells is analogous to the roles of homologous genes in the 
repertoire selection of mainstream  T cells. The dependence on molecules associated 
with CD3 complex signalling (CD3, Lck; Baur et al., 2001) and pre-TCR  chain (Eberl et 
al., 1999) are consistent either with a requirement of positive selection in NKT cell 
development or with a pre-TCR dependent checkpoint, similar to  selection of mainstream 
 T cells. 
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 As suggested by the flow cytometric analysis in Chapter 3 and the principal 
component analysis of the four populations analysed by microarray, the immature DP NKT 
cells are likely the pre-selection population of NKT cells. Therefore, in this chapter, gene 
expression comparison will be performed between immature DP T cells and immature DP 
NKT cells. The following hypothesis was tested: “The thymic immature DP NKT cells from 
V14 transgenic mice represent a pre-selection population of NKT cells or NKT cell 
progenitors at stage 0”. 
Specifically, the aims of this chapter were: 
1. To profile gene expression changes across Transition 1, between immature DP T 
cells and immature DP NKT cells. 
2. To identify significant changes in gene expression related to the differentiation of 
DP NKT cells. 
3. To functionally validate the observed changes in the expression of genes across 
development from immature DP T cells to immature DP NKT cells 
4.2. RESULTS 
4.2.1. Weighted gene co-expression network analysis of DP T cells and DP NKT cells across 
Transition 1  
Uncorrected Student’s t-Test p values of pair-wise comparisons of each transcript across 
Transition 1 were mapped onto the nodes within the network (described in Figure B.3) and then 
visualised using a heat map in Cytoscape 3 (Shannon et al., 2003; Fig. 4.1). After applying the 
Bonferroni corrected significance threshold (p<1.5 x10-6), 311 highly significantly differentially 
expressed (HDE) transcripts were defined across the transition between DP T cells and DP 
NKT cells. Of these, 116 were members of the module named “Pink” (of 525 nodes) and 48 
were in the “Purple” module (of 188 nodes; illustrated in Figure B.3; p<0.0001 2 contingency).  
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Figure 4.1. Weighted gene co-expression network analysis across Transition 1. Heat map encoding of 
Students’ t-Test p values generated by pair-wise comparisons of transcript abundance across Transition 1 
(between DP T cells and DP NKT cells) mapped onto the transcriptional regulatory network illustrated in Figure 
B.3. Data were generated with assistance from Dr. Dragana Stanley, Dr. Margaret Jordan and Prof. Alan Baxter. 
Gene Ontology analysis was performed on the transcripts within the Pink module in 
the Database for Annotation, Visualization and Integrated Discovery (DAVID) 
Bioinformatics Resources v6.7 (Huang et al., 2009). The top ranked Category 
(SP_PIR_KEYWORDS) obtained for the transcripts in the Pink module was Oxidative 
Phosphorylation with a Bonferroni corrected p value of <4.1 x 10-6. Within this category, 
there were genes encoding several components of the mitochondrial electron transport chain, 
such as NADH Dehydrogenase (Nd1, Nd2, Nd4l, Nd5), Cytochrome C Oxidase (Cox1, Cox2, 
Cox3) and ATP Synthase 6 (Atp6), all of which were down-regulated across Transition 1. 
This finding is suggestive of the Warburg phenomenon (Fig. 4.2), as the down regulation of 
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NADH Dehydrogenase, Cytochrome C Oxidase and ATP Synthase 6 suggests the 
intracellular deviation of small carbon chains, away from ATP production to fatty acid 
synthesis, implying increased cell proliferation (Warburg, 1956).  
 
Figure 4.2. Warburg phenomenon (concept adapted from Vander et al. 2009) 
4.2.2. Transcriptional analysis of DP T cells and DP NKT cells across Transition 1 
In support of the hypothesis that increased proliferation occurs across Transition 1, a 
transcriptional comparison between immature DP T cells and immature DP NKT cells was 
performed. The expression levels of all 35,556 transcripts across Transition 1 were compared 
pairwise using the Mann-Whitney U test; and those with a U statistic of zero (i.e. no overlap 
between groups) were shortlisted for ranking by t-test (i.e. transcripts for which the means of 
the groups were separated by largest multiples of SEM were prioritised). Across this transition, 
5,565 transcripts generated a Mann-Whitney U score of zero, and of these, 1,195 were highly 
differentially expressed (HDE; p < 1.4 x 10-6, by t-Test). This HDE gene list was split into 
transcripts up-regulated (624 transcripts), and those down-regulated (570 transcripts), before 
being submitted to DAVID for functional annotation clustering. 
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4.2.2.1. Increased expression of genes related to cell cycle and cell division 
 Gene Ontology analysis was performed on 624 up-regulated, HDE transcripts in the 
DAVID Bioinformatics Resources v6.7 (Huang et al., 2009). The top up-regulated annotation 
cluster (Enrichment Score 14.7) was dominated by genes associated with the cell cycle and cell 
division and contained the annotation categories DNA Metabolic Process (GO:0006259) and 
DNA Replication (GO0006260) with Bonferroni corrected p values between 10-10 and 10-14, 
respectively (Table 4.1). 
Table 4.1. Annotation clusters 1 and 2 (ranked by enrichment score) from GO analysis of 624 up-regulated 
HDE genes across Transition 1 using DAVID Bioinformatics Resources (data were generated with assistance 
from Dr. Margaret Jordan and Prof. Alan Baxter).    
 
The top ranked category (GOTERM_BP_FAT: GO:0006259) with a Bonferroni 
corrected p< 5.3 x 10-14 contained 49 transcripts (of all up-regulated HDE genes) associated 
with DNA metabolic process, such as DNA Primase (Prim1, Prim2), Polymerase (Pold2, 
Pold3) and Replication factor C (Rfc2, Rfc3, Rfc4, Rfc5).  
Annotation Cluster 1 Enrichment Score: 14.67 
Category Term Count p value Fold Enrichment Bonferroni 
GOTERM_BP_FAT GO:0006259~DNA metabolic process 49 3.35E-17 4.194963362 5.28E-14 
SP_PIR_KEYWORDS dna replication 24 4.86E-17 10.26706601 1.59E-14 
GOTERM_BP_FAT GO:0006260~DNA replication 28 9.33E-15 6.639396901 1.47E-11 
KEGG_PATHWAY mmu03030:DNA replication 15 1.39E-12 12.94285714 1.76E-10 
Annotation Cluster 2 Enrichment Score: 8.67 
Category Term Count p value Fold Enrichment Bonferroni 
GOTERM_BP_FAT GO:0007049~cell cycle 58 4.04E-16 3.421377313 7.00E-13 
SP_PIR_KEYWORDS cell cycle 49 5.26E-16 3.986048652 1.82E-13 
SP_PIR_KEYWORDS cell division 29 5.16E-10 4.119192337 1.69E-07 
GOTERM_BP_FAT GO:0000279~M phase 30 1.21E-09 3.820753391 1.91E-06 
GOTERM_BP_FAT GO:0022403~cell cycle phase 32 2.33E-09 3.516335641 3.68E-06 
GOTERM_BP_FAT GO:0022402~cell cycle process 35 3.75E-09 3.209886542 5.91E-06 
GOTERM_BP_FAT GO:0051301~cell division 29 4.44E-09 3.719682453 7.00E-06 
GOTERM_BP_FAT GO:0000278~mitotic cell cycle 24 3.02E-07 3.545158064 4.77E-04 
GOTERM_BP_FAT GO:0007067~mitosis 21 3.12E-07 3.98363814 4.91E-04 
GOTERM_BP_FAT GO:0000280~nuclear division 21 3.12E-07 3.98363814 4.91E-04 
GOTERM_BP_FAT GO:0000087~M phase of mitotic cell cycle 21 4.37E-07 3.901501272 6.89E-04 
SP_PIR_KEYWORDS mitosis 20 5.10E-07 4.062852007 1.67E-04 
GOTERM_BP_FAT GO:0048285~organelle fission 21 5.59E-07 3.842087547 8.81E-04 
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The microarray data revealed that genes involved in DNA replication: Pole 2 
(encoding Polymerase 1 epsilon 2), Prim1 (encoding DNA Primase 1), Hells (encoding 
Lymphoid-Specific Helicase) and Rpa2 (encoding Replication Protein A2) were significantly 
up-regulated (between 1.7 and 2.6 fold) in immature DP NKT cells compared to immature DP 
T cells (T test p<0.001; Mann-Whitney U statistic =0; Fig. 4.3 A). Up-regulation of Rpa2 
expression was confirmed by qPCR on an independent sample set (Fig. 4.3 B). 
 
Figure 4.3. Expression profiles of genes related to DNA replication. A. Gene expression of Prim1, Hells and Rpa2 as 
determined by microarray (data were generated with assistance from Dr. Margaret Jordan and Prof. Alan Baxter). B. 
Rpa2 expression was confirmed by qPCR. n = 6 per cell population; Mann-Whitney test, * p<0.05. Data were 
generated with assistance from Dr. Morgane Moreau. 
The second most up-regulated annotation cluster (Enrichment score: 8.7; Table 4.1) 
contained the annotation categories Cell Cycle (GO:0007049; representing 58 transcripts of a 
total 624 up-regulated HDE genes; Bonferroni corrected p< 7 x 10-13) and Cell Division 
(Bonferroni corrected p< 1.8 x 10-13; Table 4.1). Several functional families of genes related to 
cell cycle and cell division dominated the gene list, including members of the E2F signalling 
pathway (E2f1, E2f2, E2f3), Cyclin E (Ccne1, Ccne2), Cell division cycle (Cdc6, Cdc7, Cdc45) 
and Centromere protein (Cenph, Cenpi, Cenpp). 
 
The E2F family of transcription factors play an essential role in regulating cell cycle 
progression (Dimova et al., 2005; Stevaux and Dyson, 2002; Iaquinta and Lees, 2007; Fig. 
4.4). E2F1 and E2F2 are downstream of the pre-TCR and TCR signalling pathways 
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(DeRyckere and DeGregori, 2005), and they regulate the expression of a relatively large set of 
genes that are induced in the G1 to S phase transition of the cell cycle. In contrast, E2F4 and 
E2F5 appear to function as transcriptional repressors in combination with the p130 protein in 
G0 and early G1 (Sears and Nevins, 2002; Fig 4.4).  
 
Figure 4.4. E2F signalling pathway (concept adapted from Stevaux and Dyson, 2002). 
Differential expression analysis of immature DP T cells and immature DP NKT cells, 
covering Transition 1, revealed that gene expression of E2f1, E2f2 and E2f3 was significantly 
increased by 2.0, 1.3 and 2.3 times, respectively (T test p<0.001; Mann-Whitney U test =0; Fig. 
4.5 A). In contrast, E2f4 and E2f5 expression was unchanged (data not shown). E2f signalling 
components, including Rb-1, Cdc6 and Ccne1 were also up-regulated. The increased expression 
of genes associated with E2F signalling was confirmed by qPCR (Fig. 4.5 B), and provided 
further evidence to support an increase in proliferation by immature DP NKT cells compared to 
immature DP T cells. 
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Figure 4.5. Expression profiles of genes related to the E2F signalling pathway. A. Gene expression of E2f1, 
Cdc6 and Ccne1 as determined by microarray (data were generated with assistance from Dr. Margaret Jordan 
and Prof. Alan Baxter). B. E2f1, Cdc6 and Ccne1 expression was validated by qPCR across Transition 1. n = 6 per 
cell population. Data were generated with assistance from Dr. Morgane Moreau. Mann-Whitney test, ** p<0.01, 
**** p<0.0001.  
The expression of Centromere protein encoding genes was also up-regulated across 
Transition 1. Cenph (Centromere protein H), Cenpi (Centromere protein I), Cenpk 
(Centromere protein K) and Cenpm (Centromere protein M) were all 2.2 to 3.4-fold up-
regulated by immature DP NKT cells compared to immature DP T cells (T test p<0.001; 
Mann-Whitney U statistic =0; Fig. 4.6 A). To confirm our microarray data, gene expression 
of Cenpm was validated by qPCR (Fig. 4.6 B).  
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Figure 4.6. Expression profiles of genes encoding Centromere proteins. A. Gene expression of Cenph, Cenpi, 
Cenpk and Cenpm as determined by microarray (data generation were generated with the assistance from Dr. 
Margaret Jordan and Prof. Alan Baxter). B. qPCR validation of Cenpm. n = 7 per cell population. Data were 
generated with assistance from Dr. Morgane Moreau. Mann-Whitney test, *** p<0.001.  
In total, we found 18 genes encoding Centromere proteins in our microarray data set. 
All 18 showed significantly increased expression in immature DP NKT cells compared to 
immature DP T cells (T test p<0.001; Table 4.2), of which, 15 genes had a Mann-Whitney U 
statistic =0, while 3 genes had a U statistic >0 (Table 4.2). 
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Table 4.2: Expression profile of centromere protein-encoded genes at Transition 1. 
Gene symbol U Statistic T test p-value 
Fold Change 
(DP NKT cell/ DP T cell) 
Cenpa 0 1.56E-07 1.87384 
Cenpb 2 0.0005753 1.18468 
Cenpc1 0 0.0001395 1.80325 
Cenpe 0 1.17E-05 2.37934 
Cenpf 0 6.16E-05 2.28946 
Cenph 0 2.33E-07 3.36125 
Cenpi 0 8.86E-07 3.00947 
Cenpj 1 0.0138735 1.23093 
Cenpk 0 8.99E-07 2.84247 
Cenpl 0 2.23E-06 2.02518 
Cenpm 0 7.16E-11 2.26051 
Cenpn 0 7.76E-09 2.00455 
Cenpo 0 4.85E-07 1.59497 
Cenpp 0 1.64E-07 2.90862 
Cenpq 2 0.000535 1.46906 
Cenpt 0 3.27E-05 1.22957 
Cenpv 0 7.16E-09 1.66326 
Cenpw 0 1.08E-05 1.8043 
The down-regulation of genes related to the electron transport chain, increased 
expression of DNA replication genes, activation of the E2F signalling pathway and the up-
regulation of genes encoding centromere proteins all suggested that there was an increase in 
proliferation in the immature DP NKT cells compared to immature DP T cells. 
4.2.2.2. Down-regulation of genes related to TCR signalling  
 Gene Ontology analysis of 570 down-regulated, HDE transcripts using DAVID 
Bioinformatics Resources v6.7 (Huang et al., 2009) showed that the top down-regulated 
annotation cluster (Enrichment Score 7.3) contained the annotation categories Lymphocyte 
Activation (GO:0046649), Leukocyte Differentiation (GO:0002521) and T Cell Activation 
with Bonferroni corrected p values between 10-6 and 10-4. Remarkably, genes encoding 
almost all of the proximal components of the TCR signalling cascade were significantly 
down-regulated (Mann-Whitney U statistic =0): Lck (p<6.6 x 10-8; t-Test), Fyn (1.4 x 10-7), 
Zap70 (5.4 x10-5), Vav1 (1.3 x 10-6), Plcg1 (1.2 x 10-10; Fig. 4.7).  
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Figure 4.7. Down-regulation of transcriptional factors related to TCR signalling across Transition 1. Gene 
expression profiles of Fyn, Zap70, Vav and Itk as determined by microarray (data were generated with 
assistance from Dr. Margaret Jordan and Prof. Alan Baxter).  
Although not previously reported, the effects of this transition would be akin to other 
mechanisms of TCR tuning, such as down-regulation of the TCR and CD4/CD8 co-receptors, 
up-regulation of accessory molecules such as CD5, CD2 and CD28, and phosphorylation of 
SHP-1 (Grossman and Paul, 2015), suggesting that the TCR had been ligated and successfully 
signalled, constituting validation of a functionally rearranged (in this case transgenic) 
receptor. Taken together, the transcriptional evidence supported the hypothesis that the 
increase in proliferation across Transition 1 was due to TCR signalling.  
4.2.2.3. Widespread down-regulation of TCR V genes 
If the proliferation observed across Transition 1 was due to successful TCR signalling 
and validation, then allelic exclusion of endogenous alpha chain loci should have occurred. 
Consistent with this, TCR alpha chains dominated the most significantly differentially 
expressed transcripts, constituting 10 of the top 20 most significant. In particular, Tcra-V22.1 
(TCR V22-1), Trav12-2 (TCR Va12-2), Trav9-n1 (TCR V9-n1), Trav9-4 (TCR V9-4), 
Trav8d-1 (TCR V8d-1), Trav7d-4 (TCR V7d-4), Trav7d-3 (TCR V7d-3), and Trav6-3 
(TCR V6-3) all showed 1.8 to 5.8 fold down-regulation, with T test p<10-8 and Mann 
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Whitney U statistic =0 (Fig. 4.8). The down-regulation of Trav7d-3 gene by DP NKT cells 
was also confirmed by qPCR in comparison with DP T cells (Fig. 4.9).  
 
Figure 4.8. Down-regulated expression of genes encoded TCR V alpha chains across Transition 1. Gene 
expression profiles of Tcra-V22.1, Trav12-2, Trav9-n1, Trav9-4, Trav8d-1, Trav7d-4, Trav7d-3, and Trav6-3 (data 
were generated with assistance from Dr. Margaret Jordan and Prof. Alan Baxter). 
 
Figure 4.9 TCR-V7d-3 expression was validated by qPCR between DP T cells and DP NKT cells. n = 6 per cell 
population. Data were generated with assistance from Dr. Morgane Moreau. Mann-Whitney test, ** p<0.01. 
Forty-nine of a total of 60 transcripts, representing 31 different TCR V chains, 
showed significant down-regulated expression in immature DP NKT cells compared to 
immature DP T cells (Fig. 4.10). The loss of expression of the vast majority of non-NKT cell 
PART B                                 Chapter 4: Transition 1 – Allelic Exclusion and TCR Validation 
 
 
 
- 144 -  
associated V chains is consistent with successful validation of the transgene-encoded V14 
TCR initiating the mechanism for allelic exclusion of competing TCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. Widespread down regulation of TCR V alpha genes across Transition 1. Rows correspond to 
individual transcripts and columns correspond to tested populations. Trav11d encodes the NKT cell-associated 
TCR V14. Data were generated with assistance from Dr. Margaret Jordan and Prof. Alan Baxter.  
In summary, the combination of activation, proliferation, TCR tuning and allelic 
exclusion provide compelling evidence that TCR validation occurred at the DP stage, across 
Transition 1. 
 
Gene Symbol 
Tcra-V22.1 
Tcra-V22.1 
Trav1 
Trav11d 
Trav12-1 
Trav12-1 
Trav12-2 
Trav12-2 
Trav12-2 
Trav12-2 
Trav12-2 
Trav12-2 
Trav12n-2 
Trav13-2 
Trav13d-1 
Trav14-1 
Trav14d-3-dv8 
Trav14n-2 
Trav14n-2 
Trav3-4 
Trav4-2 
Trav4-4-dv10 
Trav5-4 
Trav5-4 
Trav6-3 
Trav6-5 
Trav6-7-dv9  
Trav6-7-dv9 
Trav6d-3  
Trav6d-3 
Trav6d-4 
Trav6d-5 
Trav6d-5 
Trav7-6 
Trav7-6 
Trav7d-2 
Trav7d-2 
Trav7d-3 
Trav7d-4 
Trav7d-4 
Trav7n-5 
Trav8-1 
Trav8d-1 
Trav9-4 
Trav9-4 
Trav9d-3 
Trav9d-3 
Trav9n-1 
Trav9n-1 
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4.2.3. Functional analysis of TCR validation by immature DP NKT cells 
4.2.3.1. Immature DP NKT cells express increased proliferation in vivo 
Transcriptional analyses in sections 4.2.1 and 4.2.2 revealed that immature DP NKT 
cells proliferate more than immature DP T cells. In order to validate this finding, in vivo 5-
bromodeoxyuridine (BrdU) incorporation was performed to compare their proliferative rates. 
NOD.V14Tg mice received three intraperitoneal (i.p.) injections of 1mg BrdU at 12-hourly 
intervals and thymi were collected for analysis by flow cytometry 36 hours after BrdU 
administration. Single cells from thymi of both control and BrdU injected mice were initially 
stained with surface antibodies then intracellularly stained with fluorescence-conjugated anti-
BrdU antibody. The gating strategy applied was the same as that used for sorting cells for the 
microarray experiment (Fig. 4.11).  
 
Figure 4.11. Representative FACS plots showing gating strategy for immature DP T cells (P1), immature DP NKT 
cells (P2), immature CD4+ (P3) and DN NKT cells (P4) from thymi of BrdU injected NOD.V14Tg mice.  
Following gating, the proportions of BrdU+ cells from immature DP T cells, immature 
DP NKT cells, immature CD4+ NKT cells and immature DN NKT cells from the thymi of 
NOD.V14Tg mice were identified via histogram plots as presented in Figure 4.12. 
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Figure 4.12. Proportions of BrdU positive cells among DP T cells, DP NKT cells, CD4 and DN NKT cells.             
A. Representative histograms showing proportions of BrdU+ cells in total DP T cells, DP NKT cells, CD4 and DN 
NKT cells between control and BrdU injected mice. B. Proportions of BrdU+ cells of each subset in BrdU 
injected mice. 
The flow cytometric cell analyses revealed that immature DP NKT cells had 
significantly higher proportions of BrdU+ cells compared to immature DP T cells. The 
average proportion of BrdU+ cells rose from 56% of total immature DP T cells to 86% of total 
immature DP NKT cells (p=0.0002; Mann-Whitney U test). This finding was consistent with 
a higher frequency of proliferative cells in the immature DP NKT population compared to DP 
T cells. In contrast, the proportions of BrdU+ cells decreased in immature CD4 and DN NKT 
cells with 51% of immature CD4 NKT cells bearing BrdU+ and 77% of immature DN NKT 
cells (Fig. 4.12). Taken together, these data support the hypothesis that immature DP NKT 
cells have a higher proliferative rate than immature DP T cells. 
4.2.3.2. Validation of allelic exclusion of TCR V chain 
Allelic exclusion is a mechanism whereby a product of a single allele of T cell 
receptors is selected for expression. This process is a fundamental mechanism of 
immunological self-tolerance. Incomplete allelic exclusion leads to dual T cell receptor 
expression, which can allow developing autoreactive  T lymphocytes to escape clonal 
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deletion (Morris and Allen, 2009; Kekalainen et al., 2010). Allelic exclusion at the TCR 
locus is more stringent (primarily at the gene level not the protein level) than that at the TCR 
 locus. Both alleles of TCR genes continue to rearrange until a positively-selectable 
heterodimer is formed with the previously formed  chain (Borgulya et al., 1992). Therefore, 
immature thymocytes frequently express dual  chain on the cell surface, whereas almost all 
mature thymocytes express a single  combination (Alam et al., 1995a; Boyd et al., 1998). 
To further confirm the finding that allelic exclusion of NKT cells occurs at Transition 
1, immature and mature NKT cells were examined for the expression of TCR V2, V3.2 
and V8.3 by flow cytometry. In particular, thymic, splenic and hepatic cells from 
NOD.V14Tg mice were stained with TCR and CD1d-tet to identify NKT cells; CD4, CD8, 
CD24 and NK1.1 markers were used to identify NKT cell subsets. As illustrated in Figures 
4.13 and 4.14, immature DP NKT cells, immature CD4 NKT cells and immature DN NKT 
cells were gated from the thymus of NOD.V14Tg mice, while mature NKT cells were gated 
from the thymi, spleens and livers. These NKT cell populations (those already expressing the 
TCR V14-J18 chain) were then tested for the co-expression of TCR V2, V3.2 and 
V8.3 chains. For this experiment, immature thymic DP T cells, mature thymic, splenic and 
hepatic T cells were used as controls (Fig. 4.13 and 4.14).  
 
 
 
PART B                                 Chapter 4: Transition 1 – Allelic Exclusion and TCR Validation 
 
 
 
- 148 -  
 
Figure 4.13. Representative FACS plots showing gating strategy for V2+ thymic cell populations. Thymocytes 
were stained with stage-specific antibodies. Immature DP T cells, immature DP NKT cells, immature CD4 NKT 
cells, immature DN NKT cells and mature NKT cells were gated from the thymocytes of NOD.V14Tg mice. The 
proportions of V2+ cells from these 5 cell populations were identified by histogram plots (right). The lower 
gate boundary for V2+ cells was set based on “minus one” fluorescence controls (left histogram plots). The 
same strategy was applied to identify the proportions of V3.2+ and V8.3+ cells. 
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Figure 4.14. Representative FACS plots showing gating strategy to identify the proportions of V2+ splenic, 
hepatic T and NKT cells. Splenic (A) and hepatic (B) cells were stained with antibodies for flow cytometric 
analysis. Mature T and NKT cells were gated from the spleens and livers of NOD.V14Tg mice. The proportions 
of mature T and NKT cells expressing TCR V2+ were identified in histogram plots (right). The lower gate 
boundary for V2+ cells was set based on “minus one” fluorescence controls (left histogram plots). The same 
strategy was applied to identify the proportions of V3.2+ and V8.3+ cells. 
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Flow cytometric analysis revealed that very few (less than 2%) immature thymic T 
cells expressed TCR V2, V3.2 and V8.3 chains on their cell surface (Table 4.3; Fig. 
4.15 A). For example, only 1.23±0.04%, 0.47±0.01% and 0.30±0.01% of immature DP T 
cells expressed TCR V V2 and VrespectivelyTable 4.3; Fig. 4.15 A). 
With regard to NKT cells, less than 0.6% of immature DP NKT cells expressed TCR 
V2 or V2 and V accompanied with TCR V14-J18 chain Table 4.3; Fig. 4.15 
A). The same pattern was seen with the frequencies of immature CD4 NKT cells and 
immature DN NKT cells Table 4.3; Fig. 4.15 A). The proportions of immature DP NKT 
cells, immature CD4 NKT cells and immature DN NKT cells expressing TCR V2, V3.2 
and V8.3 chains were significantly lower than those of immature DP T cells (p<0.01; 
Mann-Whitney U test), except for a slight increase in proportion of immature CD4 NKT 
cells expressing V8.3 compared to the other subsets (Table 4.3; Fig. 4.15 A).  
Table 4.3  
(Mean ± SEM) 
TCR 
chain 
Immature DP 
T cells 
Immature DP 
NKT cells 
Immature CD4 
NKT cells 
Immature DN 
NKT cells 
V2 1.23±0.04% 0.41±0.02% 0.55±0.06% 0.10±0.02% 
V3.2 0.47±0.01% 0.18±0.02% 0.18±0.05% 0.02±0.00% 
V8.3 0.30±0.01% 0.17±0.01% 0.48±0.06% 0.08±0.02% 
 
With regard to mature NKT and T cells, the proportions of mature thymic, splenic and 
hepatic NKT cells expressing V2, V3.2 and V8.3 chains were much lower than those of 
immature thymic T and NKT cells (Table 4.4; Fig. 4.15 B). Almost none of the mature NKT 
cells expressed either V2, V3.2 or V8.3 accompanied with V14-J18 chain. In contrast, 
there were large numbers of mature T cells expressing the tested V chains.  
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In the thymus, 7.12% of mature T cells expressed V2, 2.84% expressed V3.2 and 
2.45% expressed V8.3, while in the livers the proportions were 8.82%, 3.41% and 2.71%, 
and in the spleens there were 9.07%, 3.44% and 2.80%, respectively (Table 4.4; Fig. 4.15 B). 
The significantly lower proportion of immature DP NKT cells and mature NKT cells 
expressing V2, V3.2 and V8.3 compared to immature DP T cells is consistent with the 
proposed effects of TCR V allelic exclusion on that cell population. 
Table 4.4. Proportions of mature thymic, hepatic, splenic T cells and NKT cells expressing TCR V2, V3.2 
and V8.3 (Mean±SEM) 
TCR 
chain 
Thymic 
NKT cells 
Hepatic 
NKT cells 
Splenic 
NKT cells 
Thymic   
T cells 
Hepatic   
T cells 
Splenic   
T cells 
V2 0.10±0.02 0.02±0.00 0.10±0.01 7.12±0.11 8.82±0.13 9.07±0.05 
V3.2 0.04±0.01 0.05±0.04 0.04±0.00 2.84±0.04 3.41±0.09 3.44±0.04 
V8.3 0.08±0.02 0.03±0.01 0.09±0.01 2.45±0.04 2.71±0.06 2.80±0.03 
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Figure 4.15. Flow cytometric comparison of TCR V2, V3.2 and V8.3 co-expression by NKT cells. A. Dot 
plots show the proportion of immature DP T cells, immature DP NKT cells, immature CD4 NKT cells and 
immature DN NKT cells expressing TCR V2, V3.2 and V8.3 in the thymi of NOD.V14Tg mice. B. Dot plots 
show the proportion of mature NKT and T cells expressing TCR V2, V3.2 and V8.3 in the thymi, livers and 
spleens of NOD.V14Tg mice. n= 10; Mann-Whitney U test, ** p<0.01,**** p<0.0001. 
4.3. SUMMARY OF MAJOR FINDINGS 
 Transcriptional analysis by microarray of immature DP T cells and immature DP NKT 
cells raised the possibility that immature DP NKT cells had a higher proliferation rate than 
immature DP T cells. The reduction in expression of the electron transport genes Nd1, Nd2, 
Nd4l, Nd5, Cox1, Cox2, Cox3 and Atp6 suggested reduced mitochondrial oxidative 
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phosphorylation. This is a characteristic of the Warburg phenomenon, in which cancerous or 
proliferative cells predominantly rely on glycolysis and lactate fermentation instead of oxidative 
phosphorylation as a source of ATP (Vander Heiden et al., 2009; 2011; Lunt et al., 2011).  
The possibility of increased proliferation in DP NKT cells was also supported by the 
up-regulated expression of genes associated with cell cycle and division. A large number of 
genes encoding Centromere proteins and genes involved in the E2F signalling pathway and 
DNA replication were significantly up-regulated by immature DP NKT cells compared to 
immature DP T cells. E2F1, E2F2 and E2F3 act in a functionally redundant manner to 
enhance the expression of many genes required for the G1 to S phase transition of the cell 
cycle, including Cdc6, Ccne1 and Myb (Johnson et al., 1993; Wu et al., 2001). The growth 
regulatory function of the RB tumour suppressor protein is mediated by its binding to E2F 
transcription factors; so, while overexpression of E2F1, unopposed by increased RB 
expression, results in increased proliferation, so too does E2f1 gene deletion (Yamasaki et al., 
1996; Field et al., 1996). Consistent with increased E2f1 expression, E2F1-regulated genes 
encoding proteins critical for S phase entry, such as Cdc6 and Ccne1, genes encoding proteins 
critical for spindle formation and chromosome segregation (such as Cenpm) and DNA 
replication (such as Rpa2) were also up-regulated.  
The role of the E2F pathway in mediating T cell proliferation has been studied in 
E2f1/E2f2 double knockout mice. E2F1 and E2F2 appear to play a role in homeostatic 
proliferation (HP), but not in proliferative responses to exogenous antigen, as HP in 
E2f1/E2f2 double knockout mice is severely reduced (DeRyckere and DeGreori, 2005, Zhu et 
al., 2001). It is reported that homeostatic proliferation of naive T cells requires both IL7 
signalling (Schluns et al., 2000, Surh and Sprent, 2008) and TCR stimulation by MHC-self 
peptide (Ernst et al., 1999), that of memory CD4 T cells is dependent on TCR stimulation by 
MHC-self peptide alone (Tan et al., 2002). As homeostatic proliferation of all T cells, 
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including memory CD4 T cells, is impaired in E2f1/E2f2 double knockout mice, the E2F 
pathway play a role in mediating T cell proliferation in the context of homeostatic 
proliferation (Field et al., 1996).   
 Although Benlagha et al. (2005) previously reported that their DPlow CD24high NK1.1- 
NKT cells in the thymi of newborn mice were non-dividing, our functional validation by in 
vivo BrdU incorporation confirmed our hypothesis that the immature thymic DPhigh NKT cells 
in NOD.V14Tg mice have increased proliferation. The proliferation bust following TCR 
validation seems to have some similarities to HP.  
There was widespread down-regulation of non-NKT cell TCR V genes in 
immature DP NKT cells. These findings provide further evidence at the transcriptional 
level of allelic exclusion of competing TCR V chains. Alpha chain allelic exclusion is 
also reported to be mediated via other mechanisms. During the DP stage of thymocyte 
development, both alleles of the -chain gene rearrange until a positively selectable 
heterodimer is formed with the previously rearranged -chain. Positive selection causes 
the end of chain rearrangement by halting transcription of the Rag1 and Rag2 genes 
(Borgulya et al., 1992; Brandle et al., 1992; Kouskoff et al., 1995; Alam et al., 1995b). A 
post-translational mechanism ensures that only one -chain is generally present on the 
cell surface of mature T cell (Alam and Gascoigne, 1998; Gascoigne and Alam, 1999, 
Rybakin et al., 2014). Different models have been proposed to explain post-translational 
regulation of -chain allelic exclusion (Niederberger et al., 2003). The simplest model 
proposed that allelic exclusion depended on the competition between two -chain proteins 
for a limited supply of -chain protein, when the TCR level on the cell surface increases 
during positive selection (Alam et al., 1995b; Alam and Gascoigne, 1998; Gascoigne and 
Alam, 1999). In the second model, it was proposed that the CD3z chain (a component of 
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the TCR-CD3 complex) may play an important role in phenotypic allelic exclusion of the 
-chain by stabilizing preformed  pairs thereby preferentially stabilizing the  
combination with the highest interchain affinity available to the cell. In the selective 
retention model, it was indicated that the positively selected  combination is maintained 
on the cell surface while the nonselected -chain is down-regulated or retained within the 
cell by regulation of TCR degradation via ibiquitination (Boyd et al., 1998). However, 
those models do not explain how the widespread down-regulation of non-NKT cell TCR 
V genes occurs in immature DP NKT cells compared to immature DP T cells. One 
possibility is that the relatively early expression of V14 prevents further recombination 
of endogenous alleles thereby eliminating any chance of generating other viable 
transcripts. Therefore, the down-regulation of alpha chain families’ transcripts in DP NKT 
cells likely reflects transcriptional evidence of allelic exclusion of competing TCR V 
chains in immature DP NKT cells at the allele level. This finding was confirmed by the 
very low number (almost none) of immature DP NKT cells and mature NKT cells 
expressing other TCR  chains, such as TCR V2, V3.2 and V8.3 accompanied by the 
TCR V14-J18 chain. The proportion of immature DP NKT cells, as well as mature 
NKT cells expressing the tested TCR V chains, was significantly lower than in immature 
DP T cells or mature T cells.  
The Transition 1 concept strongly suggests that αβ TCR engagement of a DP T cell 
induces the formation of a DP NKT cell, however, the data also seem compatible with an 
alternative scenario, in which DP NKT cells and DP T cells might be on separate 
developmental pathways. At the (preceding) DN3 stage, any successfully rearranged TCRβ 
chain can pair with pre-Tα to form an autonomous dimerization of the pre-TCR then undergo 
the process called β selection. β selection signals the successful completion of TCRβ chain 
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gene rearrangement and results in cellular expansion, CD4 and CD8 expression, termination 
of further TCRβ chain gene rearrangement, initiation of TCRα chain gene rearrangement, 
migration into the cortex, and development of positive and negative selection “competence” 
factors (Michie et al., 2002; Neilson et al., 2004; Pang et al., 2010; Kreslavsky et al., 2012).  
Expression of the pre-TCR upon productive rearrangement of the Tcrβ gene results in 
a burst of proliferation and in progression to the DP stage - a hallmark of αβ T cell lineage 
commitment.  Although it is sometimes assumed that cells proliferating during β selection do 
not express cell surface TCR, this assumption may be incorrect as time course experiments in 
Lucas et al. work revealed low-level of TCRβ expression on the cell surface of ~20% of 
BrdU+ thymocytes 2 hours after BrdU injection, which increases to 78.2% at 24 hours. The 
results showed that TCR is expressed at a low density by most thymocytes undergoing 
proliferation and acquisition of the CD4+CD8+ phenotype (Lucas et al., 1993). The DP NKT 
cells detected in our work appear to have variable surface TCR expression ranging from low 
to high, based on staining with tetramer and anti-TCRβ. Moreover, there is evidence that the 
TCR may transduce a signal in cells proliferating during β selection. Separation of 
thymocytes by centrifugal elutriation has shown that CD4+8+ large cells are enriched for cells 
that have not yet undergone positive selection, while many CD4+8+ small cells are 
presumably on the way to death by neglect (Guidos et al., 1990; Lundberg and Shortman, 
1994). In TCRβ-transgenic mice, deletion of self-reactive thymocytes (tetramer-binding) was 
already detectable in large DP thymocytes (with high “forward scatter”; Baldwin et al., 1999). 
In Baldwin et al. study, the large size of the cells suggests they were proliferating and the DP 
phenotype suggests they were undergoing β selection. 
Whenever the DP population was subdivided into 2 subsets, if that subdivision 
delineates DP subsets of different ages, proliferation will be increased in the “younger” subset 
due to β selection-induced proliferation during the DN-DP transition. The data presented in 
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this chapter do not exclude the possibility that DP NKT cells are “younger”, on average, than 
DP T cells. If it is admitted that DP NKT cells may be “younger” than DP T cells, then this 
can also explain the finding that many Trav genes are expressed at lower levels in the DP 
NKT population compared to the DP T cell population. This is because progressive 
recombination at the TCRα locus would be expected to incorporate a greater variety of Trav 
segments over time as the DP population ages.  
In Vα14Tg+ DN3 cells, assembly of a TCRβ chain that permits CD1d engagement 
might lead to the formation of a DP NKT cell, whereas assembly of a TCRβ chain that 
precludes CD1d engagement might lead to the formation of a DP T cell. Since these 
considerations raise a caveat about the “Transition 1” concept, unfortunately, they apply 
equally to its derivative, the “TCR validation” concept. This may not strongly support for the 
stage at which the DP NKT population and DP T cell population might diverge? However, 
the down-regulation of genes related to the electron transport chain, the activation of the 
E2F pathway, T cell signalling and the down-regulation of non-NKT associated TCR V 
genes strongly suggests that successful TCR validation occurred across Transition 1. 
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5.1. INTRODUCTION 
Thymic selection ensures that the resulting T cell populations are responsive to foreign 
antigens, but not self-antigens, presented by antigen presenting cells (APCs; Starr et al., 
2003). In conventional T cells, thymic selection is primarily determined by the avidity of the 
interaction between the newly formed TCR on DP thymocytes and peptide-major 
histocompatibility complex (MHC) products on the APCs (Hogquist et al., 1994; Alam et al., 
1999; Klein et al., 2014). When DP thymocytes have a moderate avidity interaction, they are 
positively selected and, subsequently, differentiate into mature CD4 or CD8 single positive 
conventional T cells. In contrast, if there is an insufficient or high avidity interaction, they are 
negatively selected and die through neglect or apoptosis, respectively. The net result of these 
interactions allows for the generation of T cells with low recognition for self and elimination 
of potentially auto-reactive cells (Starr et al., 2003). 
The interactions between the newly formed TCRs and endogenous ligands induce a 
series of intracellular signalling cascades, which will direct the DP thymocytes to positive or 
negative selection (Starr et al., 2003). Upon engagement of the TCRs by antigens presented 
on MHC molecules, the Src family kinases Lck and Fyn are activated and phosphorylate 
immunoreceptor tyrosine-based activation motifs (ITAMs) on CD3 (Kane et al., 2000. 
Phosphorylated ITAMs promote the recruitment and subsequent activation of another tyrosine 
kinase, ZAP-70, which, in turn, phosphorylates the tyrosine residues on the adapter molecule 
LAT (Samelson, 2002). The phosphorylation of LAT results in recruitment of several 
components of the TCR signal transduction pathway, including GADs, SLP-76, PLC1 and 
Grb2 (Koretzky et al., 2006; Wange, 2000). In the presence of a moderate-avidity TCR 
ligand, partial LAT phosphorylation recruits PLC1 and GADs/SLP-76/ITK, resulting in 
activation of the Ras pathway and calcium signalling. The Ras pathway stimulates sustained, 
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low-level ERK activation, while the calcium flux activates NFAT (Brownlie et al., 2013). 
These signals ultimately result in thymocyte survival, cessation of TCR gene recombination, 
antigen receptor tuning, cell migration into a new thymic environment and lineage commitment. 
In contrast, a high-avidity TCR interaction results in full phosphorylation of LAT. Fully 
phosphorylated LAT, in turn, recruits Grb2/SOS1 and strong, transient activation of ERK 
coupled with p38 and JNK activation and leads to programmed cell death (Starr et al., 2003).   
Although less well understood than conventional T cells, it is believed that NKT cells 
also undergo positive and negative selection events. These selection processes allow for the 
elimination of highly auto-reactive cells while preserving a functional pool of cells. Unlike 
conventional T cell precursors, which are selected by peptide antigens presented in the 
context of MHC class I or II molecules on cortical epithelial cells, NKT cells are selected by 
glycolipid antigens presented by CD1d on cortical DP thymocytes (Bendelac, 1995; Cole and 
Raulet, 2000; Wei et al., 2005; Godfrey and Berzins, 2007). NKT cells are absent in both 
Cd1d-/- mice (Chen et al., 1997; Mendiratta et al., 1997; Smiley et al., 1997; Gapin et al., 
2001) and bone marrow chimeric mice that lack CD1d expression on DP thymocytes (Chun et 
al., 2003). In contrast, NKT cells develop normally in mice bearing a targeted mutation of the 
endogenous Cd1d gene if rescued by a human Cd1d transgene (Schumann et al., 2005). The 
lack of AP-3 and prosaposin, which are involved in trafficking of CD1d to lysosomes and the 
loading of glycolipids into the CD1d groove, markedly impaired NKT cell development. 
These findings suggested that CD1d expression on cortical DP thymocytes is a critical 
requirement for the positive selection of NKT cells (Chun et al., 2003).  
While the requirements for positive selection of NKT cells are gradually being 
clarified, the question of whether iNKT cells are subject to negative selection remains 
controversial (Godfrey and Berzins, 2007). The most compelling evidence has indicated that 
the early introduction of -GalCer, both in vivo (by fetal thymic organ culture) and in vitro 
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(i.p. injection of -GalCer from day 3 to day 14), could specifically ablate NKT cell 
development. However, it could not do so if the challenge was delayed after NKT cells had 
differentiated (Pellicci et al., 2003). The study of fetal thymic organ cultures (FTOC) has 
shown that NKT cells could not be generated in thymic lobes cultivated in the presence of -
GalCer, while they develop normally in cultures with -GalCer or DMSO (Pellicci et al., 
2003; Chun et al., 2003). In these studies, the presence of -GalCer, a potent antigen, was 
proposed to mediate negative selection of iNKT cells. Unfortunately, -GalCer is not a 
mammalian self-antigen for the semi-invariant TCR; thus these studies do not address the 
question of whether iNKT cells can be negatively selected under physiological conditions.  
In addition, by creating mice expressing a transgenic TCR-β chain that pairs with the 
canonical Vα14-Jα18 TCR-α chain, Bedel et al. (2014) created a model with high affinity for 
self-lipid/CD1d complexes. Their results indicated that effective functional maturation of 
invariant natural killer T cells is constrained by negative selection and T-cell antigen receptor 
affinity. Analysis with PBS57-loaded CD1 tetramers revealed a large reduction in, but not 
complete loss of, the proportion and total number of iNKT cells in the thymus, spleen, and liver 
of the 2A3-D Tg mice compared with the wild type mice. While the impairment occurs at the 
transition from stage 1 to stage 2 of NKT cell development the remained iNKT cells that avoid 
negative selection in these mice express natural sequence variants of the canonical TCR-α and 
decreased affinity for self/CD1d (Bedel et al., 2014). These results directly demonstrate that the 
TCR signaling by agonist self-ligands is the trigger of the iNKT cell differentiation pathway. It 
also emphasizes that only a limited range of TCR affinity for self is actually compatible with 
iNKT cell development versus death by neglect or negative selection. 
In contrast, other studies have examined the effects of negative selection on NKT cell 
development through altering CD1d density on ligand expressing cells. Overexpression of 
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CD1d, derived from both mice (Chun et al., 2003) and humans (Schumann et al., 2005), on 
thymic stromal, dendritic cells or DP thymocytes in transgenic mice impaired NKT cell 
development and led to reduced NKT cell numbers. This effect is biased toward the higher 
affinity TCR V8.2 but not the TCR V2, which is known to have a lower affinity for -
GalCer in the context of CD1d (Chun et al., 2003). However, the aforementioned studies all 
showed a failure of NKT cell development, as opposed to the deletion of formed iNKT cells. 
If negative selection does occur in the NKT cell lineage, it likely affects the earliest stages, 
possibly around the same time as positive selection, as acute treatment of the adult thymus 
(mostly mature NKT cells) by intrathymic injection of α-GalCer has little effect on NKT cells 
(Pellicci et al., 2003). Additionally, Nur77, a transcription factor associated with negative 
selection, is selectively expressed by very immature NKT cells (Stanic et al., 2004b). 
Therefore, further studies are required to better understand whether, or when, iNKT cells 
actually undergo positive and negative selection. 
 In Chapter 3, flow cytometric analysis of V14 transgenic mice revealed that they 
produced large numbers of thymic DPhigh CD24high NK1.1-CD1d-tet+TCRint (immature DP 
NKT) cells. Phenotypic analysis indicated that these cells exhibited a phenotype consistent 
with the earliest progenitors of NKT cells or pre-selection DP NKT cells. In Chapter 4, 
transcriptional analysis over the course of iNKT cell differentiation from immature DP T cells 
to immature DP NKT cells indicated that allelic exclusion and successful TCR validation occur 
at Transition 1, but did not show any sign of T cell selection. Based on the principal component 
and network analyses, the successful TCR validation by immature DP NKT cells might be a 
signal for thymic selection of this cell population. Therefore, in this chapter, gene expression 
will be compared between immature DP NKT cells and immature CD4 NKT cells to identify 
transcriptional evidence for thymic selection and lineage commitment of NKT cells.  
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The following hypothesis was tested: “Positive selection occurs across Transition 2 
between immature DP NKT cells and immature CD4 NKT cells during thymic 
development”. 
Specifically, the aims of this chapter were: 
1. To compare gene expression between immature DP NKT cells and immature CD4 
NKT cells. 
2. To identify significant changes in gene expression related to positive selection of 
NKT cells. 
3. To functionally validate gene expression changes occurring during thymic selection. 
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5.2. RESULTS 
5.2.1. Transcriptional analysis between immature DP NKT cells and CD4 NKT cells 
Gene expression comparison was performed between immature DP NKT cells and 
immature CD4 NKT cells across Transition 2 to identify significant gene expression changes. 
Of the 35,556 transcripts analysed by microarray, 6,791 transcripts generated a Mann-
Whitney U score of zero. Of these, 2,143 were highly differentially expressed (HDE; T test p 
< 1.4x10-6). This gene list was split into transcripts, which were up-regulated (1,216 
transcripts), and those which were down-regulated (930 transcripts). These up-regulated and 
down-regulated HDE genes were separately submitted to DAVID Bioinformatics Resources 
for functional annotation clustering.  
5.2.1.1. Transcriptional analysis of NKT cell lineage commitment 
Gene Ontology analysis was performed on 1,216 up-regulated HDE transcripts in 
DAVID Bioinformatics Resources. The top up-regulated annotation cluster (Enrichment 
Score 9.6) was dominated by integral plasma membrane proteins and contained the annotation 
categories (SP_PIR_KEYWORDS) Membrane (representing 40 of all up-regulated HDE genes; 
Bonferroni corrected p<1.6x10-17) and Glycoprotein (Bonferroni corrected p<1.1x10-14). 
Several functional families of integral plasma membrane proteins dominated the gene list, 
including Toll-like receptors (TLR1, 3, 6 and 12), receptors for cytokines (IL-1, 2, 6, 7, 10, 
18, 21, 27; IFN-, TGF- and TNFR super-family members 1b, 9, 18 and 26), receptors for 
chemokines (CCR2, 4, 7, 8, 10; CXCR2 and 6), G protein coupled receptors (114, 171, 18, 
65, 68, 83, 97, C5B), integrins (alpha 2, 4, E, L, V and FG-GAP repeat containing 3; beta 2, 3 
and 7) and leukocyte differentiation markers (CD2, 5, 7, 25, 37, 38, 40LG, 44, 48, 52, 53, 
59A, 79B, 82, 101, 160, 226, 274; Ly6A, C1, 6G and Ly9). The differential expression of 
several transcripts encoding integral plasma membrane proteins at the transition 1 (between 
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DP NKT cells and CD4 NKT cells) is shown in Figure 5.1 (the first and third rows) and 
confirmed by flow cytometry (the second and the fourth rows).  
 
Figure 5.1. Expression profiles of genes encoding integral plasma membrane proteins across Transition 2. Gene 
expression of Ccr2, Ccr7, Cd5 (the first row), Cd25, Cd53 and Cd278 (Icos; the third row) as determined by 
microarray (data were generated with assistance from Dr. Margaret Jordan and Prof. Alan Baxter). The differences 
in protein expression levels were confirmed by flow cytometry (the second row and the last row; n=5-6 mice per 
group in CCR2 and CCR7 expression experiments, n=10 mice per group in CD5, CD25, CD53 expression experiments; 
Mann-Whitney U test, ** p<0.01, **** p<0.0001). 
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Of the up-regulated HDE transcripts, amongst the most strongly differentially 
expressed (Mann-Whitney U statistic =0), there were genes associated with the 
immunomodulatory and innate-like characteristics of NKT cells, such as: Tlr1, Nkg7, 
Sema4a, Art2b, S1pr1 and Zbtb16 (Fig. 5.2).  
 
Figure 5.2. Expression profiles of genes related to lineage commitment across Transition 2. Gene expression of Tlr1, 
Nkg7, Sema4a (the first row), Art2b, S1pr1, Zbtb16 (the third row) as determined by microarray (data were generated 
with assistance from Dr. Margaret Jordan and Prof. Alan Baxter). The differences in transcriptional levels were 
confirmed by qPCR (the second row and the last row; n=5-6 for DP NKT cell samples, n=5-7 for CD4 NKT cell samples; 
data were generated with assistance from Dr. Morgane Moreau; Mann-Whitney U test, ** p<0.01).  
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Tlr1 (encoding Toll-Like Receptor 1-TLR1) was up-regulated 15-fold in CD4 NKT 
cells compared to DP NKT cells (p<1.1x10-16, t-Test). TLR1 plays a fundamental role in 
pathogen recognition and activation of innate immunity (Takeuchi et al., 2002; Vallois et al., 
2007). Nkg7 (encoding Natural Killer Cell Granule Protein 7) was up-regulated 36-fold in 
CD4 NKT cells compared to DP NKT cells (p<3.8x10-15, t-Test). NKG7 is associated with 
the cell mediated cytotoxic synapse. Sema4a (encoding Semaphorin 4A) was up-regulated 10-
fold in CD4 NKT cells compared to DP NKT cells (p<9.6x10-10; t-Test). SEMA4A is a type I 
integral membrane protein required for Th1 deviation and T-bet expression in T cells 
(Kumanogoh et al., 2005) 
In addition, a number of other NKT cell-associated surface receptors were up-regulated 
in this transition. Art2b (p<1.5x10-14; Fold change (FC) 49) encoding ADP-ribosyltransferase 
2b that mediates apoptotic deletion of T-cell subsets (Seman et al., 2003), particularly CD4+ 
NKT cells (Chen et al., 2006); S1pr1 (p<5x10-16; FC 22) encoding Sphingosine-1-Phosphate 
Receptor 1, which plays an important role in lymphocyte egress from lymphoid tissues; and 
Zbtb16 (p<6.5x10-14; FC 14) encoding Promyelocytic Leukaemia Zinc Finger (PLZF), a 
transcription factor that drives differentiation into NKT cells and human MR1-specific MAIT 
cells. These data indicated that a wide range of functional NKT cell-associated surface receptors 
were up-regulated in immature CD4 NKT cells compared to immature DP NKT cells and 
confirm the findings of Savage et al. (2008) that PLZF expression in NKT cells is up-regulated 
between Stage 0 and 1 of development (Sevage et al., 2008; Fig. 5.2).  
The strong up-regulation of such a wide range of functional lymphocyte-associated, 
surface expressed, integral membrane proteins suggests that Transition 2 is associated with 
NKT cell lineage commitment. Consistent with this is the up-regulation of Zbtb16, which is 
responsible for driving the innate-like differentiation of NKT cells. Savage et al. (2008)  
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Figure 5.3. Expression profiles of 69 transcripts, which were reported by Savage et al. (2008) to be 
modulated by PLZF. The heat map shows the expression of these 69 transcripts by 4 different cell types (P1: 
DP T cells, P2: DP NKT cells, P3: CD4 NKT cells, P4: DN NKT cells), 7 biological samples per cell type, across 3 
transitions. Pie charts show proportion of transcripts with 4 different statistic categories (up-regulated and U 
statistic = 0, up-regulated and U statistic > 0, down-regulated and U statistic = 0, and down-regulated and U 
statistic > 0) across each of the 3 transitions. 
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conducted a comparison of genome-wide transcriptions in PLZF-deficient Luxoid mutant with 
that in WT mice. The authors identified 69 genes being dependent on PLZF expression. To 
test whether the up-regulation of Zbtb16 across Transition 2 was sufficient to modulate the 
expression of PLZF targeted genes during NKT cell development, we examined the transcript 
levels of the 69 genes identified by Savage et al. (2008; Fig 5.3). Gene expression comparison 
revealed that 42 of the 69 genes had a U statistic of zero across the transition 2 (p<0.0001; 
Chi-square contingency table), the vast majority of which (39 genes) were up-regulated (Fig. 
5.3). These data are consistent with PLZF expression playing a significant role in NKT cell 
development across Transition 2.   
Overall, the coordinated expression of the innate-like lymphocyte-associated 
transcription factor PLZF and the subsequent up-regulation of a wide range of cell-surface 
functional receptors associated with NKT cell immunobiology provide evidence that NKT 
cell lineage commitment occurred across Transition 2, between Stage 0 and 1, as previously 
reported by Savage et al. (2008). 
5.2.1.2. Transcriptional evidence of NKT cell selection 
The association of NKT cell TCR validation with Transition 1 and Lineage 
commitment with Transition 2 raised the issue of the timing of NKT cell selection, which 
presumably could not occur later than Transition 2. Huang et al. (2004) published a custom 
microarray analysis of transcriptional changes during T cell selection by comparing 
transcripts between DP thymocytes that had not received a TCR signal from MHC-/- mice 
(C57BL/6.B2m-/-.Ab-/-.Enull) with those from positively selecting TCR transgenic mice (5CC7 
and either F5 or P14). We were able to identify equivalent Affymetrix transcript cluster IDs 
for 32 of the transcripts reported by Huang et al. (2004) as being up-regulated by 
conventional T cell selection (Fig. 5.4). Of these, 8 transcripts had a U statistic of zero across 
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Transition 1 (NS, Chi-square contingency table), 24 did across Transition 2 (p<0.0001) and 
12 did across Transition 3 (p<0.02). Of the transcripts that showed a U Statistic of 0 across 
transitions, 21 transcripts were up-regulated in immature CD4 NKT cells compared to 
immature DP NKT cells, across Transition 2. In contrast, only two were up-regulated across 
Transition 1, two were up-regulated across Transition 3, and none were increased in 
expression by >25%. These data are consistent with NKT cell selection occurring across 
Transition 2. 
 
Figure 5.4. Expression profiles of 32 transcripts, which were reported by Huang et al. (2004) to be involved in 
positive selection of conventional T cells. A. The heat map shows the expression of these 32 transcripts by 4 
different cell types, 7 biological samples per cell type. B. Pie charts show proportions of 32 transcripts with 4 
different statistic categories (up-regulated and U statistic = 0, up-regulated and U statistic > 0, down-regulated 
and U statistic = 0, and down-regulated and U statistic > 0) across each of the 3 transitions. 
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Figure 5.5. Expression profiles of 56 transcripts, which were reported by Mick et al. (2004) to be associated 
with positive selection of conventional T cells. The heat map shows the expression profiles of these 56 
transcripts by 4 different cell types, 7 biological samples per cell type. 
Mick et al. (2004) investigated genes regulated during thymic positive selection by 
comparing gene expression changes in CD4+CD8+ (double positive – DP) thymocytes from 
OT-I transgenic mice that have received a TCR signal with those from OT-I/TAP-/- transgenic 
mice that had not received a signal. Their data indicated that 66 genes were up-regulated 
during positive selection of conventional T cells. Compared to these 66 genes, we identified 
56 genes in our microarray data. Expression comparison of these 56 genes across the 3 
transitions indicated that 35 genes were significantly up-regulated across Transition 2 (Mann-
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Whitney U statistic =0; Fig. 5.5). In contrast, only 11 genes were significantly up-regulated 
across Transition 1 and 8 genes across Transition 3. These data further supported the 
hypothesis that positive selection of NKT cells occurs across Transition 2, between DP NKT 
cells and CD4 NKT cells. 
Taken together, the above findings suggested that positive selection of NKT cells is 
occurring between DP NKT cells and CD4 NKT cells and that DP NKT cells represent a pre-
selection population. 
5.2.2. Functional validation of positive and negative selection 
In order to functionally validate the findings from the microarray analysis that positive 
selection of NKT cells occurs across Transition 2, we examined the effects of positive and 
negative selection on immature NKT cells.  
5.2.2.1. Effects of failed positive selection on NKT cells in V14Tg mice 
 Thymic positive selection is the preferential differentiation of thymocytes with 
moderate avidity for the endogenous ligands of their TCR (Zuñiga-Pflucker et al., 1989). It is 
well demonstrated that CD1d functions as an antigen-presenting molecule to present 
endogenous glycolipid ligands for positive selection of NKT cells (Bendelac, 1995; Cole and 
Raulet, 2000; Wei et al., 2005; Godfrey and Berzins, 2007). Thus, in order to test the hypothesis 
that positive selection occurs across Transition 2 and that immature DP NKT cells in the thymi 
of NOD.V14Tg mice represent a pre-selection population, we examined the effects of targeted 
deletion of CD1d on the development of immature NKT cells in V14 transgenic mice.  
5.2.2.1.1. Effects of failed positive selection on NKT cells in NOD.V14Tg mice 
Targeted deletion of CD1d was performed on NOD.V14Tg mice by crossing 
NOD.V14Tg mice with NOD.Cd1d-/- mice. The F1 mice were intercrossed to generate 
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NOD.Cd1d-/-.V14Tg mice. Thymi and spleens were collected from 6-8 week old NOD WT, 
NOD.Cd1d-/-, NOD.V14Tg and NOD.Cd1d-/-.V14Tg mice and single cell suspensions were 
prepared. Cells were then stained with fluorescent conjugated antibodies and analysed using 
flow cytometry.  
 
Figure 5.6. Effects of targeted deletion of CD1d on NKT cells from NOD.V14Tg mice. A. Representative FACS 
plots show the mean frequencies (±SEM) of thymic NKT cells in total thymocytes of NOD WT, NOD.Cd1d-/-, 
NOD.V14Tg and NOD.Cd1d-/-.V14Tg mice. B. Dot plots show mean frequencies and absolute numbers of thymic 
NKT cells. C. Representative FACS plots show the mean frequencies (±SEM) of splenic NKT cells in total 
splenocytes of NOD WT, NOD.Cd1d-/-, NOD.V14Tg and NOD.Cd1d-/-.V14Tg mice. D. Dot plots show mean 
frequencies and absolute numbers of splenic NKT cells. n=10 for NOD WT group, n=6 for NOD.Cd1d-/-, 
NOD.V14Tg and  NOD.Cd1d-/-.V14Tg groups. 
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Flow cytometric analysis indicated that in NOD WT mice, targeted deletion of CD1d 
resulted in the loss of almost all NKT cells (identified as TCR+ CD1d-tet+), in both the 
thymus and the periphery, in accordance with previous findings (Fig. 5.6; Bendelac, 1995; 
Cole and Raulet, 2000; Wei et al., 2005).  
In sharp contrast, thymic NKT cells from NOD.Cd1d-/-.V14Tg mice were 
significantly increased compared to NOD.V14Tg mice, although NKT cells in the periphery 
were severely depleted (Fig. 5.6). Both the proportions and the absolute numbers of thymic 
NKT cells were more than doubled. For example, the proportion of thymic NKT cells 
increased from 10% of total thymocytes in NOD.V14Tg mice to 20% in NOD.Cd1d-/-
.V14Tg mice (p<0.01; Mann-Whitney U test); whereas the absolute numbers of thymic NKT 
cells rose from 11.6 x 106 cells in NOD.V14Tg mice to 22.8 x 106 cells in NOD.Cd1d-/-
.V14Tg mice (p<0.01; Fig. 5.6). 
The massive expansion of NKT cells in the thymus and their absence in the periphery 
of NOD.Cd1d-/-.V14Tg mice suggested that thymic NKT cells were precluded from 
undergoing positive selection in the absence of the antigen presenting molecule CD1d. To 
identify the major population contributing to the increase in thymic NKT cells in NOD.Cd1d-/-
.V14Tg mice or identify the stage at which NKT cells undergo positive selection, thymic 
NKT cell subsets were examined using stage-specific markers (CD4/CD8, CD24/CD44 and 
CD44/NK1.1) and presented in Figure 5.7.  
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Figure 5.7. Effects of targeted deletion of CD1d on thymic NKT cell subsets in NOD WT and NOD.V14Tg mice. A. 
CD4/CD8 NKT cell subsets. B. CD24/CD44 NKT cell subsets. C. CD44/NK1.1 NKT cell subsets. For all, representative 
FACS plots show the mean frequencies (±SEM) of thymic NKT cell subsets in total NKT cells from the thymi of NOD 
WT, NOD.Cd1d-/-, NOD.V14Tg and NOD.Cd1d-/-.V14Tg mice. Dot plots show mean frequencies and absolute 
numbers of thymic NKT cell subsets in total NKT cells. The NKT cell gates applied are illustrated in Figure 5.6 A. n=10 
for NOD WT group, n=6 for NOD.Cd1d-/-, NOD.V14Tg and NOD.Cd1d-/-.V14Tg groups. 
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Flow cytometric analysis of thymic NKT cell subsets revealed that, in NOD WT mice, 
NKT cells predominantly expressed a mature phenotype with either CD4+ or DN, CD24low 
CD44high. In sharp contrast, in NOD.Cd1d-/- mice, the few remaining NKT cells in the thymi 
showed an immature phenotype with 80% DP, 91% CD24high CD44low and 87% CD44low 
NK1.1- (Fig. 5.7). In NOD.Cd1d-/-.V14Tg mice, the proportion of thymic DP NKT cells rose 
from 60% of total thymocytes in NOD.V14Tg mice to over 80% in NOD.Cd1d-/-.V14Tg 
mice (p<0.005; Mann-Whitney U test; Fig. 5.7 A). The vast majority (>96%) of thymic NKT 
cells in NOD.Cd1d-/-.V14Tg mice expressed the immature CD24high CD44low NK1.1- 
phenotype (Fig. 5.7 B and C).  
With regard to absolute numbers, thymic DP NKT cells increased more than 3-fold, 
from 6.8 x 106 cells in NOD.V14Tg mice to 21 x 10
6 cells in NOD.Cd1d-/-.V14Tg mice  
(p<0.005; Mann-Whitney U test; Fig. 5.7 A). NOD.V14Tg mice had 8.3 x 106 CD24high 
CD44low NKT cells, while NOD.Cd1d-/-.V14Tg mice had a more than 2-fold increase to 21 x 
106 cells (p<0.005). In contrast, mature thymic CD24low CD44high NKT cells were almost 
completely depleted in NOD.Cd1d-/-.V14Tg mice. The numbers of mature thymic CD24low 
CD44high NKT cells decreased more than 20-fold, from 6.0 x 105 cells in NOD.V14Tg mice to 
0.29 x 105 cells in NOD.Cd1d-/-.V14Tg mice (p<0.005). These data indicate that the increase 
in thymic NKT cells was primarily due to an increase in numbers of immature DP NKT cells. 
The maturational arrest of immature DP NKT cells in the thymi of NOD.Cd1d-/-.V14Tg mice 
suggested that these immature DP NKT cells failed to undergo positive selection; they could not 
develop further in the absence of the antigen presenting molecule, CD1d for positive selection. 
This finding supported the hypothesis that the DPhigh CD24high CD44low NK1.1- NKT cells 
represent a pre-selection population.  
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5.2.2.1.2. Effects of failed positive selection on immature NKT cells in B6.V14Tg mice 
It has been reported that there are deficiencies in NKT cell development in NOD WT 
mice compared to other commonly used mouse strains, which result in the severe reduction in 
both NKT cell numbers and function (Gombert et al., 1996; Baxter et al., 1997; Godfrey et al., 
1997; Poulton et al., 2001; Hammond et al., 2001). Therefore, to confirm that the maturational 
arrest of immature DP NKT cells in NOD.V14Tg mice is the consequence of the absence of 
CD1d endogenous ligand, Cd1d was depleted from B6.V14Tg mice by crossing B6.V14Tg 
mice with B6.Cd1d-/- mice. The resulting F1 mice were intercrossed to generate B6.Cd1d-/-
.V14Tg mice. Thymi, spleens and livers were harvested from 6-8 week old mice for flow 
cytometric comparison of their NKT cells to those of the background strain. 
Flow cytometric analysis revealed that in B6 WT mice, the targeted deletion of CD1d 
also resulted in the loss of almost all NKT cells (identified as TCR+ CD1d-tet+) in the thymi, 
livers and spleens (Fig. 5.8). In contrast, the number of thymic NKT cells in B6.Cd1d-/-.V14Tg 
mice was more than quadrupled, concordant with very few peripheral NKT cells. The 
proportion of thymic NKT cells increased from 7.8% of total thymocytes of B6.V14Tg mice 
to almost 21% in B6.Cd1d-/-.V14Tg mice. The absolute numbers of thymic NKT cells rose 
from 3.4 x 106 cells in B6.V14Tg mice to about 20 x 106 cells in B6.Cd1d-/-.V14Tg (Fig. 
5.8). These data indicated that targeted deletion of CD1d in B6.V14Tg mice showed a similar 
effect on NKT cells as it did on those from NOD.V14Tg mice, characterised by the massive 
increase in thymic NKT cell numbers and the depletion of peripheral NKT cells. 
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Figure 5.8. Effects of targeted deletion of CD1d on NKT cells in B6.V14Tg mice. A. Representative FACS 
plots show the mean frequencies (±SEM) of thymic, hepatic and splenic NKT cells in total cells from the thymi, 
livers and spleens, respectively, of B6 WT, B6.Cd1d-/-, B6.V14Tg and B6.Cd1d-/-.V14Tg mice. B. Dot plots 
show mean frequencies and absolute numbers of thymic, hepatic and splenic NKT cells. n=10 for B6 WT, n=1 
for B6.Cd1d-/-, n=5 for B6.V14Tg and n=7 for B6.Cd1d-/-.V14Tg mice. 
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We next investigated the thymic NKT cell subsets to determine which were affected by 
the absence of CD1d. Thymic NKT cell subsets were compared between B6.V14Tg and 
B6.Cd1d-/-.V14Tg mice by flow cytometric analysis using stage-specific markers CD4/CD8, 
CD24/CD44 and CD44/NK1.1. Our data revealed that the increase in thymic NKT cells was 
largely attributed to the accumulation of immature DP NKT cells. As indicated in Figure 5.9 A, 
the proportion of immature thymic DP NKT cells rose from 48% of total thymocytes in 
B6.V14Tg mice to over 85% in B6.Cd1d-/-.V14Tg mice. With regard to absolute numbers, 
thymic DP NKT cells increased more than 10 times, from 1.2 x 106 cells in B6.V14Tg mice to 
13.6 x 106 cells in B6.Cd1d-/-.V14Tg mice (p<0.005; Fig. 5.9 A).  
 
Figure 5.9. Effects of targeted deletion of CD1d on NKT cell subsets in B6.V14Tg mice. A. CD4/CD8 NKT cell 
subsets. B. CD24/CD44 NKT cell subsets. C. CD44/NK1.1 NKT cell subsets. For all, representative FACS plots 
(left panels) show the mean frequencies (±SEM) of thymic NKT cell subsets in total NKT cells from the thymi 
of B6.V14Tg and B6.Cd1d-/-.V14Tg mice. Dot plots (right panels) show mean frequencies and absolute 
numbers of thymic NKT cell subsets in total NKT cells. The NKT cell gates applied are illustrated in Figure 5.8. 
n=5 for B6.V14Tg and n=7 for B6.Cd1d-/-.V14Tg mice. 
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With regard to CD24, CD44 and NK1.1 expression, the vast majority (>99%) of 
thymic NKT cells expressed the immature CD24high CD44low NK1.1- phenotype (Fig. 5.9 B 
and C). While B6.V14Tg mice had 1.9 x 106 CD24high CD44low NKT cells, B6.Cd1d-/-
.V14Tg mice had a >8-fold increase to 16 x 106 cells (p<0.005; Mann-Whitney U test). In 
contrast, mature CD24low CD44high NKT cells were profoundly diminished in the thymi of 
B6.Cd1d-/-.V14Tg. Their numbers fell more than 80-fold from 535,000 cells per thymus in 
B6.V14Tg mice to 6,500 cells in B6.Cd1d-/-.V14Tg mice (p<0.005). In summary, there was a 
maturational arrest of immature DP NKT cells in the thymi of B6.Cd1d-/-.V14Tg mice, similar 
to that found in NOD.Cd1d-/-.V14Tg mice. The immature thymic DP NKT cells from both 
NOD and B6.V14Tg mice failed to undergo positive selection in the absence of CD1d. Taken 
together, these data also strongly support the hypothesis that the DPhigh CD24high 
CD44lowNK1.1- NKT cells represent a pre-selection population.  
5.2.2.2. Effects of enhanced negative selection by -GalCer on NKT cells  
 If immature DP NKT cells are a pre-selection population of NKT cells, they are likely 
subjected to negative selection. Negative selection in the thymus results in the clonal deletion 
(apoptosis) of thymocytes with high avidity for the endogenous ligands of their TCR. As the 
frequency of T precursors for any given antigen is generally low in WT animals, in vivo 
models of negative selection either involve in administration of anti-TCR/CD3 antibodies 
(Kishimoto and Sprent, 1997), responses to endogenous or administered superantigens that 
ligate whole families of TCR V chains (Kappler et al., 1988; Jenkinson, 1989), or the use of 
TCR transgenic mice (Baldwin et al., 2005). While -GalCer is not technically a 
superantigen, it is a strong NKT cell antigen glycolipid capable of activating the vast majority 
of V14-J18 expressing NKT cells following presentation in the context of CD1d (Kawano 
et al., 1997), and therefore capable of causing their negative selection if administered 
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systemically or intrathymically (Pellicci et al., 2003). We made use of -GalCer to follow 
negative selection in NKT cell development. 
5.2.2.2.1. Effects of intravenous (i.v.) injection of -GalCer on NKT cells in NOD.V14Tg mice  
 The effect of negative selection on DPhigh CD24high CD44low NK1.1- NKT cells in the 
thymi of NOD.V14Tg mice was examined by i.v. injection of 4 µg -GalCer, and 
subsequent analysis by flow cytometry. Within 40 hours of injection, the proportion of thymic 
NKT cells (identified as CD1d-tet+TCR+) reduced from 7.7% of total thymocytes in control 
NOD.V14Tg, injected with PBS, to 5.4% in -GalCer injected mice (Fig. 5.10). 
 
 
Figure 5.10. Effects of enhanced negative selection on NKT cells in NOD.V14Tg mice by i.v. -GalCer 
administration. A. Representative FACS plots show the mean frequencies (±SEM) of NKT cells in total cells from 
the thymi, livers and spleens of PBS and -GalCer injected NOD.V14Tg mice. B. Dot plots show mean 
frequencies and absolute numbers of thymic, hepatic and splenic NKT cells. n=10 for each group. 
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In terms of absolute numbers, thymic NKT cells had halved, from 12 x 106 cells to 5.4 
x 106 cells after -Galcer injection (p<0.0001; Mann-Whitney U test; Fig. 5.10), while total 
thymocytes had only slightly decreased from 1.6 x 108 cells in NOD.V14Tg control mice to 
1.2 x 108 cells in -GalCer injected mice (p<0.05). In contrast, peripheral NKT cells increased 
in NOD.V14Tg mice injected with -GalCer, from 1.9 x 106 cells per liver of the control 
mice to 3.5 x 106 cells per liver of the treated mice (p<0.005), and from 4.7 x 106 to 7.2 x 106 
in the spleens (p<0.005; Fig. 5.10). These data are consistent with peripheral antigen-induced 
activation and proliferation.  
Flow cytometric analyses of thymic NKT cell subsets revealed that the majority of the 
reduction in thymic NKT cells was contributed by reduction of the DP subset, which fell from 
63% of total thymic NKT cells in control mice to 48% in -GalCer injected mice (p<0.0001; 
Mann-Whiney U test; Fig 5.11 A). In terms of absolute numbers, thymic DP NKT cells 
decreased from 7.5 x 106 cells in control mice to 3.1 x 106 cells in -GalCer injected mice 
(p<0.0001; Fig 5.11 A). In contrast, the proportions of the more mature DN and CD4+ NKT 
cells was significantly increased in the -GalCer treated mice (p<0.0001), although they 
showed modest reductions in terms of absolute numbers (CD4+ NS; DN p<0.01). 
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Figure 5.11. Effects of enhanced negative selection on thymic NKT cell subsets in NOD.V14Tg mice by i.v. -
GalCer administration. A. CD4/CD8 NKT cell subsets. B. CD24/CD44 NKT cell subsets. C. CD44/NK1.1 NKT cell 
subsets. For all, representative FACS plots (left panels) show the mean frequencies (±SEM) of thymic NKT cell 
subsets in total NKT cells from the thymi of PBS and -GalCer injected NOD.V14Tg mice. Dot plots (right 
panels) show mean frequencies and absolute numbers of thymic NKT cell subsets in total NKT cells. n=10 for 
each group. 
With regard to CD24, CD44 and NK1.1 expression, -GalCer administration affected 
only the immature thymic CD24high CD44low NK1.1- NKT subset. There were significant 
reductions in both proportions and absolute numbers of CD24high CD44low and CD44lowNK.1- 
NKT cells in the thymi of -GalCer treated mice. In contrast, the absolute numbers of semi-
mature CD44highNK1.1- and mature CD44highNK1.1+ NKT cells were unchanged. Taken 
together, the 60% reduction in DP NKT cell numbers following -GalCer injection is 
consistent with this population being subjected to negative selection. 
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5.2.2.2.2. Effects of intrathymic (i.t.) injection of -GalCer on NKT cells in NOD.V14Tg mice  
Delivery of superantigen is a preferred model of negative selection when selection 
ligands are exogenous. Indeed, as the negative selectable cohort of cells remains intact before 
encountering selecting ligands, cell death caused by negative selection can easily be 
visualized. It also allows the study of the fate of immature and mature cells following ligand 
exposure in the same system. However, thymocyte deletion can also be caused 
nonspecifically by the concomitant widespread activation of peripheral T cells and subsequent 
cytokine release (Zhan et al., 2003). Thus, to minimise the effects of systemic T cell 
activation in our model of enhanced negative selection of immature NKT cells, NOD.V14Tg 
mice were subjected to intrathymic injection of 2 µg -GalCer. NKT cell numbers and 
subsets from the thymus, liver and spleen were then examined 40 hours later. 
Flow cytometric cell analyses indicated that the proportion of thymic NKT cells 
decreased from 4.1% of total thymocytes in control NOD.V14Tg mice to 2.5% in 
NOD.V14Tg mice injected intrathymically with -GalCer (Fig. 5.12). In terms of absolute 
numbers, thymic NKT cells fell from 4.0 x 106 to 2.3 x 106 cells after intrathymic 
administration of -GalCer. In contrast, the hepatic and splenic NKT cell numbers were 
unchanged between PBS controls and -GalCer injected mice (Fig. 5.12). 
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Figure 5.12. Effects of enhanced negative selection on NKT cells in NOD.V14Tg mice following intrathymic 
administration of -GalCer. A. Representative FACS plots show the mean frequencies (±SEM) of thymic, 
hepatic and splenic NKT cells in total cells from the thymi, livers and spleens, respectively, of PBS and -GalCer 
injected NOD.V14Tg mice. B. Dot plots show mean frequencies and absolute numbers of thymic, hepatic and 
splenic NKT cells. n=5 for PBS injected control mice and n=7 for mice injected intrathymically with -GalCer. 
With regard to NKT cell subsets, the proportion of thymic NKT cells that were DP fell 
from 59% of total thymocytes in PBS controls to 18% following intrathymic injection of -
GalCer (p<0.005; Mann-Whitney U Test; Fig. 5.13 A). Again, the proportions of the more 
mature CD4 SP and DN thymic NKT cells increased, from 13.7% to 29.5% (p<0.005) and 
from 23% to 47% (p<0.005), respectively, although their absolute numbers did not change 
significantly (Fig. 5.13 A). Both proportions and absolute numbers of thymic 
CD24highCD44low and CD44lowNK1.1- NKT subsets significantly reduced in intrathymically 
injected compared to control mice (Fig. 5.13 B, C). The specificity of the deletion induced by 
intrathymic -GalCer on developing NKT cells, as distinct from conventional T cells, was 
illustrated by the relative depletion of DPhigh CD24high CD44low NKT cells (>82%) compared 
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to DPhigh CD24high CD44low conventional T cells (<19%; data not shown). These data 
suggested that the effects of intrathymic injection of -GalCer on NKT cells in NOD.V14Tg 
mice were similar to those of systemic -GalCer administration.  
 
Figure 5.13. Effects of enhanced negative selection on thymic NKT cell subsets in NOD.V14Tg mice following 
intrathymic administration of -GalCer. A. CD4/CD8 NKT cell subsets. B. CD24/CD44 NKT cell subsets. C. 
CD44/NK1.1 NKT cell subsets. For all, representative FACS plots (left panels) show the mean frequencies 
(±SEM) of thymic NKT cell subsets in total NKT cells from the thymi of PBS controls and intrathymically injected 
mice. Dot plots (right panels) show mean frequencies and absolute numbers of thymic NKT cell subsets in total 
NKT cells. n=5 for PBS injected control mice and n=7 for intrathymically injected mice. 
Together, the failed positive selection and the susceptibility to negative selection of 
immature DP NKT cells supported the hypothesis that immature DP NKT cells represent a 
pre-selection population of NKT cells or represent the earliest NKT cell progenitors. 
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5.3. SUMMARY OF MAJOR FINDINGS 
In this chapter, genome-wide gene expression comparison has defined transcriptional 
programs associated with the transformation of immature CD4 NKT cells to immature DP 
NKT cells. The results suggested that positive selection and lineage commitment of NKT 
cells occurs during this transition. 
Gene Ontogeny analysis of up-regulated HDE genes across Transition 2 revealed the 
strong up-regulation of a wide range of functional lymphocyte-associated membrane proteins, 
such as Toll-like receptors, cytokine receptors, chemokine receptors, intergrins and leukocyte 
differentiation makers. Of these, there was a predominance of genes associated with the 
immunomodulatory and innate-like properties of NKT cells, such as Tlr1, Nkg7, Sema4a, 
Art2b, S1pr1 and Zbtb16. These data suggested that Transition 2 is associated with NKT cell 
lineage commitment. 
Commitment to the NKT cell lineage is well known to be associated with the 
expression of the innate-like lymphocyte-associated transcription factor Promyelocytic 
Leukemia Zinc Finger (PLZF, encoded by Zbtb16; Savage et al., 2008). While there was no 
significant difference in expression of Zbtb16 during Transition 1 (between immature DP T 
cells and immature DP NKT cells), Zbtb16 was up-regulated more than 13-fold during the 
subsequent transition from immature DP NKT cells to immature CD4 NKT stage (Mann-
Whitney U statistic =0). This is consistent with immature CD4 NKT cells having been 
positively selected and having commenced lineage commitment.  
The coordinated expression of PLZF and the subsequent up-regulation of a wide range 
of cell-surface functional receptors associated with NKT cell immunobiology combine to 
provide evidence that NKT cell lineage commitment occurred across Transition 2, i.e. 
between Stage 0 and Stage 1. However, it raised the issue of the timing of the NKT cell 
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selection event, which seems unlikely to take place any later than Transition 2. Many of the 
genes previously described as showing increased expression through positive selection of 
conventional T cells, were up-regulated in the immature CD4 NKT subset (Huang et al., 
2004; Mick et al., 2004). These data are consistent with NKT cell selection having occurred 
across Transition 2. 
By comparing gene expression between DP NKT cells and CD4 NKT cells, we have 
identified a large number of genes encoding molecules not previously known to affect the 
biology of  type I NKT cells and many of them have been validated by qPCR and/or flow 
cytometry on an independent sample set.  
While positive and negative selection of NKT cells has been studied previously and it 
is known that NKT cell development is markedly impaired by the absence of the selection 
molecule, CD1d (Bendelac, 1995; Chen et al., 1997; Mendiratta et al., 1997; Smiley et al., 
1997; Cole and Raulet, 2000; Gapin et al., 2001; Wei et al., 2005) and that administration of 
-GalCer at an early stage results in NKT cell development impairment (Pellicci et al., 2001; 
Chun et al., 2003). In these studies, due to the very low number of DP NKT cells in wild type 
mice, the effect of targeted deletion of CD1d and administration of α-GalCer were not directly 
examined on DP NKT cells but it was presumed that the effects were on the early 
development of NKT cells because the delay administration of α-GalCer (until day 18 of 
FTOC or at 8 weeks old) could not do so on differentiated NKT cells (Pellicci et al., 2003). 
The production of very large numbers of immature DP NKT cells in the thymi of our V14 
transgenic mice has now provided an opportunity to directly examine positive and negative 
selection in various subsets of NKT cells. 
Targeted deletion of CD1d from both NOD and B6.V14Tg mice indicated that CD1d 
is required for further development of thymic immature DP NKT cells. In the absence of 
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CD1d, immature DP NKT cells did not progress to subsequent developmental stages and 
accumulated in the thymi of both NOD and B6.Cd1d-/-.V14Tg mice. The almost complete 
absence of peripheral NKT cells in both NOD.Cd1d-/-.V14Tg and B6.Cd1d-/-.V14Tg mice 
is consistent with failed positive selection of DP NKT cells in the absence of CD1d. 
Additionally, immature DP NKT cells were also susceptible to negative selection mediated by 
the administration of -GalCer, both intravenously and intrathymically. Together, these data 
are consistent with the hypothesis that DP NKT cells are a pre-selection population and that 
positive selection of NKT cells occurs between the immature DP and CD4+ NKT cell 
development stages. 
In conclusion, the data presented in this chapter provide an overall transcriptional 
profile of positive selection and lineage commitment of NKT cells. This is also the first time 
that the effects of positive and negative selection have been examined on their actual target 
population – the immature DP NKT cell subset.  
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6.1. INTRODUCTION 
NKT cells are a CD1d-dependent T cell subset that mediates potent immune-
regulatory functions in settings of autoimmunity, cancer, infection and self-tolerance. NKT 
cells can be divided into CD4+ and CD4-CD8- double negative (DN) subsets in mice 
(Hammond et al., 1999; Eberl et al., 1999), or CD4+, DN, and CD8+ subsets in humans 
(Prussin and Foster, 1997). NKT cells share their early developmental program with 
conventional T cells until the CD4+CD8+ (double positive - DP) stage. At this point NKT 
cells branch away from conventional T cells (Benlagha et al., 2002; 2005), and subsequently 
give rise to CD4+ or DN NKT cells (Godfrey and Kronenberg, 2004; Godfrey et al., 2004). 
However, whether the DP NKT cells down-regulate CD4 or CD8 markers consecutively or 
together to become CD4+ or DN NKT cells is still unknown.  
NKT cells were originally reported as arising in the thymus 5 days after birth as CD4+ 
CD8- NK1.1- NKT cells (Pellicci et al., 2002). They then become CD4+ CD8- NK1.1+ and 
DN NK1.1+ by day 7-8, but still remained a minor subset until 3 weeks of age. By applying a 
CD1d-tet+ enrichment strategy, Benlagha et al. (2005), however, identified CD4+ CD24high 
NK1.1- NKT cells in the thymi of newborn mice. This cell population was demonstrated to 
give rise to DN NKT cells after an adoptive transfer into J18-/- mice. Contrary to the Pellicci 
study of 2002, Coquet et al. (2008) reported that CD4-NK1.1- NKT cells could generate CD4-
NK1.1+ NKT cells in an adoptive transfer to fetal thymus organ culture (FTOC), but could not 
generate CD4+NK1.1+ NKT cells (Coquet et al., 2008). Furthermore, a low but consistent 
level of activation by endogenous antigen on the surface of peripheral APCs may also affect 
DN NKT cell differentiation in secondary lymphoid organs, because a large fraction of splenic 
CD4+ NKT cells become DN NKT cells after repeated activation (Chen et al., 1997). 
In addition to the developmental differences discussed above, CD4+ and CD4- NKT 
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cells are also functionally distinct subsets. Human CD4+ NKT cells were reported to make 
both Th1 and Th2 cytokines (such as IFN-, TNF, IL-4 and IL-13), whereas CD4- NKT 
cells primarily produce Th1 cytokines (IFN- and TNF; Lee et al., 2002; Gumperz et al., 
2002). In contrast, mouse CD4+ and DN NKT cells have no clear differences in cytokine 
production (Godfrey and Kronenberg, 2004). Both CD4+ and DN NKT cells from mice are 
reported to produce large amounts of IFN- and IL-4 (Hammond et al., 1999; Matsuda et 
al., 2000; 2003; Stetson et al., 2003; Coquet et al., 2007). However, CD4+ and DN NKT 
cells are distinct in their ability to modulate immune responses in vivo. For example, hepatic 
DN NKT cells are able to control tumours more effectively than CD4+ NKT cells from the 
same liver (Crowe et al., 2005).  
Recent work showed that, similar to Th cells, iNKT cells can be subdivided into three 
distinct lineages: NKT1, NKT2, and NKT17, and discriminated by the expression of cell 
surface markers or transcription factors (Lee et al., 2016). While iNKT1 cells express T-bet 
(T-bet+, PLZFlow, RORγt-); iNKT2 cells express high levels of GATA3 and PLZF (T-bet-, 
PLZFhigh, RORγt-) and iNKT17 cells have intermediate levels of PLZF, are RoRγt+ (T-bet-, 
PLZFint, RORγt+) (Lee et al., 2013). This method of defining iNKT cell subsets correlated 
precisely with cytokine production: thymic NKT1, NKT2 and NKT17 cells produced IFN-γ, 
IL-4, and IL-17, respectively, when stimulated with PMA and ionomycin (Lee et al., 2013). 
Each subpopulation expresses particular cytokine receptors: iNKT1 expresses IL-12R, iNKT2 
expresses IL-17RB and iNKT17 expresses IL-23R (Watarai et al., 2012). When stimulated 
with the corresponding cytokine, each subset produced only the cytokine corresponding to 
their subset (Watarai et al., 2012). 
Recent studies have also uncovered alternatively polarized NKT sublineages, 
including   T-bet+ NKT1, GATA3high NKT2 (Terashima et al., 2008; Watarai et al., 2012) and 
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RORγt+ NKT17 cells (Michel., 2007; et al Coquest et al., 2008; Doisne et al., 2009).  T-
bethigh NKT1 cells capable of producing large amounts of IFN-γ are the main terminal 
differentiation product in B6 mice (Benlagha et al., 2002; McNab et al., 2005). However, it 
should be stress that these cells are not fully polarized. They produce both IFN-γ and IL-4 on 
a single cell basis, although the amount of IL-4 is comparatively low compared with previous 
developmental stages. The GATA3high NKT2 and RORγt+ NKT17 sublineages are rare in B6 
mice but can be dominant in other strains or in various mutant mice. NKT2 cells, which are 
more abundant in BALB/c mice, predominate in the lung while NKT17 cells are rare and 
mostly found in peripheral lymph nodes draining the skin; NKT1 cells predominate in spleen 
and liver. 
However, it is reported that certain cytokines can also cause cells to produce IL-4. For 
example, Terashima et al. previously showed that CD4+ NK1.1− iNKT cells (similar to 
NKT2) express IL-17RB, a receptor for IL-25 (Terashima et al., 2008). IL-25 is a cytokine 
produced by stromal cells that can promote the Th2 immune response (Saenz et al., 2010). 
Indeed, hCD2 positive (IL-4 producing) cells were found within the IL17RB positive 
population both in B6 and BALB/c mice. Watarai and colleagues showed that IL-17RB+ 
iNKT cells could produce IL-4 when exposed to exogenous IL-25 and that IL-25 receptor 
deficiency partially prevented the development of NK1.1 negative iNKT cells (Watarai et al., 
2012). However, B6 NKT2 cells produce less IL-4 than BALB/c despite comparable level of 
IL17RB expression, and B6 NKT17 cells also express IL17RB indicating that IL17RB is not 
sufficient to drive IL-4 production (Lee et al., 2013).  
Furthermore, it was showed that stage 1 and stage 2 iNKT cells are composed of two 
populations, IL-17RB+ cells that make up iNKT2 and iNKT17 subsets, and IL-17RB- cells 
that are progenitors of the iNKT1 subset (Watarai et al., 2012) while iNKT1 subset is 
equivalent to stage 3 iNKT cells. It is worth noting that each subset has a tendency to produce 
PART B                        Chapter 6: Transition 3 – Differentiation and Trafficking of NKT Cells 
 
 
 
- 194 - 
particular cytokines, yet under antigen stimulation iNKT cells might have the potential to 
produce all cytokines. For example, when stimulated by phorbol 12-myristate 13-acetate 
(PMA)/ionomycin or αGC, a large proportion of these cells will co-produce cytokines of 
other subsets, particularly IL-4 and IL-13 (Yoshimoto, 1994; Watarai et al., 2012), and each 
subset expressed some cytokines of other subsets (Engel et al., 2016; Georgiev et al., 2016). 
Kronenberg and colleagues also found that the iNKT2 subset was composed of two 
subpopulations, in which one expressed a large amount of genes involved in cell cycle 
progression, indicating that it is likely a progenitor of other iNKT cells (Engel et al., 2016). 
There are also diversified functions among NKT cells from different organs. For 
example, purified NK1.1+ TCR+ thymic NKT cells produced a higher amount of cytokines, 
especially IL-4, than splenic NK1.1+ TCR+ NKT cells (Yang et al., 2003). Yang et al. (2003) 
also indicated that thymic and splenic NKT cells from both NK1.1+ and NK1.1- mouse strains 
differ in the expression of activation markers and requirements for co-stimulatory signals. 
While splenic NKT cells required both TCR and CD28 mediated signals to be fully activated, 
engagement of CD28 had no detectable effect on the activation of thymic NKT cells (Yang et 
al., 2003). Similarly, the engagement of CD40 ligand (CD40L) on the surface of thymic NKT 
cells did not affect their cytokine production, although the CD40 signal was important for the 
cytokine profile of splenic NKT cells (Hayakawa et al., 2001; Yang et al., 2003).  
The functional diversity between organs mentioned above is likely a consequence of 
differentiation of CD4+ and DN NKT cell subsets as they exhibit different chemokine 
receptor patterns (Slauenwhite and Johnston, 2015). Kim et al. (2002) indicated that NKT 
cell subsets differ substantially in their expression of some chemokine receptors, even 
though they share expression of many others. For example, most NKT cells express CCR1, 
CCR2, CCR5, CXCR3, CXCR4, and CXCR6. Among these, CCR1, CCR2, CCR5, CXCR3, 
and CXCR6 are highly related to “tissue” T cells found in extra-lymphoid tissues. However, 
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CD4 NKT cells (which produce high levels of IL-2 and IL-4) express CCR4 and respond 
strongly to CCR4 ligand (TARC), while CD8 and DN NKT cell subsets (low IL-2 and IL-4 
producers) express CCR1, CCR6 and CXCR6 and respond well to their ligands MIP-1a and 
LARC (Kim et al., 2002). The specific combinations of adhesion molecules and chemokine 
receptors that NKT cell subsets express determine their trafficking behaviours and correlate 
with the wide distribution of NKT cells in tissues (Slauenwhite and Johnston, 2015). These 
data support the idea that the tissue-specific microenvironments determine the 
differentiation of thymic NKT cells into subsets of peripheral cells that are functionally and 
phenotypically distinct. 
While tremendous progress has been made in the identification of iNKT cell 
developmental intermediates and the various signaling pathways and transcription factors 
involved in early development, the molecular mechanisms that control the differentiation of 
the different iNKT cell at later stages subsets remain mysterious. What are the original signals 
that determine which and to what extent a given signaling pathway and/or transcription factor 
expression is turned on or off to determine which developmental pathway iNKT precursors 
choose? Further investigation to seek transcriptional evidence of NKT cell differentiation is 
necessary to answer the following questions: 1) What are the developmental signals that result 
in differential branching of the CD4+ and DN NKT cell subsets? and 2) What is the stage at 
which they differentiate? Based on our data presented in Chapter 4, TCR validation is 
associated with Transition 1 and positive selection and lineage commitment are associated 
with Transition 2 as presented in Chapter 5; these findings raise the possibility that functional 
differentiation might be associated with Transition 3, between immature CD4+ NKT 
cells and immature DN NKT cells.  
Specifically, the aims of this chapter were: 
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1. To profile gene expression between immature CD4+ NKT cells and immature DN 
NKT cells. 
2. To identify significant changes in gene expression related to the differentiation of 
NKT cells. 
3. To functionally validate gene expression changes during NKT cell differentiation. 
 
6.2. RESULTS 
6.2.1. Transcriptional analysis of CD4+ NKT cells and DN NKT cells  
To test the hypothesis that functional differentiation of NKT cells occurs across 
Transition 3, transcriptional comparison between immature CD4+ NKT cells and immature DN 
NKT cells was performed. The expression levels of all 35,556 transcripts across Transition 3 
were compared pairwise by Mann-Whitney U test, and those with a U statistic of zero (i.e. no 
overlap between groups) were shortlisted for ranking by Student t Test. Across this transition, 
6,904 transcripts generated a Mann-Whitney U score of zero, and of these, 1,849 were highly 
differentially expressed (HDE; p < 1.0 x 10-6, by t-Test). Of the HDE transcripts, 1,270 were 
up-regulated in DN NKT cells compared to CD4+ NKT cells, while 579 transcripts were down-
regulated.  
To gain insights into the biological processes involved in the differentiation between 
immature CD4+ NKT cells and immature DN NKT cells, the up-regulated and down-
regulated HDE gene names were submitted to Gene Ontogeny analysis using DAVID 
Bioinformatics Resources. The top annotation cluster (Enrichment score 29) of up-regulated 
HDE genes was dominated by lumen membrane proteins and contained the following 
annotation categories: membrane-enclosed lumen (representing 160 of all up-regulated HDE 
genes; Bonferroni corrected p<8.7x10-42), intracellular organelle lumen (Bonferroni corrected 
p<2x10-38) and nucleolus (Bonferroni corrected p<1.5x10-34). In this gene list, there was a 
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predominance of genes encoding mitochondrial ribosomal proteins (Mrpl2, 12, 13, 15, 16, 17, 
19, 36, 37, 38, Mrps10, 22, 23), polymerase RNA (Polr1a, 1b, 1e, 2e, 3d, 3h) and general 
transcription factor II (Gtf2e1, e2, f2 and h3).  
Gene Ontogeny analysis of the down-regulated HDE genes revealed that there was an 
over-representation of genes associated with cell activation (GO:0001775; representing 27 of all 
down-regulated HDE genes; Bonferroni corrected p<2.3x10-8), leukocyte activation 
(GO:0045321; Bonferroni corrected p<1.4x10-7) and T cell activation (GO:0042110; 
Bonferroni corrected p<4.6x10-6). While genes related to cell activation were more highly 
expressed in CD4+ NKT cells than in DN NKT cells, genes encoding membrane-enclosed 
lumen proteins were more highly expressed in DN NKT cells. Taken together, the data suggest 
differential gene expression, subsequently functional differentiation between immature CD4+ 
NKT cells and immature DN NKT cells. 
6.2.2. Gene expression of transcriptional factors and molecules associated with NKT cell 
differentiation between CD4 and DN NKT cells 
To gain further insights into the functional differentiation between the two subsets, 
we next compared gene expression of transcriptional factors or molecules associated with 
NKT cell differentiation reported in the literature, such as ThPOK (Dave et al., 1998; He et 
al., 2005), ICOS (Akbari et al., 2008) and LY6A (Henderson et al., 1998; 2002; Fig. 6.1). 
ThPOK, a member of the BTB-POZ family of zinc finger transcription factors, is required 
for the generation of CD4+ NKT cells (He et al., 2005). Although mice with spontaneous 
mutations in Zbtb7b (encoding ThPOK) have normal frequencies and numbers of thymic 
and peripheral NKT cells, their mature NKT cells completely lack CD4 expression and they 
express CD8 on large numbers of NKT cells (Dave et al., 1998; He et al., 2005). 
Additionally, ThPOK deficient mice exhibit defects in IL-4 production and to a lesser extent 
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IFN- (Dave et al., 1998; He et al., 2005). In our microarray data, Zbtb7b expression was 
3.6-fold higher in CD4+ NKT cells compared to DN NKT cells (t-Test p<8.4x10-8; Mann-
Whitney U statistic =0; Fig. 6.1A). This is consistent with the role of ThPOK in maintaining 
the CD4 subset of the NKT cell population. 
 
Figure 6.1. Expression profiles of genes related to differentiation of CD4 NKT cells. A. Gene expression of 
Zbtb7b, Icos and Ly6a determined by microarray (microarray data were generated with assistance from Dr. 
Margaret Jordan and Prof. Alan Baxter). B. ICOS protein expression as determined by flow cytometry. n=10, 
Mann-Whitney U test, **** p<0.0001 
In mice, the Ly-6 locus encodes a family of glycophosphatidylinositol-anchored, 
developmentally regulated cell surface proteins (Rock et al., 1989). Members of the Ly-6 gene 
family are markers of different lineages of hematopoietic origin, including lymphocytes 
(Pflugh et al., 2000), monocytes and bone marrow cells (Patterson et al., 2000). Ly-6 may 
have a role in T cell activation (Rock et al., 1986), as transgenic expression of Ly-6A.2 on 
CD4+CD8+ thymocytes promoted thymic maturation of CD4+ (but not CD8+) T cells in the 
absence of TCR-MHC interactions (Henderson et al., 1998; 2002). In our microarray data, the 
expression of Ly6a was 4.6-fold higher in CD4+ NKT cells compared to DN NKT cells (t-
Test p<4.8x10-9, Mann-Whitney U statistic =0; Fig. 6.1A). 
Akbari et al. (2008) reported that Inducible T cell co-stimulator (ICOS) is highly 
expressed on both naive and activated iNKT cells. ICOS expression on the CD4+ iNKT subset 
was greater than on CD4- iNKT cells. These authors also found that ICOS is required for 
**** 
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CD4+ NKT cell survival and homeostasis in the periphery, as CD4+ NKT cell numbers were 
significantly lower in spleens and livers of ICOS deficient mice and mice lacking ICOS 
ligand. Survival of wild-type iNKT cells transferred into ICOSL-/- mice was greatly reduced 
due to the induction of apoptosis. Furthermore, the remaining NKT cells in ICOS-/- mice were 
unable to produce IL-4 and IL-13 and failed to reconstitute airway hyperreactivity when 
adoptively transferred into J18-/- mice (Akbari et al., 2008). In our work, Icos expression 
was three times higher in CD4+ NKT cells compared to DN NKT cells in our microarray data 
(t-Test p<4.9x10-8; Mann-Whitney U statistic =0; Fig. 6.1A), the protein expression level was 
confirmed by flow cytometry (p<0.0001, Mann-Whitney U test; Fig. 6.1B), consistent with its 
role in CD4+ iNKT cell function, homeostasis, and survival in the periphery. 
 
Figure 6.2. Expression profiles of genes related to proliferation between CD4 and DN NKT cells. A. Gene 
expression of Cenph, Etv5, Cd97 and Blk as determined by microarray (data were generated with assistance from 
Dr. Margaret Jordan and Prof. Alan Baxter). B. Etv5 and Blk expression were confirmed by qPCR. n=6 per cell 
population, Mann-Whitney U test, ** p<0.01. Data were generated with assistance from Dr. Morgane Moreau.  
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Transition 3 was also characterised by increased expression of genes involved in cell 
division and differentiation (such as Cenph, Ets2, Etv5 and Blk; Fig. 6.2A). The differences in 
transcriptional levels of Etv5 and Blk were confirmed by qPCR in an independent sample set 
(Fig. 6.2 B). The up-regulation of genes related to cell division by DN NKT cells is consistent 
with the increased proportion of proliferating (BrdU+) cells in DN NKT cells, compared to 
that of CD4 NKT cells mentioned in Chapter 5.  
6.2.3. Cytokine and cytokine receptor differentiation between CD4 and DN NKT cells 
6.2.3.1. Gene expression analysis of cytokine receptors between CD4 and DN NKT cells 
There is evidence that maturation and homeostasis of NKT cells is highly dependent 
on cytokines, such as IL-15 (Matsuda et al., 2002; Ranson et al., 2003), and to a lesser extent 
on IL-7 (Sanberg et al., 2004). It has been demonstrated that IL-15 regulates a large number 
of key molecules, such as BCL2, T-BET and BCL-XL, which pertain to NKT cell survival 
(Gordy et al., 2011).  
Gene expression comparison in our microarray data revealed that there were 
differences in expression of genes encoding cytokine receptors, such as IL2r, Il4r, Il6r, 
Il7r, and Il12r2 between CD4+ and DN NKT cells (Fig. 6.3). For example, Il4r, Il7r and 
Il6r expression was significantly down-regulated on DN NKT cells (2.0, 2.2 and 2.8 times, 
respectively) compared to CD4+ NKT cells (t-Test p<3.6x10-7; Mann-Whitney U statistic =0), 
while Il12r2 and Il2r was significantly up-regulated in DN NKT cells (1.7 and 2.9-fold 
higher, respectively) compared to CD4+ NKT cells (t-Test p<2.8x10-7; Mann-Whitney U 
statistic =0; Fig. 6.3 A). In contrast, Il2r/15r was expressed with relatively similar levels in 
immature CD4+ NKT cells and immature DN NKT cells after a significant up-regulation at 
positive selection stage (transition 2), (Fig. 6.3A). To confirm our microarray data, the 
differences in transcriptional levels of Il6r, Il12r2 and Il2r (encoding CD25) were 
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examined by qPCR in an independent sample set (Fig. 6.3 B) and by flow cytometry (Fig. 6.3 
C), respectively. Together, these data indicated that CD4+ and DN NKT cells express 
different cytokine receptor profiles after positive selection.  
 
Figure 6.3. Expression profiles of genes related to cytokine receptor between CD4 and DN NKT cells. A. Gene 
expression of IL2r, Il4r, Il6r, Il7r, Il12r2 and IL2r/15r as determined by microarray (data were 
generated with assistance from Dr. Margaret Jordan and Prof. Alan Baxter). B. Il6r and Il12r2 expression was 
confirmed by qPCR (data were generated with assistance from Dr. Morgane Moreau). n=6 for CD4 NKT cell 
subset, n=10-14 for DN NKT cell subset. Mann-Whitney U test, ** p<0.01. C. CD25 (IL2R) protein expression as 
presented by flow cytometry. n = 10 per cell population, Mann-Whitney U test, *** p<0.001. 
 
*** 
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6.2.3.2. Validation of cytokine differentiation between immature CD4+ and DN NKT cells 
An important question from the microarray analysis was whether the differences in 
gene expression of cytokine and cytokine receptors between immature CD4+ and DN NKT 
cells reflected functional differentiation across transition 3. To this end, FACS sorted 
immature CD4+ and DN NKT cells from thymi of NOD.V14Tg mice were stimulated in 
vitro by immobilised anti-CD3; supernatants were collected for cytokine analysis by bead 
assay. Thymic immature CD4+ and DN NKT cells were sorted from 5 individual mice.  
Culture supernatants were harvested for cytometric bead array (CBA) analyses of 
interleukin-1 (IL-1), IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, tumour necrosis factor-alpha 
(TNF-), interferon-gamma (IFN-) and granulocyte macrophage colony-stimulating factor 
(GM-CSF). A striking finding was that immature CD4+ NKT cells produced higher cytokine 
concentrations of IL-4, IL-10, IFN-, GM-CSF and INF- compared to immature DN NKT 
cells (Fig. 6.4). The most produced cytokine was IFN-, which was 3 times higher in CD4+ 
NKT cells (60 ng/ml) compared to DN NKT cells (20 ng/ml). The immature CD4 NKT cells 
also secreted 4 times more IL-4 and IL-10, and almost 2 times more GM-CSF and INF- than 
DN NKT cells. Although IL-2 was detected in the culture supernatants, IL-2 production could 
not be compared, as mouse recombinant IL-2 was added to the wells at the beginning of 
culture. We did not detect any IL-1, IL-5, IL-6 or IL-17 produced by both CD4 and DN 
NKT cells (data not shown). These findings are broadly consistent with the data reported by 
Chan et al. (2012), in which sorted CD4+ NKT cells from human adult blood expressed a 
more extended cytokine production than CD4- NKT cells (Chan et al., 2012). These data are 
also consistent with previous studies reporting that most thymic NKT cells from mice are very 
strong cytokine producers (Hammond et al., 1999; Berzins et al., 2006) even though their 
studies were on different NKT cell subsets. Taken together, the difference in cytokine 
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production between immature CD4+ NKT cells and immature DN NKT cells further supports 
the likelihood that these cells are functionally distinct or that functional differentiation occurs 
across transition 3. 
 
Figure 6.4. In vitro stimulation of thymic NKT cells with anti-CD3e. Thymic NKT immature CD4
+
 and DN cells 
were sorted and then cultured with 100UI IL-2 in RPMI complete medium. After 72 hours, supernatants were 
harvested; cytokine production was determined by CBA. These dot plot graphs show means ±SEM of cytokine 
concentration of thymic immature CD4
+
 NKT cells and immature DN NKT cells from NOD.V14Tg mice, 5 
mice/group with duplicate cultures. Mann-Whitney U test, **** p<0.0001 
6.2.4. Chemokine and chemokine receptor differentiation between CD4 and DN NKT cells 
6.2.4.1. Gene expression analysis of chemokines and chemokine receptors between CD4 
and DN NKT cells 
The ability of thymocytes to migrate between particular regions of the thymus or to 
the periphery is critical for their maturation. It is well known that migration of conventional 
T cells is mediated by large numbers of CC chemokine receptors (CCR), such as CCR4 
(Suzuki et al., 1999; Campell et al., 1999), CCR7 (Kwan and Killeen, 2004; Uneno et al., 
2002, Mick et al., 2004, Huang et al., 2004), and CCR9 (Uehara et al., 2002). However, there 
is little known about the effect of chemokine stimulation on the early development of NKT 
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cells. It has been recently reported that NKT cells in CCR5-deficient mice were resistant to 
activation-induced apoptosis and produced more IL-4 (Ajuebor et al., 2005). In addition, 
CCR7 plays an important role in controlling the development and migration of invariant NKT 
cells by enabling access to IL-15 trans-presentation (Cowan et al., 2014). In the absence of 
CCR7, NKT cell development was markedly impaired.  
 
Figure 6.5. Increased expression of genes related to chemokine receptors in CD4+ and DN NKT cells.  Gene 
expression of Ccr2, Ccr4, Ccr7, Ccr8 (the upper row), Ccr10, Cxcr6, Xcl1 and Id2 (the lower row) across 3 
transitions as determined by microarray (data were generated with assistance from Dr. Margaret Jordan and 
Prof. Alan Baxter). 
Consistent with these reports, our microarray data showed significant up-regulation of 
large numbers of chemokines and chemokine receptors, such as Ccr2, Ccr4, Ccr7, Ccr8, 
Ccr10 and Xcl1 in both immature CD4+ and DN NKT cells, compared to immature DP NKT 
cells (Fig. 6.5 A). Upon positive selection of DP NKT cells Ccr8 expression was increased 
12-fold, Ccr2 expression was increased almost 11-fold, and Ccr7 exhibited a 9-fold up-
regulation. However, there were little changes in expression of above chemokine receptors 
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across Transition 3. While the expression of Ccr2 was similar between CD4 NKT cells and 
DN NKT cells, that of Ccr4, Ccr7 was up-regulated (1.2 and 2.1 folds, respectively; t-Test 
p<0.001), that of Ccr8, Ccr10 and Xcl1 was slightly down-regulated (1.3, 1.6 and 1.3 folds, 
respectively; t-Test p<0.05) in CD4 NKT cells compared with DN NKT cells. 
We also observed the up-regulation of genes related to homeostasis of NKT cells, 
such as Cxcr6 and Id2. Cxcr6 plays a critical role in homeostasis and activation of NKT 
cells (Germanov et al., 2008). Deficiency of CXCR6 was associated with the depletion of 
NKT cells in the liver and lungs, but accumulation in the bone marrow (Geissmann et al., 
2005; Germanov et al., 2008). Similarly, NKT cell survival and homeostasis are also under 
the regulation of Id2, an inhibitor of DNA-binding protein (Monticelli et al., 2009). Id2 
expressed on T-BET+, IFN- secreting NKT cells was required for the differentiation of this 
NKT cell sub-lineage (D’Cruz et al., 2014). Knockdown of Id2 resulted in a drastic and 
selective reduction of NKT cells in the liver, while levels remained normal in thymus and 
spleen. In contrast, loss of Id2 and Id3 minimally affected iNKT cell abundance and the 
development of thymic NKT cells at stage 1 (D’Cruz et al., 2014). In our microarray data, 
we found that Cxcr6 and Id2 expression was increased 13-fold and 6-fold, respectively by 
both CD4 and DN NKT cells compared to DP NKT cells (Fig. 6.5). These findings suggest 
that the increase in expression of Cxcr6 and Id2 by CD4 and DN NKT cells is associated 
with their role in regulating their differentiation and homeostasis after positive selection.  
6.2.4.2. Functional validation of chemokine receptor on immature CD4 and DN NKT cells 
In order to functionally validate our microarray data on NKT cell trafficking and 
maturation, effects of targeted deletion of Ccr2 and Ccr7 on NKT cell numbers in B6 mice 
were examined. B6.Ccr2-/- mice were purchased from the Jackson lab (JAX), the JAX 
B6.Ccr7-/- mice were provided by the Cowan lab. 
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6.2.4.2.1. Effects of CCR2 on NKT cell distribution 
 CC chemokine ligand 2 (CCL2) is a prototypic inflammatory chemokine, which was 
initially described as a major chemo-attractant for monocytes (Matsushima et al., 1989; 
Rollins et al., 1991). However, it was recently demonstrated to be one of the most potent 
chemokines for both CD4 and CD8 effector-memory α/β T cells, γ/δ T cells (Carr et al., 1994; 
Roth et al., 1998), and NKT cells (Kim et al., 2002a; 2002b) that express its receptor, CC 
chemokine receptor 2 (CCR2). CCR2 is required for Langerhans cell migration and 
localization of T helper cell type 1 (Th1) - inducing Dendritic cells (DC; Sato et al., 2000).  
CCR2 also plays an important role in NK cell migration during intranasal influenza 
virus infection (van Helden et al., 2012) and DC maturation (Jimenez et al., 2010). During 
murine cytomegalovirus (MCMV) infection, macrophage trafficking to the liver is largely 
dependent on CCR2 signalling (Hokeness et al., 2005). Crane et al. (2009) indicated that 
monocyte/macrophage trafficking from the bone marrow into circulating blood is impaired in 
the absence of CCR2 signalling. CCR2 activation within the bone marrow is shown to control 
the magnitude of monocyte/macrophage release from this compartment following MCMV 
infection (Crane et al., 2009). In support of a role for CCR2 in mediating this process, only 
inflammatory monocyte/macrophages expressing high levels of Ly6C, which correlates with 
CCR2 expression (Geissmann et al., 2003; Tacke and Randolph, 2006), were found to 
accumulate in the bone marrow during MCMV infection. Importantly, Ly6Chigh 
monocyte/macrophages were dramatically reduced in the blood of CCR2-deficient mice. 
Consistently, this cell population was also decreased in the circulation of uninfected CCR2-
deficient mice, indicating a homeostatic role for CCR2 in regulating monocyte/macrophage 
egress from the bone marrow (Serbina and Pamer, 2006; Tsou et al., 2007; Engel et al., 2008; 
Qu et al., 2008; Yamasaki et al., 2011). 
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In order to examine the effect of CCR2 on NKT cell development, we made used of 
the B6.Ccr2-/- mouse strain. This strain has a monomeric red fluorescent protein (RFP) 
sequence replacing the coding sequence of the chemokine (C-C motif) receptor 2 gene, which 
abolishes the gene function. B6.Ccr2-/- mice were backcrossed to inbred C57BL/6 mice for 5 
generations prior to use in experiments. Flow cytometric analysis of B6.Ccr2-/- and B6 WT 
control mice revealed that both the proportions and absolute numbers of NKT cells in the thymi 
and spleens were unchanged (Fig. 6.6).  
A.       B. 
 
Figure 6.6. Effects of CCR2 deficiency on NKT cells from B6 WT mice. A. Representative FACS plots showing the 
mean proportions (±SEM) of thymic, hepatic and splenic NKT cells between B6 WT and B6.Ccr2-/- mice. B. Dot 
plot graphs show the mean frequencies and absolute numbers of thymic, hepatic and splenic NKT cells 
between B6 WT and B6.Ccr2-/- mice. n=10 for B6 WT group, n=11 for B6.Ccr2-/- group. Mann-Whitney U test, 
NS= Not significant.  
In contrast, the proportion of NKT cells drastically increased in the livers of B6.Ccr2-/- 
mice, yet overall absolute numbers were normal. In particular, the proportion of hepatic NKT 
cells significantly increased from 18.40±1.44% in B6 WT controls to 35.61±1.38% in B6.Ccr2-
/- mice (p<0.0001), whereas the absolute numbers of hepatic NKT cells were not significantly 
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different between B6 mice (1.29±0.17 x 106 cells) and B6.Ccr2-/- mice (1.94±0.41 x 106 cells). 
The increased frequency of hepatic NKT cells in the liver of B6.Ccr2-/- mice, in the absence of a 
change in the absolute number of these cells, likely reflects depletion of some other leucocyte 
subset in the liver. However, another possible explanation is that in absence of CCR2, NKT 
cells cannot receive signals of recruitment to inflammatory sites and therefore accumulate in the 
livers of B6.Ccr2-/- mice. A corollary of this hypothesis is that CCR2 expression is required for 
the recruitment of NKT cells. 
6.2.4.2.2. Effects of CCR7 on thymic NKT cell numbers 
To examine the effects of CCR7 expression on NKT cell development, we made use 
of the B6.Ccr7 knockout mouse strain. This mouse strain harbours a targeting vector, which 
was designed to replace a fragment of the third exon of the Ccr7 gene (encompassing amino 
acids Ser-139 to Asp-309) with a neomycin resistance gene, which abolishes the gene 
function. CCR7 mutant mice were backcrossed to inbred C57BL/6 mice for 5 generations 
prior to use in experiments.  
Flow cytometric analysis of NKT cells and subsets revealed that in CCR7-deficient 
mice, NKT cell numbers were reduced in both the thymus and the periphery (Fig. 6.7). In the 
thymi, the proportion of NKT cells was significantly decreased from 0.34±0.01% in WT mice 
to 0.06±0.01% in B6.Ccr7-/- mice (p<0.0001). The absolute numbers of thymic NKT cells fell 
6-fold, from 0.54±0.05 x106 in B6 WT mice to 0.09±0.01 x106 cells in B6.Ccr7-/- mice. The 
decrease in thymic NKT cells in B6.Ccr7-/- mice could be due, at least in part, to a decreased 
medullary volume in B6.Ccr7-/- mice (Ueno et al., 2004). In the periphery, similar patterns 
were seen: the proportion and numbers of NKT cells showed a 3-fold decrease in the livers 
and spleens of CCR7 KO mice (Fig. 6.7). 
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Figure 6.7. Effects of CCR7 deficiency on NKT cells from B6 WT mice. A. Representative FACS plots showing the 
mean proportions (±SEM) of thymic, hepatic and splenic NKT cells between B6 WT and B6.Ccr7-/- mice. B. Dot 
plot graphs show the mean frequencies and absolute numbers of thymic, hepatic and splenic NKT cells 
between B6 WT and B6.Ccr7-/- mice. n=10 for B6 WT group, n=9 for B6.Ccr7-/- group. Mann-Whitney U test. 
There were a number of changes in thymic NKT cell subsets in CCR7-deficient mice 
(Fig. 6.8). While the proportions of CD4+ NKT cells were significantly increased, those of DN 
NKT cells were markedly decreased in B6.Ccr7-/- mice. In terms of CD44/NK1.1 expression, 
there was a significant increase in the proportions of immature CD44-NK1.1- and semi-mature 
CD44+NK1.1- NKT cell subsets in B6.Ccr7-/- mice compared to WT controls. In contrast, the 
proportion of mature CD44+NK1.1+ NKT cells was reduced (Fig. 6.8). These results confirm 
those of Cowan et al. (2014), and are consistent with a role for CCR7 in thymic migration of 
NKT cells. 
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Figure 6.8. NK1.1- and NK1.1+ NKT cell subsets in CCR7KO mice. Dot plots show mean proportions (upper row) 
and absolute numbers (lower row) of NK1.1- and N1.1+ NKT cells in the thymi, livers and spleens of B6 WT and 
CCR7 KO mice. n=10 for B6 WT group, n=9 for B6.Ccr7-/- group. Mann-Whitney U test. 
There was a significant increase in the proportions of thymic CD4+CD8+ (DP) NKT 
cells, which rose from 1.54±0.06% of total thymic NKT cells in B6 WT mice to 4.29±0.72% 
in B6.Ccr7-/- mice (Fig. 6.9). This cell population is normally excluded from analyses due to 
its rarity. Previously, many studies reported that CCR7 ligation by SLC/CCL21 is partly 
responsible for thymic export (Norment and Bevan, 2000; Ueno et al., 2002) and NK1.1- 
NKT cells, but not mature NK1.1+ NKT cells, are reported to traffic in response to 
SLC/CCL21 (Johnston et al., 2003). However, in this chapter, the increased proportion of DP 
NKT cells, along with the expansion of immature CD44-NK1.1- NKT cells mentioned 
previously, suggests an effect of CCR7 deficiency on further development of DP NKT cells 
following positive selection. 
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Figure 6.9. Effects of CCR7 deficiency on thymic NKT cell subsets in B6 mice. A. Representative FACS plots and 
dot plot graphs showing the mean frequency (±SEM) and numbers of thymic CD4/CD8 NKT cells from B6 WT 
and B6.Ccr7-/- mice. B. Representative FACS plots and dot plot graphs showing the mean frequencies (±SEM) 
and numbers of thymic CD44/NK1.1 NKT cells from B6 WT (n=10) and B6.Ccr7-/- mice (n=10). Mann-Whitney U 
test, ** p<0.01, *** p<0.001 and **** p<0.0001. 
In order to examine the effect of CCR7 deficiency on pre-selection DP NKT cells, a 
CCR7 deficient line of B6.V14Tg mice was created. Briefly, B6.V14Tg mice were crossed to 
B6.Ccr7-/- mice. The resulting F1 mice were then inter-crossed. Pups were genotyped to select 
for mice of interest of B6.Ccr7-/-.V14Tg+/- and B6.Ccr7+/+.V14Tg+/- (also called 
B6.V14Tg+/-) mice. 
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Figure 6.10. Effects of CCR7 deficiency on NKT cells from B6.V14Tg
+/-
 mice. A. Representative FACS plots 
showing the mean frequency (±SEM) of thymic, hepatic and splenic NKT cells between B6.V14Tg+/- and 
B6.Ccr7-/-.V14Tg+/- mice. B. Dot plot graphs show the mean frequency and absolute numbers of thymic, 
hepatic and splenic NKT cells between B6.V14Tg+/- (n=10) and B6.Ccr7-/-.V14Tg+/- mice (n=9).  Mann-Whitney 
U test, ** p<0.01, *** p<0.001 and **** p<0.0001 
Flow cytometric analysis of thymic, hepatic, and splenic cells from B6.Ccr7-/-.V14Tg+/- 
and B6.V14Tg+/- control mice revealed a significant reduction in both proportions (p<0.0001; 
Mann-Whitney test) and absolute numbers (p<0.001) of thymic NKT cells in B6.Ccr7-/-
.V14Tg+/- mice compared with the controls (Fig. 6.10). In contrast, the proportions and absolute 
numbers of splenic NKT cells were unchanged between B6.Ccr7-/-.V14Tg+/- and B6.V14Tg+/- 
mice (Fig. 6.10). The proportions of hepatic NKT cells were similar, while the absolute numbers 
were significantly increased from 4.98±0.21 x 106 cells in B6.V14Tg+/- control mice to 
7.62±0.62 x 106 cells in B6.Ccr7-/-.V14Tg+/- mice (Fig. 6.10). These data imply that CCR7 
deficiency affected thymic and hepatic NKT cell numbers, but had no effect on splenic NKT cells 
in B6.V14Tg+/- mice. Even though the mechanism is unclear, it is noteworthy that the effect of 
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CCR7 deficiency in B6.V14Tg+/- mice is opposite to the 3-fold decrease in hepatic NKT cell 
numbers in B6.Ccr7-/- mice compared to B6 mice (Fig. 6.7 page 187). 
Flow cytometric analysis of NKT cell subsets from the thymi of B6.Ccr7-/-
.V14Tg+/- mice identified an increase in both the proportions and absolute numbers of 
immature DP NKT cells (Fig. 6.11).  
 
Figure 6.11. Effects of CCR7 deficiency on thymic NKT cell subsets from B6.V14Tg mice. A. Representative 
FACS plots showing the mean proportions (±SEM) of thymic CD4/CD8, CD24/CD44 and CD44/NK1.1 NKT cell 
subsets from B6.V14Tg
+/-
 and B6.Ccr7-/-.V14Tg
+/-
 mice. B. Dot plot graphs show the mean proportions and 
absolute numbers of thymic CD4/CD8, CD24/CD44 and CD44/NK1.1 NKT cells between B6.V14Tg
+/-
 (n=10) 
and B6.Ccr7-/-.V14Tg
+/-
 mice (n=8). Mann-Whitney U test, ** p<0.01, *** p<0.001 and **** p<0.0001. 
The proportions of DP NKT cells rose from 8.16±0.30% of total thymic NKT cells 
in B6.V14Tg+/- control mice to 14.99±0.88% in B6.Ccr7-/-.V14Tg+/- mice. In contrast, the 
proportions of thymic CD4+ NKT cells were unchanged, and those of DN NKT cells 
decreased. With regard to their absolute numbers, DP NKT cells were similar between 
B6.Ccr7-/-.V14Tg+/- and B6.V14Tg+/- control mice, whereas the numbers of CD4+ and 
DN NKT cells were significantly reduced in B6.Ccr7-/-.V14Tg+/- mice. A similar pattern 
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was seen with the numbers of CD24/CD44 NKT cells. While the numbers of immature 
CD24highCD44low NKT cells were not different between B6.V14Tg+/- and B6.Ccr7-/-
.V14Tg+/- mice, numbers of mature CD24lowCD44high NKT cells declined in B6.Ccr7-/-
.V14Tg+/- mice. Similarly, the numbers of CD44lowNK1.1-, CD44high NK1.1- and CD44high 
NK1.1+ NKT cells also decreased in B6.Ccr7-/-.V14Tg+/- mice. Although the proportions of 
immature (CD4+CD8+, CD24highCD44low and CD44lowNK1.1-) thymic NKT cells were 
increased (Fig. 6.11), the significant reduction of total thymic NKT cell numbers in KO mice, 
as indicated in Figure 6.10, resulted in decreased absolute numbers of all NKT cell subsets. 
Together, the differences in expression levels of genes related to some transcriptional 
factors, cytokine receptors, chemokine receptors suggest functional differentiation between 
immature CD4 and DN NKT cells. 
6.3. SUMMARY OF MAJOR FINDINGS 
Transcriptional analysis of immature CD4+ NKT cells and immature DN NKT cells 
indicated that there were large numbers of changes in gene expression across Transition 3. Gene 
Ontogeny analysis of highly differentially expressed genes revealed that there was widespread 
up-regulation of genes encoding proteins associated in lumenal membranes in DN NKT cells 
compared to CD4+ NKT cells, including membrane-enclosed lumen and intracellular organelle 
lumen proteins. In addition, Gene Ontogeny analysis of genes down-regulated in DN NKT cells 
indicated a prevalence of genes related to cell activation in the most significant annotation 
categories. These differences in gene expression between CD4+ NKT cells and DN NKT cells 
suggest differences in responses to signals and environmental cues. 
The functional differentiation between CD4+ and DN NKT cells was first confirmed 
by their distinct expression of Zbtb7, Icos and Ly6a. As microarray analysis revealed a 
significant up-regulation of Zbtb7, Icos and Ly6a transcripts in CD4+ NKT cells compared to 
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DN NKT cells. The ICOS/ICOSL interaction is required for NKT cell homeostasis and 
function, as CD4 NKT cell differentiation, as well as IL-4 and IL-13 production, is impaired 
in ICOS-/- mice (Dave et al., 1998; He et al., 2005; Akbari et al., 2008). Furthermore, survival 
of WT NKT cells transferred into ICOSL-/- mice is reduced (Akbari et al., 2008).  
NKT cells require a range of growth factors and survival signals, such as IL-2R 
(Ohteki et al., 1997), IL-7R (Boesteanu et al., 1997), and IL-15R  and  chains (Lodolce et 
al., 1998; Chang et al., 2011) to support their homeostatic proliferation and long-term 
survival (Kennedy et al., 2000; Ranson et al., 2003; McNab et al., 2005). In particular, thymic 
NKT cell numbers and proliferation are impaired in IL-15 deficient mice but are not 
completely abolished (Kennedy et al., 2000; Matsuda et al., 2002). A possible explanation is 
that distinct NKT cell subsets require different cytokines during their development. For 
example, IFN- secreting NKT cells express CD122 (the IL-2/IL-15 receptor  chain) and 
require IL-15 for their development and homeostasis, while IL-17R+ NKT cells develop 
normally in the absence of IL-15 (Watarai et al., 2012). In accordance with these findings, the 
differences in cytokine receptor expression observed between CD4+ NKT cells and DN NKT 
cells is consistent with the hypothesis that functional differentiation occurs at Transition 3. 
Perhaps the most important characteristic that distinguishes NKT cells from other cells 
in the immune system is their ability to rapidly secrete cytokines upon stimulation. In this 
chapter, cytokine analysis of culture supernatant from FACS sorted immature CD4+ and DN 
NKT cells revealed that immature CD4+ NKT cells produced significantly higher level of 
many cytokines, including IL-4, IL-10, IFN-, GM-CSF and INF- when compared to 
immature DN NKT cells. Previously, in vitro studies have reported differences in cytokine 
production between splenic (but not thymic) CD4+ and CD4- NKT cells from mice 
(Hammond et al., 1999) and human blood NKT cells (Gumperz et al., 2002; Lee et al., 2002; 
Rogers et al., 2004; Lin et al., 2004). However, these studies were performed on mature NKT 
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cells, therefore, our study is the first in vitro demonstration of immature CD4+ and DN NKT 
cell subsets being functionally distinct.  
Previously, many chemokine and chemokine receptors have been reported to be 
expressed by NKT cells and be involved in NKT cell survival and trafficking. Kim et al. 
(2002) reported that human CD4+ NKT cells express low levels of CCR5 but high levels of 
CCR4 compared to the CD4- (CD8- or DN) NKT cell subsets. In contrast, the CD4- NKT cell 
subsets characteristically express CCR1, CCR6 and CXCR6. However, all NKT cells express 
high levels of CXCR3 and CXCR4 (D’Andrea et al., 2000; Motsinger et al., 2002). In mice, 
CXCR3 and its ligand, CXCL9, are essential for the homing of mature NKT cells to the 
periphery from the thymus. NKT cells exhibited robust migration to the inflammatory 
chemokines MIG/CXCL9 and IP-10/CXCL10 (Johnstons et al., 2003).  
Additionally, CXCR6 and its trans-membrane ligand CXCL16 are important for the 
accumulation of NKT cells in the liver. NKT cells account for most hepatic CXCR6+ cells. 
They were found to crawl within hepatic sinusoids and to stop upon T cell antigen receptor 
activation. CXCR6-deficient mice exhibited a selective and severe reduction of CD1d-reactive 
NKT cells in the liver and decreased susceptibility to T-cell-dependent hepatitis (Geissmann et 
al., 2005). CXCR6 and its ligands also play a critical role in homeostasis and activation of 
CD1d-restricted NKT cells (Matloubian et al., 2000; Shimaoka et al., 2007; Germanov et al., 
2008). A study on heterozygous mice with a targeted replacement of CXCR6 by eGFP showed 
that thymic NKT cells up-regulated the chemokine receptor CXCR6 following positive 
selection and migrated toward CXCL16 in vitro (Germanov et al., 2008). Liver and lung NKT 
cells were depleted in CXCR6+/- and CXCR6-/- mice, however, there was a redistribution of 
NKT cells into their bone marrow. The neutralization of CXCL16 reduced the accumulation of 
mature NK1.1+ in the liver of wild-type mice, but not immature NK1.1- NKT cell recent thymic 
emigrants. Cytokine production by liver and spleen NKT cells was impaired in CXCR6-/- mice 
following in vivo stimulation with -galactosylceramide. These findings suggest an additional 
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role for CXCR6/CXCL16 in maturation or survival of immature liver NKT cells and a novel 
role for CXCR6 in NKT cell activation.  
In this chapter, microarray analyses of immature thymic CD4 and DN NKT cells from 
NOD.V14Tg mice revealed that both CD4+ and DN NKT cells highly expressed large 
numbers of chemokine receptors after the positive selection events, including CCR2, CCR4, 
CCR7, CCR8, CCR10 and CXCR6. Of these chemokine receptors, the role of CCR7 was 
validated on B6 WT and B6 V14Tg+/- mice. The deficiency of CCR7 resulted in 6- and 3-
fold decrease in thymic and peripheral NKT cell numbers, respectively, in B6 WT mice. 
However, it presents a different effect on B6.V14Tg+/- mice. While the CCR7 deletion on 
B6.V14Tg+/- mice leaded to a significant reduction in both proportions and absolute numbers of 
thymic NKT cells in B6.Ccr7-/-, those of splenic NKT cells were unchanged but the absolute 
numbers of hepatic NKT cells were significantly increased. The mechanisms for this discrepancy 
of CCR7 role on B6 WT and B6.V14Tg+/- mice are unclear. The effect of CCR7 on NKT 
cells from B6 WT mice seen in this chapter were confirmed in Cowan el al. work. 
 Id2 is a transcriptional regulator that plays a critical role in NKT cell homeostasis and 
hepatic localization. Id2-deficient NKT cells fail to accumulate in the liver and bone marrow. 
Monticelli et al. (2009) reported that the absence of Id2 does not affect NKT cell migration 
but results in reduction in Bcl-2 and Bcl-XL mRNA levels and increased apoptosis in these 
mice. Both hepatic and splenic NKT cells from Id2KO mice show dramatic reduction in 
CXCR6 mRNA and protein expression compared to Id2WT NKT cells (Moticelli et al., 2009; 
Geissmann et al., 2005; Germanov et al., 2008).  
In conclusion, transcriptional comparison between immature CD4+ and DN NKT cells 
indicated that the two populations exhibit different gene expression profiles, particularly 
differences in their cytokine receptor and chemokine receptor profiles. These differences in 
cytokine production support the hypothesis that functional differentiation occurs at transition 
3, between CD4+ NKT cells and DN NKT cells. 
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7.1. Production of a novel model V14 TCR transgenic strain 
Vα14-Jα18 transgenic mice have been previously developed to aid functional and 
developmental studies of invariant NKT cells (Bendelac et al., 1996; Griewank et al., 2007). 
In this work, a validated transgenic construct containing an NKT-associated Vα14-Jα18 TCR 
α chain cDNA was expressed on the NOD mouse genetic background, which confers a partial 
defect in NKT cell selection and development (Baxter et al., 1997; Poulton et al., 2001; 
Griewank et al., 2007).  
Flow cytometric analysis of CD1d-tet+TCR+ lymphocytes from NOD.V14Tg mice 
indicated that thymic, hepatic and splenic NKT cell numbers were significantly increased. 
Transgenic lines 1 and 3 had ~60-90-fold increases in thymic NKT cell numbers while lines 2 
and 4 had ~3-fold increases; numbers of hepatic NKT cells were raised ~4-fold in lines 1 and 
3, and by 25-50% in lines 2 and 4; lines 1 and 3 resulted in ~7-fold increases in splenic NKT 
cell numbers, while lines 2 and 4 had similar numbers to the non-transgenic parental strain. 
Both the CD4 SP and DN populations of mature NKT cells could be identified in the thymi, 
livers and spleens of WT mice and mice from the NOD.Vα14Tg lines. Virtually, all (>99%) 
NKT cells in the livers and spleens of NOD.Vα14Tg mice were either CD4+ or DN. In both 
peripheral organs of NOD.Vα14Tg mice, the proportions of the two major NKT cell subsets 
that express the relatively mature CD24low CD44high phenotype were similar to WT, as were 
the proportions of CD44high NKT cells of either subset that expressed NK1.1. These 
peripheral NKT cells were functional and responded to in vivo stimulation with -GalCer by 
robust cytokine production.  
The expression of the Vα14 transgene on both NOD and B6 genetic backgrounds has 
resulted in increased numbers of mature peripheral NKT cells. From a developmental and 
evolutionary perspective, the results imply that expression of the Vα14-Jα18 TCR  chain 
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alone might be sufficient information to bias the differentiation of a thymocyte towards the 
NKT cell pathway. However, it remains to be tested whether expression of the Vα14-Jα18 
TCR α chain itself is genetically programmed in iNKT cells, or whether it occurs randomly. 
7.2. Increased production of very immature NKT cells 
 As presented in this work, one of the most striking characteristics of the thymic NKT 
cell population in both NOD and B6.Vα14Tg mice was the presence of increased numbers of 
the DP subset. In particular, this population constituted between 35 and 65% of all thymic 
CD1d-tet+TCR+ NKT cells in the various lines of NOD.V14Tg mice, while it accounted for 
less than 5% of thymic NKT cells in NOD WT mice. The DP NKT cells were predominantly 
CD24high CD44low NK1.1-. Compared with previously published data (Benlagha et al., 2002, 
Godfrey and Berzins, 2007), it suggests that the thymic DPhigh CD24high CD44low NK1.1- 
CD1d-tet+TCR+ population represents NKT cells that have not yet undergone thymic 
selection because: 1) The population lacks expression of the developmental markers typical of 
mature NKT cells, viz: NK1.1 and CD44; 2) They express the CD24 marker, which is 
characteristic of conventional T cells prior to selection; 3) Cells of this phenotype were not 
found outside the thymus, despite very large numbers of them being found within it; and 4) 
Quantitative PCR analysis of V14-J18 encoded transcripts of sorted DPhigh thymocytes in a 
previous study by Gapin and colleagues found equivalent proportions in WT and Cd1d-/- mice 
(Gapin et al., 2001). Similarly, only a single V14-J18 rearrangement could be detected in 
the DPdull population of WT mice, in contrast with the multiple rearrangements detected in 
DPhigh thymocytes (Gapin et al., 2001). Therefore, the transgenic expression of an NKT-
associated Vα14-Jα18 TCR α chain cDNA in this work resulted in greatly expanded numbers 
of immature DP NKT cells with the phenotype of the earliest identifiable NKT cells.  
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In NKT cell development, much attention has been paid to mature NKT cells and the 
acquisition of the NK1.1 marker, primarily because prior to the generation of CD1d-tet 
(Benlagha et al., 2000; Matsuda et al., 2000), the expression of NK1.1 on CD3+ cells was 
used as a surrogate marker of NKT cells and almost all of NKT cells express CD44high. 
Therefore, CD44 and NK1.1 were widely used to classify NKT cell developmental subsets. 
Two thymic populations of NKT cells that have been widely studied are: CD44highNK1.1+ 
NKT cells, which appear to be non-dividing and long-lived, and do not contribute 
significantly to thymic export (Gapin et al., 2001; Pellicci et al., 2002; Benlagha et al., 2002), 
and recent thymic emigrant NKT cells, which are primarily CD44highNK1.1- and acquire 
NK1.1 expression between 24 hours and a week after thymic egress (Benlagha et al., 2002; 
McNab et al., 2005). The up-regulation of NK1.1 on CD44high NKT cells is dependent on the 
cell-intrinsic expression of the transcription factor T-bet (Townsend et al., 2004).  
The identification of the HSA
high DP
low 
and HSA
high CD4
+
 stages by in vitro 
enrichment of NKT precursors from pools of up to 60 new-born thymi with CD1d-GalCer 
tetramers and MACS sorting, essentially completed the map of the enigmatic developmental 
pathway of NKT cells (Gapin et al., 2001; Benlagha et al., 2002; Pellicci et al., 2002; Gadue 
et al., 2002). However, the very low frequency of very immature NKT cells (estimated at less 
than 1/10
6
) has precluded physical identification. The presence of greatly expanded numbers 
of very immature NKT cells in NOD.V14Tg mice provided us with an opportunity to study 
the earliest identifiable stages of NKT cell commitment and differentiation, and to help 
dissect factors controlling the numbers and function of this important immunoregulatory 
population. Therefore, our NOD.V14Tg mice provided a novel model of NKT cell selection 
in which sufficient pre-selection cells were available that the stages and processes involved 
could be clearly distinguished. 
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7.3. Supporting early stages of previously established developmental pathway of NKT cells 
In contrast to extensive work made on mature and relatively mature NKT cells, there 
were very few studies that focus on early development of NKT cells. With an attempt to 
identify the earliest CD1d-tet+ thymic NKT cells, Gapin and colleagues stained C57BL/6 
mouse thymi with CD1d-tet-phycoerythrin (PE), and isolated positive cells with anti-PE 
magnetic beads (Gapin et al., 2001). Of the NKT cells obtained from thymi of nine-day old 
mice, 25% were “DPdull”, a population whose frequency declined with age, was not seen in 
the periphery at any time, and was absent in CD1d-/- mice.  The authors postulated that this 
population probably represented early post-selection NKT cells (Gapin et al., 2001) because 
during conventional T cell development, TCR ligation of DPhigh thymocytes triggers CD4 or 
CD8 down-regulation (Swat et al., 1992; Page et al., 1993). In contrast, quantitative 
polymerase chain reaction analysis of V14-J18 encoded transcripts of sorted DPhigh 
thymocytes found equivalent proportions in wild type and Cd1d-/- mice, consistent with the 
DPhigh phenotype marking pre-selection NKT cells (Gapin et al., 2001). Further evidence of 
the DPhigh to DPdull transition representing positive selection was obtained by CDR3 
spectratyping in WT mice: Only a single peak could be detected in the DPdull population, 
which corresponded to the canonical V14-J18 rearrangement. This contrasted with the 
multiple rearrangements detected in DPhigh thymocytes (Gapin et al., 2001).  
 In 2005, Benlagha and colleagues applied a similar tetramer-based enrichment 
strategy to identify DP CD24high NK1.1- NKT cell precursors in the thymi of new-born mice. 
These cells were non-dividing and already exhibited the same V8 TCR bias characteristic of 
mature NKT cells (Benlagha et al., 2005). They therefore are likely to be post-selection, 
making them the earliest population of post selection NKT cells identified to date. In contrast, 
the subsequent population of CD24lowNK1.1- CD1d-tet+ NKT cells contained two subsets 
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(CD44low and CD44high), both of which were rapidly proliferating (Benlagha et al., 2002). On 
the basis of the changing proportions with aging from two to six weeks, Benlagha and 
colleagues proposed that the CD44low population precedes the CD44high population during 
their maturation (Benlagha et al., 2002). The developmental pathway of NKT cells in mice 
postulated by Godfrey and Berzins is therefore: DPhigh CD24high CD44low NK1.1- → selection 
→ DPlow CD24high CD44low NK1.1- (Stage 0) → DN or CD4+ CD24low CD44low NK1.1- (Stage 
1) → DN or CD4+ CD24low CD44high NK1.1- (Stage 2) → DN or CD4+ CD24low CD44high 
NK1.1+ (Stage 3; Godfrey and Berzins, 2007).  
 Although the later part of the developmental pathway postulated by Godfrey and 
Berzins is currently challenged by the more recent data in the field about the development of 
the novel NKT1, NKT2 and NKT17 lineages, the presence of large numbers of DPhigh 
CD24high CD44low NK1.1- CD1d-tet+ TCR+ cells in the thymus of NOD.V14Tg mice and 
their absence in the periphery, suggested that these cells represent a very immature, possibly 
pre-selection population of NKT cells. This gave us the opportunity to compare the 
transcriptional profiles of DPhigh CD24high CD44low NK1.1- CD1d-tet+TCR+ cells (i.e. very 
immature NKT cells) with those of more mature NKT cell subsets in order to identify the 
transcriptional transitions associated with early development of NKT cells, such as TCR 
validation, positive selection and lineage commitment.  
 Microarray analyses were performed on four different thymic populations: DPhigh 
CD24high NK1.1- CD1d-tet-TCR+ cells (immature DP conventional T cells), DP CD24high 
CD44low NK1.1- CD1d-tet+TCR+ cells (DP NKT cells), CD4+CD8-CD24high NK1.1-CD1d-
tet+TCR+ cells (CD4 NKT cells) and CD4-CD8- CD24 high NK1.1-CD1d-tet+TCR+ cells 
(DN NKT cells), which were isolated by FACS sorting from thymi of NOD.V14Tg mice. 
Principal Component (PC) analysis of transcript expression indicated that the three largest 
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PCs explained >58% of variation across all samples. Seven samples from each of the four cell 
types clustered together into groups, and the four groups were distributed evenly across PC1 
(X axis, which explained >29% of variation) in the order: DP CD24hi NK1.1- T cells → DP 
CD24hi NK1.1- NKT cells → CD4 CD24hi NK1.1- NKT cells → DN CD24hi NK1.1- NKT 
cells. The transcriptional progression of the four NKT cell subsets therefore mirrors the early 
developmental progression described by Godfrey’s group, based on their and other’s work 
(Godfrey and Berzins, 2007; Coquet et al., 2008). Of particular interest is the possibility that 
our analysis of DP NKT cells might identify the transcriptional events associated with Control 
Point 1 of NKT cell development, which Godfrey and Berzins attributed to selection (Godfrey 
and Berzins, 2007). 
In addition to the confirmation of NKT cell development, the results from this work 
indicated some other points of T lineage development. It is well demonstrated that sequential 
rearrangement of the T cell receptor for antigen and chains is a hallmark of thymocyte 
development. In TCR transgenic model systems, TCR and - chains are expressed early at 
the CD4-CD8- DN stage instead of the DP stage (Terrence et al., 2000; Lacorazza et al., 2001; 
Wolfer et al., 2002). The early expression of TCR has been suggested to affect -selection 
even in the presence of the pre-TCR because TCR has a higher affinity for TCR than it 
does for pre-T (Trop et al., 2000). In this case, the TCR heterodimer can mediate -
selection if expressed at the DN stage, but it is highly inefficient (Borowski el al., 2004). 
Therefore, early expression may affect / lineage commitment, which results in a large 
population of mature DN TCR+ cells both in the thymus and the periphery (Bruno et al., 
1996; Fritsch et al., 1998; Terrence et al., 2000; Lacorazza et al., 2001). They represent a 
terminally differentiated thymic population without the ability to seed the DP compartment 
(Lacorazza et al., 2001) and present properties consistent with -lineage cells in the 
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periphery (Terrence et al., 2000). By creating a Cre/lox-based conditional model in which 
TCR expression would be delayed until the DP stage (as is the case in normal animals), 
Baldwin et al. (2005) rescued the reduced DP and increased DN cellularity typically seen in 
TCR transgenics because the chain was expressed at the appropriate stage.  
In our work, the premature expression of transgenic Vα14TCR might promote DN T 
cell development as seen in previous studies (Baldwin et al., 2005; McDonald et al,. 2014). 
The DN:CD4 inversion seen in both NOD and B6 Vα14 transgenic mice might be due to TCR 
engagement in developing NKT cells occurring earlier, on average, in Vα14 transgenic mice 
compared to controls. The results could be postulated that, in the normal thymus, NKT cells 
might bifurcate into DN and CD4 subsets due to a difference in the “age” of the DP cell when 
it is positively selected into the NKT lineage. 
Secondly, as seen in this work, the mature NKT cells generated by NOD.Vα14Tg/1 
mice exhibited the relatively similar characteristics of TCR Vβ usage as NKT cells from 
WT mice, however, 70-80% of CD44– NKT cells and ~38% of CD44+ NKT cells in the 
thymus of NOD.Vα14Tg mice use TCR Vβ chains other than Vβ8, Vβ7 or Vβ2, exceeding by 
far the frequency detected in the thymus of WT NOD mice (~0%). These findings suggest 
that the choice of TCRβ chain affects the probability that a αGalCer/mCD1d tetramer-binding 
thymocyte will transition from a CD44– to a CD44+ phenotype. 
7.4. TCR validation was associated with the transition from DP T to DP NKT cells 
 NOD.V14Tg mice, a novel Vα14 TCR transgenic strain bearing greatly expanded 
numbers of CD24highCD44- NKT cells provided a model of NKT cell selection in which 
sufficient pre-selection cells were available that the stages and processes involved could be 
clearly distinguished. Evidence supporting the use of the model comes from the relatively 
large numbers of transcripts differentially expressed between thymic TCR+DPhigh CD24high 
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populations that either did or did not bind CD1d-tet. This comparison provided evidence of 
successful TCR signalling in thymic DPhigh CD24high NK1.1- NKT cells, including TCR 
allelic exclusion and Rag1 down-regulation.  
Transcriptional analysis comparing immature DP T cells and immature DP NKT cells 
revealed a reduction in expression of the electron transport genes, such as NADH 
Dehydrogenase (Nd1, Nd2, Nd4, Nd5), Cytochrome C Oxidase (Cox1, Cox2, Cox3) and ATP 
Synthase 6 (Atp6) suggesting reduced mitochondrial oxidative phosphorylation and raising the 
possibility that immature DP NKT cells had a higher proliferation rate. This is a characteristic 
of the Warburg phenomenon, in which cancerous or proliferative cells increase aerobic 
glycolysis at the expense of oxidative phosphorylation (Vander Heiden et al., 2009; 2011).  
Transcriptional evidence was sought to support the hypothesis that the increase in 
proliferation across Transition 1 was due to TCR signalling. Genes encoding almost all the 
proximal components of the TCR signalling cascade were significantly down regulated (U 
stat = 0): Lck (p<6.6 x 10-8; t-Test), Fyn (1.4 x 10-7), Zap70 (5.4 x10-5), Vav1 (1.3 x 10-6) and 
Plcg1 (1.2 x 10-10). Although not previously reported, the effects of this transition would be 
akin to other mechanisms of TCR tuning, such as down regulation of the TCR and CD4/CD8 
co-receptors, regulation of accessory molecules such as CD5, CD2 and CD28, and 
phosphorylation of SHP-1 (Grossman and Paul, 2015), suggesting that the TCR had been 
ligated and successfully signalled – constituting validation of a functionally rearranged (in 
this case transgenic) receptor. 
The evidence of allelic exclusion of endogenous alpha chain loci supports the 
hypothesis that the proliferation observed across Transition 1 was due to successful TCR 
signalling and validation. TCR alpha chains dominated the most significantly differentially 
expressed transcripts, constituting ten of the top 20 most significant. Highly significantly 
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down-regulated TCR variable-alpha gene segments included: Tcra-V22.1, Trav8d-1, Trav7d-
4, Trav12-2, Trav9-4, Trav6-5, Trav9n-1, Trav6-3, Trav7d-3, Trav9d-3, Trav13d-1, Trav7d-2, 
Trav6-7-dv9, Trav7-6, Trav6d-5, Trav9-4, Trav13-2, Trav12-2, Trav12n-2, Trav14-1, Trav7-
6, Trav5-4, Trav6d-3, Trav1, Trav14n-2, Trav12-2, Trav12-1, Trav7d-4, Trav4-4-dv10, 
Trav9d-3, Trav7n-5, Trav14d-3-dv8, Trav8-1 and Trav12-1 (all U=0; p<1.4x10-6, t-Test). The 
loss of expression of the great majority of non-NKT cell associated V chains is consistent 
with successful validation of the transgene-encoded TCR initiating the mechanism for allelic 
exclusion of competing TCR. 
The possibility of increased proliferation in DP NKT cells was also supported by the 
up-regulated expression of genes associated with the cell cycle and cell division. A large 
number of genes involved in the E2F signalling pathway, DNA replication and Centromere 
proteins were significantly up-regulated by immature DP NKT cells compared to immature 
DP T cells. The most strongly differentially expressed gene identified across Transition 1 
encoded the transcription factor E2f1, which was highly significantly up-regulated, lending 
support for increased proliferation in DP NKT cells. E2F1, E2F2 and E2F3 act in a 
functionally redundant manner to enhance the expression of many genes required for G1 to S 
phase cell cycle progression, proliferation and development, including Cdc6, Ccne1 and Myb 
(Johnson et al., 1993; Wu et al., 2001). The growth regulatory function of the Rb tumour 
suppressor protein is mediated by its binding to E2F transcription factors, so that while 
overexpression of E2F1 unopposed by increased RB expression results in increased 
proliferation, so does E2f1 gene deletion (Yamasaki et al., 1996; Field et al., 1996). 
Consistent with increased E2f1 expression, E2F-regulated genes, such as Cdc6 and Ccne1 
were also significantly up-regulated, as were genes encoding proteins critical for spindle 
formation and chromosome segregation (such as Cenpm) and DNA replication (such as Rpa2) 
consistent with E2F1 up-regulation driving cell proliferation.  
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The role of the E2F pathway in mediating T cell proliferation has been studied in 
E2f1/E2f2 double knockout mice. It appears to play a role in homeostatic proliferation (HP) 
but not in proliferative responses to exogenous antigen, as HP in E2f1/E2f2 double knockout 
mice is severely reduced (DeRyckere and DeGregori, 2005), but proliferation in response to 
exogenous antigen is not (Zhu et al., 2001; DeRyckere and DeGregori, 2005). While HP of 
naive T cells requires both IL7 signalling (Schluns et al., 2000) and TCR stimulation by 
MHC-self peptide (Ernst et al., 1999), HP of memory CD4 T cells is dependent on TCR 
stimulation by MHC-self peptide alone (Tan et al., 2002). As HP of all T cells, including 
memory CD4 T cells is impaired in E2f1/E2f2 double knockout mice, the E2F pathway must 
play a role in mediating T cell proliferation in the context of HP (Field et al., 1996). The early 
processes of thymocyte TCR validation and T cell selection resemble those of HP, in that they 
are mediated by MHC-self peptide recognition and stimulate proliferation. Activation of the 
E2F pathway in Transition 1 therefore suggests that T cell signalling, and therefore TCR 
validation, has occurred. 
 While Benlagha and colleagues previously reported that their DPlow CD24high NK1.1- 
NKT cells in the thymi of newborn mice were non-dividing (Benlagha et al., 2005), our 
functional validation by in vivo BrdU incorporation confirmed our hypothesis that the 
immature thymic DPhigh NKT cells in NOD.Vα14Tg mice have increased proliferation. 
Transcriptional evidence of allelic exclusion of competing TCR Vα chains in immature DP 
NKT cells was provided by the widespread down-regulation of non-NKT cell TCR Vα genes 
in Transition 1. This finding was confirmed by the almost complete absence of immature DP 
NKT cells and mature NKT cells expressing other TCR V chains, such as TCR Vα2, Vα3.2 
and Vα8.3 accompanied with TCR V14-J18 chain. Together, down-regulation of genes 
related to the electron transport chain, the activation of the E2F pathway, T cell signaling and 
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the down-regulation of non-NKT associated TCR Vα genes suggests that successful TCR 
validation occurs across Transition 1.  
7.5. Positive selection and lineage commitment were associated with the transition 2 from 
immature DP NKT cells to immature CD4 NKT cells 
Transcriptional analysis across Transition 2 suggests that positive selection and 
lineage commitment of NKT cells occurs during the transition from immature DP NKT cells 
to immature CD4 NKT cells. Gene Ontogeny analysis of up-regulated HDE genes revealed 
the strong up-regulation of a wide range of functional lymphocyte-associated membrane 
proteins, such as Toll-like receptors, Cytokine receptors, Chemokine receptors, Intergrins and 
Leukocyte differentiation markers. Of these, there was a predominance of genes associated 
with the immunomodulatory and innate-like properties of NKT cells, such as Tlr1, Nkg7, 
Sema4a, Art2b, S1pr1 and Zbtb16.  
Commitment to the NKT cell lineage is well known to be associated with the 
expression of the transcription factor PLZF, a transcription factor that drives differentiation 
into NKT cells and human MR1-specific MAIT cells, encoded by Zbtb16 (Savage et al., 
2008). Transactivation of PLZF appears to be the molecular switch that differentiates a T cell 
into an innate-like effector T cell. Physiologically, only V14-J18 TCR-expressing DP 
thymocytes and a few others (such as Vγ1.1Vδ6.3 γδ NKT cells, innate lymphoid cells in 
mice and mucosal-associated invariant T (MAIT) cells, NK cells, γδ T cells in humans) are 
able to up-regulate PLZF and acquire this phenotype. In the absence of PLZF, these V14-
J18 TCR-expressing cells join the heterogeneous pool of naïve conventional helper T cells, 
migrating through secondary lymphoid tissue and being reliant on primary activation before 
being able to express effector functions. However, the complex phenotype of these residual 
cells hints at the necessity of other PLZF functions or interactions with other pathways 
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engaged during NKT cell-like positive selection. Ectopic expression of PLZF on cells that 
normally do not induce expression confers a robust and coherent effector program similar to 
that of NKT cells, indicating that PLZF is a lineage commitment factor for the innate-like 
phenotype. The close apposition of evolutionarily conserved TCRs, non-polymorphic ligands, 
and the unique effector program regulated by PLZF is a tantalizing clue as to the necessity of 
these rare, atypical T cell subsets for protective immunity.  
Previous studies indicated that PLZF does not seem to have a dominant impact on the 
DP pool or thymic selection and does not significantly alter negative selection or the TCR 
repertoire (Savage et al., 2011). Analyses of PLZF transgenic cells in the presence or absence 
of the Marilyn TCR transgene of male mice (those express the H-Y antigen and as a 
consequence negatively select T cells bearing the anti-H-Y specific Marilyn TCR) indicated 
that in the presence of PLZF, I-Ab-HY-specific Marilyn TCR transgenic thymocytes 
underwent negative selection at the DP stage of development as expected (Savage et al., 
2011). PLZF did not seem to alter the TCR signaling threshold of DP thymocytes as judged 
by CD69 induction upon graded TCR stimulation by a range of antigen concentrations. In 
addition, assessment of retroviral super antigens-mediated deletion of cells bearing Vβ 
families associated with recognition of BALB/c super antigens indicated that the presence of 
the PLZF transgene provided a partial rescue from deletion in BALB/c x PLZF transgenic 
(B6) F1 mice (Savage et al., 2011).  Given such limited information on PLZF activity in T 
cells, it is difficult to speculate on how ectopic expression could be preserving cells normally 
deleted. However, the defect on numbers of NKT cells found in PLZF-mutant mice is 
localized to the intrathymic Stage 1 (CD24lowCD44lowNK1.1-) to Stage 2 
(CD24lowCD44highNK1.1-) transition. Mixed bone marrow chimeras clearly revealed normal 
frequencies of Stage 0 (CD24highCD44lowNK1.1-) and Stage 1 populations with a sharp 
decline of the subsequent stage 2 cells (Savage et al., 2011).  
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In our work, there was no significant difference in expression of Zbtb16 between 
immature DP T cells and immature DP NKT cells, consistent with the immature DP NKT 
cells not yet having undergone positive selection, while Zbtb16 was up-regulated more than 
13-fold during the subsequent transition from immature DP NKT cells to immature CD4 NKT 
stage. These findings are consistent with immature CD4 NKT cells having been positively 
selected and commenced lineage commitment. The strong up-regulation of such a wide range 
of functional lymphocyte-associated, surface expressed, integral membrane proteins at 
Transition 2 is also consistent with this transition being associated with NKT cell lineage 
commitment and confirms the finding by Savage and colleagues that PLZF expression in 
NKT cells is up-regulated between Stage 0 and Stage 1 in development and responsible for 
driving the innate-like differentiation of NKT cells (Savage et al., 2008).  
By comparison of genome-wide transcription in PLZF-deficient Luxoid mutant mice 
with that in WT mice, Savage and colleagues identified 69 genes being dependent on PLZF 
expression (Savage et al., 2008). The examination of transcript levels of these 69 genes in our 
microarray data confirmed that the up-regulation of Zbtb16 across transition 2 was sufficient 
to modulate expression of PLZF target genes. Forty-two of the 69 genes identified by Savage 
and colleagues had a U statistic of zero across the transition (p<0.0001; Chi-square 
contingency table), and the vast majority (39/42) were up-regulated, consistent with PLZF 
expression playing a significant role in Transition 2 of NKT cell development. 
The coordinated expression of the innate-like lymphocyte-associated transcription 
factor PLZF and the subsequent up-regulation of a wide range of cell-surface functional 
receptors associated with NKT cell immunobiology combine to provide evidence that NKT 
cell lineage commitment occurred across Transition 2, between Stage 0 and 1. However, it 
raised the issue of the timing of the NKT cell selection event, which could not take place later 
than lineage commitment in Transition 2. Of the genes showing up-regulation in immature 
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CD4 NKT cells, many have been previously described as increased in expression during 
positive selection of conventional T cells (Huang et al., 2004; Mick et al., 2004). These data 
are consistent with NKT cell selection occurring across Transition 2.  
Positive and negative selection of NKT cells has been previously studied. NKT 
development is markedly impaired by the absence of the antigen presenting molecule, CD1d 
for positive selection (Bendelac, 1995; Chen et al., 1997; Smiley et al., 1997; Mendiratta et 
al., 1997; Coles and Raulet, 2000; Gapin et al., 2001; Wei et al., 2005) or by the early 
administration of -GalCer (Pellicci et al., 2003; Chun et al., 2003). However, in these 
studies, due to the very low number of DP NKT cells in wild type mice, the effect of targeted 
deletion of CD1d and administration of α-GalCer were not directly examined on DP NKT 
cells. It was assumed that negative selection affected the early development stage cells as 
delayed treatment with -GalCer in vivo did not deplete NKT cells (Pellicci et al., 2003). In 
contrast, the production of very large numbers of immature DP NKT cells in the thymi of 
Vα14 transgenic mice provided us with an opportunity to directly examine the positive and 
negative selection of NKT cells. 
Targeted deletion of CD1d from NOD.Vα14Tg mice indicated that CD1d is required 
for further development of thymic immature DP NKT cells. In the absence of CD1d, 
immature DP NKT cells did not progress to subsequent developmental stages and 
accumulated in the thymi of these mice. The almost complete absence of peripheral NKT 
cells in NOD.Cd1d-/-.Vα14Tg mice is consistent with failed positive selection of DP NKT 
cells in the absence of CD1d. Additionally, the immature DP NKT cells were also susceptible 
to negative selection mediated by the administration of α-GalCer both intravenously and 
intrathymically. The behaviour of DP NKT cells under these experimental conditions was 
consistent with them not yet having undergone selection, as: 1) DP NKT cells were not found 
outside the thymus, despite very large numbers of them being found within it; 2) Their 
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numbers were more than doubled by targeted deletion of CD1d, which is the antigen 
presentation glycoprotein required for NKT cell positive selection; 3) They were depleted to 
about half their numbers by systemic or intrathymic injection of the strong NKT cell 
glycolipid antigen -GalCer in a CD1d-dependent manner; and 4) DP NKT cells showed only 
three of the 44 transcriptional hallmarks of positive selection. Together, these data are 
consistent with the hypothesis that DP NKT cells are a pre-selection population and that 
positive selection of NKT cells occurs between immature DP NKT cells and CD4 NKT cells. 
NKT cells are positively selected by ligating CD1d expressed on DP cortical 
thymocytes, which account for >80% of all thymocytes. If this was sufficient for positive 
selection, as distinct from merely necessary, the accumulation of pre-selection DP NKT in 
NOD.V14Tg mice can probably not be explained. On the contrary, these results suggest that 
positive selection of NKT cells is not just dependent on ligation of conventional DP 
thymocytes, as these are abundant. Instead this model shows evidence of a backlog of positive 
selection when numbers of pre-selection NKT cells are increased by transgenesis, consistent 
with a rate-limiting step.  
CD1d is required for NKT cell positive selection (Bendelac et al., 2007; Godfrey and 
Berzins, 2007). The absence of CD1d on thymocytes abrogates the DP-DP interaction, which 
is required for selection of the lineage (Bendelac, 1995). However, an additional signal such 
as the SLAM-SLAM homotypic interaction between immature NKT cells and selecting DP 
thymocytes might be a reasonable candidate for a necessary second signal. SAP mediates the 
SLAM receptor signaling that has been shown to occur upon DP-DP interactions and is 
required for NKT cell development (Chan et al., 2003; Griewank et al., 2007; Jordan et al. 
2011). In SAP-/- mice, CD1d-tet-reactive cells never mature past the transitional CD24high 
stage (Griewank et al., 2007). These studies highlight the unique selection event that drives 
commitment of the NKT cell lineage: positive selection by ligand-bearing DP thymocytes 
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coincident with SLAM receptor signaling. However, in addition to the SLAM receptor 
signaling other co-stimulators or cytokines, such as IL7 or IL15, may be required.  
Although the approach used in this thesis to study positive and negative selection is 
not new, our findings elucidate some long-standing issues regarding the positive and negative 
of NKT cells by directly testing on a real DP NKT cell population. Additionally, it is showed 
in our work and others that CD4 NKT and DN NKT cells are very rare in the thymus of 
CD1d-/- mice (Gapin et al., 2001 and in this thesis). By contrast, it is surprising and interesting 
that CD1d-tet+ cells attain non-DP phenotypes in the absence of CD1d. These cells were 
either CD4 or DN and still expressed the CD24+CD44- phenotype. They are present in the 
thymus of Cd1d-/-.Vα14Tg mice, with population sizes similar to Cd1d+/+.Vα14Tg mice. 
Although the mechanism for the appearance of these non-DP phenotypes is unclear, the 
possible explanation is that they might develop in a CD1d-independent manner. Their 
ontogeny is related to the premature expression of the Tg TCRα chain that binds to the TCRβ 
chains expressed at the DN3 stage. It is believed that, by modifying the signals that normally 
emanate from the pTα-TCRβ complexes, the TCRα transgene bypasses the subsequent need 
for TCR-mediated positive selection (von Boehmer et al., 1991; Bruno et al., 1996; Eberl et 
al., 1999b; Terrence et al., 2000; Borowski et al., 2004; Baldwin et al., 2005). Therefore, 
similar to a subset of mature NKT cells, these Tg cells do not express CD8 or both CD4 and 
CD8. In TCRβ rearranging cells, TCRα proteins are expressed so early that they mimic the 
pre-TCRα chain with regard to induction of cell maturation as well as allelic exclusion (Buer 
et al., 1997). It will be useful to identify these cells at an early stage of development and to 
determine whether they represent a CD1d-independent NKT cells. 
Secondly, the checkpoints imposed on developing T cells mandate that they generate 
TCR α and β chains that form an αβ TCR capable of positive selection (Goldrath and Bevan, 
1999). TCR α and β chain gene assembly is precisely modulated within the context of normal 
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thymocyte development. TCRβ chain genes are rearranged in DN thymocytes (Godfrey and 
Zlotnik, 1993; Starr et al., 2003). Expression of a TCRβ chain, as a pre-TCR, results in 
signals that promote cellular expansion and developmental progression to the DP stage of 
thymocyte development (Godfrey and Zlotnik, 1993; Michie and Zuniga-Pflucker, 2002; Starr 
et al., 2003). Pre-TCR signals also promote TCRα chain gene rearrangement and prohibit 
further TCRβ chain gene assembly through the process of allelic exclusion (Aifantis et al., 
1997; von Boehmer and Fehling, 1997; Khor and Sleckman, 2002). Because allelic exclusion 
prohibits DP thymocytes from generating new TCRβ chains, these cells must generate TCRα 
chains that form an αβ TCR capable of positive selection if they are to become mature T cells. 
Data presented in this thesis confirms that the requirements to complete NKT development in 
vivo extend beyond the mere capacity to bind αGalCer/mCD1d tetramer. Two potential 
requirements are (i) a “selectable” TCRβ chain sequence and (ii) TCR engagement with a 
particular glycolipid inside CD1d.  
TCRβ chain repertoire of NKT cells is generated through the step-wise assembly and 
subsequent selection of TCRβ variable region exons during thymocyte development. Earlier 
studies using TCRβ chain transgenic mice (on a TCRβ–/– background) showed that the Vβ 
segment utilized is critical for NKT cell development (Ohteki and MacDonald, 1996). Vβ 
usage analysis in our work revealed that NKT cells produced by Vα14 transgenic mice present 
the bias toward Vβ2, Vβ7 and Vβ8. However, it also showed that 70-80% of CD44– NKT 
cells and ~38% of CD44+ NKT cells in the thymus of NOD.Vα14Tg mice use TCR Vβ 
chains other than Vβ8, Vβ7 or Vβ2, exceeding by far the frequency detected in the thymus of 
WT NOD mice (~0%). These findings suggest that the choice of TCRβ chain affects the 
probability that a αGalCer/mCD1d tetramer-binding thymocyte will transition from a CD44– 
to a CD44+ phenotype. 
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Some recent studies suggested that the bias toward the NKT lineage is generally 
associated with CDR3β (complementarity-determining region 3β) sequences. Analyses of the 
length and sequence heterogeneity of CDR3β domains in Vα14+ NKT cells by Ronet et al. 
(2001) and Matsuda et al. (2001) concluded that CDR3 lengths of permissive TCRβ chains 
(Vβ2, Vβ7 and Vβ8) were equally heterogeneous for NKT cells and conventional T cells. The 
distinctive CDR3β sequence motifs are not apparent for NKT cells, it remains possible that 
certain TCRβ chain sequences may bias positive selection in favor of NKT cells. By 
expressing a TCRβ chain (Vβ8.2–Jβ1.4) derived from a transgenic Vα14+ NKT hybridoma, 
Viret et al. (2000) indicated that canonical Vα14–Jα281 rearrangements were increased in the 
thymus of these transgenic mice in a CD1d-dependent fashion and NKT cells (defined as 
NK1.1+ TCRαβ+) were twice as frequent as in control mice. These findings suggested that 
certain CDR3β motifs are critical for CD1d recognition during NKT cell development. 
In terms of antigens, NKT cells can recognize CD1d molecules bound to a number of 
different glycolipids. Because some of these glycolipids are microbial in origin, it is thought 
that NKT cells contribute to responses to invading bacteria. However, NKT cells also react 
with CD1d-expressing antigen presenting cells (APCs) in the absence of infectious organisms, 
suggesting that NKT TCRs can recognize CD1d plus endogenous lipids and thus play a role 
in autoimmunity or indirectly play a role in innate response to infections. Several studies have 
investigated the nature of the endogenous lipid antigen(s) presented by CD1d molecules in 
various immunological contexts. More than 170 lipid species, comprising 
glycerophospholipids and sphingolipids, have been identified from human CD1d monomers 
produced by the human B cell line 721.221 (Cox et al., 2009). Another study revealed that 
phosphatidylcholine, lysophospholipids, and sphingomyelin represent the main lipids 
associated with human CD1d molecules expressed in this cell line (Yuan et al., 2009). Several 
glycosphingolipids, including GM1a, GD1a, and GM2, are also found bound by mouse CD1d 
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expressed by myeloid APCs (Muindi et al., 2010). Finally, various molecular species of 
phosphatidylcholine with different fatty acid compositions are found loaded into mouse CD1d 
molecules produced by insect cells. These studies reveal the great diversity of self-lipids that 
can be found associated with CD1d molecules when produced in different systems 
The structures of several mouse and human NKT TCRs in complex with CD1d bound 
to the marine sponge-derived antigen α-galactosylceramide (α-GalCer) (Borg et al., 2007; 
Pellicci et al., 2009), α-GalCer analogs (Wun et al., 2011), or related microbial glycolipids 
(Li et al., 2010) have recently been solved. These structures show that NKT TCRs, regardless 
of their precise TCRβ sequence, dock similarly on CD1d. The location and details of the 
docking are quite different from those seen in the engagement of conventional TCRs to their 
MHC plus peptide ligands (Godfrey et al., 2008). A ‘‘hot spot’’ on the NKT TCR, composed 
only of germline encoded residues, is essential for recognition of CD1d plus several 
structurally diverse antigens, including isoglobotrihexosylceramide (iGb3), which has been 
proposed to be one of the self-antigens responsible for NKT cell autoreactivity (Zhou et al., 
2004). These studies also suggest that the diverse CDR3β loop can modulate and fine tune the 
interaction of NKT TCRs with CD1d-glycolipid antigen complexes (Mallevaey et al., 2009). 
In this thesis, TCR engagement with a well known a-GalCer glycolipid inside CD1d, in vivo 
demonstrated negative selection of NKT cells and also confirm the requirement for the 
involvement of CD1d. 
Early T cell development leads to at least five major outcomes, including thymocyte 
survival, allelic exclusion, migration into a new thymic microenvironment, TCR tuning of 
antigenic responsiveness and lineage commitment. The first outcome of positive selection is 
regulation of survival and cell death. Survival signals received by developing thymocytes 
during positive selection prevent programed cell death and allow the thymocytes to continue 
along their maturation pathway. The anti-apoptotic factor (Bcl-2) has been reported to 
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maintain DP thymocyte survival. Bcl-2 gene expression was found to be up-regulated during 
DP stage of conventional T cells (Linette et al., 1994) and these levels are maintained in post-
selection thymocytes (Mick et al., 2004). In our microarray data, Bcl-2 expression was 
relatively similar between DP T cells and DP NKT cells, but was differentially up-regulated 
by immature CD4 and DN NKT cells, suggesting these post-selection NKT cells need Bcl-2 
expression to survive.  
In wild type mice, the Vα14 and Jα18 gene segments are distally located in the TCRα 
gene and it has been shown that the Vα14-to-Jα18 re-arrangement requires an extended period 
at the DP stage to take place, and is dependent on the expression of a number of factors 
including Bcl-xL (a Bcl-2 homologue, encoded by Bcl2l1; Bezbradica et al., 2005; Egawa et 
al., 2005). In contrast, our microarray data showed that the anti-apoptotic factor Bcl2l1 was 
down-regulated across Transition 1 from immature DP T cells to immature DP NKT cells. 
The exact mechanism remains to be determined, however, one possible explanation is that the 
expression of the rearranged Vα14-Jα18 gene segments by transgenesis may have rendered 
the up regulation of Bcl2l1 unnecessary. 
The protein Programmed Cell Death 1 (PD-1) also plays an important role in 
thymocyte survival by controlling the threshold of positive selection in conventional T cells. 
The effects of the PD-1 deficiency on the thymocyte differentiation were examined at the 
clonal level on transgenic mice crossed between TCR-V8 and TCR-/ (H-Y and 2C) 
transgenic mice and PD-1-/- mice on neutral genetic backgrounds (Nishimura et al., 2000). It 
was reported that these mice exhibited a selective increase in the CD4+CD8+ population with 
little impact on other thymocyte subsets. The absence of PD-1 significantly facilitated the 
transition of thymocytes from DN to DP stage in the TCR transgenic lines as well as in RAG-
2-/- mice injected with anti-CD3 mAb, suggesting that PD-1 controls the threshold of 
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selection, probably by affecting the threshold of pre-TCR/CD3 complex–mediated signalling 
(Nishimura et al., 2000). In contrast, H-Y or 2C transgenic PD-1-/- mice with the positively 
selecting background revealed significantly reduced efficiency for the generation of CD8+ 
single positive cells bearing the transgenic TCR-/in spite of the increased DP population. 
The results collectively indicate that PD-1 negatively regulates the  selection and modulates 
the positive selection (Nishimura et al., 2000).  
In our microarray, Pd-1 gene expression levels were lowest on immature DP T cells, 
showing a 1.5 fold increase on DP NKT cells, but were 6 times higher in immature CD4 and 
DN NKT cells compared to immature DP NKT cells. This is in good agreement with previous 
studies, which found that PD-1 was not expressed on pre-selection DP thymocytes, but highly 
expressed on post-selection T cells (Nishimura et al., 1996; Mick et al., 2004). Consistent 
with studies mentioned above, our findings indicated an association between PD-1 expression 
and thymic selection of NKT cells.  
Allelic exclusion is the second outcome of early T cell development by which a 
product of single allele is selected for expression. Allelic exclusion of T cell receptor genes is 
regulated differently between the  and  chains (Gascoigne and Alam, 1999). For the  
chain, the presence of a productively rearranged  chain gene generally prevents further 
rearrangement of the other  chain genes, therefore, only one of the  chain loci is able to 
produce full-length, correctly rearranged  chain protein (Uematsu et al., 1988; Krimpenfort 
et al., 1989). In contrast, both alleles of the chain rearrange until a positively selectable 
heterodimer of TCR is formed and undergoes positive selection (Malissen et al., 1992), 
leading to Rag1/2-turnoff, which stops further rearrangement (Borgulya et al., 1992; Brandle 
et al., 1992; Petrie et al., 1993; Kouskoff et al., 1995). Thus, immature (TCRlow) DP 
thymocytes have the potential to produce two  chain messages and express dual TCR  
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chain proteins on the cell surface. Therefore, some T cells express two functionally 
rearranged and expressed  chains, but most express a single  chain on their cell surface 
(Alam et al., 1995; Boyd et al., 1998). It is reported that the number of peripheral T cells 
expressing two different  chains as part of two functional and independent TCRs vary 
widely from 5% to 15% in mice (Heath et al., 1995; Elliott and Altmann, 1995; Alam and 
Gascoigne, 1998; Corthay et al., 2001; Rybakin et al., 2014) and about 30% in human 
(Padovan et al., 1993). Cell surface expression of two  chains has also been detected in TCR 
transgenic mice (Heath and Miller, 1993; Hardardottir et al., 1995).  
In contrast, although mouse T cell clones frequently carry two in-frame 
Vrearrangements and express two mRNA species, they have not been found to express two 
cell surface  chains (Malissen et al., 1988; Kuida et al., 1991; Couez et al., 1991). In 
addition, Rybakin and colleagues indicated that transgenic mice bearing V3.2 and V2 
miniloci showed low frequency of cells in these transgenic mice that actually rearranged the  
chain miniloci (Rybakin et al., 2014). However, once expressed, both the V3.2 and V2 
containing  chains had a strong ability to be positively selected with either a rearranged V5 
containing transgene or the natural repertoire of TCR  chains, the authors reported the failure 
to find a distinct population of cells that expressed dual TCRs, even intracellularly.  
In our work, microarray analyses show the widespread down-regulation of non-
NKT cell TCR V genes in immature DP NKT cells. This finding likely provides further 
evidence of allelic exclusion of competing TCR V chains at the transcriptional level. 
The primary mechanism of -chain allelic exclusion described in literature is mediated at 
the protein level. During the DP stage of thymocyte development, both alleles of the  
chain gene rearrange until a positively selectable heterodimer is formed with the 
previously rearranged  chain. Positive selection ceases -chain rearrangement by 
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shutting off the Rag1 and Rag2 genes (Borgulya et al., 1992; Brandle et al., 1992; 
Kouskoff et al., 1995; Alam et al., 1995). A post-translational mechanism ensures that 
only one  chain is generally present on the cell surface of mature T cells (Alam and 
Gascoigne, 1998; Gascoigne and Alam, 1999, Rybakin et al., 2014). Different models 
have been proposed to explain the post-translational regulation of the  chain allelic 
exclusion (Niederberger et al., 2003). The simplest model proposed that allelic exclusion 
depended on the competition between two  chain proteins for a limiting supply of  
chain protein, when the TCR level on the cell surface increases during positive selection 
(Alam et al., 1995; Alam and Gascoigne, 1998; Gascoigne and Alam, 1999). In the second 
model, the CD3z chain (a component of the TCR-CD3 complex) might play an important 
role in phenotypic allelic exclusion of chain by stabilizing preformed  pairs and thus 
preferentially stabilizing the  combination with the highest interchain affinity available 
to the cell. In the selective retention model, it was indicated that the positively selected  
combination is maintained on the cell surface while the nonselected -chain is down-
regulated or retained within the cell by regulation of TCR degradation via ubiquitylation 
(Boyd et al., 1998). However, those models do not explain how the widespread down-
regulation of non-NKT cell TCR V genes occurs in immature DP NKT cells compared 
to immature DP T cells. The possibility is that the relatively early expression of V14 
stops further recombination of endogenous alleles so that they have a greater chance of 
not having generated a viable transcript. Therefore, the down-regulation of alpha chain 
families’ transcripts in DP NKT cells is likely the transcriptional evidence of allelic 
exclusion of competing TCR V chains in immature DP NKT cells at allele level. This 
finding was confirmed by the very low number (almost none) of immature DP NKT cells 
and mature NKT cells expressing other TCR  chains, such as TCR V2, V3.2 and 
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V8.3 accompanied with TCR V14-J18 chain. The proportion of immature DP NKT 
cells, as well as mature NKT cells expressing the tested TCR V chains, was significantly 
lower than immature DP T cells and mature T cells.  
Regulation of migration and adhesion is also a critical outcome of thymic selection. 
Following positive selection, there are two significant changes in thymocyte motility and 
localisation: thymocytes begin to migrate rapidly and they relocate to the thymic medulla 
(Akiyama et al., 2008; Bonito et al., 2013). Chemokine receptor signaling is the most 
important mechanism that enables thymocytes to enter the medulla and accumulate therein. 
Numerous studies have implicated CCR7 as a key chemokine receptor responsible for the 
accumulation of SP thymocytes within the medulla (Suzuki et al., 1999; Bleul and Boehm, 
2000; Ehrlich et al., 2009; Cowan et al., 2014). It is reported that SP thymocytes undergo in 
vitro chemotaxis toward CCR7 ligands, whereas CCR7 mediates chemotaxis of SP 
thymocytes from the cortex toward the medulla (Suzuki et al., 1999; Bleul and Boehm, 2000; 
Ehrlich et al., 2009). Overexpression of CCR7 leads to inappropriate translocation of DP 
thymocytes to the medulla (Kwan and Killeen, 2004), whereas lack of CCR7 or its ligands 
results in decreased accumulation of SP thymocytes within the medulla, impaired TCR 
signalling, negative selection and general autoimmunity (Davalos-Misslitz et al., 2007; 
Cowan et al., 2014).  
In our microarray data, we found a large number of changes in gene expression of 
chemokine receptors, which have been previously reported as being related to positive 
selection of conventional T cells (Campell et al., 1999; Mick et al., 2004; Huang et al., 2004; 
Kwan et al., 2004). For example, we observed increased expression of Ccr4 and Ccr7 upon 
selection. Ccr4 expression was slightly down-regulated by immature DP NKT cells compared 
to immature DP T cells but showed four times higher expression in immature CD4 and DN 
NKT cells compared to immature DP NKT. Ccr7 expression was equal between DP T cells 
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and DP NKT cells, but was increased almost nine fold in immature CD4 and DN NKT cells. 
This is concurrent with the role of Ccr7 in medulla migration and immigration from the 
thymus (Kwan and Killeen, 2004; Ueno et al., 2002).  
CCR4 also affects medullary entry, however, it is up-regulated first on postpositive 
selection CD69+ DP and CD69+ CD4 thymocytes, before the up-regulation of CCR7 at the SP 
stage (Suzuki et al., 1999; Cowan et al., 2014; Ki et al., 2014). In the absence of CCR4, 
thymocyte negative selection is impaired, which causes the accumulation of autoreactive 
naïve T cells in secondary lymphoid organs and autoimmunity ensues (Hu et al., 2015). In 
addition to promoting thymocyte chemokinesis and chemotaxis, chemokine receptors likely 
mediate efficient interactions of SP thymocytes with medullary APCs. Both CCR4 and CCR7 
have been shown to facilitate interactions of T cells with APCs in secondary lymphoid organs 
as well as interactions of SP thymocytes with medullary APCs (Tang and Cyster, 1999; 
Friedman et al., 2006, Hu et al., 2015).  
The fourth outcome of early T cell development is the tuning of T cell antigen 
receptor responsiveness, which allows immature thymocytes to be positively selected by 
complexes of self-peptide and MHC molecules (peptide-MHC) of lower affinity but prevents 
mature T cells from responding to similar complexes in the periphery. Negative selection 
prevents generalized T cell aggression towards healthy tissue, while preserving a naïve T cell 
repertoire available to produce T cell responses against foreign peptide-MHC when they are 
summoned to fight infection or malignant cell transformation (Palmer, 2003, Fu et al., 2014). 
This task is fulfilled only when the survival during thymic development of immature T cells 
to recognize self peptide-MHC with low-to-moderate strength in a process termed positive 
selection is ensured. Positive selection generally precedes negative selection in the thymus, 
signaling survival of the positively selected thymocytes enables these cells to distinguish 
foreign antigen in the context of their own self-MHC (i.e., MHC restriction).  
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CD5, a monomeric cell surface glycoprotein expressed on thymocytes, T cells, and a 
subset of B cells, has been shown to negatively modulate signaling through both the B and T 
cell antigen receptors (Tarakhovsky et al., 1995, Bikah et al., 1996). Although the precise 
mechanism by which CD5 inhibits TCR signaling has not been elucidated, it is reported that 
after TCR engagement, CD5 is tyrosine-phosphorylated and associates with several effector 
molecules that could potentially influence the TCR signaling response, including Cbl, 
rasGAP, SHP-1, casein kinase 2, and TCR-ζ/ZAP-70 (Davies et al., 1992; Pani et al., 1996; 
Gary-Gouy et al., 1997; Raman et al., 1998; Dennehy et al., 1998). CD5 deficiency in wild-
type mice has no obvious effects on T cell development (Tarakhovsky et al., 1994). However, 
the analysis of thymocytes expressing a transgenic αβTCR revealed that thymocyte selection 
was dramatically affected in mice lacking CD5 (Tarakhovsky et al., 1995, Pena-Rossi et al., 
1999). The decrease in DP thymocyte numbers in TCR transgenic/CD5-/- mice compared to 
TCR transgenic and CD5+/+ mice is suggestive of enhanced TCR signaling. However, the 
impact of CD5 deletion on thymocyte selection varies depending on the transgenic TCR 
analyzed, ranging from a mild to a significant shift from positive toward negative selection. 
CD5 surface expression is regulated by TCR signal intensity during development. CD5 
surface expression levels on mature thymocytes and T cells parallel the avidity of the 
positively selecting TCR/MHC/ligand interaction. In another study, Azzam and colleagues 
manipulated CD5 expression in mutant mice during thymocyte development to examine the 
effect of CD5 overexpression or CD5 deletion on selection of thymocytes that express TCR 
transgenes (Azzam et al., 2001). Their findings revealed that the impact of altering CD5 
expression on thymic selection depends on the avidity of the selecting interaction and, 
subsequently, the level of endogenous CD5 surface expression. Substitution of endogenous 
CD5 with a transgene encoding a truncated form of the protein failed to rescue the CD5-/- 
phenotype, which demonstrated that the cytoplasmic domain of CD5 is required for its 
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inhibitory function. Together, these results indicate that inducible regulation of CD5 surface 
levels during thymocyte selection functions to fine tune the TCR signaling response.  
Previous findings in conventional T cells indicated that TCR tuning at the proximal 
stage of conventional T cells requires up-regulation of Cbl-b and CD5-associated Shp-1 to 
block Vav activation (Sprent and Surh, 2011). In this case, CD5 acts as a negative modulator 
of TCR signalling due to the preferential shift from positive to negative selection in CD5-
deficient mice (Azzam et al., 2001). In our microarray data, it was reported that Cd5, Btla and 
Cbl-b expression was increased by positive selection of NKT cells. Cd5 expression was up-
regulated by positively selected (immature CD4 and DN) NKT cells. A 6.2 fold higher in 
expression of Btla (encoding B and T lymphocyte-associated gene; Han et al., 2004) and a 2.5 
fold greater expression of Cbl-b was also found on these post-selection NKT cell populations 
compared to the two pre-selection populations (immature DP T and immature DP NKT cells). 
Taken together, these data suggest that the changes in Cd5, Btla and Cbl-b levels might relate 
to TCR tuning processes during NKT cell development  
The commitment to the NKT lineage, as well as other lineages of innate-like 
lymphocytes is associated with the expression of Promyelocytic Leukemia Zinc Finger 
(PLZF, encoded by Zbtb16; Savage et al., 2008), and T-bet (encoded by Tbx21; Townsend et 
al., 2004). Our microarray data indicated that there was no significant difference in expression 
of Zbtb16 between immature DP NKT cells and immature DP conventional thymocytes, but 
there was a more than 13-fold up-regulation across Transition 2, consistent with lineage 
commitment occurring at this point. Tbx21 was significantly, but only slightly higher 
expressed in immature DP NKT cells compared to immature DP conventional thymocytes. In 
contrast, the immature CD4 NKT cells showed reduced expression of Tbx21. This slight 
increase in the expression of Tbx21 in immature DP NKT cells suggests a possibility for an 
earlier commencement of lineage commitment. 
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 In 2012, Cohen et al. reported gene expression profiles of CD44-NK1.1- iNKT cells at 
stage 1 (shortly after the DP branch point). Of the top 100 genes, they found differentially up-
regulated by the stage 1 NKT cells compared to DP thymocytes, 41 genes were in our top 100 
gene list which were highly significantly up-regulated by immature CD4 NKT cells compared 
to immature DP NKT cells (p<0.05) and another forty-three genes also had significantly 
increased expression (p<0.05; Supplementary Table 5.5). These datasets are comparable in 
terms of addressing changes during positive selection of NKT cells and the results provide 
evidence that our iNKT cell transgenic mouse strain is a valid model for early NKT cell 
development study. 
In conclusion, the data presented in this work provided, for the first time, an overall 
transcriptional profile during TCR validation, positive selection and lineage commitment of 
NKT cells. These findings have further confirmed phenotypic changes during NKT cell 
development observed by previous studies and suggest that immature DP NKT cells are pre-
selection progenitors of NKT cells. Our data also offer a new view of gene-expression 
programs at early stage of NKT cells through a large number of novel gene changes observed 
during positive selection of NKT cells. The transcriptional analyses in this chapter indicated 
that TCR validation occurs prior to positive selection in NKT cells. Our transcriptional 
regulatory network approach mapped TCR validation to the transition from DP T to DP NKT 
cells, while positive selection and lineage commitment were associated with the transition 
from DP NKT to CD4 NKT. This is the first time that the effects of positive and negative 
selection have been examined on their actual population – the immature DP NKT cells. Here 
we confirm by in vivo experimentation that both positive and negative selection occur at the 
latter transition, separating for the first time in any T cell population the events associated 
with TCR validation from those associated with positive selection. NOD.V14Tg mice 
provide an opportunity to study the earliest identifiable stages of NKT cell commitment and 
differentiation, and will help dissect factors controlling the numbers and function of this 
important immunoregulatory population. 
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Table S-1: List of genes that are overlapped between our research and Cohen et al. 
data 
 
CD44-NK1.1-NKT cells/  
DP Thymocytes 
(Cohen et al., 2012) 
Gene 
# 
CD4 NKT cells/DP NKT cells 
(from this research) 
Gene Symbol FC p-value Gene Symbol FC p-value 
9930111J21Rik  9.20 0.00036 1 9930111J21Rik2 7.60 2.57E-13 
Adh1  8.54 0.00819 2 Adh1 7.02 1.72E-13 
Art2b  29.40 0.01128 3 Art2b 50.93 1.15E-15 
Atp8b4 17.12 0.00000 4 Atp8b4 8.09 1.79E-14 
Ccr2 8.13 0.00780 5 Ccr2 10.95 4.06E-13 
Ccr8  9.97 0.00011 6 Ccr8 11.67 3.14E-12 
Cd226  11.99 0.00001 7 Cd226 9.19 6.47E-16 
Cd40lg  8.86 0.00202 8 Cd40lg 10.83 4.74E-12 
Cd53  15.33 0.00064 9 Cd53 9.70 3.09E-15 
Cd7  10.33 0.00578 10 Cd7 16.95 1.70E-13 
Chn2  31.51 0.00039 11 Chn2 18.82 9.39E-16 
Ctsw  10.20 0.00343 12 Ctsw 11.31 1.31E-15 
Cxcr6  12.37 0.00829 13 Cxcr6 12.76 8.51E-14 
Ephx1  14.52 0.00001 14 Ephx1 9.08 4.89E-13 
Fam129a  23.81 0.00025 15 Fam129a 11.79 8.17E-13 
Folr4  11.21 0.00046 16 Folr4 14.52 8.94E-15 
Gimap4  25.98 0.00011 17 Gimap4 12.62 1.03E-14 
Gm4759  16.22 0.00086 18 Gm4759 7.37 1.05E-11 
Gm8995  21.81 0.00004 19 Gm8995 8.55 6.93E-14 
Id2  33.65 0.00060 20 Id2 6.21 4.34E-12 
Igfbp4  10.29 0.01018 21 Igfbp4 27.77 1.72E-16 
Il2rb  21.41 0.00498 22 Il2rb 37.79 3.20E-15 
Il7r  45.14 0.00003 23 Il7r 34.76 5.43E-14 
Ipcef1  11.31 0.00000 24 Ipcef1 6.23 1.13E-11 
Itgae  17.37 0.00028 25 Itgae 6.74 2.16E-12 
Itgb3  7.22 0.00003 26 Itgb3 12.80 1.06E-13 
Lfng  7.06 0.00003 27 Lfng 11.11 6.36E-15 
Ly6a  43.88 0.00027 28 Ly6a 55.80 4.00E-15 
Nrgn  8.99 0.00950 29 Nrgn 11.56 3.41E-12 
Nt5e  18.56 0.00122 30 Nt5e 7.24 5.87E-12 
Oasl2  6.71 0.00108 31 Oasl2 7.53 6.66E-13 
Parp8  9.15 0.00211 32 Parp8 11.40 7.93E-15 
Pdcd1  11.94 0.00046 33 Pdcd1 6.41 3.37E-14 
Plac8  14.48 0.02293 34 Plac8 11.54 2.03E-13 
S1pr1  10.02 0.00683 35 S1pr1 23.08 2.07E-15 
Sema4a  9.14 0.00003 36 Sema4a 11.31 2.10E-13 
Slfn1  13.15 0.00218 37 Slfn1 8.97 1.29E-11 
Smpdl3a 21.13 0.00886 38 Smpdl3a 7.31 2.75E-14 
St8sia6  8.38 0.00121 39 St8sia6 7.03 3.48E-11 
Tagap  11.45 0.04544 40 Tagap 8.38 1.20E-12 
Zbtb16  37.64 0.00016 41 Zbtb16 14.07 2.62E-14 
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Figure S-1. Expression profiles of 41 genes that overlap with Cohen’s data 
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Table S-2: Genes were found in Cohen’s top 100 up-regulated gene list and also 
significantly increased expression in our microarray analysis of immature CD4 NKT 
cells compared to DP NKT cells. 
 
CD44-NK1.1-NKT cells/ 
DP Thymocytes 
(Cohen et al., 2012) Gene # 
CD4NKT cells/DPNKT cells 
(from this research) 
Gene 
Symbol 
FC p-value 
Gene 
Symbol 
FC p-value 
Icos  32.42 0.00000 1 Icos 4.96 5.47E-10 
Il18r1  25.02 0.00097 2 Il18r1 2.57 8.91E-10 
Ifi30  18.08 0.00060 3 Ifi30 1.8 4.17E-08 
Capg  14.72 0.00835 4 Capg 2.57 7.74E-09 
Inpp4b  13.14 0.00000 5 Inpp4b 5.6 2.37E-15 
Myo1e  11.48 0.00775 6 Myo1e 5.08 8.04E-12 
Rbpms  11.46 0.00034 7 Rbpms 4.82 4.00E-11 
Fam134b  11.15 0.00006 8 Fam134b 4.81 4.01E-13 
Pde3b  10.96 0.00006 9 Pde3b 4.17 7.76E-11 
Akr1c18  10.63 0.06761 10 Akr1c18 1.47 8.63E-08 
Gm1966  10.37 0.00073 11 Gm1966 4.95 1.16E-11 
Rexo2 10.18 0.00096 12 Rexo2 2.33 2.78E-11 
Endod1  9.72 0.00754 13 Endod1 5.61 3.30E-10 
Cd9  9.5 0.00453 14 Cd9 2.44 3.36E-08 
Gm5068  9.17 0.00004 15 Gm5068 1.91 1.68E-05 
Rtp4  8.58 0.00107 16 Rtp4 4.6 4.15E-10 
Adam19  8.53 0.00002 17 Adam19 2.43 5.91E-09 
Gm4955 8.45 0.00207 18 Gm4955 2.52 9.94E-08 
S100a6  8.22 0.00926 19 S100a6 2.16 1.78E-08 
Gpr65  8.1 0.00035 20 Gpr65 4.02 5.23E-11 
Ndfip1  8.1 0.00005 21 Ndfip1 2.31 2.80E-13 
Il4  7.95 0.03278 22 Il4 1.24 4.49E-05 
Gm5921  7.88 0.00413 23 Gm5921 1.14 0.036846 
Plekha1  7.84 0.00468 24 Plekha1 2.78 1.29E-08 
Srgn  7.79 0.00001 25 Srgn 1.38 3.62E-07 
B2m  7.73 0.00210 26 B2m 1.35 1.73E-07 
Trpm6  7.69 0.00074 27 Trpm6 1.32 1.59E-06 
Il17rb  7.61 0.00042 28 Il17rb 1.17 0.004988 
Irgm1  7.6 0.00047 29 Irgm1 2.71 8.94E-11 
Ass1  7.56 0.00404 30 Ass1 1.32 9.26E-07 
Gramd1b  7.54 0.00004 31 Gramd1b 4.6 1.27E-11 
Lgmn  7.52 0.00945 32 Lgmn 3.23 3.20E-10 
Ubash3b  7.37 0.00029 33 Ubash3b 3.98 9.81E-14 
Ddx60  7.31 0.00031 34 Ddx60 5.04 6.37E-11 
Cd82  7.26 0.00137 35 Cd82 2.5 1.39E-14 
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Ugcg  6.98 0.00002 36 Ugcg 1.22 0.000359 
Tmem64  6.88 0.01191 37 Tmem64 2.01 1.70E-08 
Cnn2  6.85 0.00005 38 Cnn2 2.87 2.13E-12 
Mapre2  6.8 0.00010 39 Mapre2 2.17 5.53E-09 
Cap2  6.74 0.00736 40 Cap2 3.55 1.45E-11 
Tmem173 7.02 0.00397 41 Tmem173 4.11 1.12E-11 
Stk39  7.03 0.01051 42 Stk39 5.5 4.67E-12 
Ttc39b  7.14 0.00400 43 Ttc39b 2.11 7.36E-11 
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BUFFER FOR CELL SUSPENSION PREPARATION AND FLOW CYTOMETRY  
MACS Buffer  
500 ml of 1X DPBS 
5% (v/v) Bovine Serum 
2mM EDTA 
Mix well. Stored at 4°C  
 
DNA EXTRACTION BUFFERS:  
Digest Buffer  
Stock Final Add 
1M Tris pH8.0 100 mM 10 ml 
0.5M EDTA 5 mM 1 ml 
10% SDS 0.2% 2 ml 
5M NaCl 200mM 4 ml 
dH2O Up to 100 ml 84 ml 
 
 
Proteinase-K  
Final Add  
100mM 10ml 5mM 1ml 0.2% 2ml 200mM 4ml upto 100ml 84ml  
10mg dissolved in 1ml d H2O. Store at -20°C in aliquots. 
1. Add 500l digest buffer to approx. 1cm of tail in an eppendorf tube.  
2. Add 10l [10mg/ml] proteinase-K. 
3. Incubate tails 56°C at least 3hrs (or O/N).  
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BUFFERS FOR GEL ELECTROPHORESIS  
 
50X TAE Buffer (Tris-Acetate-EDTA)  
242 g   Tris base 
57.1 ml  Glacial Acetic acid 
100ml   0.5M EDTA 
DI H2O to 1 liter 
1. Weigh out 242 g Tris base (FW=121.14) and dissolve in 750 mL deionized water.  
2. Carefully add 57.1 ml glacial acetic acid and 100 mL of 0.5 M EDTA (pH 8.0) and adjust 
the solution to a final volume of 1 L.  
3. This stock solution can be stored at room temperature. The pH of this buffer is not adjusted 
and should be about 8.5.  
 
1X TAE Buffer (working solution)  
The working solution of 1X TAE buffer is made by simply diluting the stock solution by 50x 
in deionized water. Final solute concentrations are 40mM Tris acetate and 1mM EDTA. The 
buffer is now ready for use in agarose gel electrophoresis.  
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Annual Meeting of the Australian Society for Immunology, 2012, Melbourne  (Poster) 
Townsville festival of life sciences, 2013, 2014 and 2015 (Poster).  
Annual Meeting of the Australian Society for Immunology, 2013, Wellington, (Poster) 
Annual Meeting of the Australian Society for Immunology, 2014, Wollongong, (Poster) 
Brisbane Immunology Group 15th Annual Retreat, 2014, Gold Coast (Poster) 
6th Congress of FIMSA, 2015, Singapore (Talk) 
Annual Meeting of the Australian Society for Immunology, 2015, Canberra, (Poster) 
 
Primary publications  
TCR validation distinct from selection and lineage commitment in NKT cells. Xuyen T Dinh, 
Margaret A Jordan, Dragana Stanley, Morgane Moreau, Stuart Berzins, Adrian Gemiarto, and 
Alan G Baxter. (manuscript under preparation: Journal of Nature Immunology)  
Other publications  
MicroRNA-146a regulates ICOS–ICOSL signalling to limit accumulation of T follicular 
helper cells and germinal centres  Alvin Pratama, Monika Srivastava, Naomi J. Williams, 
Ilenia Papa, Sau K. Lee, Xuyen T. Dinh, Andreas Hutloff, Margaret A. Jordan, Jimmy L. 
Zhao, Rafael Casellas, Vicki Athanasopoulos & Carola G. Vinuesa. Nature communication 
6:6436. DOI: 10.1038/ncomms7436. 
Biological processing of dinuclear ruthenium complexes in eukaryotic cells. Xin Li, Kirsten 
Heimann, Xuyen Thi Dinh, F. Richard Keene and J. Grant Collins. Mol. BioSyst. 2016, 12, 
3032-3045. DOI: 10.1039/C6MB00431H. 
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Australian Development Scholarship: Doctor of Philosophy at JCU  
Robert Logan memorial grant: FIMSA conference, Singapore, 2015. 
FIMSA travel Bursary: FIMSA/IIS Advanced Immunology course, Singapore, 2015.  
ASI conference travel award: Annual Meeting of ASI, Canberra, 2015.  
